|
4.5.2018 |
SK |
Úradný vestník Európskej únie |
L 115/1 |
NARIADENIE KOMISIE (EÚ) 2018/669
zo 16. apríla 2018,
ktorým sa na účely prispôsobenia technickému a vedeckému pokroku mení nariadenie Európskeho parlamentu a Rady (ES) č. 1272/2008 o klasifikácii, označovaní a balení látok a zmesí
(Text s významom pre EHP)
EURÓPSKA KOMISIA,
so zreteľom na Zmluvu o fungovaní Európskej únie,
so zreteľom na nariadenie Európskeho parlamentu a Rady (ES) č. 1272/2008 zo 16. decembra 2008 o klasifikácii, označovaní a balení látok a zmesí, o zmene, doplnení a zrušení smerníc 67/548/EHS a 1999/45/ES a o zmene a doplnení nariadenia (ES) č. 1907/2006 (1), a najmä na jeho článok 53 ods. 1,
keďže:
|
(1) |
Tabuľky 3.1 a 3.2 v prílohe VI k nariadeniu (ES) č. 1272/2008 obsahujú zoznam harmonizovanej klasifikácie a označovania nebezpečných látok, ktorý je však vo všetkých jazykových zneniach uvedeného nariadenia len v angličtine. |
|
(2) |
Dňa 2. decembra 2008 (2) sa Komisia zaviazala zabezpečiť, aby chemické názvy zodpovedajúce medzinárodnej identifikácii chemických látok uvedenej v tabuľkách 3.1 a 3.2 v prílohe VI k nariadeniu (ES) č. 1272/2008 boli uverejnené v rovnakom jazyku ako jazykové znenia, v ktorých bolo uverejnené uvedené nariadenie. |
|
(3) |
Tabuľka 3.1 v prílohe VI k nariadeniu (ES) č. 1272/2008 bola niekoľkokrát zmenená, aby sa zohľadnil technický a vedecký pokrok, a to doplnením, vypustením alebo zmenou látok alebo ich klasifikácie. S cieľom zohľadniť tieto zmeny a zabezpečiť, aby všetky chemické názvy v tabuľke 3.1 v prílohe VI k nariadeniu (ES) č. 1272/2008 boli v rovnakom jazyku ako jazykové znenia, v ktorých bolo uvedené nariadenie uverejnené, treba tabuľku 3.1 čiastočne nahradiť. |
|
(4) |
Vzhľadom na výnimku (3) týkajúcu sa prekladu aktov, ktoré neprijímajú spoločne Európsky parlament a Rada, do írčiny, by sa chemické názvy v tabuľke 3.1 v prílohe VI nemali prekladať do írčiny. |
|
(5) |
V tabuľke 3.2 sa uvádza zoznam harmonizovanej klasifikácie a označovania nebezpečných látok na základe kritérií stanovených v prílohe VI k smernici Rady 67/548/EHS (4), ktorá bola zrušená s účinnosťou od 1. júna 2015. V dôsledku toho treba tabuľku 3.2 vypustiť v súlade s článkom 1 ods. 2 nariadenia Komisie (EÚ) 2016/1179 (5) s účinnosťou od 1. júna 2017. Uvedenú tabuľku preto netreba meniť. V dôsledku toho treba tabuľku 3.1 premenovať na tabuľku 3 v súlade s článkom 2 ods. 2 nariadenia Komisie (EÚ) 2017/776 (6) s účinnosťou od 1. júna 2017. |
|
(6) |
Dodávatelia by mali mať dostatočný čas na to, aby prispôsobili označovanie a balenie látok a zmesí novým ustanoveniam týkajúcim sa prekladu a aby dopredali existujúce zásoby. |
|
(7) |
Dodávatelia by mali mať možnosť uplatňovať toto nariadenie pred dátumom jeho uplatňovania, aby sa zabezpečila vysoká úroveň ochrany ľudského zdravia a životného prostredia a aby sa dodávateľom poskytla dostatočná flexibilita. |
|
(8) |
Opatrenia uvedené v tomto nariadení sú v súlade so stanoviskom výboru zriadeného na základe článku 133 nariadenia Európskeho parlamentu a Rady (ES) č. 1907/2006 (7), |
PRIJALA TOTO NARIADENIE:
Článok 1
Položky uvedené v prílohe VI k nariadeniu (ES) č. 1272/2008 a zodpovedajúce položkám uvedeným v prílohe k tomuto nariadeniu sa nahrádzajú položkami uvedenými v prílohe k tomuto nariadeniu.
Článok 2
Toto nariadenie nadobúda účinnosť dvadsiatym dňom po jeho uverejnení v Úradnom vestníku Európskej únie.
Uplatňuje sa od 1. decembra 2019.
Odchylne od druhého pododseku sa môžu látky a zmesi pred 1. decembrom 2019 klasifikovať, označovať a baliť v súlade s nariadením (ES) č. 1272/2008 zmeneným týmto nariadením.
Toto nariadenie je záväzné v celom rozsahu a priamo uplatniteľné vo všetkých členských štátoch.
V Bruseli 16. apríla 2018
Za Komisiu
predseda
Jean-Claude JUNCKER
(1) Ú. v. EÚ L 353, 31.12.2008, s. 1.
(2) Korigendum k pozícii Európskeho parlamentu prijatej v prvom čítaní 3. septembra 2008 na účely prijatia nariadenia Európskeho parlamentu a Rady (ES) č. 1272/2008 o klasifikácii, označovaní a balení látok a zmesí, o zmene, doplnení a zrušení smerníc 67/548/EHS a 1999/45/ES a o zmene a doplnení nariadenia (ES) č. 1907/2006 – P6_TA(2008)0392 [KOM(2007) 0355 – C6-0197/2007 – 2007/0121(COD)].
(3) Nariadenie Rady (EÚ) č. 1257/2010 z 20. decembra 2010, ktorým sa predlžujú dočasné výnimky z nariadenia č. 1 z 15. apríla 1958 o používaní jazykov v Európskom hospodárskom spoločenstve a nariadenia č. 1 z 15. apríla 1958, ktorým sa určujú jazyky používané Európskym spoločenstvom pre atómovú energiu, zavedené nariadením (ES) č. 920/2005 (Ú. v. EÚ L 343, 29.12.2010, s. 5).
(4) Smernica Rady 67/548/EHS z 27. júna 1967 o aproximácii zákonov, iných právnych predpisov a správnych opatrení týkajúcich sa klasifikácie, balenia a označovania nebezpečných látok (Ú. v. ES L 196, 16.8.1967, s. 1).
(5) Nariadenie Komisie (EÚ) 2016/1179 z 19. júla 2016, ktorým sa na účely prispôsobenia technickému a vedeckému pokroku mení nariadenie Európskeho parlamentu a Rady (ES) č. 1272/2008 o klasifikácii, označovaní a balení látok a zmesí (Ú. v. EÚ L 195, 20.7.2016, s. 11) .
(6) Nariadenie Komisie (EÚ) 2017/776 zo 4. mája 2017, ktorým sa na účely prispôsobenia technickému a vedeckému pokroku mení nariadenie Európskeho parlamentu a Rady (ES) č. 1272/2008 o klasifikácii, označovaní a balení látok a zmesí (Ú. v. EÚ L 116, 5.5.2017, s. 1).
(7) Nariadenie Európskeho parlamentu a Rady (ES) č. 1907/2006 z 18. decembra 2006 o registrácii, hodnotení, autorizácii a obmedzovaní chemikálií (REACH) a o zriadení Európskej chemickej agentúry, o zmene a doplnení smernice 1999/45/ES a o zrušení nariadenia Rady (EHS) č. 793/93 a nariadenia Komisie (ES) č. 1488/94, smernice Rady 76/769/EHS a smerníc Komisie 91/155/EHS, 93/67/EHS, 93/105/ES a 2000/21/ES (Ú. v. EÚ L 396, 30.12.2006, s. 1).
PRÍLOHA
|
Indexové číslo |
Medzinárodná identifikácia látok |
Číslo ES |
Číslo CAS |
Klasifikácia |
Označovanie |
Špecifické koncentračné limity, M-faktory |
Poznámky |
|||
|
Kódy tried a kategórií nebezpečnosti |
Kódy výstražných upozornení |
Kódy piktogramov a výstražných slov |
Kódy výstražných upozornení |
Kódy ďalších výstražných upozornení |
||||||
|
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
(7) |
(8) |
(9) |
(10) |
(11) |
|
001-001-00-9 |
vodík |
215-605-7 |
1333-74-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
001-002-00-4 |
tetrahydridohlinitan lítny |
240-877-9 |
16853-85-3 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
|
|
|
|
001-003-00-X |
hydrid sodný |
231-587-3 |
7646-69-7 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
001-004-00-5 |
hydrid vápenatý |
232-189-2 |
7789-78-8 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
003-001-00-4 |
lítium |
231-102-5 |
7439-93-2 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
003-002-00-X |
hexyllítium |
404-950-0 |
21369-64-2 |
Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
003-003-00-5 |
2-metylpropyllítium; izobutyllítium |
440-620-2 |
920-36-5 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H314 H336 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H260 H250 H314 H336 H410 |
EUH014 |
|
|
|
004-001-00-7 |
berýlium |
231-150-7 |
7440-41-7 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
|
004-002-00-2 |
zlúčeniny berýlia okrem kremičitanov berylnato-hlinitých a tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
|
|
A |
|
004-003-00-8 |
oxid berylnatý |
215-133-1 |
1304-56-9 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
|
005-001-00-X |
fluorid boritý |
231-569-5 |
7637-07-2 |
Press. Gas Acute Tox. 2 * Skin Corr. 1A |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
EUH014 |
|
U |
|
005-002-00-5 |
chlorid boritý |
233-658-4 |
10294-34-5 |
Press. Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B |
H330 H300 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
U |
|
005-003-00-0 |
bromid boritý |
233-657-9 |
10294-33-4 |
Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A |
H330 H300 H314 |
GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
|
|
005-004-00-6 |
trialkylborány, v tuhom skupenstve |
— |
— |
Pyr. Sol. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-004-01-3 |
trialkylborány, kvapalné |
— |
— |
Pyr. Liq. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-005-00-1 |
trimetyl-borát |
204-468-9 |
121-43-7 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H312 |
GHS02 GHS07 Wng |
H226 H312 |
|
|
|
|
005-006-00-7 |
hydrogenboritan dibutylciničitý |
401-040-5 |
75113-37-0 |
Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H341 H372** H312 H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H360FD H341 H372** H312 H302 H318 H317 H410 |
|
|
|
|
005-007-00-2 |
kyselina boritá; [1] kyselina boritá; [2] |
233-139-2 [1] 234-343-4 [2] |
10043-35-3 [1] 11113-50-1 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD: C ≥ 5,5 % |
|
|
005-008-00-8 |
oxid boritý; oxid boritý |
215-125-8 |
1303-86-2 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD:C ≥ 3,1 % |
|
|
005-009-00-3 |
tetrabutylamónium-butyltri(fenyl)boranuid |
418-080-4 |
120307-06-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
005-010-00-9 |
N, N-dimetylanilínium-tetrakis(pentafluórfenyl)boranuid |
422-050-6 |
118612-00-3 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H351 H302 H315 H318 |
|
|
|
|
005-011-00-4 |
bezvodý tetraboritan disodný; kyselina boritá, disodná soľ [1] hydrát tetraboritanu disodného; [2] sodná soľ kyseliny trihydrogenboritej [3] |
215-540-4 [1] 235-541-3 [2] 237-560-2 [3] |
1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr. 1B; H360FD: C ≥4,5 % |
|
|
005-011-01-1 |
dekahydrát tetraboritanu disodného; bórax dekahydrát |
215-540-4 |
1303-96-4 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD: C ≥ 8,5 % |
|
|
005-011-02-9 |
pentahydrát tetraboritanu disodného; bórax pentahydrát |
215-540-4 |
12179-04-3 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.B; H360FD: C ≥ 6,5 % |
|
|
005-012-00-X |
(dietyl{4-[1,5,5-tris(4-dietylaminofenyl)penta-2,4-dienylidén]cyklohexa-2,5-dienylidén}amónium)-butyltri(fenyl)boranuid |
418-070-1 |
141714-54-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
005-013-00-5 |
dietyl(metoxy)borán |
425-380-9 |
7397-46-8 |
Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H250 H332 H312 H302 H373** H314 H317 H413 |
|
|
|
|
005-014-00-0 |
kyselina 4-formylfenylborónová |
438-670-5 |
87199-17-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
005-015-00-6 |
1-fluór-4-(chlórmetyl)-1,4-diazóniabicyklo[2.2.2]oktán-bis(tetrafluórborát) |
414-380-4 |
140681-55-6 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
|
005-016-00-1 |
tetrabutylamónium-(butoxy)tris(4-terc-butylfenyl)boranuid |
431-370-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
005-017-00-7 |
tetrahydrogentetraoxodiperoxodiboritan disodný; [1] oxoperoxoboritan monosodný; [2] peroxoboritan sodný; [s obsahom < 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr.1B; H360Df: C ≥9% Repr.1B; H360 D: 6,5 % ≤ C <9% Eye Dam. 1; H318: C ≥ 22% Eye Irrit. 2; H319: 14% ≤ C < 22 % |
|
|
005-017-01-4 |
tetrahydrogentetraoxodiperoxodiboritan disodný; [1] oxoperoxoboritan monosodný; [2] peroxoboritan sodný; [s obsahom ≥ 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥9% Repr. 1B; H360D: 6,5 % ≤ C < 9% Eye Dam. 1; H318: C ≥ 22% Eye Irrit. 2; H319: 14% ≤ C < 22% |
|
|
005-018-00-2 |
trihydrát monosodnej soli kyseliny trihydrogendioxodiperoxoboritej (H3BO2(O2)); [1] [1] tetrahydrát oxoperoxoboritanu monosodného; [2] [2] tetrahydrát sodnej soli kyseliny hydrogenoxoperoxoboritej (HBO(O2)); [3] hexahydrát peroxoboritanu sodného; [s obsahom < 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B STOT SE 3 Eye Dam. 1 |
H360Df H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H335 H318 |
|
Repr. 1B; H360Df: C ≥ 14% Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36% Eye Irrit. 2; H319: 22% ≤ C < 36% |
|
|
005-018-01-X |
trihydrát monosodnej soli kyseliny trihydrogendioxodiperoxoboritej (H3BO2(O2)); [1] tetrahydrát oxoperoxoboritanu monosodného; [2] [2] tetrahydrát sodnej soli kyseliny hydrogenoxoperoxoboritej (HBO(O2)); [3] hexahydrát peroxoboritanu sodného; [s obsahom ≥ 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H360Df H332 H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H332 H335 H318 |
|
Repr. 1B; H360 Df: C ≥ 14% Repr. 1B; H360D: 10% ≤ C < 14% Eye Dam. 1; H318: C ≥ 36% Eye Irrit. 2; H319: 22% ≤ C < 36% |
|
|
005-019-00-8 |
sodná soľ kyseliny trihydrogendioxodiperoxoboritej; [1] monohydrát sodnej soli kyseliny trihydrogendioxodiperoxoboritej; [2] monohydrát sodnej soli kyseliny hydrogenoxoperoxoboritej (HBO(O2)); [3] peroxoboritan sodný; [s obsahom < 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9% Repr. 1B; H360D: 6,5 % ≤ C < 9% Eye Dam. 1; H318: C ≥ 22% Eye Irrit. 2; H319: 14% ≤ C < 22% |
|
|
005-019-01-5 |
sodná soľ kyseliny trihydrogendioxodiperoxoboritej; [1] monohydrát sodnej soli kyseliny trihydrogendioxodiperoxoboritej; [2] monohydrát sodnej soli kyseliny hydrogenoxoperoxoboritej (HBO(O2)); [3] peroxoboritan sodný; [s obsahom ≥ 0,1 hmotn. % častíc s aerodynamickým priemerom menším ako 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9% Repr. 1B; H360D: 6,5 % ≤ C < 9% Eye Dam. 1; H318: C ≥ 22% Eye Irrit. 2; H319: 14% ≤ C < 22% |
|
|
006-001-00-2 |
oxid uhoľnatý |
211-128-3 |
630-08-0 |
Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 * STOT RE 1 |
H220 H360D *** H331 H372 ** |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H360D *** H331 H372 ** |
|
|
U |
|
006-002-00-8 |
fosgén; dichlorid-oxid uhličtý |
200-870-3 |
75-44-5 |
Press. Gas Acute Tox. 2 * Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
|
|
U |
|
006-003-00-3 |
sulfid uhličitý |
200-843-6 |
75-15-0 |
Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372 ** H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H361fd H372 ** H319 H315 |
|
Repr. 2; H361fd: C ≥ 1% STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,2 % ≤ C < 1% |
|
|
006-004-00-9 |
karbid vápenatý |
200-848-3 |
75-20-7 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
T |
|
006-005-00-4 |
tirám (ISO); bis(dimetyltiokarbamoyl)disulfán |
205-286-2 |
137-26-8 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H332 H302 H373 ** H319 H315 H317 H410 |
|
M = 10 |
|
|
006-006-00-X |
kyanovodík; kyselina kyanovodíková |
200-821-6 |
74-90-8 |
Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H330 H410 |
|
|
|
|
006-006-01-7 |
kyanovodík … %; kyselina kyanovodíková … % |
200-821-6 |
74-90-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
B |
|
006-007-00-5 |
soli kyanovodíka okrem komplexných kyanidov, ako sú hexakyanoželeznatany, hexakyanoželezitany a dikyanid-oxid ortuťnatý a tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
EUH032 |
|
A |
|
006-008-00-0 |
antu (ISO); 1-(1-naftyl)tiomočovina |
201-706-3 |
86-88-4 |
Acute Tox. 2 * Carc. 2 |
H300 H351 |
GHS06 GHS08 Dgr |
H300 H351 |
|
|
|
|
006-009-00-6 |
(1-izopropyl-3-metylpyrazol-5-yl)-dimetylkarbamát; izolán |
204-318-2 |
119-38-0 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
006-010-00-1 |
(5,5-dimetyl-3-oxocyklohex-1-enyl)-dimetylkarbamát; dimetylkarbamát 5,5-dimetyldihydrorezorcinolu; dimetán |
204-525-8 |
122-15-6 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
006-011-00-7 |
karbaryl (ISO); (1-naftyl)-metylkarbamát |
200-555-0 |
63-25-2 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H302 H400 |
|
M=100 |
|
|
006-012-00-2 |
ziram (ISO); zinkium-bis(dimetylditiokarbamát) |
205-288-3 |
137-30-4 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373 ** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H302 H373 ** H335 H318 H317 H410 |
|
M = 100 |
|
|
006-013-00-8 |
metám-nátrium (ISO); nátrium-metylditiokarbamát |
205-293-0 |
137-42-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
EUH031 |
|
|
|
006-014-00-3 |
nabám (ISO); dinátrium-N, N'-etylénbis(ditiokarbamát) |
205-547-0 |
142-59-6 |
Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Wng |
H302 H335 H317 H410 |
|
|
|
|
006-015-00-9 |
diurón (ISO); 3-(3,4-dichlórfenyl)-1,1-dimetylmočovina |
206-354-4 |
330-54-1 |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H373** H410 |
|
M = 10 |
|
|
006-016-00-4 |
propoxur (ISO); O-(2-izopropyloxyfenyl)-N-metylkarbamát; (2-izopropoxyfenyl)-metylkarbamát |
204-043-8 |
114-26-1 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
006-017-00-X |
aldikarb (ISO); 2-metyl-2-(metylsulfanyl)propanál-O-(N-metylkarbamoyl)oxím |
204-123-2 |
116-06-3 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
|
|
|
006-018-00-5 |
aminokarb (ISO); [4-(dimetylamino)-3-metylfenyl]-metylkarbamát |
217-990-7 |
2032-59-9 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
006-019-00-0 |
di-alát (ISO); S-(2,3-dichlóralyl)-N, N-diizopropyltiokarbamát |
218-961-1 |
2303-16-4 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
006-020-00-6 |
barbán (ISO); O-(4-chlórbut-2-inyl)-N-(3-chlórfenyl)karbamát |
202-930-4 |
101-27-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
006-021-00-1 |
linurón (ISO); 3-(3,4-dichlórfenyl)-1-metoxy-1-metylmočovina |
206-356-5 |
330-55-2 |
Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H351 H302 H373 ** H410 |
|
|
|
|
006-022-00-7 |
dekarbofurán (ISO); (2-metyl-2,3-dihydrobenzofurán-7-yl)-metylkarbamát |
— |
1563-67-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
006-023-00-2 |
merkaptodimetur (ISO); metiokarb (ISO); O-[3,5-dimetyl-4-(metylsulfanyl)fenyl]-N-metylkarbamát |
217-991-2 |
2032-65-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
006-024-00-8 |
proxán-nátrium (ISO); nátrium-O-izopropylditiokarbonát |
205-443-5 |
140-93-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
006-025-00-3 |
aletrín; (RS)-(3-alyl-2-metyl-4-oxocyklopent-2- enyl)-(1RS,3RS;1RS,3SR)-2,2-dimetyl-3-(2- metylprop-1-én-1- yl)cyklopropánkarboxylát; bioaletrín; (RS)-(3-alyl-2-metyl-4-oxocyklopent-2- enyl)-(1R,3R)-2,2-dimetyl-3-(2-metylprop- 1-én-1-yl)cyklopropánkarboxylát; [1] S-bioaletrín; [3] (S)-(3-alyl-2-metyl-4-oxocyklopent-2- enyl)-(1R,3R)-2,2-dimetyl-3-(2-metylprop- 1-én-1-yl)cyklopropánkarboxylát; [2] esbiotrín; (RS)-(3-alyl-2-metyl-4-oxocyklopent-2- enyl)-(1R,3R)-2,2-dimetyl-3-(2-metylprop- 1-én-1-yl)cyklopropánkarboxylát [3] |
209-542-4 [1] 249-013-5 [2]-[3] |
584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
C |
|
006-026-00-9 |
karbofurán (ISO); O-(2,2-dimetyl-2,3-dihydrobenzofurán-7-yl)-N-metylkarbamát |
216-353-0 |
1563-66-2 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
|
006-028-00-X |
dinobutón (ISO); [2-(bután-2-yl)-4,6-dinitrofenyl]-izopropyl-karbonát |
213-546-1 |
973-21-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
006-029-00-5 |
dioxakarb (ISO); O-[2-(1,3-dioxolán-2-yl)fenyl]-N-metylkarbamát |
230-253-4 |
6988-21-2 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
006-030-00-0 |
EPTC (ISO); S-etyl-dipropyltiokarbamát |
212-073-8 |
759-94-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-031-00-6 |
formetanát (ISO); {3-[(EZ)-(dimetylaminometylidén)amino]fenyl}-metylkarbamát |
244-879-0 |
22259-30-9 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
006-032-00-1 |
monolinurón (ISO); 3-(4-chlórfenyl)-1-metoxy-1-metylmočovina |
217-129-5 |
1746-81-2 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
|
006-033-00-7 |
metoxurón (ISO); 3-(3-chlór-4-metoxyfenyl)-1,1-dimetylmočovina |
243-433-2 |
19937-59-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
006-034-00-2 |
pebulát (ISO); S-propyl-N-butyl-N-etyltiokarbamát |
214-215-4 |
1114-71-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
006-036-00-3 |
benztiazurón (ISO); 1-(benzotiazol-2-yl)-3-metylmočovina |
217-685-9 |
1929-88-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-037-00-9 |
promekarb (ISO); O-(3-izopropyl-5-metylfenyl)-N-metylkarbamát |
220-113-0 |
2631-37-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
006-038-00-4 |
sulfalát (ISO); S-(2-chlóralyl)-N, N-dimetylditiokarbamát |
202-388-9 |
95-06-7 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
006-039-00-X |
tri-alát (ISO); S-(2,3,3-trichlóralyl)-diizopropyltiokarbamát |
218-962-7 |
2303-17-5 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
|
006-040-00-5 |
(3-metylpyrazol-5-yl)-dimetylkarbamát; monometilán |
— |
2532-43-6 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
006-041-00-0 |
dimetylkarbamoylchlorid |
201-208-6 |
79-44-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H331 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H331 H302 H319 H335 H315 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
|
006-042-00-6 |
monurón (ISO); 3-(4-chlórfenyl)-1,1-dimetylmočovina |
205-766-1 |
150-68-5 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
006-043-00-1 |
[3-(4-chlórfenyl)-1,1-dimetylurónium]-trichlóracetát; monurón-TCA |
— |
140-41-0 |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H319 H315 H410 |
|
|
|
|
006-044-00-7 |
izoproturón (ISO); 3-(4-izopropylfenyl)-1,1-dimetylmočovina |
251-835-4 |
34123-59-6 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 10 |
|
|
006-045-00-2 |
metomyl (ISO); O-[1-(metylsulfanyl)etylidénamino]-N-metylkarbamát |
240-815-0 |
16752-77-5 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
|
M=100 |
|
|
006-047-00-3 |
bufenkarb (ISO); produkt reakcie zložený z O-[3-(1-metylbutyl)fenyl]-N-metylkarbamátu a O-[3-(1-etylpropyl)fenyl]-N-metylkarbamátu |
— |
8065-36-9 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
006-048-00-9 |
etiofenkarb (ISO); O-[2-(etylsulfanylmetyl)fenyl]-N-metylkarbamát |
249-981-9 |
29973-13-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
006-049-00-4 |
dixantogén; O, O-dietyl-disulfánbis(karbotioát) |
207-944-4 |
502-55-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-050-00-X |
(1,1-dimetyl-3-fenylurónium)-trichlóracetát; fenurón-TCA |
— |
4482-55-7 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
006-051-00-5 |
ferbám (ISO); ferium-tris(dimetylditiokarbamát) |
238-484-2 |
14484-64-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
006-052-00-0 |
hydrochlorid formetanátu; O-{3-[(N, N-dimetylaminometylidén)amino]fenyl}-N-metylkarbamát |
245-656-0 |
23422-53-9 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
006-053-00-6 |
izoprokarb (ISO); O-(2-izopropylfenyl)-N-metylkarbamát |
220-114-6 |
2631-40-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
006-054-00-1 |
mexakarbát (ISO); O-[4-(dimetylamino)-3,5-dimetylfenyl]-N-metylkarbamát |
206-249-3 |
315-18-4 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
006-055-00-7 |
xylylkarb (ISO); O-(3,4-dimetylfenyl)-N-metylkarbamát; (3,4-xylyl)-metylkarbamát; MPMC |
219-364-9 |
2425-10-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
006-056-00-2 |
metolkarb (ISO); meta-tolyl-metylkarbamát; MTMC |
214-446-0 |
1129-41-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
006-057-00-8 |
nitrapyrín (ISO); 2-chlór-6-(trichlórmetyl)pyridín |
217-682-2 |
1929-82-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
006-058-00-3 |
norurón (ISO); 1,1-dimetyl-3-(perhydro-4,7-metanoindén-5-yl)močovina |
— |
2163-79-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-059-00-9 |
oxamyl (ISO); N',N'-dimetylkarbamoyl(metyltio)metylénamín N-metylkarbamát; |
245-445-3 |
23135-22-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2 |
H330 H300 H312 H411 |
GHS06 GHS09 Dgr |
H330 H300 H312 H411 |
|
|
|
|
006-060-00-4 |
oxykarboxín (ISO); 5-(N-fenylkarbamoyl)-6-metyl-2,3-dihydro- 1,4-oxotiín-4,4-dioxid |
226-066-2 |
5259-88-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
006-061-00-X |
hydrochlorid S-etyl-N-[3-(dimetylamino)propyl]tiokarbamátu; hydrochlorid protiokarbu |
243-193-9 |
19622-19-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
006-062-00-5 |
metyl-(3,4-dichlórfenyl)karbamát; SWEP. |
— |
1918-18-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-063-00-0 |
tiobenkarb (ISO); S-(4-chlórbenzyl)-N, N-dietyltiokarbamát |
248-924-5 |
28249-77-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
006-064-00-6 |
tiofanox (ISO); 3,3-dimetyl-1-(metylsulfanyl)butanón-O-(N-metylkarbamoyl)oxím |
254-346-4 |
39196-18-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
006-065-00-1 |
3-chlór-6-kyanobicyklo[2.2.1]heptán-2-ón- O-(N-metylkarbamoyl)oxím; triamid |
— |
15271-41-7 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2 |
H300 H311 H411 |
GHS06 GHS09 Dgr |
H300 H311 H411 |
|
|
|
|
006-066-00-7 |
vernolát (ISO); S-propyl-N, N-dipropyltiokarbamát |
217-681-7 |
1929-77-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
006-067-00-2 |
XMC; (3,5-xylyl)-metylkarbamát |
— |
2655-14-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
006-068-00-8 |
diazometán |
206-382-7 |
334-88-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
006-069-00-3 |
tiofanát-metyl (ISO); 1,2-bis[3-(metoxykarbonyl)tioureido]benzén |
245-740-7 |
23564-05-8 |
Muta. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H332 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H332 H317 H410 |
|
|
|
|
006-070-00-9 |
furmecyklox (ISO); N-cyklohexyl-N-metoxy-2,5-dimetylfurán- 3-karboxamid |
262-302-0 |
60568-05-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
006-071-00-4 |
(cyklookt-4-enyl)-metyl-karbonát |
401-620-8 |
87731-18-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
006-072-00-X |
prosulfokarb (ISO); S-benzyl-N, N-dipropyltiokarbamát |
401-730-6 |
52888-80-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
006-073-00-5 |
[3-(dimetylamino)propyl]močovina |
401-950-2 |
31506-43-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
006-074-00-0 |
2-[3-(prop-1-én-2-yl)fenyl]propán-2-ylizokyanát |
402-440-2 |
2094-99-7 |
Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H314 H373 ** H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H314 H373 ** H334 H317 H410 |
|
|
|
|
006-076-00-1 |
mankozeb (ISO); komplex polymérneho mangánium-etylénbis(ditiokarbamátu) so zinočnatou soľou |
— |
8018-01-7 |
Repr. 2 Skin Sens. 1 Aquatic Acute 1 |
H361d*** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H361d*** H317 H400 |
|
M=10 |
|
|
006-077-00-7 |
maneb (ISO); polymérny mangánium-etylénbis (ditiokarbamátu) |
235-654-8 |
12427-38-2 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H332 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H332 H319 H317 H410 |
|
M=10 |
|
|
006-078-00-2 |
zineb (ISO); polymérny zinkium-etylénbis(ditiokarbamát) |
235-180-1 |
12122-67-7 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
|
|
|
006-079-00-8 |
disulfirám; tetraetyldisulfánbis(karbotioamid) |
202-607-8 |
97-77-8 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
|
006-080-00-3 |
tetrametyltiurámmonosulfid |
202-605-7 |
97-74-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
006-081-00-9 |
zinkium-bis(dibutylditiokarbamát) |
205-232-8 |
136-23-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
006-082-00-4 |
zinkium-bis(dietylditiokarbamát) |
238-270-9 |
14324-55-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H317 H410 |
|
|
|
|
006-083-00-X |
butokarboxím (ISO); 3-(metylsulfanyl)butanón-O-(metylkarbamoyl)oxím |
252-139-3 |
34681-10-2 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H331 H311 H301 H319 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H311 H301 H319 H410 |
|
|
|
|
006-084-00-5 |
karbosulfán (ISO); O-(2,2-dimetyl-2,3-dihydrobenzofurán-7-yl)-N-{[(dibutylamino)sulfanyl]metyl}karbamát |
259-565-9 |
55285-14-8 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H317 H410 |
|
|
|
|
006-085-00-0 |
fenobukarb (ISO); (2-butylfenyl)-metylkarbamát |
223-188-8 |
3766-81-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
006-086-00-6 |
fenoxykarb (ISO); O-etyl-N-[2-(4-fenoxyfenoxy)etyl]karbamát |
276-696-7 |
72490-01-8 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 M = 10 000 |
|
|
006-087-00-1 |
furatiokarb (ISO); (2,2-dimetyl-2,3-dihydrobenzofurán-7-yl)-2,4-dimetyl-5-oxo-6-oxa-3-tia-2,4-diazadekanoát |
265-974-3 |
65907-30-4 |
Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H373** H319 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H301 H373** H319 H315 H317 H410 |
|
M = 100 |
|
|
006-088-00-7 |
benfurakarb (ISO); O-etyl-3-{N-[(2,2-dimetyl-2,3- dihydrobenzofurán-7-yloxykarbonyl)-N-metylamino] sulfanyl]-N-izopropylamino} propanoát |
— |
82560-54-1 |
Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H331 H302 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f*** H331 H302 H410 |
|
|
|
|
006-090-00-8 |
O-[2-(3-jódprop-2-ín-1-yloxy)etyl]-N-fenylkarbamát |
408-010-0 |
88558-41-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H332 H318 H412 |
GHS05 GHS07 Dgr |
H332 H318 H412 |
|
|
|
|
006-091-00-3 |
propineb (ISO); polymérny zinkium-(propán-1,2-diyl)bis(ditiokarbamát) |
— |
9016-72-2 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 |
H332 H373** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H332 H373** H317 H400 |
|
|
|
|
006-092-00-9 |
O-terc-butyl-(1S)-N-[2-fenyl-1-((2S)-oxirán-2-yl)etyl]karbamát |
425-420-5 |
98737-29-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
006-093-00-4 |
[2,2'-disulfándiyldi(etán-1-amínium)]-bis(dibenzylditiokarbamát) |
427-180-7 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
006-094-00-X |
O-izobutyl-N-(etoxykarbonyl)tiokarbamát |
434-350-4 |
103122-66-3 |
Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H226 H350 H340 H302 H373** H317 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H340 H302 H373** H317 H411 |
|
|
|
|
006-095-00-5 |
fosetyl-alumínium (ISO); alumínium-trietyl-trifosfonát |
254-320-2 |
39148-24-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
006-096-00-0 |
chlórprofám (ISO); O-izopropyl-3-chlórkarbanilát |
202-925-7 |
101-21-3 |
Carc. 2 STOT RE 2 * Aquatic Chronic 2 |
H351 H373** H411 |
GHS08 GHS09 Wng |
H351 H373** H411 |
|
|
|
|
006-097-00-6 |
1-fenyl-3-(4-metylbenzénsulfonyl)močovina |
424-620-1 |
13909-63-2 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
|
006-098-00-1 |
O-terc-butyl-N-((1R,5S)-3-azabicyklo[3.1.0]hexán-6-yl)karbamát |
429-170-8 |
134575-17-0 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
|
006-099-00-7 |
N-(4-metylbenzénsulfonyl)-N'-[3-(4- metylbenzénsulfonyloxy)fenyl]močovina; O-(3-{[(4- metylbenzénsulfonyl)karbamoyl]amino}fen yl)-4-metylbenzénsulfonát |
520-2 |
232938-43-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
006-101-00-6 |
reakčná zmes zložená z týchto látok: 3,3'-difenyl-1,1'-[metyléndi(4,1-fenylén)]bis(močovina); 1-cyklohexyl-3-(4-{[4-(3-fenylureido)fenyl]metyl}fenyl)močovina; 3,3'-dicyklohexyl-1,1'-[metyléndi(4,1-fenylén)]bis(močovina) |
423-070-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
006-102-00-1 |
O-hexyl-N-(etoxykarbonyl)tiokarbamát |
432-750-3 |
— |
Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H340 H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H302 H373** H317 H411 |
|
|
|
|
006-103-00-7 |
3,3'-dioktyl-1,1'-[metyléndi(4,1-fenylén)]bis(močovina) |
445-760-8 |
— |
Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H318 H334 H410 |
|
M=100 |
|
|
007-001-00-5 |
amoniak, bezvodý |
231-635-3 |
7664-41-7 |
Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H221 H331 H314 H400 |
GHS04 GHS06 GHS05 GHS09 Dgr |
H221 H331 H314 H400 |
|
|
U |
|
007-001-01-2 |
amoniak ….% |
215-647-6 |
1336-21-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
STOT SE 3; H335: C ≥ 5% |
B |
|
007-002-00-0 |
oxid dusičitý; [1] tetraoxid didusičitý [2] |
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
* STOT SE 3; H335: C ≥0,5 % |
5 |
|
007-003-00-6 |
chlórmekvát-chlorid (ISO); (2-chlóretyl)trimetylamónium-chlorid |
213-666-4 |
999-81-5 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
007-006-00-2 |
etyl-nitrit |
203-722-6 |
109-95-5 |
Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H220 H332 H312 H302 |
GHS02 GHS04 GHS07 Dgr |
H220 H332 H312 H302 |
|
|
U |
|
007-007-00-8 |
etyl-nitrát |
210-903-3 |
625-58-1 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
007-008-00-3 |
hydrazín |
206-114-9 |
302-01-2 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H350 H331 H311 H301 H314 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H226 H350 H331 H311 H301 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3% ≤ C < 10% Eye Irrit. 2; H319: 3% ≤ C < 10% |
|
|
007-009-00-9 |
dicyklohexylamónium-nitrit |
221-515-9 |
3129-91-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
|
007-010-00-4 |
dusitan sodný |
231-555-9 |
7632-00-0 |
Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
007-011-00-X |
dusitan draselný |
231-832-4 |
7758-09-0 |
Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
007-012-00-5 |
N, N-dimetylhydrazín |
200-316-0 |
57-14-7 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H331 H301 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H301 H314 H411 |
|
|
|
|
007-013-00-0 |
1,2-dimetylhydrazín |
— |
540-73-8 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
007-014-00-6 |
soli hydrazínu |
— |
— |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H317 H410 |
|
|
A |
|
007-015-00-1 |
O-etylhydroxylamín |
402-030-3 |
624-86-2 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
|
|
|
|
007-016-00-7 |
butyl-nitrit |
208-862-1 |
544-16-1 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H301 |
GHS02 GHS06 Dgr |
H225 H331 H301 |
|
|
|
|
007-017-00-2 |
izobutyl-nitrit |
208-819-7 |
542-56-3 |
Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H341 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H341 H332 H302 |
|
|
|
|
007-018-00-8 |
sek-butyl-nitrit |
213-104-8 |
924-43-6 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
007-019-00-3 |
terc-butyl-nitrit |
208-757-0 |
540-80-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
007-020-00-9 |
pentyl-nitrit; [1] (C5-alkyl)-nitrit, zmes izomérov [2] |
207-332-7 [1] 203-770-8 [2] |
463-04-7 [1] 110-46-3 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
007-021-00-4 |
hydrazobenzén; 1,2-difenylhydrazín |
204-563-5 |
122-66-7 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
007-022-00-X |
hydrazínium-bis(4-hydroxy-3-karboxybenzénsulfonát) |
405-030-1 |
— |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H302 H314 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H350 H302 H314 H317 H412 |
|
|
|
|
007-023-00-5 |
nátrium-3,5-bis{[3-(2,4-di-terc-pentylfenoxy)propyl]karbamoyl}benzénsulfonát |
405-510-0 |
— |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
007-024-00-0 |
[2-(decylsulfanyl)etyl]amónium-chlorid |
405-640-8 |
36362-09-1 |
STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H315 H318 H410 |
|
|
|
|
007-025-00-6 |
hydrochlorid (4-hydrazinofenyl)-N-metylmetánsulfónamidu |
406-090-1 |
81880-96-8 |
Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H301 H372 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H301 H372 ** H317 H410 |
|
|
|
|
007-026-00-1 |
2-hydrazinyl-2-oxo-N-(2,2,6,6-tetrametylpiperidín-4-yl)acetamid |
413-230-5 |
122035-71-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
007-027-00-7 |
3,3,3’,3’-tetrakis[3-(hexán-2-ylidénamino)propyl]-1,1’-(hexán-1,6-diyl)bis(močovina) |
420-190-2 |
771478-66-1 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H317 H410 |
|
|
|
|
007-028-00-2 |
dusičnan hydroxylamónia |
236-691-2 |
13465-08-2 |
Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
|
|
|
|
007-029-00-8 |
dietyldi(metyl)amónium-hydroxid |
419-400-5 |
95500-19-9 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
008-001-00-8 |
kyslík |
231-956-9 |
7782-44-7 |
Ox. Gas 1 Press. Gas |
H270 |
GHS03 GHS04 Dgr |
H270 |
|
|
U |
|
008-003-00-9 |
peroxid vodíka, roztok … % |
231-765-0 |
7722-84-1 |
Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H271 H332 H302 H314 |
GHS03 GHS05 GHS07 Dgr |
H271 H332 H302 H314 |
|
Ox. Liq. 1; H271: C ≥70%**** Ox. Liq. 2; H272: 50 % ≤ C < 70% **** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50% Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35% |
B |
|
009-001-00-0 |
fluór |
231-954-8 |
7782-41-4 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
|
|
|
009-002-00-6 |
fluorovodík |
231-634-8 |
7664-39-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
009-003-00-1 |
kyselina fluorovodíková … % |
231-634-8 |
7664-39-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 % |
B |
|
009-004-00-7 |
fluorid sodný |
231-667-8 |
7681-49-4 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
EUH032 |
|
|
|
009-005-00-2 |
fluorid draselný |
232-151-5 |
7789-23-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
009-006-00-8 |
fluorid amónny |
235-185-9 |
12125-01-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
009-007-00-3 |
difluorid monosodný; hydrogendifluorid sodný |
215-608-3 |
1333-83-1 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
*Skin Corr. 1B; H314: C ≥ 1% Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2; H319: 0,1 % ≤ C < 1% |
|
|
009-008-00-9 |
difluorid monodraselný; hydrogendifluorid draselný |
232-156-2 |
7789-29-9 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
009-009-00-4 |
difluorid monoamónny; hydrogendifluorid amónny |
215-676-4 |
1341-49-7 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1% Skin Irrit.2; H315: 0,1 % ≤ C < 1% Eye Irrit. 2; H319: 0,1 % ≤ C < 1% |
|
|
009-010-00-X |
kyselina tetrafluoroboritá ... % |
240-898-3 |
16872-11-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H315: 10% ≤ C < 25% Eye Irrit. 2; H319: 10% ≤ C < 25% |
B |
|
009-011-00-5 |
kyselina hexafluorokremičitá ... % |
241-034-8 |
16961-83-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
B |
|
009-012-00-0 |
hexafluorokremičitan sodný; [1] hexafluorokremičitan draselný; [2] hexafluorokremičitan amónny [3] |
240-934-8 [1] 240-896-2 [2] 240-968-3 [3] |
16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
* |
A |
|
009-013-00-6 |
hexafluorokremičitany okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
* |
A |
|
009-014-00-1 |
hexafluorokremičitan olovnatý |
247-278-1 |
25808-74-6 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
009-015-00-7 |
difluorid sulfurylu |
220-281-5 |
2699-79-8 |
Press. Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H373 ** H400 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H331 H373 ** H400 |
|
|
U |
|
009-016-00-2 |
hexafluorohlinitan trisodný [1] hexafluorohlinitan trisodný (kryolit) [2] |
237-410-6 [1] 239-148-8 [2] |
13775-53-6 [1] 15096-52-3 [2] |
STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 |
H372 H332 H411 |
GHS07 GHS08 GHS09 Dgr |
H372 H332 H411 |
|
|
|
|
009-017-00-8 |
kálium-μ-fluóro-bis(trietylalumínium) |
400-040-2 |
12091-08-6 |
Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4 * |
H228 H270 H314 H332 |
GHS02 GHS05 GHS07 Dgr |
H228 H270 H314 H332 |
EUH014 |
|
T |
|
009-018-00-3 |
hexafluorokremičitan horečnatý |
241-022-2 |
16949-65-8 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
* |
|
|
011-001-00-0 |
sodík |
231-132-9 |
7440-23-5 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
011-002-00-6 |
hydroxid sodný lúh sodný |
215-185-5 |
1310-73-2 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 5% Skin Corr. 1B; H314 2% ≤ C < 5% Skin Irrit. 2; H315: 0,5 % ≤ C < 2% Eye Irrit.2; H319: 0,5 % ≤ C < 2% |
|
|
011-003-00-1 |
peroxid sodný |
215-209-4 |
1313-60-6 |
Ox. Sol. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
|
|
|
011-004-00-7 |
azid sodný |
247-852-1 |
26628-22-8 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H400 H410 |
EUH032 |
|
|
|
011-005-00-2 |
uhličitan sodný |
207-838-8 |
497-19-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
011-006-00-8 |
kyanatan sodný |
213-030-6 |
917-61-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
011-007-00-3 |
propoxykarbazón-nátrium |
— |
181274-15-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 |
|
|
012-001-00-3 |
práškový horčík (pyroforický) |
231-104-6 |
7439-95-4 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
012-002-00-9 |
horčík, vo forme prášku alebo stružlín |
231-104-6 |
— |
Flam. Sol. 1 Water-react. 2 Self-heat. 1 |
H228 H261 H252 |
GHS02 Dgr |
H228 H261 H252 |
|
|
T |
|
012-003-00-4 |
dialkylmagnézium |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
012-004-00-X |
hydrát hydroxid-chlorečnan-uhličitanu hlinito-horečnatého |
422-150-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
013-001-00-6 |
práškový hliník (pyroforický) |
231-072-3 |
7429-90-5 |
Water-react. 2 Pyr. Sol. 1 |
H261 H250 |
GHS02 Dgr |
H261 H250 |
|
|
T |
|
013-002-00-1 |
práškový hliník (stabilizovaný) |
231-072-3 |
7429-90-5 |
Water-react. 2 Flam. Sol. 1 |
H261 H228 |
GHS02 Dgr |
H261 H228 |
|
|
T |
|
013-003-00-7 |
chlorid hlinitý, bezvodý |
231-208-1 |
7446-70-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
013-004-00-2 |
trialkylalumínium |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
013-005-00-8 |
dietyl[etyldi(metyl)silanoláto]alumínium |
401-160-8 |
55426-95-4 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
013-006-00-3 |
[2-(dimetylamino)etanoláto]-(etyl-3-oxobutanoáto-O 1,O 3)-(1-metoxypropán-2-oláto)hlinitý komplex, dimér |
402-370-2 |
— |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
013-007-00-9 |
poly{[(2-butoxyetyl)-3-oxobutanoáto-O'1,O'3]-μ-hlinitý komplex} |
403-430-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
013-008-00-4 |
dioktylalumínium-jodid |
408-190-0 |
7585-14-0 |
Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H314 H410 |
EUH014 |
|
|
|
013-009-00-X |
[(butyl)x(etyl)ydihydrido]hlinitan sodný x = 0,5 y = 1,5 |
418-720-2 |
— |
Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A |
H228 H260 H250 H332 H314 |
GHS02 GHS05 GHS07 Dgr |
H228 H260 H250 H332 H314 |
EUH014 |
|
T |
|
013-010-00-5 |
hydroxid-bis(2,4,8,10-tetra-terc-butyl-6-hydroxy-12H-dibenzo[d, g][1,3,2]dioxafosfocín-6-oxid) hlinitý |
430-650-4 |
151841-65-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-001-00-9 |
trichlórsilán |
233-042-5 |
10025-78-2 |
Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H224 H250 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H224 H250 H332 H302 H314 |
EUH014 EUH029 |
* STOT SE 3; H335: C ≥ 1% |
T |
|
014-002-00-4 |
chlorid kremičitý |
233-054-0 |
10026-04-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
EUH014 |
|
|
|
014-003-00-X |
dichlórdi(metyl)silán |
200-901-0 |
75-78-5 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
014-004-00-5 |
trichlór(metyl)silán; trichlórmetylsilán |
200-902-6 |
75-79-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
EUH014 |
Skin Irrit.2; H315: C ≥ 1% Eye Irrit. 2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
|
|
014-005-00-0 |
tetraetyl-silikát; etyl-silikát |
201-083-8 |
78-10-4 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H226 H332 H319 H335 |
GHS02 GHS07 Wng |
H226 H332 H319 H335 |
|
|
|
|
014-006-00-6 |
hydrochlorid bis(4-fluórfenyl)(metyl)(1,2,4-triazol-4-ylmetyl)silánu |
401-380-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
014-007-00-1 |
trietoxy(izobutyl)silán |
402-810-3 |
17980-47-1 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
014-008-00-7 |
bis(4-fluórfenyl)(chlórmetyl)(metyl)silán |
401-200-4 |
85491-26-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-009-00-2 |
izobutyl(izopropyl)di(metoxy)silán |
402-580-4 |
111439-76-0 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H315 |
GHS02 GHS07 Wng |
H226 H332 H315 |
|
|
|
|
014-010-00-8 |
kremičitan disodný |
229-912-9 |
6834-92-0 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
014-011-00-3 |
cyklohexyldi(metoxy)(metyl)silán |
402-140-1 |
17865-32-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
014-012-00-9 |
bis(3-(trimetoxysilyl)propyl)amín |
403-480-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
014-013-00-4 |
α-hydroxypoly{(metyl)[3-(2,2,6,6-tetrametylpiperidín-4-yloxy)propyl]siloxán} |
404-920-7 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H312 H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H411 |
|
|
|
|
014-014-00-X |
etacelasil (ISO); 6-(2-chlóretyl)-6-(2-metoxyetoxy)-2,5,7,10-tetraoxa-6-silaundekán |
253-704-7 |
37894-46-5 |
Repr. 1B Acute Tox. 4 * STOT RE 2 * |
H360D *** H302 H373 ** |
GHS08 GHS07 Dgr |
H360D *** H302 H373 ** |
|
|
|
|
014-015-00-5 |
α-trimetylsilanyl-ω-trimetylsiloxypoly(oxy{3-[2-(2-metoxypropoxy)propoxy]propyl}(metyl)silándiyl]-co-[oxy(dimetylsilándiyl)]) |
406-420-4 |
69430-40-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
014-016-00-0 |
reakčná zmes zložená z týchto látok: 1,3-di(hex-5-én-1-yl)-1,1,3,3- tetrametyldisiloxán; 1,3-di(hex-a-én-1-yl)-1,1,3,3- tetrametyldisiloxán |
406-490-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-017-00-6 |
flusilazol (ISO); bis(4-fluórfenyl)(metyl)(1H-1,2,4-triazol-1- ylmetyl)silán |
— |
85509-19-9 |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
|
014-018-00-1 |
oktametylcyklotetrasiloxán |
209-136-7 |
556-67-2 |
Repr. 2 Aquatic Chronic 4 |
H361f *** H413 |
GHS08 Wng |
H361f *** H413 |
|
|
|
|
014-019-00-7 |
reakčná zmes zložená z týchto látok: 4-{[bis(4-fluórfenyl)(metyl)silyl]metyl}- 4H-1,2,4-triazol; 1-{[bis-(4-fluórfenyl)(metyl)silyl]metyl}- 1H-1,2,4-triazol |
403-250-2 |
— |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
|
014-020-00-2 |
bis(1,1-dimetylprop-2-inyloxy)di(metyl)silán |
414-960-7 |
53863-99-3 |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
014-021-00-8 |
(fenyl)tris(izopropenyloxy)silán |
411-340-8 |
52301-18-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H400 H410 |
|
|
|
|
014-022-00-3 |
produkt reakcie týchto látok: {[4-(alyloxy)-2-hydroxyfenyl](fenyl)metanónu a trietoxysilánu} s [produktom hydrolýzy silikgélu a metyltri(metoxy)silánu] |
401-530-9 |
— |
Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H228 H370 ** H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H228 H370 ** H332 H312 H302 |
|
|
T |
|
014-023-00-9 |
α-hydrogen-ω-hydroxypoly{oxy[(hex-5-én-1-yl)(metyl)silándiyl]} |
408-160-7 |
125613-45-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-024-00-4 |
1-etoxy-4-{[3-(4-fluór-3-chlórfenyl)propyl]di(metyl)silanyl}benzén |
412-620-2 |
121626-74-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-025-00-X |
4-{3-[dietoxy(metyl)silanyl]propoxy}-2,2,6,6-tetrametylpiperidín |
411-400-3 |
102089-33-8 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H373 ** H315 H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 H412 |
|
|
|
|
014-026-00-5 |
[3-(4-fluór-3-chlórfenyl)propyl]di(chlór)(metyl)silán |
407-180-3 |
770722-36-6 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
014-027-00-0 |
[3-(4-fluór-3-chlórfenyl)propyl](chlór)di(metyl)silán |
410-270-5 |
770722-46-8 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
014-028-00-6 |
α-[3-(prop-2-enoyl)propanoyl]di(metoxy)silanyloxy]-ω-[3-(prop-2-enoyl)propenoyl]di(metoxy)silanyl]-poly(dimetylsiloxán) |
415-290-8 |
193159-06-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
014-029-00-1 |
O, O’-[etenyl(metyl)silándiyl]bis(4-metylpentán-2-ón-oxím) |
421-870-1 |
156145-66-3 |
Repr. 2 Acute Tox. 4 * STOT RE 2 * |
H361f *** H302 H373 ** |
GHS08 GHS07 Wng |
H361f *** H302 H373 ** |
|
|
|
|
014-030-00-7 |
dimetyl{1,1’-(dimetylsilándiyl)bis[(1,2,3,3a,7a-η)-1H-indén-1-ylidén)]}hafnium |
422-060-0 |
137390-08-0 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
014-031-00-2 |
diizopropyldi(metoxy)silán |
421-540-7 |
18230-61-0 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H226 H315 H317 H412 |
GHS02 GHS07 Wng |
H226 H315 H317 H412 |
|
|
|
|
014-032-00-8 |
dicyklopentyldi(metoxy)silán |
404-370-8 |
126990-35-0 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
014-033-00-3 |
produkt hydrolýzy [2-metyl-3-(trimetoxysilyl)propyl]-propenoátu so silikagélom |
419-030-4 |
125804-20-8 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
014-034-00-9 |
3-hexylheptametyltrisiloxán |
428-700-5 |
1873-90-1 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
014-035-00-4 |
[2-(3,4-epoxycyklohexyl)etyl]tri(etoxy)silán |
425-050-4 |
10217-34-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
014-036-00-X |
(4-etoxyfenyl)[3-(3-fenoxy-4-fluórfenyl)propyl]di(metyl)silán tris[(bután-2-ylidénamino)oxy](fenyl)silán |
405-020-7 |
105024-66-6 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H400 H410 |
GHS08 GHS09 Dgr |
H360F*** H410 |
|
M=1000 |
|
|
014-037-00-5 |
tris[(bután-2-ylidénamino)oxy](fenyl)silán |
433-360-6 |
34036-80-1 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Wng |
H373** H317 H412 |
|
|
|
|
014-038-00-0 |
(S-[3-(trietoxysilyl)propyl]-oktántioát |
436-690-9 |
220727-26-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
014-039-00-6 |
(2,3-dimetylbután-2-yl)tri(metoxy)silán |
439-360-2 |
142877-45-0 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
014-041-00-7 |
{3- [bis(trimetylsilyl)amino]propyl}di(etoxy)(m etyl)silán |
445-890-5 |
201290-01-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
014-042-00-2 |
reakčná zmes zložená z týchto látok: tetrakis[(4-metylpentán-2-ylidénamino)oxy]silán (3 stereoizoméry) |
423-010-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
014-043-00-8 |
produkt reakcie amorfného silikagélu (50 – 85 %), butyl(bután-2-yl)magnézia (3 – 15 %), (tetraetoxy)silánu (5 – 15 %) a chloridu titaničitého (5 – 20 %) |
432-200-2 |
— |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H335 H315 H318 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H412 |
|
|
|
|
014-044-00-3 |
{3-[(4'-acetoxy-3'-metoxyfenyl)propyl]}tri(metoxy)silán |
433-050-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-045-00-9 |
fluorid-kremičitan horečnato-sodný |
442-650-1 |
— |
STOT RE 2 * |
H373** |
GHS08 Wng |
H373** |
|
|
|
|
015-001-00-1 |
biely fosfor |
231-768-7 |
12185-10-3 |
Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H250 H330 H300 H314 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H250 H330 H300 H314 H400 |
|
|
|
|
015-002-00-7 |
červený fosfor |
231-768-7 |
7723-14-0 |
Flam. Sol. 1 Aquatic Chronic 3 |
H228 H412 |
GHS02 Dgr |
H228 H412 |
|
|
|
|
015-004-00-8 |
fosfid hlinitý |
244-088-0 |
20859-73-8 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
015-005-00-3 |
fosfid horečnatý; difosfid trihorečnatý |
235-023-7 |
12057-74-8 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
015-006-00-9 |
difosfid trizinočnatý; fosfid zinočnatý |
215-244-5 |
1314-84-7 |
Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H260 H300 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H410 |
EUH029 EUH032 |
M=100 |
T |
|
015-007-00-4 |
chlorid fosforitý |
231-749-3 |
7719-12-2 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A |
H330 H300 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H300 H373 ** H314 |
EUH014 EUH029 |
|
|
|
015-008-00-X |
chlorid fosforečný |
233-060-3 |
10026-13-8 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B |
H330 H302 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H302 H373 ** H314 |
EUH014 EUH029 |
|
|
|
015-009-00-5 |
trichlorid-oxid fosforečný |
233-046-7 |
10025-87-3 |
Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A |
H330 H372 ** H302 H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H372 ** H302 H314 |
EUH014 EUH029 |
|
|
|
015-010-00-0 |
oxid fosforečný |
215-236-1 |
1314-56-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
015-011-00-6 |
kyselina fosforečná %, kyselina trihydrogenfosforečná % |
231-633-2 |
7664-38-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H315: 10% ≤ C < 25% Eye Irrit. 2; H319: 10% ≤ C < 25% |
B |
|
015-012-00-1 |
trisulfid tetrafosforu; seskvisulfid fosforu |
215-245-0 |
1314-85-8 |
Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H302 H400 |
|
|
T |
|
015-013-00-7 |
trietyl-fosfát |
201-114-5 |
78-40-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-014-00-2 |
tributyl-fosfát |
204-800-2 |
126-73-8 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 |
H351 H302 H315 |
GHS08 GHS07 Wng |
H351 H302 H315 |
|
|
|
|
015-015-00-8 |
trikrezyl-fosfát (o-,o-,o-; o-,o-,m-; o-,o-,p-; o- ,m-,m-; o-,m-,p-; o-,p-,p-); tritolyl-fosfát (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); |
201-103-5 |
78-30-8 |
STOT SE 1 Aquatic Chronic 2 |
H370 ** H411 |
GHS08 GHS09 Dgr |
H370 ** H411 |
|
STOT SE 1; H370: C ≥ 1% STOT SE 2; H371: 0,2 % ≤ C < 1% |
C |
|
015-016-00-3 |
trikrezyl-fosfát (m-,m-,m-; m-,m-,p-; m-,p-,p-; p-,p-,p-); tritolyl-fosfát (m-m-m-, m-m-p-, m-p-p-, p-p-p-); |
201-105-6 |
78-32-0 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Wng |
H312 H302 H411 |
|
* |
C |
|
015-019-00-X |
dichlórvos (ISO); (2,2-dichlórvinyl)-dimetyl-fosfát |
200-547-7 |
62-73-7 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 |
H330 H311 H301 H317 H400 |
GHS06 GHS09 Dgr |
H330 H311 H301 H317 H400 |
|
M=1000 |
|
|
015-020-00-5 |
mevinfos (ISO); [2-(metoxykarbonyl)-1-metylvinyl]-dimetyl-fosfát |
232-095-1 |
7786-34-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10000 |
|
|
015-021-00-0 |
trichlorfón (ISO); dimetyl-1-hydroxy-2,2,2-trichlóretylfosfonát |
200-149-3 |
52-68-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H400 H410 |
|
M = 1000 |
|
|
015-022-00-6 |
fosfamidón (ISO); [2-(dietylkarbamoyl)-2-chlór-1-metylvinyl]-dimetyl-fosfát |
236-116-5 |
13171-21-6 |
Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H300 H311 H410 |
|
|
|
|
015-023-00-1 |
pyrazoxón; dietyl-(3-metylpyrazol-5-yl)-fosfát |
— |
108-34-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
015-024-00-7 |
triamifos (ISO); 2-[bis(dimetylamino)fosforyl]-5-fenyl-2H-1,2,4-triazol-3-amín |
— |
1031-47-6 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-025-00-2 |
TEPP (ISO); tetraetyl-difosfát |
203-495-3 |
107-49-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
015-026-00-8 |
šradán (ISO); oktametyldifosfortetramid |
205-801-0 |
152-16-9 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-027-00-3 |
sulfotep (ISO); O, O,O, O-tetraetyl-difosforoditioát |
222-995-2 |
3689-24-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
015-028-00-9 |
demetón-O (ISO); O, O-dietyl-O-[2-(etylsulfanyl)etyl]- fosforotioát |
206-053-8 |
298-03-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
015-029-00-4 |
demetón-S (ISO); O, O-dietyl-S-[2-(etylsulfanyl)etyl]-fosforotioát |
204-801-8 |
126-75-0 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-030-00-X |
demetón-O-metyl (ISO); O-[2-(etylsulfanyl)etyl]-O, O-dimetylfosforotioát |
212-758-1 |
867-27-6 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
015-031-00-5 |
demetón-S-metyl (ISO); S-[2-(etylsulfanyl)etyl]-dimetyl-fosforotioát |
213-052-6 |
919-86-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H311 H301 H411 |
GHS06 GHS09 Dgr |
H311 H301 H411 |
|
|
|
|
015-032-00-0 |
protoát (ISO); O, O-dietyl-S-[(izopropylkarbamoyl)metyl]- fosforoditioát |
218-893-2 |
2275-18-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3 |
H310 H300 H412 |
GHS06 Dgr |
H310 H300 H412 |
|
|
|
|
015-033-00-6 |
forát (ISO); O, O-dietyl-S-[(etylsulfanyl)metyl]- fosforoditioát |
206-052-2 |
298-02-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
015-034-00-1 |
paratión (ISO); O, O-dietyl-O-(4-nitrofenyl)-fosforotioát |
200-271-7 |
56-38-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H311 H372 ** H410 |
|
M = 100 |
|
|
015-035-00-7 |
paratión-metyl (ISO); O, O-dimetyl-O-(4-nitrofenyl)-fosforotioát |
206-050-1 |
298-00-0 |
Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H330 H300 H311 H373 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H330 H300 H311 H373 ** H410 |
|
M = 100 |
|
|
015-036-00-2 |
O-etyl-O-(4-nitrofenyl)-fenylfosfonotioát; EPN |
218-276-8 |
2104-64-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
015-037-00-8 |
fenkaptón (ISO); S-{[(2,5-dichlórfenyl)sulfanyl]metyl}-O, O-dietyl-fosforoditioát |
218-892-7 |
2275-14-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
015-038-00-3 |
kumafos (ISO); O-(3-chlór-4-metyl-2-oxo-2H-chromén-7- yl)-O, O-dietyl-fosforotioát |
200-285-3 |
56-72-4 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
015-039-00-9 |
azinfos-metyl (ISO); O, O-dimetyl-S-(4-oxo[1,2,3]benzotriazín-3- ylmetyl)-fosforoditioát |
201-676-1 |
86-50-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H317 H410 |
|
|
|
|
015-040-00-4 |
diazinón (ISO); O, O-dietyl-O-(2-izopropyl-6- metylpyrimidín-4-yl)-fosforotioát |
206-373-8 |
333-41-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
015-041-00-X |
malatión (ISO); S-[1,2-bis(etoxykarbonyl)etyl]-O, O-dimetyl- fosforoditioát; [s obsahom ≤ 0,03 % izomalatiónu] |
204-497-7 |
121-75-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=1000 |
|
|
015-042-00-5 |
chlórtión O-(3-chlór-4-nitrofenyl)-O, O-dimetyl-fosforotioát |
207-902-5 |
500-28-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 100 |
|
|
015-043-00-0 |
fosnichlór (ISO); O-(4-chlór-3-nitrofenyl)-O, O-dimetyl-fosforotioát |
— |
5826-76-6 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
|
015-044-00-6 |
karbofenotión (ISO); O, O-dietyl-S-{[(4- chlórfenyl)sulfanyl]metyl}-fosforoditioát |
212-324-1 |
786-19-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
015-045-00-1 |
mekarbám (ISO); O, O-dietyl-S-{[(etoxykarbonyl)(metyl)karbamoyl]metyl}-fosforoditioát |
219-993-9 |
2595-54-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H400 H410 |
|
|
|
|
015-046-00-7 |
oxydemetón-metyl; S-[2-(etylsulfinyl)etyl]-O, O-dimetylfosforotioát |
206-110-7 |
301-12-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H311 H301 H400 |
GHS06 GHS09 Dgr |
H311 H301 H400 |
|
|
|
|
015-047-00-2 |
etión (ISO); O, O,O',O'-tetraetyl-S, S'-metylén-bis(fosforoditioát); dietión |
209-242-3 |
563-12-2 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 10000 |
|
|
015-048-00-8 |
fentión (ISO); O, O-dimetyl-O-[(3-metyl-4-(metylsulfanyl)fenyl]-fosforotioát |
200-231-9 |
55-38-9 |
Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H312 H302 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H312 H302 H372** H410 |
|
M=100 |
|
|
015-049-00-3 |
endotión (ISO); S-[(5-metoxy-4-oxopyrán-2-yl)metyl]-O, O-dimetyl-fosforotioát |
220-472-3 |
2778-04-3 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
015-050-00-9 |
tiometón (ISO); S-[2-(etylsulfanyl)etyl]-O, O-dimetylfosforoditioát |
211-362-6 |
640-15-3 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
015-051-00-4 |
dimetoát (ISO); O, O-dimetyl-S-[(metylkarbamoyl)metyl]-fosforoditioát |
200-480-3 |
60-51-5 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
015-052-00-X |
fenchlórfos (ISO); O, O-dimetyl-O-(2,4,5-trichlórfenyl)-fosforotioát |
206-082-6 |
299-84-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
015-053-00-5 |
menazón (ISO); S-[(4,6-diamino-1,3,5-triazín-2-yl)metyl]-O, O-dimetyl-fosforoditioát |
201-123-4 |
78-57-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
015-054-00-0 |
fenitrotión (ISO); O, O-dimetyl-O-(3-metyl-4-nitrofenyl)-fosforotioát |
204-524-2 |
122-14-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
015-055-00-6 |
naled (ISO); (1,2-dibróm-2,2-dichlóretyl)-dimetyl-fosfát |
206-098-3 |
300-76-5 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H312 H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H400 |
|
M = 1000 |
|
|
015-056-00-1 |
azínfos-etyl (ISO); O, O-dietyl-S-[(4-oxobenzotriazín-3- yl)metyl]-fosforoditioát |
220-147-6 |
2642-71-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M=100 |
|
|
015-057-00-7 |
formotión (ISO); S-{[formyl(metyl)karbamoyl]metyl}-O, O-dimetyl-fosforoditioát |
219-818-6 |
2540-82-1 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
015-058-00-2 |
morfotión (ISO); O, O-dimetyl-S-[(morfolín-4-ylkarbonyl)metyl]-fosforoditioát |
205-628-0 |
144-41-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
015-059-00-8 |
vamidotión (ISO); N-metyl-2-{[2- (dimetoxyfosforylsulfanyl)etyl]sulfanyl}propánamid |
218-894-8 |
2275-23-2 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
015-060-00-3 |
disulfotón (ISO); O, O-dietyl-S-[2-(etylsulfanyl)etyl]- fosforoditioát |
206-054-3 |
298-04-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
015-061-00-9 |
dimefox (ISO); tetrametylfosfordiamidoylfluorid |
204-076-8 |
115-26-4 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-062-00-4 |
mipafox (ISO); N, N'-diizopropylfosfordiamidoylfluorid |
206-742-3 |
371-86-8 |
STOT SE 1 |
H370 ** |
GHS08 Dgr |
H370 ** |
|
|
|
|
015-063-00-X |
dioxatión (ISO); S, S’-(1,4-dioxán-2,3-diyl)-O, O,O',O'- tetraetyl-bis(fosforoditioát) |
201-107-7 |
78-34-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
M = 1000 |
|
|
015-064-00-5 |
bromofos-etyl (ISO); O-(4-bróm-2,5-dichlórfenyl)- O, O-dimetyl-fosforotioát |
225-399-0 |
4824-78-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
015-065-00-0 |
S-[2-(etylsulfinyl)etyl]-O, O-dimetylfosforoditioát |
— |
2703-37-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Dgr |
H330 H310 H300 H411 |
|
|
|
|
015-066-00-6 |
ometoát (ISO); O, O-dimetyl-S-[(metylkarbamoyl)metyl]-fosforotioát |
214-197-8 |
1113-02-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
015-067-00-1 |
fosalón (ISO); O, O-dietyl-S-[(6-chlór-2-oxobenzoxazolín-3-yl)metyl]-fosforoditioát |
218-996-2 |
2310-17-0 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H410 |
|
M=1000 |
|
|
015-068-00-7 |
dichlofentión (ISO); O, O-dietyl-O-(2,4-dichlórfenyl)-fosforotioát |
202-564-5 |
97-17-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
015-069-00-2 |
metidatión (ISO); S-[(5-metoxy-2-oxo-2,3-dihydro-1,3,4- tiadiazol-3-yl)metyl]-O, O-dimetylfosforoditioát |
213-449-4 |
950-37-8 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
015-070-00-8 |
kyantoát (ISO); S-{[(1-kyano-1- metyletyl)karbamoyl]metyl}-O, O-dietylfosforotioát |
223-099-4 |
3734-95-0 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
015-071-00-3 |
chlórfenvinfos (ISO); [1-(2,4-dichlórfenyl)-2-chlórvinyl]-dietylfosfát |
207-432-0 |
470-90-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
015-072-00-9 |
monokrotofos (ISO); [2-(metylkarbamoyl)-1-metylvinyl]-dimetyl-fosfát |
230-042-7 |
6923-22-4 |
Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H330 H300 H311 H410 |
|
|
|
|
015-073-00-4 |
dikrotofos (ISO); (Z)-[2-(dimetylkarbamoyl)-1-metylvinyl]- dimetyl-fosfát |
205-494-3 |
141-66-2 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
015-074-00-X |
krufomát (ISO); (4-terc-butyl-2-chlórfenyl)-metyl-metylfosforamidát |
206-083-1 |
299-86-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
015-075-00-5 |
S-[2-(izopropylsulfinyl)etyl]-O, O-dimetyl-fosforotioát |
— |
2635-50-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
015-076-00-0 |
potasán; O, O-dietyl-O-(4-metyl-2-oxochromén-7- yl)-fosforotioát |
— |
299-45-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M = 1000 |
|
|
015-077-00-6 |
(2,2-dichlórvinyl)-[(2-etylsulfinyl)etyl]-metyl-fosfát |
— |
7076-53-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
015-078-00-1 |
demetón-S-metylsulfón (ISO); S-[(2-etylsulfonyl)etyl]-O, O-dimetyl-fosforotioát |
241-109-5 |
17040-19-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H301 H312 H411 |
GHS06 GHS09 Dgr |
H301 H312 H411 |
|
|
|
|
015-079-00-7 |
acefát (ISO); O, S-dimetyl-N-acetylfosforamidotioát |
250-241-2 |
30560-19-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-080-00-2 |
amiditión (ISO); S-[(2-metoxyetyl)karbamoylmetyl]-O, O-dimetyl- fosforoditioát |
— |
919-76-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-081-00-8 |
O, O,O',O'-tetrapropyl-difosforoditioát |
221-817-0 |
3244-90-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
015-082-00-3 |
azotoát (ISO); O-[4-(4-chlórfenyldiazenyl)fenyl]-O, O-dimetyl- fosforotioát |
227-419-3 |
5834-96-8 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
015-083-00-9 |
bensulid (ISO); O, O-diizopropyl-S-[2-(benzénsulfónamido)etyl]-fosforoditioát |
212-010-4 |
741-58-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
015-084-00-4 |
chlórpyrifos (ISO); O, O-dietyl-O-(3,5,6-trichlór-2-pyridyl)- fosforotioát |
220-864-4 |
2921-88-2 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H400 H410 |
|
M = 10000 |
|
|
015-085-00-X |
chlorfónium-chlorid (ISO); tributyl(2,4-dichlórbenzyl)fosfónium-chlorid |
204-105-4 |
115-78-6 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H312 H319 H315 |
GHS06 Dgr |
H301 H312 H319 H315 |
|
|
|
|
015-086-00-5 |
kumitoát (ISO); O, O-dietyl-O-(5-oxo-1,2,3,4-tetrahydro-benzo[ c]chromén-8-yl)-fosforotioát |
— |
572-48-5 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
015-087-00-0 |
kyanofos (ISO); O-(4-kyanofenyl)-O, O-dimetyl-fosforotioát |
220-130-3 |
2636-26-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
015-088-00-6 |
dialifos (ISO); S-(2-chlór-1-ftalimidoetyl)-O, O-dietyl-fosforoditioát |
233-689-3 |
10311-84-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H400 H410 |
|
|
|
|
015-089-00-1 |
etoát-metyl (ISO); S-[(etylkarbamoyl)metyl]-O, O-dimetyl-fosforoditioát |
204-121-1 |
116-01-8 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
015-090-00-7 |
fensulfotión (ISO); O, O-dietyl-O-[4-(metylsulfinyl)fenyl]- fosforotioát |
204-114-3 |
115-90-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
015-091-00-2 |
fonofos (ISO); O-etyl-S-fenyl-etylfosfonoditioát |
213-408-0 |
944-22-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
015-092-00-8 |
fosacetím (ISO); O, O-bis(4-chlórfenyl)-N-acetimidoylfosforamidotioát |
223-874-7 |
4104-14-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
015-093-00-3 |
leptofos (ISO); O-(4-bróm-2,5-dichlórfenyl)-O-metyl-fenylfosfonotioát |
244-472-8 |
21609-90-5 |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H370 ** H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H410 |
|
|
|
|
015-094-00-9 |
mefosfolán (ISO); dietyl-(4-metyl-1,3-ditiolán-2-ylidén)fosforamidát |
213-447-3 |
950-10-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H310 H300 H411 |
GHS06 GHS09 Dgr |
H310 H300 H411 |
|
|
|
|
015-095-00-4 |
metamidofos (ISO); O, S-dimetyl-fosforamidotioát |
233-606-0 |
10265-92-6 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 |
H330 H300 H311 H400 |
GHS06 GHS09 Dgr |
H330 H300 H311 H400 |
|
|
|
|
015-096-00-X |
oxydisulfotón (ISO); O, O-dietyl-S-[(2-etylsulfinyl)etyl]-fosforoditioát |
219-679-1 |
2497-07-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 10 |
|
|
015-097-00-5 |
fentoát (ISO); S-[(etoxykarbonyl)(fenyl)metyl]-O, Odimetyl- fosforoditioát |
219-997-0 |
2597-03-7 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
|
015-098-00-0 |
trichloronát (ISO); O-etyl-O-(2,4,5-trichlórfenyl)-etylfosfonotioát |
206-326-1 |
327-98-0 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
015-099-00-6 |
pirimifos-etyl (ISO); O, O-dietyl-O-[2-(dietylamino)-6- metylpyrimidín-4-yl]-fosforotioát |
245-704-0 |
23505-41-1 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
015-100-00-X |
foxím (ISO); O, O-dietyl-O- {[fenyl(kyano)metylidén]iminyl}- fosforotioát |
238-887-3 |
14816-18-3 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f*** H302 H317 H410 |
|
M=1000 |
|
|
015-101-00-5 |
fosmet (ISO); S-ftalimidometyl-O, O-dimetyl-fosforoditioát |
211-987-4 |
732-11-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
|
015-102-00-0 |
tris(2-chlóretyl)-fosfát |
204-118-5 |
115-96-8 |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360F*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H302 H411 |
|
|
|
|
015-103-00-6 |
bromid fosforitý |
232-178-2 |
7789-60-8 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
015-104-00-1 |
pentasulfid difosforečný sulfid fosforečný |
215-242-4 |
1314-80-3 |
Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H332 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H332 H302 H400 |
EUH029 |
|
T |
|
015-105-00-7 |
trifenyl-fosfit |
202-908-4 |
101-02-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
Skin Irrit. 2; H315: C ≥ 5% Eye Irrit. 2; H319: C ≥ 5% |
|
|
015-106-00-2 |
hexametylfosfortriamid; tris(dimetylamid) kyseliny fosforečnej |
211-653-8 |
680-31-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
015-107-00-8 |
etoprofos (ISO); O-etyl-S, S-dipropyl-fosforoditioát |
236-152-1 |
13194-48-4 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H301 H317 H410 |
|
|
|
|
015-108-00-3 |
bromofos (ISO); O-(4-bróm-2,5-dichlórfenyl)-O, O-dimetyl-fosforotioát |
218-277-3 |
2104-96-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 100 |
|
|
015-109-00-9 |
krotoxyfos (ISO); O-(1-fenyletyl)-3- [(dimetoxyfosforyl)oxy]but-2-enoát |
231-720-5 |
7700-17-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 10 |
|
|
015-110-00-4 |
kyanofenfos (ISO); O-etyl-O-(4-kyanofenyl)-fenylfosfonotioát |
— |
13067-93-1 |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H301 H370 ** H312 H319 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H319 H411 |
|
|
|
|
015-111-00-X |
fosfolán (ISO); O, O-dietyl-N-(1,3-ditiolán-2- ylidén)fosforamidát |
213-423-2 |
947-02-4 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-112-00-5 |
tionazín (ISO); O, O-dietyl-O-(pyrazín-2-yl)-fosforotioát; |
206-049-6 |
297-97-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-113-00-0 |
tolklofos-metyl (ISO); O-(2,6-dichlór-4-metylfenyl)-O, O-dimetyl-tiofosfát |
260-515-3 |
57018-04-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
015-114-00-6 |
chlórmefos (ISO); O, O-dietyl-S-(chlórmetyl)-fosforoditioát |
246-538-1 |
24934-91-6 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10 |
|
|
015-115-00-1 |
chlórtiofos (ISO); [izomérna reakčná zmes, v ktorej prevláda O-[2,5-dichlór-4-(metylsulfanyl)fenyl]-O, O-dietyl-fosforotioát] |
244-663-6 |
21923-23-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 1000 |
|
|
015-116-00-7 |
demefión-O (ISO); O, O-dimetyl-O-[2-(metylsulfanyl)etyl]-fosforotioát |
211-666-9 |
682-80-4 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
015-117-00-2 |
demefión-S (ISO); O, O-dimetyl-S-[2-(metylsulfanyl)etyl]-fosforotioát |
219-971-9 |
2587-90-8 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
015-118-00-8 |
demetón |
— |
8065-48-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
015-119-00-3 |
dimetyl-[4-(metylsulfanyl)fenyl]-fosfát |
— |
3254-63-5 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-120-00-9 |
ditalimfos (ISO); O, O-dietyl-N-ftaloylfosforamidotioát |
225-875-8 |
5131-24-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
015-121-00-4 |
edifénfos (ISO); O-etyl-S, S-difenyl-fosforoditioát |
241-178-1 |
17109-49-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
|
|
|
|
015-122-00-X |
etrimfos (ISO); O-(6-etoxy-2-etylpyrimidín-4-yl)-O, O-dimetyl-fosforotioát |
253-855-9 |
38260-54-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
015-123-00-5 |
fenamifos (ISO); etyl-[3-metyl-4-(metylsulfanyl)fenyl]-N-izopropylfosforamidát |
244-848-1 |
22224-92-6 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H300 H310 H330 H319 H400 H410 |
GHS06 GHS09 Dgr |
H300 H310 H330 H319 H410 |
|
M = 100 M = 100 |
|
|
015-124-00-0 |
fostietán (ISO); dietyl-N-(1,3-ditietán-2-ylidén)fosforamidát |
244-437-7 |
21548-32-3 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
015-125-00-6 |
glyfozín (ISO); N, N-bis(fosfonometyl)glycín |
219-468-4 |
2439-99-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
015-126-00-1 |
heptenofos (ISO); (7-chlórbicyklo[3.2.0]hepta-2,6-dién-6-yl)-dimetyl-fosfát |
245-737-0 |
23560-59-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
015-127-00-7 |
iprobénfos (ISO); S-benzyl-O, O-diizopropyl-fosforotioát |
247-449-0 |
26087-47-8 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
015-128-00-2 |
IPSP; S-[(etylsulfinyl)metyl]-O, O-diizopropyl-fosforoditioát |
— |
5827-05-4 |
Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H301 H400 H410 |
GHS06 GHS09 Dgr |
H310 H301 H410 |
|
M = 100 |
|
|
015-129-00-8 |
izofénfos (ISO); O-etyl-O-[2-(izopropoxykarbonyl)fenyl]-N-izopropylfosforamidotioát |
246-814-1 |
25311-71-1 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 100 |
|
|
015-130-00-3 |
izotioát (ISO); S-[2-(izopropylsulfanyl)etyl]-O, O-dimetylfosforoditioát; |
— |
36614-38-7 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
015-131-00-9 |
izoxatión (ISO); O, O-dietyl-O-(5-fenylizoxazol-3-yl)-fosforotioát |
242-624-8 |
18854-01-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
015-132-00-4 |
S-{[(4-chlórfenyl)sulfanyl]metyl}-O, O-dimetyl-fosforoditioát; metylkarbofenotión |
— |
953-17-3 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 1000 |
|
|
015-133-00-X |
piperofos (ISO); S-[(2-metylpiperidín-1-karbonyl)mety1]-O, O-dipropyl-fosforoditioát |
— |
24151-93-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
015-134-00-5 |
pirimifos-metyl (ISO); O-[2-(dietylamino)-6-metylpyrimidín-4-yl]-O, O-dimetyl-fosforotioát |
249-528-5 |
29232-93-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
015-135-00-0 |
profenofos (ISO); O-(4-bróm-2-chlórfenyl)-O-etyl-S-propylfosforotioát |
255-255-2 |
41198-08-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 1000 |
|
|
015-136-00-6 |
O-izopropyl-(Z)-3-{[(etylamino)(metoxy)fosforotioyl]oxy}but-2-enoát; izopropyl-(E)-3-{[(etylamino)(metoxy)fosforotioyl]oxy}but-2-enoát; propetámfos (ISO) |
250-517-2 |
31218-83-4 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
015-137-00-1 |
pyrazofos (ISO); O, O-dietyl-O-[6-(etoxykarbonyl)-5-metylpyrazolo[2,3-a]pyrimidín-2-yl]-fosforotioát |
236-656-1 |
13457-18-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
|
|
015-138-00-7 |
kvinalfos (ISO); O, O-dietyl-O-(chinoxalín-2-yl)-fosforotioát |
237-031-6 |
13593-03-8 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 1000 |
|
|
015-139-00-2 |
terbufos (ISO); S-[terc-(butylsulfanyl)metyl]-O, O-dietyl-fosforoditioát |
235-963-8 |
13071-79-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
015-140-00-8 |
triazofos (ISO); O, O-dietyl-O-(1-fenyl-1H-1,2,4-triazol-3-yl)-fosforotioát |
245-986-5 |
24017-47-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H410 |
|
M=100 |
|
|
015-141-00-3 |
etyléndiamónium-O, O-di(C8-alkyl)-fosforoditioát, zmes izomérov |
400-520-1 |
— |
Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H410 |
|
|
|
|
015-142-00-9 |
butyl-[dialkyloxy(dibutoxyfosforyloxy)titánium]-(trialkyloxytitánium)-fosfát |
401-100-0 |
— |
Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 |
H225 H319 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H319 H411 |
|
|
T |
|
015-143-00-4 |
reakčná zmes zložená z izomérov (2-chlóretyl)-(chlórpropyl)-(2-chlóretyl)fosfonátu a izomérov (2-chlóretyl)-(chlórpropyl)-(2-chlórpropyl)fosfonátu |
401-740-0 |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-144-00-X |
reakčná zmes zložená z pentyl-metylfosfinátu a (2-metylbutyl)-metylfosfinátu |
402-090-0 |
87025-52-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
015-145-00-5 |
reakčná zmes zložená z kuprium(I)-O, O-diizopropyl-fosforoditioátu a kuprium(I)-O-izopropyl-O-(4-metylpentán-2-yl)-fosforoditioátu a kuprium(I)-O, O-bis(4-metylpentán-2-yl)-fosforoditioátu |
401-520-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-146-00-0 |
S-{tricyklo[5.2.1.02,6]deka-3-én-8(alebo 9)-yl}-O-(izopropyl alebo izobutyl alebo 2-etylhexyl)-O-(izopropyl alebo izobutyl alebo 2-etylhexyl)-fosforoditioát |
401-850-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-147-00-6 |
reakčná zmes zložená z (C12-14-terc-alkylamónium)-difenyl-fosforotioátu a dinonylsulfánu (alebo disulfánu) |
400-930-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
015-148-00-1 |
kyselina 2-(difosfonometyl)jantárová |
403-070-4 |
51395-42-7 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
015-149-00-7 |
reakčná zmes zložená z týchto látok: hexyldi(oktyl)fosfán-oxid; dihexyl(oktyl)fosfán-oxid; trioktylfosfán-oxid |
403-470-9 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
015-150-00-2 |
[2-(1,3-dioxolán-2-yl)etyl]tri(fenyl)fosfónium-bromid |
404-940-6 |
86608-70-0 |
Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3 |
H302 H318 H373 ** H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H318 H373 ** H412 |
|
|
|
|
015-151-00-8 |
tris(izopropyl/terc-butylfenyl)-fosfát |
405-010-2 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-152-00-3 |
dioxabenzofos (ISO); 2-metoxy-4H-1,3,2-benzodioxafosforín-2-sulfid |
223-292-3 |
3811-49-2 |
Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2 |
H311 H301 H370 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H311 H301 H370 ** H411 |
|
|
|
|
015-153-00-9 |
isazofos (ISO); O, O-dietyl-O-(5-chlór-1-izopropyl-1,2,4-triazol-3-yl)-fosforotioát |
255-863-8 |
42509-80-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H311 H301 H373 ** H317 H410 |
|
|
|
|
015-154-00-4 |
etefón; kyselina (2-chlóretyl)fosfónová |
240-718-3 |
16672-87-0 |
Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 |
H311 H332 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H332 H302 H314 H411 |
EUH071 |
|
|
|
015-155-00-X |
glufosinát-amónium (ISO); amónium-2-amino-4-[hydroxy(metyl)fosforyl]butanoát |
278-636-5 |
77182-82-2 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H360Fd H332 H312 H302 H373** |
GHS08 GHS07 Dgr |
H360Fd H332 H312 H302 H373** |
|
|
|
|
015-156-00-5 |
O-metyl-3-[(dimetoxyfosforotioyl)oxy]-2-metylpropenoát; [1] metakrifos (ISO); O-metyl-(E)-3-[(dimetoxyfosforotioyl)oxy]-2-metylpropenoát [2] |
250-366-9 [1]-[2] |
30864-28-9 [1] 62610-77-9 [2] |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
015-157-00-0 |
kyselina fosforitá; [1] kyselina dihydrogenhydridotrioxofosforečná [2] |
237-066-7 [1] 233-663-1 [2] |
13598-36-2 [1] 10294-56-1 [2] |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
015-158-00-6 |
hexafluorofosforečnan (η-cyklopentadienido)-(η-izopropylbenzén)železnatý |
402-340-9 |
32760-80-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
015-159-00-1 |
kyselina fosfono(hydroxy)octová |
405-710-8 |
23783-26-8 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 |
H302 H373 ** H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H314 H317 |
|
|
|
|
015-160-00-7 |
difosforečnan vanadylu |
406-260-5 |
58834-75-6 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
015-161-00-2 |
difosforečnan divanadylu |
407-130-0 |
65232-89-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
015-162-00-8 |
hemihydrát hydrohenfosforečnan-oxidu vanadičitého, s prímesou lítia, zinku, molybdénu, železa a chlóru |
407-350-7 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H373 ** H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H332 H373 ** H318 H411 |
|
|
|
|
015-163-00-3 |
bis(2,6-dimetoxybenzoyl)(2,4,4- trimetylpentyl)fosfán-oxid |
412-010-6 |
145052-34-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
015-164-00-9 |
dihydrát kalcium-P, P'-(1- hydroxyetylén)bis(hydrogenfosfonátu) |
400-480-5 |
36669-85-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
015-165-00-4 |
reakčná zmes zložená z týchto látok: bishexafluorofosforečnan S, S,S',S'- tetrafenylsulfándiylbis(4,1- fenylén)disulfónia; difenyl[4-(fenylsulfanyl)fenyl]sulfónium-hexafluorofosfát; |
404-986-7 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
015-166-00-X |
3,9-bis(2,6-di-terc-butyl-4-metylfenoxy)- 2,4,8,10-tetraoxa-3,9- difosfaspiro[5.5]undekán |
410-290-4 |
80693-00-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
015-167-00-5 |
kyselina 3-[fenyl(hydroxy)fosforyl]propánová |
411-200-6 |
14657-64-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
015-168-00-0 |
fostiazát (ISO); (RS)-S-sek-butyl-O-etyl-(2-oxo-1,3- tiazolidín-3-yl)fosfonotioát |
— |
98886-44-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
EUH070 |
|
|
|
015-169-00-6 |
tetrafluoroboritan tributyl(tetradecyl)fosfónia |
413-520-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H317 H410 |
|
|
|
|
015-170-00-1 |
reakčná zmes zložená z týchto látok: bis(N, N,N-trimetyloktán-1-amónium)-oktylfosfát; (N, N,N-trimetyloktán-1-amónium)-dioktylfosfát; (N, N,N-trimetyloktán-1-amónium)-oktylhydrogenfosfát |
407-490-9 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
015-171-00-7 |
O, O,O-tris[2(alebo 4)-C9-10-izoalkylfenyl]-fosforotioát |
406-940-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-172-00-2 |
reakčná zmes zložená z týchto látok: bis(izotridecylamónium)-[bis(4- metylpentán-2- yloxy)fosforoditionylizopropyl]-fosfát; (izotridecylamónium)-bis[bis(4- metylpentán-2- yloxy)fosforoditionylizopropyl]-fosfát |
406-240-6 |
— |
Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 |
H226 H314 H411 |
GHS02 GHS05 GHS09 Dgr |
H226 H314 H411 |
|
|
|
|
015-173-00-8 |
(2-terc-butyl-6-metoxypyrimidín-4-yl)- metyl-etylfosfonotioát |
414-080-3 |
117291-73-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
015-174-00-3 |
1-chlór-N, N-dietyl-1,1-difenyl-1-(fenylmetyl) fosfánamín |
411-370-1 |
82857-68-9 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2 |
H301 H318 H411 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H411 |
|
|
|
|
015-175-00-9 |
terc-butyl-(trifenylfosforanylidén)acetát |
412-880-7 |
35000-38-5 |
Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H301 H373 ** H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H319 H317 H411 |
|
|
|
|
015-176-00-4 |
P, P,P',P'-tetrakis-(2-metoxyfenyl)propán-1,3-difosfán |
413-430-2 |
116163-96-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-177-00-X |
kyselina [(4-fenylbutyl)(hydroxy)fosforyl]octová |
412-170-7 |
83623-61-4 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373 ** H318 H317 |
GHS08 GHS05 Dgr |
H373 ** H318 H317 |
|
|
|
|
015-178-00-5 |
monohydrát (R)-(1-fenyletán-1-amónium)-(- )-(1R,2S)-(2-metyloxiranyl)fosfonátu |
418-570-8 |
25383-07-7 |
Repr. 2 Aquatic Chronic 2 |
H361f *** H411 |
GHS08 GHS09 Wng |
H361f *** H411 |
|
|
|
|
015-179-00-0 |
UVCB produkt kondenzácie tetrakis(hydroxymetyl)fosfónium-chloridu, močoviny a destilovaných (C16-18-alkyl)amínov získaných z hydrogenovaného loja |
422-720-8 |
166242-53-1 |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H302 H373 ** H314 H317 H410 |
|
|
|
|
015-180-00-6 |
kyselina [R-(R*,S*)]-(4-fenylbutyl)[2-metyl-1-(propanoyloxy)propoxy]fosfanyl]octová, soľ s (-)-cinchonidínom (1:1) |
415-820-8 |
137590-32-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
015-181-00-1 |
fosfán |
232-260-8 |
7803-51-2 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H220 H330 H314 H400 |
GHS02 GHS04 GHS06 GHS05 GHS09 Dgr |
H220 H330 H314 H400 |
|
|
U |
|
015-182-00-7 |
tetraizopropyl-(dichlórmetylén)bisfosfonát |
430-630-5 |
10596-22-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
015-183-00-2 |
kyselina (1-hydroxydodekán-1,1-diyl)difosfónová |
425-230-2 |
16610-63-2 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
015-184-00-8 |
soli glyfozátu, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
A |
|
015-186-00-9 |
chlórpyrifos-metyl (ISO) O, O-dimetyl-O-(3,5,6-trichlór-2-pyridyl)- fosforotioát |
227-011-5 |
5598-13-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 10000 |
|
|
015-187-00-4 |
reakčná zmes zložená z týchto látok: N-oxid tetranátrium-{[(2-hydroxyetyl)imino]bis(metylén)}difosfonátu; N, P-dioxid trinátrium-[(2-oxidotetrahydro- 4H-1,4,2-oxazafosforín-4-yl]- metylfosfonátu |
417-540-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
015-189-00-5 |
fenylbis(2,4,6-trimetylbenzoyl)fosfán-oxid |
423-340-5 |
162881-26-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
015-190-00-0 |
bis(2,4-dikumylfenyl)-neopentyl-difosfit; 3,9-bis[2,4-bis(2-fenylpropán-2-yl)fenoxy]- 2,4,8,10-tetraoxa-3,9- difosfaspiro[5.5]undekán |
421-920-2 |
154862-43-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
015-191-00-6 |
dodecyl-difenyl-fosfát |
431-760-5 |
27460-02-2 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
015-192-00-1 |
tetrakis(2,6-dimetylfenyl)-(1,3-fenylén)- bisfosfát |
432-770-2 |
139189-30-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
015-193-00-7 |
[benzyltri(fenyl)fosfónium]-N-metyl-N- (1,1,2,2,3,3,4,4,4-nonafluórbután-1- sulfonyl)azanid (1:1) |
442-960-7 |
332350-93-3 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H400 H410 |
GHS05 GHS06 GHS09 Dgr |
H301 H318 H410 |
|
|
|
|
015-194-00-2 |
(tetrabutylfosfónium)-nonafluórbután-1- sulfonát |
444-440-5 |
220689-12-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
015-195-00-8 |
reakčná zmes zložená z týchto látok: kálium-2-metylfenylfosfonát; kálium-3-metylfenylfosfonát; kálium-4-metylfenylfosfonát |
433-860-4 |
— |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
015-196-00-3 |
reakčná zmes zložená z týchto látok: dimetyl-{2- [(hydroxymetyl)karbamoyl]etyl}fosfonát; dietyl-{2- [(hydroxymetyl)karbamoyl]etyl}fosfonát; etyl-metyl-{2- [(hydroxymetyl)karbamoyl]etyl}fosfonát |
435-960-3 |
— |
Carc. 1B Muta. 1B Skin Sens. 1 |
H350 H340 H317 |
GHS08 GHS07 Dgr |
H350 H340 H317 |
|
|
|
|
015-197-00-9 |
kyselina bis(2,4,4- trimetylpentyl)ditiofosfónová |
420-160-9 |
107667-02-7 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H302 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H302 H314 H411 |
|
|
|
|
015-198-00-4 |
kyselina (4-fenylbutyl)fosfínová |
420-450-5 |
86552-32-1 |
Carc. 2 Eye Dam. 1 |
H351 H318 |
GHS05 GHS08 Dgr |
H351 H318 |
|
|
|
|
015-199-00-X |
tris[2-chlór-1-(chlórmetyl)etyl]-fosfát |
237-159-2 |
13674-87-8 |
Carc. 2 |
H351 |
GSH08 Wng |
H351 |
|
|
|
|
015-200-00-3 |
fosfid india |
244-959-5 |
22398-80-7 |
Carc. 1B Repr. 2 STOT RE 1 |
H350 H361f H372 (pľúca) |
GHS08 Dgr |
H350 H361f H372 (pľúca) |
|
STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % |
|
|
015-201-00-9 |
trixylyl fosfát |
246-677-8 |
25155-23-1 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
015-202-00-4 |
tris(nonylfenyl)fosfit |
247-759-6 |
26523-78-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
015-203-00-X |
difenyl(2,4,6-trimetylbenzoyl)fosfinoxid |
278-355-8 |
75980-60-8 |
Repr. 2 |
H361f (spôsobuje atrofiu semenníkov) |
GHS08 Wng |
H361f (spôsobuje atrofiu semenníkov) |
|
|
|
|
016-001-00-4 |
sírovodík |
231-977-3 |
7783-06-4 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * Aquatic Acute 1 |
H220 H330 H400 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H330 H400 |
|
|
U |
|
016-002-00-X |
sulfid bárnatý |
244-214-4 |
21109-95-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
EUH031 |
|
|
|
016-003-00-5 |
polysulfidy bárnaté |
256-814-3 |
50864-67-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
016-004-00-0 |
sulfid vápenatý |
243-873-5 |
20548-54-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
016-005-00-6 |
polysulfidy vápenaté |
215-709-2 |
1344-81-6 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
016-006-00-1 |
sulfid draselný; sulfid draselný |
215-197-0 |
1312-73-8 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
016-007-00-7 |
polysulfidy draselné |
253-390-1 |
37199-66-9 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
016-008-00-2 |
polysulfidy amónne |
232-989-1 |
9080-17-5 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥1% |
|
|
016-009-00-8 |
sulfid sodný; sulfid sodný |
215-211-5 |
1313-82-2 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H311 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H400 |
|
|
|
|
016-010-00-3 |
polysulfidy sodné |
215-686-9 |
1344-08-7 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
EUH031 |
|
|
|
016-011-00-9 |
oxid siričitý |
231-195-2 |
7446-09-5 |
Press. Gas Acute Tox. 3 * Skin Corr. 1B |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
* |
U5 |
|
016-012-00-4 |
dichlorid disíry; chlorid sírny |
233-036-2 |
10025-67-9 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H301 H332 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H332 H314 H400 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1% |
|
|
016-013-00-X |
chlorid sírnatý |
234-129-0 |
10545-99-0 |
Skin Corr. 1B STOT SE 3 Aquatic Acute 1 |
H314 H335 H400 |
GHS05 GHS07 GHS09 Dgr |
H314 H335 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5% |
|
|
016-014-00-5 |
chlorid siričitý |
— |
13451-08-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5% |
|
|
016-015-00-0 |
dichlorid-oxid siričitý; chlorid tionylu; |
231-748-8 |
7719-09-7 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H332 H302 H314 |
GHS05 GHS07 Dgr |
H332 H302 H314 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1% |
|
|
016-016-00-6 |
chlorid sulfurylu |
232-245-6 |
7791-25-5 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
016-017-00-1 |
kyselina chlórsírová |
232-234-6 |
7790-94-5 |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
016-018-00-7 |
kyselina fluorosírová |
232-149-4 |
7789-21-1 |
Acute Tox. 4 * Skin Corr. 1A |
H332 H314 |
GHS05 GHS07 Dgr |
H332 H314 |
|
|
|
|
016-019-00-2 |
óleum ... % SO3 |
— |
— |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
B |
|
016-020-00-8 |
kyselina sírová ... % |
231-639-5 |
7664-93-9 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 15% Skin Irrit. 2; H315: 5% ≤ C < 15% Eye Irrit. 2; H319: 5% ≤ C < 15% |
B |
|
016-021-00-3 |
metántiol; metylsulfán |
200-822-1 |
74-93-1 |
Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
|
016-022-00-9 |
etántiol; etylsulfán |
200-837-3 |
75-08-1 |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H410 |
|
|
|
|
016-023-00-4 |
dimetyl-sulfát |
201-058-1 |
77-78-1 |
Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H350 H341 H330 H301 H314 H317 |
GHS06 GHS08 GHS05 Dgr |
H350 H341 H330 H301 H314 H317 |
|
Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5% |
|
|
016-024-00-X |
dimexano (ISO); O, O’-dimetyl-disulfánbis(karbotioát) |
215-993-8 |
1468-37-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
016-025-00-5 |
disul (ISO); [2-(2,4-Dichlórfenoxy)etyl]-hydrogensulfát; 2,4-DES |
205-259-5 |
149-26-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Dgr |
H302 H315 H318 |
|
|
|
|
016-026-00-0 |
kyselina amidosírová; kyselina sulfámová; kyselina sulfamidová |
226-218-8 |
5329-14-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
016-027-00-6 |
dietyl-sulfát |
200-589-6 |
64-67-5 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H340 H332 H312 H302 H314 |
GHS05 GHS08 GHS07 Dgr |
H350 H340 H332 H312 H302 H314 |
|
|
|
|
016-028-00-1 |
ditioničitan sodný; ditioničitan sodný |
231-890-0 |
7775-14-6 |
Self-heat. 1 Acute Tox. 4 * |
H251 H302 |
GHS02 GHS07 Dgr |
H251 H302 |
EUH031 |
|
|
|
016-029-00-7 |
kyselina 4-metylbenzénsulfónová, s obsahom viac ako 5 % H2SO4 |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H315: 10% ≤ C < 25% Eye Irrit. 2; H319: 10% ≤ C < 25% |
|
|
016-030-00-2 |
kyselina 4-metylbenzénsulfónová (s obsahom maximálne 5 % H2SO4) |
203-180-0 |
104-15-4 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 20% |
|
|
016-031-00-8 |
tetrahydrotiofén-1,1-dioxid; sulfolán |
204-783-1 |
126-33-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
016-032-00-3 |
propán-1,3-sultón; 1,2-oxatiolán-2,2-dioxid |
214-317-9 |
1120-71-4 |
Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H350 H312 H302 |
GHS08 GHS07 Dgr |
H350 H312 H302 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
016-033-00-9 |
dimetylsulfamoylchlorid |
236-412-4 |
13360-57-1 |
Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H330 H312 H302 H314 |
GHS06 GHS05 GHS08 Dgr |
H350 H330 H312 H302 H314 |
|
|
|
|
016-034-00-4 |
tetranátrium-3,3'-{(piperazín-1,4- diyl)bis[(6-chlór-1,3,5-triazín-2,4- diyl)imino(2-acetamido-4,1- fenylén)diazenyl]}bis(naftalén-1,5- disulfonát) |
400-010-9 |
81898-60-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-035-00-X |
pentanátrium-5-anilino-3-{[4-({4-[6-chlór- 4-(3-sulfonátoanilino)-1,3,5-triazín-2- ylamino]-2,5-dimetylfenyl}diazenyl)-2,5- disulfonátofenyl]diazenyl}-4- hydroxynaftalén-2,7-disulfonát |
400-120-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-036-00-5 |
tetranátrium-4-[(4,6-dichlór-5- kyanopyrimidín-2-yl)amino]-6-[(1,5- disulfonátonaftalén-2-yl)diazenyl]-5- hydroxynaftalén-1,7-disulfonát |
400-130-1 |
— |
Resp. Sens. 1 Aquatic Chronic 2 |
H334 H411 |
GHS08 GHS09 Dgr |
H334 H411 |
|
|
|
|
016-037-00-0 |
dinátrium-1-amino-4-(4- benzénsulfónamido-3-sulfonátoanilino)- 9,10-dioxo-9,10-dihydroantracén-2-sulfonát |
400-350-8 |
85153-93-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
016-038-00-6 |
dinátrium-7-{[6-(N,2-dimetylanilino)-4- chlór-1,3,5-triazín-2-yl]amino}-4-hydroxy- 3-[(4-metoxy-2- sulfonátofenyl)diazenyl]naftalén-2-sulfonát |
400-380-1 |
86393-35-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-039-00-1 |
tetranátrium-2-(4-{4-[2,5-dimetyl-4-(2,5- disulfonátofenyldiazenyl)fenyldiazenyl]-3- ureidoanilino}-6-chlór-1,3,5-triazín-2- ylamino)benzén-1,4-disulfonát |
400-430-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-040-00-7 |
reakčná zmes zložená z dinátrium-6-(2,4- dihydroxyfenyldiazenyl)-3-{4-[4-(2,4- dihydroxyfenyldiazenyl)anilino]-3- sulfonátofenyldiaazenyl}-4- hydroxynaftalén-2-sulfonátu a dinátrium-6-(2,4-diaminofenyldiazenyl)- 3-{4-[4-(2,4-diaminofenyldiazenyl)anilino]- 3-sulfonátofenyldiazenyl}-4- hydroxynaftalén-2-sulfonátu a trinátrium-6- (2,4-dihydroxyfenyldiazenyl)-3-(4-{4-[7- (2,4-dihydroxyfenyldiazenyl)-1-hydroxy-3- sulfonáto-2-naftyldiazenyl]anilino}-3- sulfonátofenyldiazenyl)-4-hydroxynaftalén- 2-sulfonátu |
400-570-4 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-041-00-2 |
kalcium-4-[5-hydroxy-4-(5-chlór-4-metyl- 2-sulfonátofenyldiazenyl)-3-metylpyrazol- 1-yl]-2,5-dichlórbenzénsulfonát |
400-710-4 |
— |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
016-042-00-8 |
tetranátrium-5-benzamido-3-{5-[4-fluór-6- (1-sulfonáto-2-naftylamino)-1,3,5-triazín-2- ylamino]-2-sulfonátofenyldiazenyl}-4- hydroxynaftalén-2,7-disulfonát |
400-790-0 |
85665-97-0 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
016-043-00-3 |
dilítium-6-acetamido-4-hydroxy-3-{4-[(2- sulfonátooxy)etylsulfonyl]fenyldiazenyl}na ftalén-2-sulfonát |
401-010-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-044-00-9 |
dihydrát dinátrium-S, S’-(hexán-1,6-diyl)- bis(tiosulfátu) |
401-320-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
016-045-00-4 |
lítium-nátrium-hydrogen-4-amino-6-[5- (2,6-difluór-5-chlór-pyrimidín-4-ylamino)- 2-sulfonátofenyldiazenyl]-5-hydroxy-3-{4- [2- (sulfonátooxy)etylsulfonyl]fenyldiazenyl}n aftalén-2,7-disulfonát |
401-560-2 |
108624-00-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-046-00-X |
hydrogensíran sodný |
231-665-7 |
7681-38-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
016-047-00-5 |
hexanátrium-7-(4-{4-[4-(2,5- disulfonátoanilino)-6-fluór-1,3,5-triazín-2- ylamino]-2-metylfenyldiazenyl}-7- sulfonátonaftalén-1-yldiazenyl)naftalén- 1,3,5-trisulfonát |
401-650-1 |
85665-96-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-048-00-0 |
nátrium-2-[2,6-bis(3-hydroxypropylamino)- 5-kyano-4-metylpyridín-3-yldiazenyl]-3,5- dichlórbenzénsulfonát |
401-870-8 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
016-049-00-6 |
kalcium-dimetyl(oktadecyl)benzénsulfonát |
402-040-8 |
— |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
016-050-00-1 |
kálium-nátrium-2,2'-{(N-metylbenzén-1,4- diamín-N, N'-diyl)bis[(6-chlór-1,3,5-triazín- 2,4-diyl)imino(1-hydroxy-3,6- disulfonátonaftalén-8,2- diyl)diazenyl]}di(benzén-1-sulfonát) |
402-150-6 |
— |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
016-051-00-7 |
trinátrium-7-[4-(6-fluór-4-{2-[2- (vinylsulfonyl)etoxy]etylamino}-1,3,5- triazín-2-ylamino)-2- ureidofenyldiazenyl]naftalén-1,3,6- trisulfonát |
402-170-5 |
106359-91-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-052-00-2 |
[benzyltri(butyl)amónium]-4-hydroxynaftalén-1-sulfonát |
402-240-5 |
102561-46-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
016-053-00-8 |
[(hexadecyl- alebo oktadecyl)(hexadecyl- alebo oktadecyl)amónium]-{2-[(hexadecyl- alebo oktadecyl)(hexadecyl- alebo oktadecyl)karbamoyl]benzénsulfonát} |
402-460-1 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
016-054-00-3 |
nátrium-4-(2,4,4-trimetylpentylkarbonyloxy)benzénsulfonát |
400-030-8 |
— |
Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Sens. 1 |
H331 H372 ** H302 H319 H335 H317 |
GHS06 GHS08 Dgr |
H331 H372 ** H302 H319 H335 H317 |
|
|
|
|
016-055-00-9 |
tetranátrium-4-amino-5-hydroxy-3,6-bis{5- [6-chlór-4-(2-hydroxyetylamino)-1,3,5- triazín-2-ylamino]-2- sulfonátofenyldiazenyl}naftalén-2,7- sulfonát (s obsahom viac ako 35 % chloridu sodného a octanu sodného) |
400-510-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
016-056-00-4 |
hydrogensíran draselný |
231-594-1 |
7646-93-7 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
016-057-00-X |
4-vinylbenzénsulfonylchlorid |
404-770-2 |
2633-67-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
016-058-00-5 |
produkt reakcie chloridu tionylu s 1,3,4-tiadiazol-2,5-ditiolom, terc-nonántiolom a (C12-14-terc-alkyl)amínom |
404-820-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
016-059-00-0 |
N, N,N',N'-tetrametyl-2,2'- disulfándiylbis(etán-1-amónium)-dichlorid |
405-300-9 |
17339-60-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H317 H410 |
|
|
|
|
016-060-00-6 |
peroxodisíran amónny; amónium-persulfát |
231-786-5 |
7727-54-0 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
016-061-00-1 |
peroxodisíran draselný; kálium-persulfát |
231-781-8 |
7727-21-1 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
016-062-00-7 |
bensultap (ISO); bensultap (ISO); S, S-[2-(dimetylamino)prop-1-én-1,3-diyl]- bis(benzéntiosulfonát) |
— |
17606-31-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
016-063-00-2 |
disiričitan sodný |
231-673-0 |
7681-57-4 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
EUH031 |
|
|
|
016-064-00-8 |
hydrogensiričitan sodný... %; hydrogensiričitan sodný. . . % |
231-548-0 |
7631-90-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
EUH031 |
|
B |
|
016-065-00-3 |
nátrium-1-amino-4-[2-metyl-5-(4- metylbenzénsulfónamido)fenylamino]antrac hinón-2-sulfonát |
400-100-8 |
84057-97-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
016-066-00-9 |
{5-[(4-amino-6-chlór-1,3,5-triazín-2- yl)amino]-2-[(2-hydroxy-3,5- disulfonátofenyldiazenyl)-2- sulfonátobenzylidénhydrazino]benzoáto}me ďnatan tetrasodný |
404-070-7 |
116912-62-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
016-067-00-4 |
O-(4-metylfenyl)-2,4,6- trimetylbenzénsulfonát |
407-530-5 |
67811-06-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
016-068-00-X |
nátrium-3,5- bis(tetradecyloxykarbonyl)benzénsulfinát |
407-720-8 |
155160-86-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
016-069-00-5 |
kyselina 3,5-bis- (tetradecyloxykarbonyl)benzénsulfinová |
407-990-7 |
141915-64-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
016-070-00-0 |
[4-(benzyloxy)fenyl]{4'-[(1- metyloxiranyl)metoxy]fenyl}sulfón |
408-220-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
016-071-00-6 |
trinátrium-3-amino-6,13-dichlór-10-[(3-{[4- chlór-6-(2-sulfonátoanilino)-1,3,5-triazín-2- yl]amino}propyl)amino]-1,4- benzoxazino[2,3-b]fenoxazín-4,11- disulfonát |
410-130-3 |
136248-03-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-072-00-1 |
3-amino-4-hydroxy-N-(2-metoxyetyl)benzénsulfónamid |
411-520-6 |
112195-27-4 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
016-073-00-7 |
N, N,N',N'-tetrabenzyldisulfánbis(karbotioamid) |
404-310-0 |
10591-85-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
016-074-00-2 |
6-fluór-2-metyl-3-[4-(metylsulfanyl)benzyl]indén |
405-410-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
016-075-00-8 |
2,2'-dialyl-4,4'-sulfonyldifenol |
411-570-9 |
41481-66-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
016-076-00-3 |
2,3-bis[(2-sulfanyletyl)sulfanyl]propán-1-tiol |
411-290-7 |
131538-00-6 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
|
016-077-00-9 |
2-chlór-4-metylbenzénsulfonylchlorid |
412-890-1 |
42413-03-6 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H314 H317 H412 |
GHS05 GHS07 Dgr |
H314 H317 H412 |
|
|
|
|
016-078-00-4 |
4-metyl-N, N-bis[2-(4-metylbenzénsulfónamido)etyl]benzénsulfónamid |
413-300-5 |
56187-04-3 |
Aquatic Chronic 4 |
H413 |
— |
|
|
|
|
|
016-079-00-X |
4-metyl-N, N-bis[2-(4-metylbenzénsulfonyloxy)etyl]benzénsulfónamid |
412-920-3 |
16695-22-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
016-080-00-5 |
nátrium-2-anilino-5-[4-(N-fenylsulfamoyl)- 2-nitroanilino]benzénsulfonát |
412-320-1 |
31361-99-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
016-081-00-0 |
[hexahydrocyklopenta[c]pyrol-1-(1H)-amónium]-N-(etoxykarbonyl)-N-(4-metylbenzénsulfonyl)azanid |
418-350-1 |
— |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H302 H319 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H319 H317 H411 |
|
|
|
|
016-082-00-6 |
etoxysulfurón (ISO); 1-(4,6-dimetoxypyrimidín-2-yl)-3-(2- etoxyfenoxysulfonyl)močovina |
— |
126801-58-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
016-083-00-1 |
acibenzolar-S-metyl; S-metylester kyseliny benzo[1,2,3]tiadiazol- 7-karbotiovej |
420-050-0 |
135158-54-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
016-084-00-7 |
prosulfurón (ISO); 1-(4-metoxy-6-metyl-1,3,5-triazín-2-yl)-3- [2-(3,3,3- trifluórpropyl)benzénsulfonyl]močovina |
— |
94125-34-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=100 |
|
|
016-085-00-2 |
flazasulfurón (ISO); 1-(4,6-dimetoxypyrimidín-2-yl)-3-[3- (trifluórmetyl)pyridín-2-sulfonyl]močovina |
— |
104040-78-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
016-086-00-8 |
tetranátrium-10-amino-3-{3-[4-(2,5-disulfonátoanilino)-6-fluór-1,3,5-triazín-2-ylamino]prop-3-ylamino}-6,13-dichlór-5,12-dioxa-7,14-diazapentacén-4,11-disulfonát |
402-590-9 |
109125-56-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
016-087-00-3 |
reakčná zmes zložená z týchto látok: S, S,S',S'-tetrafenylsulfándiylbis(4,1- fenylén)disulfónium-bishexafluorofosfát; difenyl[4-(fenylsulfanyl)fenyl]sulfóniumhexafluorofosfát; propán-1,2-diyl-karbonát |
403-490-8 |
104558-95-4 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H317 H410 |
|
|
|
|
016-088-00-9 |
kyselina 4-{bis[4-(dietylamino)fenyl]metyl}benzén-1,2-di(metánsulfónová) |
407-280-7 |
71297-11-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
016-089-00-4 |
reakčná zmes zložená z esterov 3,3,3',3'-tetrametyl-1,1'-spirobiindán-5,5',6,6',7,7'-hexaolu a kyseliny 2-diazo-1- oxo-1,2-dihydronaftalén-5-sulfónovej |
413-840-1 |
— |
Self-react. C **** Aquatic Chronic 4 |
H242 H413 |
GHS02 Dgr |
H242 H413 |
|
|
|
|
016-090-00-X |
4-metyl-N-(metánsulfonyl)benzénsulfónamid |
415-040-8 |
14653-91-9 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
|
|
|
016-091-00-5 |
(C12-14-terc-alkyl)amónium-1-amino-9,10- dioxo-4-(2,4,6-trimetylanilino)-9,10- dihydroantracén-2-sulfonát |
414-110-5 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
016-092-00-0 |
reakčná zmes zložená z týchto látok: 4,7-bis(sulfanylmetyl)-3,6,9-tritiaundekán- 1,11-ditiol; 4,8-bis(sulfanylmetyl)-3,6,9-tritiaundekán- 1,11-ditiol; 5,7-bis(sulfanylmetyl)-3,6,9-tritiaundekán- 1,11-ditiol; |
427-050-1 |
— |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f H315 H317 H410 |
|
|
|
|
016-093-00-6 |
reakčná zmes zložená z týchto látok: tris(6-diazo-5-oxo-5,6-dihydronaftalén-1- sulfonát)-4-(7-hydroxy-2,4,4- trimetylchromán-2-yl)benzén-1,3-diol; bis(6-diazo-5-oxo-5,6-dihydronaftalén-1- sulfonát)-4-(7-hydroxy-2,4,4- trimetylchromán-2-yl)benzén-1,3-diol (2:1) |
414-770-4 |
140698-96-0 |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
016-094-00-1 |
síra |
231-722-6 |
7704-34-9 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
016-095-00-7 |
reakčná zmes zložená z týchto látok: produkt reakcie 4,4'-metylénbis[2-(4-hydroxybenzyl)-3,6-dimetylfenolu] a 6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonátu (1:2); produkt reakcie 4,4'-metylénbis[2-(4-hydroxybenzyl)-3,6-dimetylfenolu] a 6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonátu (1:3) |
417-980-4 |
— |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
016-096-00-2 |
tifénsulfurón-metyl (ISO); metyl-3-{[(4-metoxy-6-metyl-1,3,5-triazín-2-yl)karbamoyl]sulfamoyl}tiofén-2-karboxylát |
— |
79277-27-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
016-097-00-8 |
2-metyl-2-sulfanylpropán-1-amínium-chlorid |
434-480-1 |
32047-53-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H302 H314 H317 H412 |
|
|
|
|
017-001-00-7 |
chlór |
231-959-5 |
7782-50-5 |
Ox. Gas 1 Press. Gas Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H270 H331 H319 H335 H315 H400 |
GHS03 GHS04 GHS06 GHS09 Dgr |
H270 H331 H319 H335 H315 H400 |
|
M = 100 |
U |
|
017-002-00-2 |
chlorovodík |
231-595-7 |
7647-01-0 |
Press. Gas Acute Tox. 3 * Skin Corr. 1A |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
|
U5 |
|
017-002-01-X |
kyselina chlorovodíková ... % |
231-595-7 |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H315: 10% ≤ C < 25% EyeIrrit. 2; H319: 10% ≤ C < 25% STOT SE 3; H335: C ≥ 10% |
B |
|
017-003-00-8 |
chlorečnan bárnatý |
236-760-7 |
13477-00-4 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
|
017-004-00-3 |
chlorečnan draselný |
223-289-7 |
3811-04-9 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
|
017-005-00-9 |
chlorečnan sodný |
231-887-4 |
7775-09-9 |
Ox. Sol. 1 Acute Tox. 4 * Aquatic Chronic 2 |
H271 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H302 H411 |
|
|
|
|
017-006-00-4 |
kyselina chloristá ... % |
231-512-4 |
7601-90-3 |
Ox. Liq. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10% ≤ C < 50% Skin Irrit. 2; H315: 1% ≤ C < 10% Eye Irrit. 2; H319: 1% ≤ C < 10% Ox. Liq. 1; H271: C > 50%: Ox. Liq. 2; H272: C ≤ 50%: |
B |
|
017-007-00-X |
chloristan bárnatý |
236-710-4 |
13465-95-7 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * |
H271 H332 H302 |
GHS03 GHS07 Dgr |
H271 H332 H302 |
|
|
|
|
017-008-00-5 |
chloristan draselný |
231-912-9 |
7778-74-7 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
017-009-00-0 |
chloristan amónny |
232-235-1 |
7790-98-9 |
Expl. 1.1 Ox. Sol. 1 |
H201 H271 |
GHS01 Dgr |
H201 H271 |
|
|
T |
|
017-010-00-6 |
chloristan sodný |
231-511-9 |
7601-89-0 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
017-011-00-1 |
chlórnan sodný, roztok s ... % aktívneho chlóru |
231-668-3 |
7681-52-9 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥5% |
B |
|
017-012-00-7 |
chlórnan vápenatý |
231-908-7 |
7778-54-3 |
Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H272 H302 H314 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H400 |
EUH031 |
Skin Corr. 1B; H314: C ≥ 5% Skin Irrit. 2; H315: 1% ≤ C < 5% Eye Dam.1; H318: 3% ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3% M = 10 |
T |
|
017-013-00-2 |
chlorid vápenatý |
233-140-8 |
10043-52-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
017-014-00-8 |
chlorid amónny |
235-186-4 |
12125-02-9 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
017-015-00-3 |
hydrochlorid [2-(aminometyl)fenyl]acetylchloridu |
417-410-4 |
61807-67-8 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
017-016-00-9 |
trifenyl(metyl)fosfónium-chlorid |
418-400-2 |
1031-15-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H411 |
|
|
|
|
017-017-00-4 |
(Z)-N, N-bis(2-hydroxyetyl)-N-metyldokoz- 13-én-1-amónium-chlorid |
426-210-6 |
120086-58-0 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
017-018-00-X |
N, N,N-trimetyl-2,3-bis(stearoyloxy)propán-1-amónium-chlorid |
405-660-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
017-019-00-5 |
hydrochlorid (R)-1-(3,4-dimetoxyfenyl)-6,7-dimetoxy-1,2,3,4-tetrahydroizochinolínu |
415-110-8 |
54417-53-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
017-020-00-0 |
etyl(propoxy)alumínium-chlorid |
421-790-7 |
13014-29-4 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
017-021-00-6 |
(dihydroxypropyl)(dokozánamidopropyl)di(metyl)amónium-chlorid |
423-420-1 |
136920-10-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
017-023-00-7 |
3,3',3''-[fosfántriyltris(oxy)]tris[N-(C6-18-alkyl)-2-hydroxy-N, N-dimetylpropán-1-amínium]-trichloridy |
425-520-9 |
197179-61-6 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
017-026-00-3 |
oxid chloričitý |
233-162-8 |
10049-04-4 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H270 H330 H314 H400 |
GHS04 GHS03 GHS06 GHS05 GHS09 Dgr |
H270 H330 H314 H400 |
|
M = 10 |
5 |
|
017-026-01-0 |
oxid chloričitý . . . % |
233-162-8 |
10049-04-4 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
|
Skin Corr. 1B; H314: C ≥ 5% Skin Irrit. 2; H315: 1% ≤ C < 5 % Eye Dam.1; H318: 3% ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3% STOT SE 3; H335: C ≥ 3% M = 10 |
B |
|
019-001-00-2 |
draslík |
231-119-8 |
7440-09-7 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
019-002-00-8 |
hydroxid draselný; lúh draselný |
215-181-3 |
1310-58-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
Skin Corr. 1A; H314: C ≥ 5% Skin Corr. 1B; H314: 2% ≤ C < 5% Skin Irrit. 2; H315: 0,5 % ≤ C < 2% Eye Irrit. 2; H319: 0,5 % ≤ C < 2% |
|
|
020-001-00-X |
vápnik |
231-179-5 |
7440-70-2 |
Water-react. 2 |
H261 |
GHS02 Dgr |
H261 |
|
|
|
|
020-002-00-5 |
kyanid vápenatý |
209-740-0 |
592-01-8 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
EUH032 |
|
|
|
020-003-00-0 |
reakčná zmes zložená z týchto látok: dikalcium-[bis(5-dodecyl-2-hydroxybenzyl)(metyl)amín]-dihydroxid; trikalcium-[tris(5-dodecyl-2-hydroxybenzyl)(metyl)amín]-trihydroxid; poly[kalcium-[(5-dodecyl-2-hydroxybenzyl)(metyl)amín]-hydroxid] |
420-470-4 |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
022-001-00-5 |
chlorid titaničitý |
231-441-9 |
7550-45-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
EUH014 |
|
|
|
022-002-00-0 |
titánium(4+)-oxalát |
403-260-7 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
022-003-00-6 |
bis(η5-cyklopentadienyl)-bis[2,6-difluór-3-(pyrol-1-yl)fenyl]titánium |
412-000-1 |
125051-32-3 |
Flam. Sol. 1 Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H228 H361f *** H373 ** H411 |
GHS02 GHS08 GHS09 Dgr |
H228 H361f *** H373 ** H411 |
|
|
T |
|
022-004-00-1 |
oxid didraselno-hexatitaničitý (K2Ti6O13) |
432-240-0 |
12056-51-8 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
022-005-00-7 |
[N-terc-butyl-1,1-dimetyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetrametylcyklopentadienyl]silánamináto(2-)-κN]-[(1,2,3,4-η)-penta-1,3-dién]titánium |
419-840-8 |
169104-71-6 |
Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H228 H314 H317 H413 |
GHS02 GHS05 GHS07 Dgr |
H228 H314 H317 H413 |
|
|
|
|
023-001-00-8 |
oxid vanadičný; oxid vanadičný |
215-239-8 |
1314-62-1 |
Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Chronic 2 |
H341 H361d *** H372 ** H332 H302 H335 H411 |
GHS08 GHS07 GHS09 Dgr |
H341 H361d *** H372 ** H332 H302 H335 H411 |
|
|
|
|
024-001-00-0 |
oxid chrómový |
215-607-8 |
1333-82-0 |
Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 1% |
|
|
024-002-00-6 |
dichróman draselný |
231-906-6 |
7778-50-9 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5% |
3 |
|
024-003-00-1 |
dichróman amónny |
232-143-1 |
7789-09-5 |
Ox. Sol. 2 **** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5% Resp. Sens.; H334: C ≥0,2 % Skin Sens.; H317:C ≥0,2 % |
G3 |
|
024-004-00-7 |
dichróman sodný |
234-190-3 |
10588-01-9 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS05 GHS08 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 |
|
Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317:C ≥0,2 % STOT SE 3; H335: C ≥ 5% |
3 |
|
024-005-00-2 |
dichlorid chromylu; dioxid-dichlorid chrómový |
239-056-8 |
14977-61-8 |
Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350i H340 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350i H340 H314 H317 H410 |
|
Skin Corr. 1A; H314: C ≥ 10% Skin Corr. 1B; H314: 5% ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5% STOT SE 3; H335: 0,5 % ≤ C < 5% Skin Sens. 1; H317: C ≥ 0,5 % |
T3 |
|
024-006-00-8 |
chróman draselný |
232-140-5 |
7789-00-6 |
Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H340 H319 H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H340 H319 H335 H315 H317 H410 |
|
Skin Sens. 1; H317:C ≥ 0,5 % |
3 |
|
024-007-00-3 |
chrómany zinočnaté vrátane chrómanu draselno-zinočnatého |
— |
— |
Carc. 1A Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H410 |
|
|
A |
|
024-008-00-9 |
chróman vápenatý |
237-366-8 |
13765-19-0 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
024-009-00-4 |
chróman strontnatý |
232-142-6 |
7789-06-2 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H400 H410 |
|
|
|
|
024-010-00-X |
trischróman dichromitý; trischróman dichromitý; chróman chromitý |
246-356-2 |
24613-89-6 |
Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350 H314 H317 H410 |
|
|
T |
|
024-011-00-5 |
bis[1-(3,5-dinitro-2-oxidofenyldiazenyl)-3- (N-fenylkarbamoyl)-naftalén-2- oláto]chromitan(1-) amónny |
400-110-2 |
109125-51-1 |
Self-react. C **** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Dgr |
H242 H410 |
|
|
|
|
024-012-00-0 |
bis[6-acetamido-3-(4-nitro-2- oxidofenyldiazenyl)-4-oxidonaftalén-2- sulfonáto]chromitan trisodný |
400-810-8 |
— |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
024-013-00-6 |
[7-anilino-3-(5-nitro-2-oxidofenyldiazenyl)- 4-oxidonaftalén-2-sulfonáto]-[3-oxido-4-(2- oxido-1-naftyldiazenyl)naftalén-1- sulfonáto]chromitan trisodný |
402-500-8 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
024-014-00-1 |
bis[6-(5-chlór-4-nitro-2- oxidofenyldiazenyl)-5-oxidonaftalén-1- sulfonáto]chromitan trisodný |
402-870-0 |
93952-24-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
024-015-00-7 |
[3-metyl-4-(5-nitro-2-oxidofenyldiazenyl)- 1-fenylpyrazoláto]-[3-nitro-4-oxido-5-(2- oxido-1- naftyldiazenyl)benzénsulfonáto]chromitan disodný |
404-930-1 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H318 H411 |
|
|
|
|
024-016-00-2 |
bis[1-(5-chlór-2- oxidofenyldiazenyl)naftalén-2- oláto]chromitan tetradecylamónny |
405-110-6 |
88377-66-6 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
|
024-017-00-8 |
zlúčeniny chrómu (VI), okrem chrómanu bárnatého a okrem zlúčenín, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H317 H410 |
|
|
A |
|
024-018-00-3 |
chróman sodný |
231-889-5 |
7775-11-3 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317:C ≥ 0,2 % |
3 |
|
024-019-00-9 |
hlavná zložka: acetoacetanilid/3-aminofenol (ATAN-MAP): {7-[(2 alebo 3 alebo 4)-amino-(4 alebo 5 alebo 6)-hydroxyfenyldiazenyl]-3-[2-(fenylsulfamoyl)-6-oxidofenyldiazenyl]-4-oxidonaftalén-2-sulfonáto}chromitan trisodný a{7-[1-(fenylkarbamoyl)etyldiazenyl]-3-[2-(fenylsulfamoyl)-6-oxidofenyldiazenyl]-4-oxidonaftalén-2-sulfonáto}chromitan trisodný; vedľajší produkt č. 1: acetoacetanilid/acetoacetanilid (ATAN-ATAN): {7-[1- (fenylkarbamoyl)etyldiazenyl]-3-[2- (fenylsulfamoyl)-6-oxidofenyldiazenyl]-4- oxidonaftalén-2-sulfonáto}chromitan trisodný; vedľajší produkt č. 2: 3-aminofenol/3-aminofenol (MAP-MAP): {7-[(2 alebo 3 alebo 4)-amino-(4 alebo 5 alebo 6)-hydroxyfenyldiazenyl]-3-[2- (fenylsulfamoyl)-6-oxidofenyldiazenyl]-4- oxidonaftalén-2-sulfonáto}chromitan trisodný |
419-230-1 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-020-00-4 |
bis(3-{4-amino-2-[4-(2-hydroxy-1- naftyldiazenyl)benzénsulfónamido]-6- oxidopyrimidín-5-yldiazenyl}-5-nitro-4- oxidobenzénsulfonáto)chromitan trisodný |
418-220-4 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-021-00-X |
bis[(N, N'-n)-2-{[1-(fenylkarbamoyl)-2- oxido-κO-prop-1-én-1-yl]diazenyl}-3- oxido-κO-benzén-1,4-disulfonáto]chromitan draselno-tetrasodný |
425-830-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
025-001-00-3 |
oxid manganičitý |
215-202-6 |
1313-13-9 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
025-002-00-9 |
manganistan draselný |
231-760-3 |
7722-64-7 |
Ox. Sol. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H400 H410 |
GHS03 GHS07 GHS09 Dgr |
H272 H302 H410 |
|
|
|
|
025-003-00-4 |
síran mangánatý |
232-089-9 |
7785-87-7 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
|
025-004-00-X |
monohydrát bis(hexafluorofosforečnanu) bis(N, N',N''-trimetyl-1,4,7-triazacyklononán)-trioxo-dimanganičitého |
411-760-1 |
116633-53-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
025-005-00-5 |
reakčná zmes zložená z týchto látok: reakčná zmes zložená z týchto látok: [29H,31H-ftalocyanín-C, C,C-trisulfonáto- N29,N30,N31,N32]manganatan trisodný; [29H,31H-ftalocyanín-C, C,C, C-tetrasulfonáto-N29,N30,N31,N32]manganatan tetrasodný; [29H,31H-ftalocyanín-C, C,C, C,Cpentasulfonáto- N29,N30,N31,N32]manganatan pentasodný |
417-660-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
026-001-00-6 |
hexafluoroantimoničnan (η-cyklopentadienido)-(η-izopropylbenzén)železnatý |
407-840-0 |
100011-37-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
026-002-00-1 |
trifluórmetánsulfonát (η-cyklopentadienido)-(η-izopropylbenzén)železnatý |
407-880-9 |
117549-13-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
026-003-00-7 |
síran železnatý |
231-753-5 |
7720-78-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
026-003-01-4 |
heptahydrát síranu železnatého; kyselina sírová, železnatá soľ, heptahydrát; heptahydrát síranu železnatého |
231-753-5 |
7782-63-0 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
Skin Irrit.2; H315: C ≥ 25% |
|
|
026-004-00-2 |
ferit draselný |
430-010-4 |
12160-44-0 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
027-001-00-9 |
kobalt |
231-158-0 |
7440-48-4 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H334 H317 H413 |
GHS08 Dgr |
H334 H317 H413 |
|
|
|
|
027-002-00-4 |
oxid kobaltnatý |
215-154-6 |
1307-96-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=10 |
|
|
027-003-00-X |
sulfid kobaltnatý |
215-273-3 |
1317-42-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
|
027-004-00-5 |
chlorid kobaltnatý |
231-589-4 |
7646-79-9 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
027-005-00-0 |
síran kobaltnatý |
233-334-2 |
10124-43-3 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
027-006-00-6 |
octan kobaltnatý |
200-755-8 |
71-48-7 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
027-007-00-1 |
hexakyanokobaltitan zinočnatý, komplex s terciárnym butylalkoholom/polypropylénglykolom |
425-240-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
027-008-00-7 |
bis{4-[5-(etylsulfonyl)-2- hydroxyfenyldiazenyl]-N-fenyl-3- hydroxynaftalénkarboxamidáto}kobaltitý komplex, hydratovaný (n H2O, 2<n<3) |
427-390-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
027-009-00-2 |
dusičnan kobaltnatý |
233-402-1 |
10141-05-6 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
027-010-00-8 |
uhličitan kobaltnatý |
208-169-4 |
513-79-1 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
028-001-00-1 |
tetrakarbonyl niklu; nikélium-tetrakarbonyl |
236-669-2 |
13463-39-3 |
Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H351 H360D *** H330 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H351 H360D *** H330 H410 |
|
|
|
|
028-002-00-7 |
nikel |
231-111-4 |
7440-02-0 |
Carc. 2 STOT RE 1 Skin Sens. 1 |
H351 H372** H317 |
GHS08 GHS07 Dgr |
H351 H372** H317 |
|
|
S7 |
|
028-002-01-4 |
práškový nikel; [s priemerom častíc < 1 mm] |
231-111-4 |
7440-02-0 |
Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H372** H317 H412 |
GHS08 GHS07 Dgr |
H351 H372** H317 H412 |
|
|
|
|
028-003-00-2 |
oxid nikelnatý; [1] oxid niklu; [2] bunsenit [3] |
215-215-7[1] 234-323-5[2]-[3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
028-004-00-8 |
oxid nikeličitý |
234-823-3 |
12035-36-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
028-005-00-3 |
oxid nikelitý |
215-217-8 |
1314-06-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
028-006-00-9 |
sulfid nikelnatý; [1] sulfid niklu; [2] millerit [3] |
240-841-2[1] 234-349-7[2]-[3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
|
028-007-00-4 |
sulfid nikelitý subsulfid nikelitý [1] heazlewoodit [2] |
234-829-6[1] -[2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
|
028-008-00-X |
hydroxid nikelnatý; [1] hydroxid nikelnatý [2] |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-009-00-5 |
síran nikelnatý |
232-104-9 |
7786-81-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Irrit. 2; H315: C ≥ 20% Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
028-010-00-0 |
uhličitan nikelnatý; bázický uhličitan nikelnatý; kyselina uhličitá, nikelnatá soľ; [1] nikel-karbonát; [2] dihydroxo-{μ-[karbonáto(2-)- O:O’]}dinikélium; [3] tetrahydroxid-uhličitan trinikelnatý [4] |
222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] |
3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-011-00-6 |
chlorid nikelnatý |
231-743-0 |
7718-54-9 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
028-012-00-1 |
dusičnan nikelnatý; [1] nikelnatá soľ kyseliny dusičnej [2] |
236-068-5 [1] 238-076-4 [2] |
13138-45-9 [1] 14216-75-2 [2] |
Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 |
GHS03 GHS05 GHS08 GHS07 GHS09 Dgr |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % < C < 1% Skin Irrit. 2; H315: C ≥ 20% Skin Sens. 1; H317 C ≥0,01 % M = 1 |
|
|
028-013-00-7 |
niklový kamienok |
273-749-6 |
69012-50-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-014-00-2 |
bahná a kaly z elektrolytického čistenia medi, zbavované medi, s obsahom síranu nikelnatého |
295-859-3 |
92129-57-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373:0,1 % ≤ C < % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-015-00-8 |
bahná a kaly z elektrolytického čistenia medi, zbavované medi |
305-433-1 |
94551-87-8 |
Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
|
|
|
028-016-00-3 |
chloristan nikelnatý; nikelnatá soľ kyseliny chloristej |
237-124-1 |
13637-71-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-017-00-9 |
bissíran didraselno-nikelnatý; [1] bissíran diamónno-nikelnatý [2] |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373:0,1 % ≤ C < 1% Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-018-00-4 |
bis(amidosíran) nikelnatý; nikélium-bis(sulfamát) |
237-396-1 |
13770-89-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-019-00-X |
tetrafluoroboritan nikelnatý |
238-753-4 |
14708-14-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
028-021-00-0 |
mravčan nikelnatý; nikélium-diformiát; [1] nikelnatá soľ kyseliny mravčej; [2] meďnato-nikelnatá soľ kyseliny mravčej [3] |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
028-022-00-6 |
octan nikelnatý; nikélium-diacetát; [1] nikélium-acetát [2] |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C≥ 0,01 % M = 1 |
|
|
028-024-00-7 |
benzoan nikelnatý; nikélium-dibenzoát |
209-046-8 |
553-71-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C≥ 0,01 % M=1 |
|
|
028-025-00-2 |
nikélium-bis(4-cyklohexylbutanoát) |
223-463-2 |
3906-55-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
028-026-00-8 |
stearan nikelnatý; nikélium(II)-oktadekanoát |
218-744-1 |
2223-95-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1% Skin Sens. 1; H317:C;≥0,01 % M=1 |
|
|
028-027-00-3 |
mliečnan nikelnatý; nikélium-dilaktát |
— |
16039-61-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1% STOT RE 2; H373:0,1 % ≤ C < 1% Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-028-00-9 |
nikélium(II)-dioktanoát |
225-656-7 |
4995-91-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-029-00-4 |
fluorid nikelnatý; [1] bromid nikelnatý; [2] jodid nikelnatý; [3] fluorid draselno-nikelnatý [4] |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] -[4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
028-030-00-X |
hexafluorokremičitan nikelnatý |
247-430-7 |
26043-11-8 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-031-00-5 |
selénan nikelnatý |
239-125-2 |
15060-62-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
028-032-00-0 |
hydrogenfosforečnan nikelnatý; [1] bis(dihydrogenfosforečnan) nikelnatý; [2] bis(fosforečnan) trinikelnatý; [3] difosforečnan dinikelnatý; [4] bis(fosfornan) nikelnatý; nikélium-bis(fosfinát); [5] fosfornan nikelnatý; nikélium-fosfinát; [6] nikelnato-vápenatá soľ kyseliny fosforečnej; [7] nikelnatá soľ kyseliny difosforečnej [8] |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] -[7] -[8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-033-00-6 |
hexakyanoželeznatan diamónno-nikelnatý |
— |
74195-78-1 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-034-00-1 |
kyanid nikelnatý |
209-160-8 |
557-19-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
EUH032 |
|
|
|
028-035-00-7 |
chróman nikelnatý |
238-766-5 |
14721-18-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-036-00-2 |
kremičitan nikelnatý; [1] tetraoxokremičitan dinikelnatý; [2] nikelnatá soľ kyseliny kremičitej (3:4); [3] nikelnatá soľ kyseliny kremičitej; [4] kyselina trihydrogenhydroxo-bis[tetraoxokremičitano(4-)]trinikelnatá [5] |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-037-00-8 |
hexakyanoželeznatan dikelnatý |
238-946-3 |
14874-78-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-038-00-3 |
bis(arzeničnan) trinikelnatý; arzeničnan nikelnatý |
236-771-7 |
13477-70-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H372** H317 H410 |
|
|
|
|
028-039-00-9 |
šťaveľan nikelnatý; [1] nikelnatá soľ kyseliny šťaveľovej [2] |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-040-00-4 |
telurid nikelnatý |
235-260-6 |
12142-88-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-041-00-X |
tetrasulfid triniklu |
— |
12137-12-1 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-042-00-5 |
bis(arzenitan) trinikelnatý |
— |
74646-29-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-043-00-0 |
sivý periklas s obsahom kobaltu a niklu; C.I. čierny pigment 25; C.I. 77332; [1] dioxid kobatnato-nikelnatý; [2] oxid kobaltu a niklu [3] |
269-051-6 [1] 261-346-8 [2] -[3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-044-00-6 |
trioxid ciničito-nikelnatý; ciničitan nikelnatý |
234-824-9 |
12035-38-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-045-00-1 |
dekaoxid nikelnato-triuránový |
239-876-6 |
15780-33-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-046-00-7 |
ditiokyanatan nikelnatý |
237-205-1 |
13689-92-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
EUH032 |
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
028-047-00-2 |
dichróman nikelnatý |
239-646-5 |
15586-38-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
028-048-00-8 |
seleničitan nikelnatý |
233-263-7 |
10101-96-9 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-049-00-3 |
selenid nikelnatý |
215-216-2 |
1314-05-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-050-00-9 |
nikelnato-olovnatá soľ kyseliny kremičitej |
— |
68130-19-8 |
Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360Df H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360Df H372** H317 H410 |
|
|
|
|
028-051-00-4 |
diarsenid niklu; [1] arsenid niklu [2] |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-052-00-X |
svetložltý priderit s obsahom niklu, bária a titánu; C.I. žltý pigment 157; C.I. 77900 |
271-853-6 |
68610-24-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-053-00-5 |
chlorečnan nikelnatý; [1] bromičnan nikelnatý; [2] nikélium-bis(etyl-sulfát) [3] |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < % Skin Sens. 1; H317:C≥0,01 %1 M=1 |
|
|
028-054-00-0 |
trifluóroctan nikelnatý; nikélium(II)- trifluóracetát; [1] propionan nikelnatý; nikélium(II)-dipropanoát; [2] nikélium-bis(benzénsulfonát); [3] nikélium(II)-hydrogen-citrát; [4] amónno-nikelnatá soľ kyseliny citrónovej; [5] nikelnatá soľ kyseliny citrónovej; [6] nikélium-bis(2-etylhexanoát); [7] nikelnatá soľ kyseliny 2-etylhexánovej; [8] nikelnatá soľ kyseliny dimetylhexánovej; [9] nikélium(II)-bis(izooktanoát); [10] nikélium-izooktanoát; [11] nikélium-bis(izononanoát); [12] [nikélium(II)-bis(neononanoát); [13] nikélium(II)-bis(izodekanoát); [14] nikélium(II)-bis(neononanoát); [15] nikelnatá soľ kyseliny neodekánovej;[16] nikélium(II)-bis(neoundekanoát); [17] bis(D-glukonáto-O 1,O 2)nikelnatý komplex; [18] nikélium-bis(3,5-di-terc-butyl-4-hydroxybenzoát) (1:2); [19] palmitan nikelnatý; nikélium(II)-palmitát; [20] nikélium(II)-(2-etylhexanoát)- (izononanoát); [21] nikélium(II)-(izononanoát)-(izooktanoát); [22] nikélium(II)-(izooktanoát)-(neodekanoát); [23] nikélium(II)-(2-etylhexanoát)- (izodekanoát); [24] nikélium(II)-(2-etylhexanoát)- (neodekanoát); [25] nikélium(II)-(izodekanoát)-(izooktanoát); [26] nikélium(II)-(izodekanoát)-(izononanoát); [27] nikélium(II)-(izononanoát)-(neodekanoát); [28] nikelnaté soli C6-19-mastných kyselín s rozvetveným reťazcom; [29] nikelnaté soli C8-18- a C18-nenasýtených mastných kyselín; [30] nikelnatá soľ kyseliny naftalén-2,7- disulfónovej; [31] |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1% STOT RE 2; H373: 0,1 % ≤ C < 1% Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-055-00-6 |
siričitan nikelnatý; [1] trioxid nikelnato-teluričitý; teluričitan nikelnatý; [2] tetraoxid nikelnato-telúrový; telúran nikelnatý [3] fosforečnan-hydroxid-oxid molybdénu a niklu [4] |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-056-00-1 |
borid niklu (NiB); [1] borid diniklu; [2] borid triniklu; [3] borid niklu; [4] silicid nikelnatý; silicid diniklu; [5] disilicid niklu; [6] fosfid diniklu; [7] fosfid bóru a niklu [8] |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] -[8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-057-00-7 |
tetraoxid dihlinito-nikelnatý; dihliničitan nikelnatý; [1] trioxid nikelnato-titaničitý; titaničitan nikelnatý; [2] trioxid nikelnato-titaničitý; titaničitan nikelnatý; [3] hexaoxid nikelnato-divanadičný; divanadičnan nikelnatý; [4] oktaoxid kobatnato-dimolybdénovo-nikelnatý; dimolybdénan kobaltnato-nikelnatý; [5] trioxid nikelnato-zirkoničitý; zirkoničitan nikelnatý; [6] tetraoxid molybdénovo-nikelnatý; molybdénan nikelnatý; [7] tetraoxid nikelnato-volfrámový; volfráman nikelnatý; [8] olivín, niklová zelená; [9] dioxid lítno-nikelnatý; nikelnatan dilítny; [10] oxid molybdénu a niklu; [11] |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] -[10] -[11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-058-00-2 |
oxid kobaltu, lítia a niklu |
442-750-5 |
— |
Carc. 1A Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H330 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H372** H317 H410 |
|
|
|
|
029-001-00-4 |
chlorid meďný chlorid meďný; chlorid meďný |
231-842-9 |
7758-89-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
029-003-00-5 |
cykloalkánkarboxylové kyseliny, meďnaté soli; kuprium-naftenát |
215-657-0 |
1338-02-9 |
Flam. Liq. 3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H302 H410 |
|
|
|
|
029-004-00-0 |
síran meďnatý |
231-847-6 |
7758-98-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
029-005-00-6 |
[tris(chlórmetyl)ftalocyanináto]meďnatý komplex, produkty reakcie s N-metylpiperazínom a kyselinou metoxyoctovou |
401-260-1 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
029-006-00-1 |
(ftalocyaníntrisulfonáto)meďnatan tris(oktadec-9-én-1-amónia) |
403-210-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
029-007-00-7 |
hydroxid-{[2-({3-[4-(2-chlór-5-sulfonátoanilino)-6-(3-karboxylátopyridínio)-1,3,5-triazín-2-ylamino]-2-oxido-5-sulfonátofenyldiazenyl}benzyldiazenyl)-4-sulfonátobenzoáto]meďnatan} trisodný |
404-670-9 |
89797-01-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
G |
|
029-008-00-2 |
kuprium(II)-metánsulfonát |
405-400-2 |
54253-62-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
029-009-00-8 |
{[N-3-(dietylamino)propán-1- sulfónamid]ftalocyanináto}meďnatý komplex |
413-650-9 |
93971-95-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
029-010-00-3 |
reakčná zmes zložená zo zlúčenín od [dodekakis(para-tolylsulfanyl) ftalocyanináto]meďnatého komplexu po [hexadekakis(para-tolylsulfanyl) ftalocyanináto]meďnatý komplex |
407-700-9 |
101408-30-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
029-011-00-9 |
[(N-{3-[(2- hydroxyetyl)(metyl)amino]propyl}amino}s ulfónamido)-29H,31H-ftalocyanín- N 29,N 30,N 31,N 32-sulfonáto]meďnatan sodný |
412-730-0 |
150522-10-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
029-012-00-4 |
({[N-(3- (trimetylamónio)propylsulfamoyl]metyl}fta locyanináto)meďnatan sodný |
407-340-2 |
124719-24-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
029-013-00-X |
[2-({fenyl[3-(4-chlór-6-{2-[2- (vinylsulfonyl)etoxy]etylamino}-1,3,5- triazín-2-ylamino)-2-oxido-5- sulfonátofenyldiazenyl]metylidén}ydrazino) - 4-sulfonátobenzoáto]meďnatan trisodný |
407-580-8 |
130201-51-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
029-014-00-5 |
reakčná zmes zložená z týchto látok: {2,2'-[(cis-cyklohexán-1,2- diyl)bis(nitrilometylidén)]difenoláto(2-)- N, N',O, O'}meďnatý komplex; {2,2'-[(trans-cyklohexán-1,2- diyl)bis(nitrilometylidín)]difenoláto(2-)- N, N',O, O'}meďnatý komplex |
419-610-7 |
171866-24-3 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
030-001-00-1 |
práškový zinok (pyroforický) |
231-175-3 |
7440-66-6 |
Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H400 H410 |
GHS02 GHS09 Dgr |
H260 H250 H410 |
|
|
T |
|
030-001-01-9 |
práškový zinok (stabilizovaný) |
231-175-3 |
7440-66-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
030-003-00-2 |
chlorid zinočnatý |
231-592-0 |
7646-85-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
030-004-00-8 |
dimetylzinkium; [1] dietylzinkium [2] |
208-884-1 [1] 209-161-3 [2] |
544-97-8 [1] 557-20-0 [2] |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H260 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H260 H314 H410 |
EUH014 |
|
|
|
030-005-00-3 |
diammin-diizokyanátozinočnatý komplex |
401-610-3 |
— |
Acute Tox. 4 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H318 H334 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H318 H334 H317 H400 |
|
|
|
|
030-006-00-9 |
hydratovaný síran zinočnatý (mono-, hexa- a heptahydrát); [1] bezvodý síran zinočnatý [2] |
231-793-3 [1] 231-793-3 [2] |
7446-19-7 [1] 7733-02-0 [2] |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
030-007-00-4 |
bis(3,5-di-terc-butylsalicyláto- O 1,O 2)zinočnatý komplex |
403-360-0 |
42405-40-3 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
030-008-00-X |
hydroxo-[2-(benzénsulfónamido)benzoáto]zinočnatý komplex |
403-750-0 |
113036-91-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
030-009-00-5 |
dihydrát bis(2-hydroxy-4-{[(oktyloxy)karbonyl]amino}benzoáto)zinočnatého komplexu |
417-130-2 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
030-010-00-0 |
zinkium-bis[4-O-metyl-2-(dodec-1-én-1-yl)butándioát] |
430-740-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
030-011-00-6 |
fosforečnan zinočnatý |
231-944-3 |
7779-90-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
030-012-00-1 |
hydroxid-uhličitan hlinito-horečnato-zinočnatý |
423-570-6 |
169314-88-9 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
030-013-00-7 |
oxid zinočnatý |
215-222-5 |
1314-13-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
030-015-00-8 |
dioctan-bis(hexakyanokobaltitan) tetrazinočnatý |
440-060-9 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
033-001-00-X |
arzén |
231-148-6 |
7440-38-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
033-002-00-5 |
zlúčeniny arzénu, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
* |
A1 |
|
033-003-00-0 |
oxid arzenitý; oxid arzenitý |
215-481-4 |
1327-53-3 |
Carc. 1A Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H300 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H300 H314 H410 |
|
|
|
|
033-004-00-6 |
oxid arzeničný; oxid arzeničný; oxid arzeničný |
215-116-9 |
1303-28-2 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
033-005-00-1 |
kyselina arzeničná a jej soli, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
A |
|
033-006-00-7 |
arzán |
232-066-3 |
7784-42-1 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H330 H373 ** H400 H410 |
GHS02 GHS04 GHS06 GHS08 GHS09 Dgr |
H220 H330 H373 ** H410 |
|
|
U |
|
033-007-00-2 |
terc-butylarzán |
423-320-6 |
4262-43-5 |
Pyr. Liq. 1 Acute Tox. 2 * |
H250 H330 |
GHS02 GHS06 Dgr |
H250 H330 |
|
|
|
|
034-001-00-2 |
selén |
231-957-4 |
7782-49-2 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 4 |
H331 H301 H373 ** H413 |
GHS06 GHS08 Dgr |
H331 H301 H373 ** H413 |
|
|
|
|
034-002-00-8 |
zlúčeniny selénu okrem sulfidu-selenidu kademnatého (xCdS.yCdSe) a tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H373** H410 |
|
|
A |
|
034-003-00-3 |
seleničitan sodný |
233-267-9 |
10102-18-8 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 2 |
H300 H331 H317 H411 |
GHS06 GHS09 Dgr |
H300 H331 H317 H411 |
EUH031 |
|
|
|
035-001-00-5 |
bróm |
231-778-1 |
7726-95-6 |
Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H330 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H314 H400 |
|
|
|
|
035-002-00-0 |
bromovodík |
233-113-0 |
10035-10-6 |
Press. Gas Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS04 GHS05 GHS07 Dgr |
H314 H335 |
|
|
U |
|
035-002-01-8 |
kyselina bromovodíková ... % |
— |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10% ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40% STOT SE 3; H335: C ≥ 10% |
B |
|
035-003-00-6 |
bromičnan draselný |
231-829-8 |
7758-01-2 |
Ox. Sol. 1 Carc. 1B Acute Tox. 3 * |
H271 H350 H301 |
GHS03 GHS06 GHS08 Dgr |
H271 H350 H301 |
|
|
|
|
035-004-00-1 |
(2-hydroxyetán-1-amónium)-tribromid(1-) |
407-440-6 |
— |
Ox. Sol. 2 **** Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H272 H302 H314 H317 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H317 H400 |
|
|
|
|
040-001-00-3 |
práškové zirkónium (pyroforické) |
231-176-9 |
7440-67-7 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
040-002-00-9 |
práškové zirkónium, suché (nepyroforické) |
— |
— |
Self-heat. 1 |
H251 |
GHS02 Dgr |
H251 |
|
|
T |
|
040-003-00-4 |
produkt reakcie kyseliny 3,5-di-terc-butyl-2-hydroxybenzoovej a chlorid-oxidu zirkoničitého, dehydratovaný, (v pomere 1,0 : 1,0 až 1,0 : 1,5 |
430-610-6 |
226996-19-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
042-001-00-9 |
oxid molybdénový |
215-204-7 |
1313-27-5 |
Carc. 2 Eye Irrit. 2 STOT SE 3 |
H351 H319 H335 |
GHS08 GHS07 Wng |
H351 H319 H335 |
|
|
|
|
042-002-00-4 |
hexa-μ-oxo-tetra-μ3-oxo-di-μ5- oxotetradekaoxooktamolybdénan tetrakis[dimetyldi(tetradecyl)amónia] |
404-760-8 |
117342-25-3 |
Acute Tox. 3 * Eye Dam. 1 |
H331 H318 |
GHS06 GHS05 Dgr |
H331 H318 |
|
|
|
|
042-003-00-X |
hexa-μ-oxo-tetra-μ3-oxo-di-μ5-oxotetradekaoxooktamolybdénan tetrakis[trimetyl(hexadecyl)amónia] |
404-860-1 |
116810-46-9 |
Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H318 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H228 H318 H410 |
|
|
T |
|
042-004-00-5 |
produkt reakcie molybdénanu amónneho a dietoxylovaného (C12-C24-alkyl)amínu (1:5-1:3) |
412-780-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
042-005-00-0 |
reakčná zmes zložená z týchto látok: mono- a di-glyceroly z repkového oleja; amidy kyselín z repkového oleja s N-[3-(C30-alkoxy)propyl]propán-1,3-diamínom, kde C30-alkyl je rozvetvený; N, N-dialkylditiokarbamátový komplex molybdénu |
434-240-6 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
046-001-00-X |
Hydrogenuhličitan tetraamminpaládnatý |
425-270-0 |
134620-00-1 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
|
047-001-00-2 |
dusičnan strieborný |
231-853-9 |
7761-88-8 |
Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H272 H314 H400 H410 |
GHS03 GHS05 GHS09 Dgr |
H272 H314 H410 |
|
|
|
|
047-002-00-8 |
horečnato-meďnato-sodno-strieborno-vápenato-zinočnatá soľ kyseliny polyfosforečnej |
416-850-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
048-001-00-5 |
zlúčeniny kadmia, okrem selenidu-sulfidu kademnatého (xCdS.yCdSe), reakčná zmes zložená zo sulfidu kademnatého a sulfidu zinočnatého (xCdS.yZnS), reakčná zmes zložená zo sulfidu kademnatého a sulfidu ortuťnatého (xCdS.yHgS), a okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
048-002-00-0 |
kadmium (nepyroforické); [1] oxid kademnatý (nepyroforický) [2] |
231-152-8 [1] 215-146-2 [2] |
7440-43-9 [1] 1306-19-0 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361fd H330 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361fd H330 H372 ** H410 |
|
|
|
|
048-003-00-6 |
mravčan kademnatý; kadmium-diformiát |
224-729-0 |
4464-23-7 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,25 % |
|
|
048-004-00-1 |
kyanid kademnatý |
208-829-1 |
542-83-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H351 H373 ** H410 |
EUH032 |
STOT RE 2; H373: C ≥0,1 % EUH032:C≥1% |
|
|
048-005-00-7 |
hexaflurokremičitan kademnatý; flurokremičitan kademnatý |
241-084-0 |
17010-21-8 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
|
|
048-006-00-2 |
fluorid kademnatý |
232-222-0 |
7790-79-6 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C <7 % |
|
|
048-007-00-8 |
jodid kademnatý |
232-223-6 |
7790-80-9 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
|
|
048-008-00-3 |
chlorid kademnatý |
233-296-7 |
10108-64-2 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7% STOT RE 2; H373: 0,1 % ≤ C < 7% |
|
|
048-009-00-9 |
síran kademnatý |
233-331-6 |
10124-36-4 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7% STOT RE 2; H373 0,1 % ≤ C < 7% |
|
|
048-010-00-4 |
sulfid kademnatý |
215-147-8 |
1306-23-6 |
Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 4 |
H350 H341 H361fd H372 ** H302 H413 |
GHS08 GHS07 Dgr |
H350 H341 H361fd H372 ** H302 H413 |
|
* STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10% |
1 |
|
048-011-00-X |
kadmium (pyroforické) |
231-152-8 |
7440-43-9 |
Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H250 H350 H341 H361fd H330 H372 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H250 H350 H341 H361fd H330 H372 ** H410 |
|
|
|
|
050-001-00-5 |
chlorid ciničitý; chlorid ciničitý |
231-588-9 |
7646-78-8 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
STOT SE 3; H335:C≥5 % |
|
|
050-002-00-0 |
cyhexatín (ISO); hydroxytri(cyklohexyl)stanán; tri(cyklohexyl)stanium-hydroxid |
236-049-1 |
13121-70-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M=1000 |
|
|
050-003-00-6 |
fencín-acetát (ISO); trifenylstanium-acetát |
212-984-0 |
900-95-8 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
050-004-00-1 |
fencín-hydroxid (ISO); trifenylstanium-hydroxid |
200-990-6 |
76-87-9 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
050-005-00-7 |
trimetylciničité zlúčeniny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-006-00-2 |
trietylciničité zlúčeniny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-007-00-8 |
tripropylciničité zlúčeniny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* |
A1 |
|
050-009-00-9 |
fluórtri(pentyl)stanán; [1] hexapentyldistanoxán [2] |
243-546-7 [1] 247-143-7 [2] |
20153-49-5 [1] 25637-27-8 [2] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
050-010-00-4 |
fluórtri(hexyl)stanán |
243-547-2 |
20153-50-8 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
050-011-00-X |
trifenylciničité zlúčeniny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* M=100 |
A1 |
|
050-012-00-5 |
tetracyklohexylstanán; [1] chlórtri(cyklohexyl)stanán; [2] butyltri(cyklohexyl)stanán [3] |
215-910-5 [1] 221-437-5 [2] 230-358-5 [3] |
1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
050-013-00-0 |
trioktylciničité zlúčeniny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 |
H319 H335 H315 H413 |
GHS07 Wng |
H319 H335 H315 H413 |
|
Skin Irrit. 2; H315: C ≥ 1% Eye Irrit.2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
A1 |
|
050-017-00-2 |
fenbutacín-oxid (ISO); bis[tris(2-fenyl-2-metylpropyl)stanium]-oxid |
236-407-7 |
13356-08-6 |
Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H330 H319 H315 H410 |
|
|
|
|
050-018-00-8 |
stanium(II)-metánsulfonát |
401-640-7 |
53408-94-9 |
Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H317 H411 |
|
|
|
|
050-019-00-3 |
azocyklocín (ISO); 1-(tricyklohexylstannyl)-1H-1,2,4-triazol |
255-209-1 |
41083-11-8 |
Acute Tox. 2 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H301 H335 H315 H318 H410 |
|
|
|
|
050-020-00-9 |
trioktylstanán |
413-320-4 |
869-59-0 |
STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 |
H372 ** H315 H413 |
GHS08 GHS07 Dgr |
H372 ** H315 H413 |
|
|
|
|
050-021-00-4 |
dichlórdioktylstanán; dioktylstanium-dichlorid |
222-583-2 |
3542-36-7 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H331 H372** H412 |
GHS06 GHS08 Dgr |
H331 H372** H412 |
|
|
|
|
050-022-00-X |
dibutyldichlórstanán; dibutylstanium-dichlorid; (DBTC) (DBTC) |
211-670-0 |
683-18-1 |
Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360FD H330 H301 H312 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H360FD H330 H301 H312 H372** H314 H410 |
|
Skin Corr. 1B; H314: C ≥ 5% Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam.1; H318: 3% ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3% M=10 |
|
|
050-023-00-5 |
reakčná zmes zložená z týchto látok: bis(2-etylhexanoyloxy)di(oktyl)stanán; Sn, Sn'-bis(2-etylhexanoyloxy)-Sn, Sn, Sn',Sn'-tetraoktyldistanoxán; bis(1-fenyl-3-oxodec-1-én-1- yloxy)di(oktyl)stanán; (2-etylhexanoyloxy)(1-fenyl-3-oxodec-1- én-1-yloxy)di(oktyl)stanán |
422-920-5 |
— |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
M=10 |
|
|
050-024-00-0 |
reakčná zmes zložená z týchto látok: tri-para-tolylstanium-hydroxid; hexa-para-tolyldistanoxán |
432-230-6 |
— |
STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H372** H302 H315 H318 H317 H410 |
|
|
|
|
050-025-00-6 |
trichlór(metyl)stanán |
213-608-8 |
993-16-8 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
050-026-00-1 |
(2-etylhexyl)- 10-etyl-4-[[[[(2-etylhexyl)oxy]karbonyl]metyl]sulfanyl]-4-metyl-7-oxo-8-oxa-3,5-ditia-4- stanatetradekanoát |
260-828-5 |
57583-34-3 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
050-027-00-7 |
(2-etylhexyl)-10-etyl-4,4-dioktyl-7-oxo-8-oxa-3,5-ditia-4- stanatetradekanoát |
239-622-4 |
15571-58-1 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
|
050-028-00-2 |
(2-etylhexyl)-10-etyl-4,4-dimetyl-7-oxo-8-oxa-3,5-ditia-4-stanatetradekanoát |
260-829-0 |
57583-35-4 |
Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A |
H361d H302 H372 (nervový systém, imunitný systém) H317 |
GHS08 GHS07 Dgr |
H361d H302 H372 (nervový systém, imunitný systém) H317 |
|
|
|
|
050-029-00-8 |
dimetylstanium-dichlorid |
212-039-2 |
753-73-1 |
Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B |
H361d H330 H301 H311 H372 (nervový systém, imunitný systém) H314 |
GHS08 GHS06 GHS05 Dgr |
H361d H330 H301 H311 H372 (nervový systém, imunitný systém) H314 |
EUH071 |
|
|
|
051-001-00-8 |
chlorid antimonitý |
233-047-2 |
10025-91-9 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE3; H335: C ≥ 5 % |
|
|
051-002-00-3 |
chlorid antimoničný |
231-601-8 |
7647-18-9 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
051-003-00-9 |
zlúčeniny antimónu, okrem tetraoxidu antimonatého (Sb2O4), oxidu antimoničného (Sb2O5), sulfidu antimonitého (Sb2S3), sulfidu antimoničného (Sb2S5) a okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
* |
A1 |
|
051-004-00-4 |
fluorid antimonitý |
232-009-2 |
7783-56-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
|
051-005-00-X |
oxid antimonitý |
215-175-0 |
1309-64-4 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
051-006-00-5 |
hexafluoroantimoničnan difenyl[4-(fenylsulfanyl)fenyl]sulfónia |
403-500-0 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
051-007-00-0 |
hexafluoroantimoničnan bis(4-dodecylfenyl)jodónia |
404-420-9 |
71786-70-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
053-001-00-3 |
jód |
231-442-4 |
7553-56-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H312 H400 |
GHS07 GHS09 Wng |
H332 H312 H400 |
|
|
|
|
053-002-00-9 |
jodovodík |
233-109-9 |
10034-85-2 |
Press. Gas Skin Corr. 1A |
H314 |
GHS04 GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥0,02 % |
U5 |
|
053-002-01-6 |
kyselina jodovodíková ... % |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
|
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10% ≤ C < 25% Eye Irrit. 2; H319: 10% ≤ C < 25% |
B |
|
053-003-00-4 |
jódoxybenzén |
— |
696-33-3 |
Expl. **** |
**** |
**** |
**** |
|
|
|
|
053-004-00-X |
jódoxybenzoát vápenatý |
— |
— |
Expl. **** |
**** |
**** |
**** |
|
|
C |
|
053-005-00-5 |
[(4-izopropylfenyl)(4- metylfenyl)iodónium]- tetrakis(pentafluórfenyl)boranuid(1-) |
422-960-3 |
178233-72-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373 ** H410 |
|
|
|
|
056-001-00-1 |
peroxid bárnatý |
215-128-4 |
1304-29-6 |
Ox. Sol. 2 Acute Tox. 4 * Acute Tox. 4 * |
H272 H332 H302 |
GHS03 GHS07 Dgr |
H272 H332 H302 |
|
|
|
|
056-002-00-7 |
bárnaté soli, okrem síranu bárnatého, solí (2-hydroxy-1- naftyldiazenyl)arénsulfónových kyselín a okrem solí, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
A1 |
|
056-003-00-2 |
uhličitan bárnatý |
208-167-3 |
513-77-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
056-004-00-8 |
chlorid bárnatý |
233-788-1 |
10361-37-2 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H332 |
GHS06 Dgr |
H301 H332 |
|
|
|
|
064-001-00-8 |
trihydrát siričitanu gadolinitého |
456-900-2 |
51285-81-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
072-001-00-4 |
hafnium-tetra(bután-1-olát) |
411-740-2 |
22411-22-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
074-001-00-X |
hydrát volfrámanu hexasodného |
412-770-9 |
12141-67-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
074-002-00-5 |
produkty reakcie chloridu volfrámového s 2-metylpropán-2-olom, nonylfenolom a pentán-2,4-diónom |
408-250-6 |
— |
Flam. Liq. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H314 H317 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H314 H317 H410 |
|
|
|
|
076-001-00-5 |
oxid osmičelý; kyselina osmičelá |
244-058-7 |
20816-12-0 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
078-001-00-0 |
tetrachlórplatnatany okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-002-00-6 |
tetrachloroplatnatan diamónny |
237-499-1 |
13820-41-2 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
078-003-00-1 |
tetrachloroplatnatan disodný |
233-051-4 |
10026-00-3 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
078-004-00-7 |
tetrachloroplatnatan didraselný |
233-050-9 |
10025-99-7 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
078-005-00-2 |
hexachloroplatičitany, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-006-00-8 |
hexachloroplatičitan disodný |
240-983-5 |
16923-58-3 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
078-007-00-3 |
hexachloroplatičitan didraselný |
240-979-3 |
16921-30-5 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
078-008-00-9 |
hexachloroplatičitan diamónny |
240-973-0 |
16919-58-7 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
078-009-00-4 |
kyselina hexachloroplatičitá |
241-010-7 |
16941-12-1 |
Acute Tox. 3 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H301 H314 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H314 H334 H317 |
|
|
|
|
078-010-00-X |
hydrogenuhličitan tetraamminplatnatý |
426-730-3 |
123439-82-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
078-011-00-5 |
kyselina hydroxo-disulfitoplatnatá |
423-310-1 |
61420-92-6 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 H314 H334 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H302 H373 H314 H334 H317 H412 |
|
|
|
|
078-012-00-0 |
roztok dusičnanu platičitého a kyseliny dusičnej |
432-400-1 |
— |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
080-001-00-0 |
ortuť |
231-106-7 |
7439-97-6 |
Repr. 1B Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D*** H330 H372** H410 |
|
|
|
|
080-002-00-6 |
anorganické zlúčeniny ortuti okrem sulfidu ortuťnatého a okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
A1 |
|
080-003-00-1 |
dichlorid diortuťný; chlorid ortuťný; kalomel |
233-307-5 |
10112-91-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
080-004-00-7 |
organické zlúčeniny ortuti, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
A1 |
|
080-005-00-2 |
hydrargýrium-difulminát; fulminát ortuťnatý; fulminát ortuťnatý; |
211-057-8 |
628-86-4 |
Unst. Expl. Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H331 H311 H301 H373 ** H400 H410 |
|
|
|
|
080-005-01-X |
hydrargýrium-difulminát; fulminát ortuťnatý; fulminát ortuťnatý (≥ 20 % inertnej zrieďovacej látky) |
211-057-8 |
628-86-4 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373 ** H400 H410 |
|
|
|
|
080-006-00-8 |
dikyanid-oxid ortuťnatý; hydrargýrium-dikyanid-oxid |
215-629-8 |
1335-31-5 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373** H410 |
|
|
|
|
080-007-00-3 |
dimetylhydrargýrium; [1] dietylhydrargýrium [2] |
209-805-3 [1] 211-000-7 [2] |
593-74-8 [1] 627-44-1 [2] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,05 % |
1 |
|
080-008-00-9 |
fenylhydrargýrium-nitrát; [1] fenylhydrargýrium-hydroxid; [2] zásaditý fenylhydrargýrium-nitrát [3] |
200-242-9 [1] 202-866-7 [2] -[3] |
55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
080-009-00-4 |
(2-metoxyetyl)hydrargýrium-chlorid |
204-659-7 |
123-88-6 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
080-010-00-X |
chlorid ortuťnatý; chlorid ortuťnatý |
231-299-8 |
7487-94-7 |
Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H361f*** H300 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H361f*** H300 H372** H314 H410 |
|
|
|
|
080-011-00-5 |
fenylhydrargýrium-acetát |
200-532-5 |
62-38-4 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
081-001-00-3 |
tálium |
231-138-1 |
7440-28-0 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
|
081-002-00-9 |
zlúčeniny tália, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373 ** H411 |
|
|
A |
|
081-003-00-4 |
síran tálny; síran tálny |
231-201-3 |
7446-18-6 |
Acute Tox. 2 * STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H300 H372 ** H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H300 H372 ** H315 H411 |
|
|
|
|
082-001-00-6 |
zlúčeniny olova, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
Repr.2 H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥0,5 % |
A1 |
|
082-002-00-1 |
alkyly olova |
— |
— |
Repr. 1A Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H330 H310 H300 H373 ** H410 |
|
Repr.1A; H360D: C≥ 0,1 % * STOT RE 2; H373: C ≥0,05 % |
A1 |
|
082-003-00-7 |
azid olovnatý; azid olovnatý |
236-542-1 |
13424-46-9 |
Unst. Expl. Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
082-003-01-4 |
azid olovnatý; azid olovnatý (≥ 20 % inertnej zrieďovacej látky) |
236-542-1 |
13424-46-9 |
Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
082-004-00-2 |
chróman olovnatý |
231-846-0 |
7758-97-6 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
082-005-00-8 |
octan olovnatý; plumbium-diacetát |
206-104-4 |
301-04-2 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
|
082-006-00-3 |
fosforečnan olovnatý |
231-205-5 |
7446-27-7 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
|
082-007-00-9 |
zásaditý octan olovnatý |
215-630-3 |
1335-32-6 |
Carc. 2 Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H351 H360Df H373 ** H410 |
|
|
1 |
|
082-008-00-4 |
plumbium(II)-di(metánsulfonát) |
401-750-5 |
17570-76-2 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H360Df H332 H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H360Df H332 H302 H373 ** H315 H318 |
|
|
1 |
|
082-009-00-X |
žltá na báze chrómano-síranu olovnatého; C.I. žltý pigment 34; [Táto látka je identifikovaná v Indexe farieb pod identifikačným číslom Indexu farieb C.I. 77603.] |
215-693-7 |
1344-37-2 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
082-010-00-5 |
červená na báze chrómano-molybdénano-síranu olovnatého; C.I. červený pigment 104; [Táto látka je identifikovaná v Indexe farieb pod identifikačným číslom Indexu farieb C.I. 77605.] |
235-759-9 |
12656-85-8 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
082-011-00-0 |
hydrogenarzeničnan olovnatý |
232-064-2 |
7784-40-9 |
Carc. 1A Repr. 1A Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H331 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H360Df H331 H301 H373 ** H410 |
|
|
1 |
|
082-012-00-6 |
fluorid-chlorid-jodid bárnato-cézno-olovnato-samárnato-strontnato-vápenatý s prídavkom európia |
431-780-4 |
199876-46-5 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H411 |
|
|
|
|
092-001-00-8 |
urán |
231-170-6 |
7440-61-1 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
|
092-002-00-3 |
zlúčeniny uránu, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373** H411 |
|
|
A |
|
601-001-00-4 |
metán |
200-812-7 |
74-82-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
601-002-00-X |
etán |
200-814-8 |
74-84-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
601-003-00-5 |
propán |
200-827-9 |
74-98-6 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
601-004-00-0 |
bután; [1] a izobután [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-004-01-8 |
bután (s obsahom ≥ 0,1 % buta-1,3-diénu (203-450-8)); [1] izobután (s obsahom ≥ 0,1 % buta-1,3-diénu (203-450-8)) [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
C S U |
|
601-005-00-6 |
2,2-dimetylpropán; neopentán |
207-343-7 |
463-82-1 |
Flam. Gas 1 Press. Gas Aquatic Chronic 2 |
H220 H411 |
GHS02 GHS04 GHS09 Dgr |
H220 H411 |
|
|
U |
|
601-006-00-1 |
pentán |
203-692-4 |
109-66-0 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H336 H411 |
EUH066 |
|
C |
|
601-007-00-7 |
hexán (s obsahom < 5 % hexánu (203-777-6)); 2-metylpentán;[1] 3-metylpentán; [2] 2,2-dimetylbután; [3] 2,3-dimetylbután [4] |
203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] |
107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
C |
|
601-008-00-2 |
heptán; n-heptán; [1] 2,4-dimetylpentán; [2] 2,2,3-trimetylbután; [3] 3,3-dimetylpentán; [4] 2,3-dimetylpentán; [5] 3-metylhexán; [6] 2,2-dimetylpentán; [7] 2-metylhexán; [8] 3-etylpentán; [9] izoheptán; [10] |
205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] |
142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-009-00-8 |
oktán; n-oktán; [1] 2,2,4-trimetylpentán; [2] 2,3,3-trimetylpentán; [3] 3,3-dimetylhexán; [4] 2,2,3-trimetylpentán; [5] 2,3,4-trimetylpentán; [6] 3,4-dimetylhexán; [7] 2,3-dimetylhexán; [8] 2,4-dimetylhexán; [9] 4-metylheptán; [10] 3-metylheptán; [11] 2,2-dimetylhexán; [12] 2,5-dimetylhexán; [13] 2-metylheptán; [14] 2,2,3,3-tetrametylbután; [15] 3-etyl-2-metylpentán; [16] 3-etylhexán; [17] 3-etyl-3-metylpentán; [18] izooktán; [19] |
203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] |
111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-010-00-3 |
etén; etylén |
200-815-3 |
74-85-1 |
Flam. Gas 1 Press. Gas STOT SE 3 |
H220 H336 |
GHS02 GHS04 GHS07 Dgr |
H220 H336 |
|
|
U |
|
601-011-00-9 |
propén; propylén |
204-062-1 |
115-07-1 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
601-012-00-4 |
but-1-én; [1] butény, zmes-1- a-2-izomérov; [2] 2-metylpropén; [3] (Z)-but-2-én; [4] (E)-but-2-én [5] |
203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] |
106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-013-00-X |
1,3-butadién; buta-1,3-dién |
203-450-8 |
106-99-0 |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
D U |
|
601-014-00-5 |
izoprén (stabilizovaný) 2-metylbuta-1,3-dién |
201-143-3 |
78-79-5 |
Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 |
H224 H350 H341 H412 |
GHS02 GHS08 Dgr |
H224 H350 H341 H412 |
|
|
D |
|
601-016-00-6 |
cyklopropán |
200-847-8 |
75-19-4 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
601-017-00-1 |
cyklohexán |
203-806-2 |
110-82-7 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
|
|
601-018-00-7 |
metylcyklohexán |
203-624-3 |
108-87-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
601-019-00-2 |
1,4-dimetylcyklohexán |
209-663-2 |
589-90-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
601-020-00-8 |
benzén |
200-753-7 |
71-43-2 |
Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H350 H340 H372 ** H304 H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H340 H372 ** H304 H319 H315 |
|
|
E |
|
601-021-00-3 |
toluén |
203-625-9 |
108-88-3 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 |
H225 H361d *** H304 H373 ** H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H361d *** H304 H373 ** H315 H336 |
|
|
|
|
601-022-00-9 |
orto-xylén; [1] para-xylén; [2] meta-xylén; [3] xylén [4] |
202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] |
95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H312 H315 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 |
|
* |
C |
|
601-023-00-4 |
etylbenzén |
202-849-4 |
100-41-4 |
Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 |
H225 H332 H373 (sluchové orgány) H304 |
GHS02 GHS07 GHS08 Dgr |
H225 H332 H373 (sluchové orgány) H304 |
|
|
|
|
601-024-00-X |
kumén; [1] propylbenzén [2] |
202-704-5 [1] 203-132-9 [2] |
98-82-8 [1] 103-65-1 [2] |
Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H304 H335 H411 |
|
|
C |
|
601-025-00-5 |
mezitylén; 1,3,5-trimetylbenzén |
203-604-4 |
108-67-8 |
Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 |
H226 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H335 H411 |
|
STOT SE 3; H335: C ≥ 25% |
|
|
601-026-00-0 |
styrén |
202-851-5 |
100-42-5 |
Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 |
H226 H361d H332 H372 (sluchové orgány) H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H226 H361d H332 H372 (sluchové orgány) H315 H319 |
|
* |
D |
|
601-027-00-6 |
2-fenylpropén; α-metylstyrén |
202-705-0 |
98-83-9 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H226 H319 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H411 |
|
STOT SE 3; H335: C ≥ 25% |
|
|
601-028-00-1 |
2-metylstyrén; 2-vinyltoluén |
210-256-7 |
611-15-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
601-029-00-7 |
1-metyl-4-(prop-1-én-2-yl)cyklohexén limonén;[1] (R)-1-metyl-4-(prop-1-én-2-yl)cyklohexén; (+)-limonén; [2] (S)-1-metyl-4-(prop-1-én-2-yl)cyklohexén (-)-limonén; [3] trans-1-metyl-4-(prop-1-én-2-yl)cyklohexén; [4] (±)-1-metyl-4-(prop-1-én-2-yl)cyklohexén [5] |
205-341-0 [1] 227-813-5 [2] 227-815-6 [3] 229-977-3 [4] 231-732-0 [5] |
138-86-3 [1] 5989-27-5 [2] 5989-54-8 [3] 6876-12-6 [4] 7705-14-8 [5] |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H315 H317 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H317 H410 |
|
|
C |
|
601-030-00-2 |
cyklopentán |
206-016-6 |
287-92-3 |
Flam. Liq. 2 Aquatic Chronic 3 |
H225 H412 |
GHS02 Dgr |
H225 H412 |
|
|
|
|
601-031-00-8 |
2,4,4-trimetylpent-1-én |
203-486-4 |
107-39-1 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
601-032-00-3 |
benzo[a]pyrén; benzo[def]chryzén |
200-028-5 |
50-32-8 |
Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H360FD H317 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
601-033-00-9 |
benzo[a]antracén |
200-280-6 |
56-55-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
M=100 |
|
|
601-034-00-4 |
benzo[e]acefenantrylén |
205-911-9 |
205-99-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
601-035-00-X |
benzo[j]fluorantén |
205-910-3 |
205-82-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
601-036-00-5 |
benzo[k]fluorantén |
205-916-6 |
207-08-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
601-037-00-0 |
hexán |
203-777-6 |
110-54-3 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H361f *** H304 H373 ** H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H361f *** H304 H373 ** H315 H336 H411 |
|
STOT RE 2; H373: C ≥ 5% |
|
|
601-041-00-2 |
dibenzo[a, h]antracén |
200-181-8 |
53-70-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % M=100 |
|
|
601-042-00-8 |
bifenyl; difenyl |
202-163-5 |
92-52-4 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
601-043-00-3 |
1,2,4-trimetylbenzén |
202-436-9 |
95-63-6 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H319 H335 H315 H411 |
|
|
|
|
601-044-00-9 |
3a,4,7,7a-tetrahydro-4,7-metanoindén |
201-052-9 |
77-73-6 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H332 H302 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H302 H319 H335 H315 H411 |
|
|
|
|
601-045-00-4 |
1,2,3,4-tetrahydronaftalén |
204-340-2 |
119-64-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
EUH019 |
|
|
|
601-046-00-X |
7-metylokta-1,6-dién |
404-210-7 |
42152-47-6 |
Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H400 H410 |
GHS02 GHS09 Wng |
H226 H410 |
|
|
|
|
601-047-00-5 |
3-izopropylidén-1-metylcyklohexán; meta-menta-1,3(8)-dién |
404-150-1 |
17092-80-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
601-048-00-0 |
chryzén |
205-923-4 |
218-01-9 |
Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H400 H410 |
GHS08 GHS09 Dgr |
H350 H341 H410 |
|
|
|
|
601-049-00-6 |
benzo[e]pyrén |
205-892-7 |
192-97-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
601-051-00-7 |
4-fenylbut-1-én |
405-980-7 |
768-56-9 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
601-052-00-2 |
naftalén |
202-049-5 |
91-20-3 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
601-053-00-8 |
nonylfenol; [1] 4-(C9-alkyl)fenol, rozvetvený [2] |
246-672-0 [1] 284-325-5 [2] |
25154-52-3 [1] 84852-15-3 [2] |
Repr. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361fd H302 H314 H410 |
|
|
|
|
601-054-00-3 |
reakčná zmes zložená z izomérov: dibenzylbenzén; dibenzyl(metyl)benzén; dibenzyldi(metyl)benzén; dibenzyltri(metyl)benzén |
405-570-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-055-00-9 |
reakčná zmes zložená z izomérov: mono(tetradekán-2-yl)naftalény; di(tetradekán-2-yl)naftalény; tri(tetradekán-2-yl)naftalény |
410-190-0 |
132983-41-6 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
601-056-00-4 |
reakčná zmes zložená z izomérov: metyldifenylmetán; dimetyldifenylmetán |
405-470-4 |
73807-39-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
601-057-00-X |
[3-(4-(dimetylamino)benzamido)propyl](dodecyl)di(metyl)amónium-tozylát |
421-130-8 |
156679-41-3 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
601-058-00-5 |
di-L-para-mentén |
417-870-6 |
83648-84-4 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
601-059-00-0 |
O-metyl-2-benzylidén-3-oxobutanoát |
420-940-9 |
15768-07-7 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
601-060-00-6 |
kálium0,245-nátrium7,755-1,2-bis(4-fluór-6- {4-sulfonáto-5-[2-(4-sulfonátonaftalén-3- yldiazenyl)-1-hydroxy-3,6-disulfonáto-8- aminonaftalén-7-yldiazenyl]fenylamino}- 1,3,5-triazín-2-ylamino)etán . |
417-610-1 |
155522-09-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
601-061-00-1 |
(etyletán-1,2-diyl)[-α-(2-{[(2-hydroxyetyl)metylamino]acetyl}propyl)-ω-(nonylfenoxy)-poly][oxy(metyletán-1,2-diyl)] |
418-960-8 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
601-062-00-7 |
reakčná zmes zložená z týchto látok: rozvetvený C30-alkán; rozvetvený C32-alkán; rozvetvený C34-alkán; rozvetvený C36-alkán |
417-030-9 |
151006-59-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
601-063-00-2 |
reakčná zmes zložená z izomérov rozvetveného C24-alkánu |
417-060-2 |
151006-61-0 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
601-064-00-8 |
rozvetvený C36-alkán |
417-070-7 |
151006-62-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
601-065-00-3 |
reakčná zmes zložená z týchto látok: (1'α,3'α,6'α)-2,2,3',7',7'-pentametylspiro(1,3- dioxán-5,2'-bicyklo[4.1.0]heptán); (1'α,3'β,6'α)-2,2,3',7',7'-pentametylspiro(1,3- dioxán-5,2'-bicyklo[4.1.0]heptán) |
416-930-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
601-066-00-9 |
1-[4-(trans-4-heptylcyklohexyl)fenyl]etanón |
426-820-2 |
78531-60-9 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
601-067-00-4 |
trietyl-arzenát |
427-700-2 |
15606-95-8 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
601-068-00-X |
(but-3-én-1,2-diyl)-diacetát |
421-720-5 |
18085-02-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
601-069-00-5 |
2-etyl-1-[2-(1,3-dioxanyl)etyl]pyridínium-bromid |
422-680-1 |
287933-44-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
601-070-00-0 |
reakčná zmes zložená z týchto látok: rozvetvený C20-alkán; rozvetvený C22-alkán; rozvetvený C24-alkán |
417-050-8 |
151006-58-5 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
601-071-00-6 |
1-(dimetoxymetyl)-2-nitrobenzén |
423-830-9 |
20627-73-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
601-072-00-1 |
reakčná zmes zložená z týchto látok: 1-(4-izopropylfenyl)-1-fenyletán; 1-fenyl-1-(3-izopropylfenyl)etán; 1-fenyl-1-(2-izopropylfenyl)etán |
430-690-2 |
52783-21-8 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
601-073-00-7 |
1-bróm-3,5-difluórbenzén |
416-710-2 |
461-96-1 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373 ** H315 H317 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Wng |
H226 H302 H373 ** H315 H317 H410 |
|
|
|
|
601-074-00-2 |
reakčná zmes zložená z týchto látok: 1-metyl-4-(2,2,3-trimetylcyklopent-3-én-1- yl)-2-oxabicyklo[2.2.2]oktán; 5-metyl-1-(2,2,3-trimetylcyklopent-3-én-1- yl)-6-oxabicyklo[3.2.1]oktán; 3,6',6',6'a-tetrametyl-4',5',6',6'a-tetrahydro- 2'H,3'aH-spiro[cyklohex-3-én-1,3'- cyklopenta[b]furán]; 4,6',6',6'a-tetrametyl-4',5',6',6'a-tetrahydro- 2'H,3'aH-spiro[cyklohex-3-én-1,3'- cyklopenta[b]furán] |
422-040-1 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
601-075-00-8 |
1,1'-bis(4-metylbenzénsulfonyl)-1,1'- [metyléndi(4,1-fenylén)]bis(močovina) |
418-770-5 |
151882-81-4 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
601-076-00-3 |
etinylcyklopropán |
425-430-1 |
6746-94-7 |
Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H315 H318 H412 |
GHS02 GHS05 Dgr |
H225 H315 H318 H412 |
|
|
|
|
601-077-00-9 |
reakčná zmes zložená z týchto látok: 4-etyl-1-heptyl-2,6,7- trioxabicyklo[2.2.2]oktán; 4-etyl-1-nonyl-2,6,7- trioxabicyklo[2.2.2]oktán |
426-510-7 |
196965-91-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-078-00-4 |
reakčná zmes zložená z týchto látok: 1,7-dimetyl-2-[(3- metylbicyklo[2.2.1]heptán-2- yl)metyl]bicyklo[2.2.1]heptán; 2,3-dimetyl-2-[(3- metylbicyklo[2.2.1]heptán-2- yl)metyl]bicyklo[2.2.1]heptán |
427-040-5 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
601-079-00-X |
reakčná zmes zložená z týchto látok: trans, trans-cyklohexadeka-1,9-dién; cis, trans-cyklohexadeka-1,9-dién |
429-620-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
601-080-00-5 |
reakčná zmes zložená z týchto látok: (sek-butylfenyl)(fenyl)metán, zmes izomérov; 1-(sek-butylfenyl)-2-fenyletán, zmes izomérov; 1-(sek-butylfenyl)-1-fenyletán, zmes izomérov; |
431-100-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-081-00-0 |
cyklohexadeka-1,9-dién |
431-730-1 |
4277-06-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
601-082-00-6 |
reakčná zmes zložená z týchto látok: 2endo,3exo-dimetyl-2exo-[(3exo-metylbicyklo[2.2.1]heptán-2exo-yl)metyl]bicyklo[2.2.1]heptán; 2exo,3exo-dimetyl-2endo-[(3endometylbicyklo[ 2.2.1]heptán-2exoyl) metyl]bicyklo[2.2.1]heptán |
434-420-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
601-083-00-1 |
5endo-hexyl-bicyklo[2.2.1]hept-2-én |
435-000-3 |
22094-83-3 |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 |
H304 H315 H413 |
GHS08 GHS07 Dgr |
H304 H315 H413 |
|
|
|
|
601-084-00-7 |
reakčná zmes zložená z týchto látok: 5endo-butylbicyklo[2.2.1]hept-2-én; 5exo-butylbicyklo[2.2.1]hept-2-én (80: 20) |
435-180-3 |
— |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H315 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H304 H315 H410 |
|
|
|
|
601-085-00-2 |
izopentán; 2-metylbután |
201-142-8 |
78-78-4 |
Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H224 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H224 H304 H336 H411 |
EUH066 |
|
|
|
601-087-00-3 |
2,4,4-trimetylpentén |
246-690-9 |
25167-70-8 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 |
H225 H304 H336 |
GHS02 GHS07 GHS08 Dgr |
H225 H304 H336 |
|
|
D |
|
601-088-00-9 |
4-vinylcyklohexén |
202-848-9 |
100-40-3 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
601-089-00-4 |
muscalure; trikoz-9-én |
248-505-7 |
27519-02-4 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
602-001-00-7 |
chlórmetán; metylchlorid |
200-817-4 |
74-87-3 |
Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 * |
H220 H351 H373 ** |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H373 ** |
|
|
U |
|
602-002-00-2 |
brómmetán; metylbromid |
200-813-2 |
74-83-9 |
Press. Gas Muta. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 |
H341 H331 H301 H373** H319 H335 H315 H400 H420 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H341 H331 H301 H373 ** H319 H335 H315 H400 H420 |
|
|
U |
|
602-003-00-8 |
dibrómmetán |
200-824-2 |
74-95-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
* |
|
|
602-004-00-3 |
dichlórmetán; metylénchlorid |
200-838-9 |
75-09-2 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
602-005-00-9 |
metyljodid; jódmetán |
200-819-5 |
74-88-4 |
Carc. 2 Acute Tox. 4 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 |
H351 H312 H331 H301 H335 H315 |
GHS06 GHS08 Dgr |
H351 H312 H331 H301 H335 H315 |
|
|
|
|
602-006-00-4 |
chloroform; trichlórmetán; |
200-663-8 |
67-66-3 |
Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H351 H361d H331 H302 H372 H319 H315 |
GHS06 GHS08 Dgr |
H351 H361d H331 H302 H372 H319 H315 |
|
|
|
|
602-007-00-X |
bromoform; tribrómmetán |
200-854-6 |
75-25-2 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H331 H302 H319 H315 H411 |
GHS06 GHS09 Dgr |
H331 H302 H319 H315 H411 |
|
|
|
|
602-008-00-5 |
chlorid uhličitý; tetrachlórmetán |
200-262-8 |
56-23-5 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 Ozone 1 |
H351 H331 H311 H301 H372** H412 H420 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 H372 ** H412 H420 |
|
* STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C < 1% |
|
|
602-009-00-0 |
chlóretán |
200-830-5 |
75-00-3 |
Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 |
H220 H351 H412 |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H412 |
|
|
U |
|
602-010-00-6 |
1,2-dibrómetán |
203-444-5 |
106-93-4 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H331 H311 H301 H319 H335 H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H319 H335 H315 H411 |
|
* |
|
|
602-011-00-1 |
1,1-dichlóretán |
200-863-5 |
75-34-3 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H225 H302 H319 H335 H412 |
GHS02 GHS07 Dgr |
H225 H302 H319 H335 H412 |
|
* |
|
|
602-012-00-7 |
1,2-dichlóretán; etyléndichlorid |
203-458-1 |
107-06-2 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H302 H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H302 H319 H335 H315 |
|
|
|
|
602-013-00-2 |
1,1,1-trichlóretán; metylchloroform |
200-756-3 |
71-55-6 |
Acute Tox. 4 * Ozone 1 |
H332 H420 |
GHS07 Wng |
H332 H420 |
|
|
F |
|
602-014-00-8 |
1,1,2-trichlóretán |
201-166-9 |
79-00-5 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H351 H332 H312 H302 |
GHS08 GHS07 Wng |
H351 H332 H312 H302 |
EUH066 |
* |
|
|
602-015-00-3 |
1,1,2,2-tetrachlóretán |
201-197-8 |
79-34-5 |
Acute Tox. 2 * Acute Tox. 1 Aquatic Chronic 2 |
H330 H310 H411 |
GHS06 GHS09 Dgr |
H330 H310 H411 |
|
|
|
|
602-016-00-9 |
1,1,2,2-tetrabrómetán |
201-191-5 |
79-27-6 |
Acute Tox. 2 * Eye Irrit. 2 Aquatic Chronic 3 |
H330 H319 H412 |
GHS06 Dgr |
H330 H319 H412 |
|
|
|
|
602-017-00-4 |
pentachlóretán |
200-925-1 |
76-01-7 |
Carc. 2 STOT RE 1 Aquatic Chronic 2 |
H351 H372 ** H411 |
GHS08 GHS09 Dgr |
H351 H372 ** H411 |
|
STOT RE 1; H372: C≥ 1% STOT RE 2; H373: 0,2 % ≤ C < 1% |
|
|
602-018-00-X |
1-chlórpropán; [1] 2-chlórpropán [2] |
208-749-7 [1] 200-858-8 [2] |
540-54-5 [1] 75-29-6 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-019-00-5 |
1-brómpropán; propylbromid |
203-445-0 |
106-94-5 |
Flam. Liq. 2 Repr. 1B STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 |
H225 H360FD H373 ** H319 H335 H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H373 ** H319 H335 H315 H336 |
|
|
|
|
602-021-00-6 |
1,2-dibróm-3-chlórpropán |
202-479-3 |
96-12-8 |
Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H340 H360F *** H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H340 H360F *** H301 H373 ** H412 |
|
|
|
|
602-022-00-1 |
1-chlórpentán; [1] 2-chlórpentán; [2] 3-chlórpropán [3] |
208-846-4 [1] 210-885-7 [2] 210-467-4 [3] |
543-59-9 [1] 625-29-6 [2] 616-20-6 [3] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-023-00-7 |
vinylchlorid; chlóretén |
200-831-0 |
75-01-4 |
Press. Gas Flam. Gas 1 Carc. 1A |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
D U |
|
602-024-00-2 |
brómetén |
209-800-6 |
593-60-2 |
Press. Gas Flam. Gas 1 Carc. 1B |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
U |
|
602-025-00-8 |
1,1-dichlóretén; vinylidénchlorid |
200-864-0 |
75-35-4 |
Flam. Liq. 1 Carc. 2 Acute Tox. 4 * |
H224 H351 H332 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H332 |
|
* |
D |
|
602-026-00-3 |
1,2-dichlóretén; [1] cis-1,2-dichlóretén; [2] trans-1,2-dichlóretén [3] |
208-750-2 [1] 205-859-7 [2] 205-860-2 [3] |
540-59-0 [1] 156-59-2 [2] 156-60-5 [3] |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H225 H332 H412 |
GHS02 GHS07 Dgr |
H225 H332 H412 |
|
* |
C |
|
602-027-00-9 |
trichlóretylén; trichlóretén |
201-167-4 |
79-01-6 |
Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H350 H341 H319 H315 H336 H412 |
GHS08 GHS07 Dgr |
H350 H341 H319 H315 H336 H412 |
|
|
|
|
602-028-00-4 |
tetrachlóretén |
204-825-9 |
127-18-4 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
602-029-00-X |
3-chlórpropén; alylchlorid |
203-457-6 |
107-05-1 |
Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
|
|
D |
|
602-030-00-5 |
1,3-dichlórpropén; [1] (Z)-1,3-dichlórpropén [2] |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 |
|
|
C D |
|
602-031-00-0 |
1,1-dichlórpropén |
209-253-3 |
563-58-6 |
Flam. Liq. 2 Acute Tox. 3 * Aquatic Chronic 3 |
H225 H301 H412 |
GHS02 GHS06 Dgr |
H225 H301 H412 |
|
|
|
|
602-032-00-6 |
3-chlór-2-metylpropén |
209-251-2 |
563-47-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H302 H314 H317 H411 |
|
|
|
|
602-034-00-7 |
1,2-dichlórbenzén; orto-dichlórbenzén |
202-425-9 |
95-50-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
* |
|
|
602-035-00-2 |
1,4-dichlórbenzén; para-dichlórbenzén |
203-400-5 |
106-46-7 |
Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H400 H410 |
GHS08 GHS09 Wng |
H351 H319 H410 |
|
|
|
|
602-036-00-8 |
chloroprén (stabilizovaný); 2-chlórbuta-1,3-dién (stabilizovaný) |
204-818-0 |
126-99-8 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
|
|
D |
|
602-037-00-3 |
(chlórmetyl)benzén; benzylchlorid |
202-853-6 |
100-44-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H373 ** H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H373 ** H335 H315 H318 |
|
|
|
|
602-038-00-9 |
(trichlórmetyl)benzén; benzotrichlorid |
202-634-5 |
98-07-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H335 H315 H318 |
|
|
|
|
602-039-00-4 |
polychlórované bifenyly; PCB |
215-648-1 |
1336-36-3 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
STOT RE 2; H373: C ≥ 0,005 % |
C |
|
602-040-00-X |
2-chlórtoluén; [1] 3-chlórtoluén; [2] 4-chlórtoluén; [3] chlórtoluén [4] |
202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] |
95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
C |
|
602-041-00-5 |
pentachlórnaftalén |
215-320-8 |
1321-64-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H410 |
|
|
C |
|
602-042-00-0 |
1,2,3,4,5,6-hexachlórcyklohexány, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H410 |
|
|
A C |
|
602-043-00-6 |
lindán (ISO); γ-HCH alebo γ-BHC; γ-1,2,3,4,5,6-hexachlórcyklohexán |
200-401-2 |
58-89-9 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H373 ** H362 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H312 H373 ** H362 H410 |
|
M=10 |
|
|
602-044-00-1 |
kamfechlór (ISO); toxafén; |
232-283-3 |
8001-35-2 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H335 H315 H410 |
|
|
|
|
602-045-00-7 |
DDT (ISO); klofenotán (INN); dikofán; 1,1,1-trichlór-2,2-bis(4-chlórfenyl)etán; dichlórdifenyltrichlóretán |
200-024-3 |
50-29-3 |
Carc. 2 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H372 ** H410 |
|
|
|
|
602-046-00-2 |
heptachlór (ISO); 1,4,5,6,7,8,8-heptachlór-3a,4,7,7a-tetrahydro-4,7-metanoindén |
200-962-3 |
76-44-8 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H373 ** H410 |
|
|
|
|
602-047-00-8 |
chlordán (ISO); 1,2,4,5,6,7,8,8-oktachlór-3a,4,7,7atetrahydro-4,7-metanoindán |
200-349-0 |
57-74-9 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H312 H302 H410 |
|
|
|
|
602-048-00-3 |
aldrín (ISO) |
206-215-8 |
309-00-2 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H372 ** H410 |
|
|
|
|
602-049-00-9 |
dieldrín (ISO) |
200-484-5 |
60-57-1 |
Carc. 2 Acute Tox. 1 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H310 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H310 H301 H372 ** H410 |
|
|
|
|
602-050-00-4 |
izodrín; (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10- hexachlór-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimetanonaftalén; |
207-366-2 |
465-73-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M=100 |
|
|
602-051-00-X |
endrín (ISO); 1,2,3,4,10,10-hexachlór-6,7-epoxy- 1,4,4a,5,6,7,8,8a-oktahydro-1,4:5,8- dimetanonaftalén |
200-775-7 |
72-20-8 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
602-052-00-5 |
endosulfán (ISO); 6,7,8,9,10,10-hexachlór-5a,6,9,9atetrahydro- 6,9-metano-1H,4H-2,4,3-benzodioxatiepín-3-oxid 1,4,5,6,7,7-hexachlór-8,9,10-trinorborn-5-én-2,3-ylénbismetylén-sulfit |
204-079-4 |
115-29-7 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H312 H410 |
|
|
|
|
602-053-00-0 |
izobenzán (ISO); 1,3,4,5,6,7,8,8-oktachlór-1,3,3a,4,7,7a-hexahydro-4,7-metanoizobenzofurán |
206-045-4 |
297-78-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
602-054-00-6 |
3-jódpropén; alyljodid |
209-130-4 |
556-56-9 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
602-055-00-1 |
brómetán; etylbromid |
200-825-8 |
74-96-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H351 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H302 |
|
|
|
|
602-056-00-7 |
(trifluórmetyl)benzén; benzotrifluorid |
202-635-0 |
98-08-8 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
602-057-00-2 |
(brómmetyl)benzén; benzylbromid |
202-847-3 |
100-39-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
|
|
|
602-058-00-8 |
(dichlórmetyl)benzén; benzylidéndichlorid; (dichlórmetyl)benzén |
202-709-2 |
98-87-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H351 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H351 H331 H302 H335 H315 H318 |
|
|
|
|
602-059-00-3 |
1-chlórbután; butylchlorid |
203-696-6 |
109-69-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
602-060-00-9 |
brómbenzén |
203-623-8 |
108-86-1 |
Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H411 |
|
|
|
|
602-061-00-4 |
hexafluórpropén; hexafluórpropylén |
204-127-4 |
116-15-4 |
Press. Gas Acute Tox. 4 * STOT SE 3 |
H332 H335 |
GHS07 Wng |
H332 H335 |
|
|
U |
|
602-062-00-X |
1,2,3-trichlórpropán |
202-486-1 |
96-18-4 |
Carc. 1B Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H350 H360F *** H332 H312 H302 |
GHS08 GHS07 Dgr |
H350 H360F *** H332 H312 H302 |
|
|
D |
|
602-063-00-5 |
heptachlórepoxid; 1,4,5,6,7,8,8-heptachlór-2,3-epoxy- 3a,4,7,7a-tetrahydro-4,7-metanoindán |
213-831-0 |
1024-57-3 |
Carc. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H373 ** H410 |
|
|
|
|
602-064-00-0 |
1,3-dichlórpropán-2-ol |
202-491-9 |
96-23-1 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * |
H350 H301 H312 |
GHS06 GHS08 Dgr |
H350 H301 H312 |
|
|
|
|
602-065-00-6 |
hexachlórbenzén |
204-273-9 |
118-74-1 |
Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372 ** H400 H410 |
GHS08 GHS09 Dgr |
H350 H372 ** H410 |
|
|
|
|
602-066-00-1 |
tetrachlór-para-benzochinón |
204-274-4 |
118-75-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
602-067-00-7 |
1,3-dichlórbenzén |
208-792-1 |
541-73-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
602-068-00-2 |
etylén-bis(trichlóracetát) |
219-732-9 |
2514-53-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
602-069-00-8 |
dichlóracetylén |
— |
7572-29-4 |
Unst. Expl. Carc. 2 STOT RE 2 * |
H200 H351 H373 ** |
GHS01 GHS08 Wng |
H200 H351 H373 ** |
|
|
|
|
602-070-00-3 |
1,2-difluór-3-chlór-5-(trifluórmetyl)benzén |
401-930-3 |
77227-99-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H332 H302 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H302 H400 |
|
|
|
|
602-071-00-9 |
bróm(brómbenzyl)(metyl)benzén, reakčná zmes zložená z izomérov |
402-210-1 |
99688-47-8 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
|
602-072-00-4 |
[(dichlórfenyl)metyl]di(chlór)(metyl)benzén, reakčná zmes zložená z izomérov; (dichlórfenyl)(dichlórtolyl)metán, reakčná zmes zložená z izomérov (IUPAC) |
278-404-3 |
76253-60-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
602-073-00-X |
1,4-dichlórbut-2-én |
212-121-8 |
764-41-0 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H330 H311 H301 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H330 H311 H301 H314 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5% |
|
|
602-074-00-5 |
pentachlórbenzén |
210-172-0 |
608-93-5 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
602-075-00-0 |
4,4,5,5-tetrachlór-1,3-dioxolán-2-ón |
404-060-2 |
22432-68-4 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS05 Dgr |
H330 H302 H314 |
|
|
|
|
602-076-00-6 |
2,3,4-trichlórbut-1-én |
219-397-9 |
2431-50-7 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H302 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H302 H319 H335 H315 H410 |
|
Carc. 2; H351: C ≥ 0,1 % |
|
|
602-077-00-1 |
dodekachlórpentacyklo[5.2.1.02,6.03,9.05,8]dekán; mirex |
219-196-6 |
2385-85-5 |
Carc. 2 Repr. 2 Lact. Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H362 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H362 H312 H302 H410 |
|
|
|
|
602-078-00-7 |
hexachlórcyklopentadién |
201-029-3 |
77-47-4 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H302 H314 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H311 H302 H314 H410 |
|
|
|
|
602-079-00-2 |
2,3-dichlórpropén; 2,3-dichlórpropylén |
201-153-8 |
78-88-6 |
Flam. Liq. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
|
|
|
|
602-080-00-8 |
chlór-C10-13-alkány; chlórované C10-13-alkány |
287-476-5 |
85535-84-8 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
EUH066 |
|
|
|
602-081-00-3 |
kyselina 4,5-difluór-2-chlórbenzoová |
405-380-5 |
— |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H312 H302 H318 H317 |
GHS05 GHS07 Dgr |
H312 H302 H318 H317 |
|
|
|
|
602-082-00-9 |
2,2,6,6-tetrakis(brómmetyl)-4-oxaheptán-1,7-diol |
408-020-5 |
109678-33-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
602-083-00-4 |
pentabrómderivát difenyléteru; pentabrómdifenyléter |
251-084-2 |
32534-81-9 |
STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H362 H400 H410 |
GHS08 GHS09 Wng |
H373 ** H362 H410 |
|
|
|
|
602-084-00-X |
1-fluór-1,1-dichlóretán |
404-080-1 |
1717-00-6 |
Aquatic Chronic 3 Ozone 1 |
H412 H420 |
GHS07 Wng |
H412 H420 |
|
|
|
|
602-085-00-5 |
2-brómpropán |
200-855-1 |
75-26-3 |
Flam. Liq. 2 Repr. 1a STOT RE 2 * |
H225 H360F *** H373 ** |
GHS02 GHS08 Dgr |
H225 H360F *** H373 ** |
EUH066 |
|
|
|
602-086-00-0 |
trifluórjódmetán; trifluórmetyljodid |
219-014-5 |
2314-97-8 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
602-087-00-6 |
1,2,4-trichlórbenzén |
204-428-0 |
120-82-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
602-088-00-1 |
2,3-dibrómpropán-1-ol; 2,3-dibróm-1-propanol |
202-480-9 |
96-13-9 |
Carc. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H350 H361f *** H311 H332 H302 H412 |
GHS08 GHS07 Dgr |
H350 H361f *** H311 H332 H302 H412 |
|
|
|
|
602-089-00-7 |
4-bróm-1-fluór-2-chlórbenzén |
405-580-2 |
60811-21-4 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
602-090-00-2 |
4-alyl-1-fluór-2-chlórbenzén |
406-630-6 |
121626-73-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
602-091-00-8 |
1-fluór-2,4-dichlórbenzén |
406-160-1 |
1435-48-9 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 |
H302 H373 ** H315 H411 |
GHS08 GHS07 Wng |
H302 H373 ** H315 H411 |
|
|
|
|
602-092-00-3 |
5-bróm-1,2,3-trifluórbenzén |
418-480-9 |
138526-69-9 |
Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H351 H315 H318 H411 |
GHS02 GHS08 GHS05 GHS09 Dgr |
H226 H351 H315 H318 H411 |
|
|
|
|
602-093-00-9 |
1-chlór-4-(trichlórmetyl)benzén; para-chlórbenzotrichlorid |
226-009-1 |
5216-25-1 |
Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H350 H361f *** H372 ** H312 H302 H335 H315 |
GHS08 GHS07 Dgr |
H350 H361f *** H372 ** H312 H302 H335 H315 |
|
|
|
|
602-094-00-4 |
oktabrómderivát difenyléteru |
251-087-9 |
32536-52-0 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
602-095-00-X |
chlór-C14-17-alkány; chlórované C14-17-alkány |
287-477-0 |
85535-85-9 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
EUH066 |
|
|
|
602-096-00-5 |
malachitová zelená, hydrochlorid; [1] malachitová zelená, oxalát [2] |
209-322-8 [1] 219-441-7 [2] |
569-64-2 [1] 2437-29-8 [2] |
Repr. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d *** H302 H318 H410 |
|
|
|
|
602-097-00-0 |
1-bróm-9-(4,4,5,5,5-pentafluórpentylsulfanyl)nonán |
422-850-5 |
148757-89-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
602-098-00-6 |
2-(3-brómfenoxy)tetrahydro-2H-pyrán |
429-030-6 |
57999-49-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
602-099-00-1 |
3-(4-fluórfenyl)-2-metylpropanoylchlorid |
426-370-7 |
— |
Skin Corr. 1A Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
EUH014 EUH029 |
|
|
|
602-100-00-5 |
reakčná zmes zložená z týchto látok: (R, R)-1,1,1,2,2,3,4,5,5,5-dekafluórpentán; (S, S)-1,1,1,2,2,3,4,5,5,5-dekafluórpentán |
420-640-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
602-101-00-0 |
(4-fluór-2-chlór-5-nitrofenyl)-(izobutyl)-karbonát |
427-020-6 |
141772-37-4 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373** H317 H410 |
|
|
|
|
602-102-00-6 |
1,1,1,3,3-pentafluórbután |
430-250-1 |
406-58-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
602-103-00-1 |
fenyl(chlór)(2-metylfenyl)metán |
431-450-1 |
41870-52-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
602-104-00-7 |
1,1,2,2,3,3,4-heptafluórcyklopentán |
430-710-1 |
15290-77-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
602-105-00-2 |
nátrium-1,1,2,2,3,3,4,4,4-nonafluórbután-1-sulfinát |
422-100-7 |
102061-82-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
602-106-00-8 |
2-bróm-4,6-difluóranilín |
429-430-0 |
444-14-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
602-107-00-3 |
3,3,4,4-tetrafluór-4-jódbut-1-én |
439-500-2 |
33831-83-3 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
602-108-00-9 |
(2,3,5,6-tetrafluórfenyl)metanol |
443-840-7 |
4084-38-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
602-109-00-4 |
hexabrómcyklododekán [1] 1,2,5,6,9,10-hexabrómcyklodekán [2] |
247-148-4 [1] 221-695-9[2] |
25637-99-4[1] 3194-55-6[2] |
Repr. 2 Lact. |
H361 H362 |
GHS08 Wng |
H361 H362 |
|
|
|
|
603-001-00-X |
metanol |
200-659-6 |
67-56-1 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 |
H225 H331 H311 H301 H370 ** |
GHS02 GHS06 GHS08 Dgr |
H225 H331 H311 H301 H370 ** |
|
* STOT SE 1; H370: C≥10% STOT SE 2; H371: 3% ≤ C<10% |
|
|
603-002-00-5 |
etanol; etylalkohol |
200-578-6 |
64-17-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
603-003-00-0 |
propán-1-ol; propanol |
200-746-9 |
71-23-8 |
Flam. Liq. 2 Eye Dam. 1 STOT SE 3 |
H225 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H225 H318 H336 |
|
|
|
|
603-004-00-6 |
bután-1-ol butanol |
200-751-6 |
71-36-3 |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H302 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H335 H315 H318 H336 |
|
|
|
|
603-005-00-1 |
2-metylpropán-2-ol; terc-butylalkohol |
200-889-7 |
75-65-0 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
|
|
|
|
603-006-00-7 |
izoméry pentanolu, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
250-378-8 |
|
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 |
H226 H332 H335 |
GHS02 GHS07 Wng |
H226 H332 H335 |
EUH066 |
|
C |
|
603-007-00-2 |
2-metylbután-2-ol; terc-pentylalkohol |
200-908-9 |
75-85-4 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H225 H332 H335 H315 |
GHS02 GHS07 Dgr |
H225 H332 H335 H315 |
|
|
|
|
603-008-00-8 |
4-metylpentán-2-ol; metyl(izobutyl)karbinol |
203-551-7 |
108-11-2 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 25% |
|
|
603-009-00-3 |
cyklohexanol |
203-630-6 |
108-93-0 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H332 H302 H335 H315 |
GHS07 Wng |
H332 H302 H335 H315 |
|
|
|
|
603-010-00-9 |
2-metylcyklohexanol, zmes izomérov; [1] cis-2-metylcyklohexanol; [2] trans-2-metylcyklohexanol [3] |
209-512-0 [1] 231-187-9 [2] 231-186-3 [3] |
583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
C |
|
603-011-00-4 |
2-metoxyetanol; etylénglykol-monometyléter |
203-713-7 |
109-86-4 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
603-012-00-X |
2-etoxyetanol; etylénglykol-monoetyléter |
203-804-1 |
110-80-5 |
Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H226 H360FD H331 H302 |
GHS02 GHS08 GHS06 Dgr |
H226 H360FD H331 H302 |
|
|
|
|
603-013-00-5 |
2-izopropoxyetanol; etylénglykol-monoizopropyléter |
203-685-6 |
109-59-1 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H332 H312 H319 |
GHS07 Wng |
H332 H312 H319 |
|
|
|
|
603-014-00-0 |
2-butoxyetanol; etylénglykol -monobutyléter |
203-905-0 |
111-76-2 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H332 H312 H302 H319 H315 |
GHS07 Wng |
H332 H312 H302 H319 H315 |
|
|
|
|
603-015-00-6 |
alylalkohol |
203-470-7 |
107-18-6 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H331 H311 H301 H319 H335 H315 H400 |
GHS02 GHS06 GHS09 Dgr |
H225 H331 H311 H301 H319 H335 H315 H400 |
|
|
|
|
603-016-00-1 |
4-hydroxy-4-metylpentán-2-ón; diacetón-alkohol |
204-626-7 |
123-42-2 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
Eye Irrit. 2; H319: C≥ 10% |
|
|
603-018-00-2 |
furfurylalkohol |
202-626-1 |
98-00-0 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 |
H351 H331 H312 H302 H373** H319 H335 |
GHS06 GHS08 Dgr |
H351 H331 H312 H302 H373** H319 H335 |
|
|
|
|
603-019-00-8 |
dimetyléter |
204-065-8 |
115-10-6 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
603-020-00-3 |
etyl(metyl)éter |
— |
540-67-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
603-021-00-9 |
metyl(vinyl)éter |
203-475-4 |
107-25-5 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
D U |
|
603-022-00-4 |
dietyléter; éter |
200-467-2 |
60-29-7 |
Flam. Liq. 1 Acute Tox. 4 * STOT SE 3 |
H224 H302 H336 |
GHS02 GHS07 Dgr |
H224 H302 H336 |
EUH019 EUH066 |
|
|
|
603-023-00-X |
etylénoxid; oxirán |
200-849-9 |
75-21-8 |
Press. Gas Flam. Gas 1 Carc. 1B Muta. 1B Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H220 H350 H340 H331 H319 H335 H315 |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H350 H340 H331 H319 H335 H315 |
|
|
U |
|
603-024-00-5 |
1,4-dioxán |
204-661-8 |
123-91-1 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H319 H335 |
EUH019 EUH066 |
|
D |
|
603-025-00-0 |
tetrahydrofurán |
203-726-8 |
109-99-9 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H319 H335 |
EUH019 |
STOT SE 3; H335: C≥25% Eye Irrit.2; H319: C ≥ 25% |
|
|
603-026-00-6 |
(chlórmetyl)oxirán; epichlórhydrín |
203-439-8 |
106-89-8 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
* |
|
|
603-027-00-1 |
etán-1,2-diol; etylénglykol |
203-473-3 |
107-21-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
603-028-00-7 |
2-chlóretanol; etylén-chlórhydrín |
203-459-7 |
107-07-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
603-029-00-2 |
bis(2-chlóretyl)éter |
203-870-1 |
111-44-4 |
Carc. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H351 H330 H310 H300 |
GHS06 GHS08 Dgr |
H351 H330 H310 H300 |
|
|
|
|
603-030-00-8 |
2-aminoetanol; etanolamín |
205-483-3 |
141-43-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H332 H312 H302 H314 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
603-031-00-3 |
1,2-dimetoxyetán; etylénglykol-dimetyléter; EGDME |
203-794-9 |
110-71-4 |
Flam. Liq. 2 Repr. 1B Acute Tox. 4 * |
H225 H360FD H332 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H332 |
EUH019 |
|
|
|
603-032-00-9 |
etylén-dinitrát; etylénglykol-dinitrát |
211-063-0 |
628-96-6 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 |
H200 H330 H310 H300 H373** |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373** |
|
|
|
|
603-033-00-4 |
oxydietylén-dinitrát; dietylénglykol-dinitrát; digol-dinitrát |
211-745-8 |
693-21-0 |
Unst. Expl Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H200 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373 ** H412 |
|
|
|
|
603-033-01-1 |
oxydietylén-dinitrát; dietylénglykol-dinitrát; digol-dinitrát; [>25 % inertnej zrieďujúcej látky] |
211-745-8 |
693-21-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H201 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H201 H330 H310 H300 H373 ** H412 |
|
|
|
|
603-034-00-X |
propán-1,2,3-triyl-trinitrát; nitroglycerín |
200-240-8 |
55-63-0 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H200 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H330 H310 H300 H373 ** H411 |
|
|
|
|
603-034-01-7 |
propán-1,2,3-triyl-trinitrát; nitroglycerín; [>40 % inertnej zrieďujúcej látky] |
200-240-8 |
55-63-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H201 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373 ** H411 |
|
|
|
|
603-035-00-5 |
tetranitrát pentaerytritolu; P.E.T.N. |
201-084-3 |
78-11-5 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
603-035-01-2 |
tetranitrát pentaerytritolu; P.E.T.N.; [>20 % inertnej zrieďujúcej látky] |
201-084-3 |
78-11-5 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
603-036-00-0 |
hexanitrát manitolu; nitromanit |
239-924-6 |
15825-70-4 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
603-036-01-8 |
hexanitrát manitolu; nitromanit [>40 % inertnej zrieďujúcej látky] |
239-924-6 |
15825-70-4 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
|
|
603-037-00-6 |
nitrát celulózy; nitrocelulóza |
— |
— |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
603-038-00-1 |
[(alyloxy)metyl]oxirán; alyl(oxiranylmetyl)éter; prop-2-én-1-yl(2,3-epoxypropyl)éter |
203-442-4 |
106-92-3 |
Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
|
|
|
|
603-039-00-7 |
(butoxymetyl)oxirán butyl(oxiranylmetyl)éter |
219-376-4 |
2426-08-6 |
Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H332 H302 H335 H317 H412 |
GHS02 GHS08 GHS07 Wng |
H226 H351 H341 H332 H302 H335 H317 H412 |
|
|
|
|
603-040-00-2 |
nátrium-metanolát; metoxid sodný; [1] kálium-metanolát; metoxid draselný; [2] lítium-metanolát; metoxid lítny [3] |
204-699-5 [1] 212-736-1 [2] 212-737-7 [3] |
124-41-4 [1] 865-33-8 [2] 865-34-9 [3] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-041-00-8 |
kálium-etanolát; etoxid draselný; [1] nátrium-etanolát; etoxid sodný [2] |
213-029-0 [1] 205-487-5 [2] |
917-58-8 [1] 141-52-6 [2] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-042-00-3 |
alumínium-tris(propán-2-olát) |
209-090-8 |
555-31-7 |
Flam. Sol. 1 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
603-043-00-9 |
triarimol (ISO); (2,4-dichlórfenyl)(fenyl)(pyrimidín-5-yl)metanol |
— |
26766-27-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
603-044-00-4 |
dikofol (ISO); 2,2,2-trichlór-1,1-bis(4-chlórfenyl)etanol |
204-082-0 |
115-32-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H315 H317 H410 |
|
|
|
|
603-045-00-X |
diizopropyléter; [1]dipropyléter [2] |
203-560-6 [1] 203-869-6 [2] |
108-20-3 [1] 111-43-3 [2] |
Flam. Liq. 2 STOT SE 3 |
H225 H336 |
GHS02 GHS07 Dgr |
H225 H336 |
EUH019 EUH066 |
|
C |
|
603-046-00-5 |
bis(chlórmetyl)éter; oxybis(chlórmetán) |
208-832-8 |
542-88-1 |
Flam. Liq. 2 Carc. 1A Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * |
H225 H350 H330 H311 H302 |
GHS02 GHS06 GHS08 Dgr |
H225 H350 H330 H311 H302 |
|
Carc. 1A; H350: C ≥ 0,001 % |
|
|
603-047-00-0 |
2-(dimetylamino)etanol; N,N-dimetyletanolamín |
203-542-8 |
108-01-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5% |
|
|
603-048-00-6 |
2-(dietylamino)etanol N,N-dietyletanolamín |
202-845-2 |
100-37-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5% |
|
|
603-049-00-1 |
chlórfenetol (ISO); 1,1-bis(4-chlórfenyl)etanol |
201-246-3 |
80-06-8 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
603-050-00-7 |
1-(2-butoxypropoxy)propán-2-ol |
246-011-6 |
24083-03-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
603-051-00-2 |
2-etylbután-1-ol |
202-621-4 |
97-95-0 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
603-052-00-8 |
3-butoxypropán-2-ol; propylénglykol-monobutyléter |
225-878-4 |
5131-66-8 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
603-053-00-3 |
2-metylpentán-2,4-diol |
203-489-0 |
107-41-5 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
603-054-00-9 |
di-n-butyléter; dibutyléter |
205-575-3 |
142-96-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H226 H319 H335 H315 H412 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H412 |
|
STOT SE 3; H335: C≥10% |
|
|
603-056-00-X |
[(para-tolyloxy)metyl]oxirán; [1] [(meta-tolyloxy)metyl]oxirán; [2] [(orto-tolyloxy)metyl]oxirán; [3] [(tolyloxy)metyl]oxirán; glycidyl(krezyl)éter [4] |
218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] |
2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] |
Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H315 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H315 H317 H411 |
|
|
C |
|
603-057-00-5 |
benzylalkohol |
202-859-9 |
100-51-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
603-058-00-0 |
oxetán |
207-964-3 |
503-30-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
|
|
603-059-00-6 |
hexán-1-ol |
203-852-3 |
111-27-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
603-060-00-1 |
2,2‘-bioxirán; 1,2:3,4-diepoxybután |
215-979-1 |
1464-53-5 |
Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H350 H340 H330 H311 H301 H314 |
GHS06 GHS08 GHS05 Dgr |
H350 H340 H330 H311 H301 H314 |
|
|
|
|
603-061-00-7 |
tetrahydrofurán-2-metanol; tetrahydrofurfurylalkohol |
202-625-6 |
97-99-4 |
Repr. 1B Eye Irrit. 2 |
H360Df H319 |
GHS08 GHS07 Dgr |
H360Df H319 |
|
|
|
|
603-062-00-2 |
tetrahydrofurán-2,5-dimetanol |
203-239-0 |
104-80-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥10% |
|
|
603-063-00-8 |
2,3-epoxypropán-1-ol; glycidol; oxiránmetanol |
209-128-3 |
556-52-5 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
|
|
|
|
603-064-00-3 |
1-metoxypropán-2-ol; |
203-539-1 |
107-98-2 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
603-065-00-9 |
monopropylénglykol-metyléter;(1,3-fenylén)bismetyléndi(oxirán); |
202-987-5 |
101-90-6 |
Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H351 H341 H312 H302 H319 H315 H317 H412 |
GHS08 GHS07 Wng |
H351 H341 H312 H302 H319 H315 H317 H412 |
|
|
|
|
603-066-00-4 |
1,3-bis(2,3-epoxypropoxy)benzén4-oxiranyl-1,2-epoxycyklohexán; |
203-437-7 |
106-87-6 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H351 H331 H311 H301 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 |
|
* |
|
|
603-067-00-X |
4-vinylcyklohexén-diepoxid; fenyl(glycidyl)éter; fenyl(oxiranylmetyl)éter; (fenoxymetyl)oxirán |
204-557-2 |
122-60-1 |
Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H332 H335 H315 H317 H412 |
GHS08 GHS07 Dgr |
H350 H341 H332 H335 H315 H317 H412 |
|
|
|
|
603-068-00-5 |
(2-etylcyklohexyl)(oxiranylmetyl)éter; (etylcyklohexyl)(glycidyl)éter |
— |
130014-35-6 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
603-069-00-0 |
2,4,6-tris(dimetylaminometyl)fenol |
202-013-9 |
90-72-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
603-070-00-6 |
2-amino-2-metylpropán-1-ol |
204-709-8 |
124-68-5 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
603-071-00-1 |
2,2'-iminodietanol; dietanolamín |
203-868-0 |
111-42-2 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 |
|
|
|
|
603-072-00-7 |
1,4-bis(oxiranylmetoxy)bután; butándiol(diglycidyl)éter |
219-371-7 |
2425-79-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H312 H319 H315 H317 |
GHS07 Wng |
H332 H312 H319 H315 H317 |
|
|
|
|
603-073-00-2 |
2,2-bis[4-(oxiranylmetoxy)fenyl]propán |
216-823-5 |
1675-54-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
Eye Irrit. 2; H319: C≥ 5% Skin Irrit. 2; H315: C≥5 % |
|
|
603-074-00-8 |
produkt reakcie: bisfenolu A a epichlórhydrínu; epoxidová živica (s priemernou početnou molekulovou hmotnosťou ≤ 700) |
500-033-5 |
25068-38-6 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H315 H317 H411 |
|
Eye Irrit. 2; H319: C ≥ 5% Skin Irrit 2; H315: C≥ 5% |
|
|
603-075-00-3 |
(chlórmetyl)(metyl)éter; chlórdimetyléter |
203-480-1 |
107-30-2 |
Flam. Liq. 2 Carc. 1A Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H312 H302 |
|
|
|
|
603-076-00-9 |
but-2-ín-1,4-diol; 2-butín-1,4-diol |
203-788-6 |
110-65-6 |
Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H331 H301 H312 H373 ** H317 |
GHS06 GHS05 GHS08 Dgr |
H314 H331 H301 H312 H373 ** H317 |
|
Skin Corr. 1B; H314: C≥50% Skin Irrit. 2; H315: 25%≤ C < 50% Eye Irrit. 2; H319: 25 %≤ C<50% |
D |
|
603-077-00-4 |
1-(dimetylamino)propán-2-ol; dimepranol (INN) |
203-556-4 |
108-16-7 |
Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B |
H226 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H314 |
|
|
|
|
603-078-00-X |
prop-2-ín-1-ol; propargylalkohol |
203-471-2 |
107-19-7 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H311 H301 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H311 H301 H314 H411 |
|
|
|
|
603-079-00-5 |
2,2'-(metylimino)dietanol; N-metyldietanolamín |
203-312-7 |
105-59-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-080-00-0 |
2-metylaminoetanol; N-metyletanolamín; N-metyl-2-etanolamín; N-metyl-2-aminoetanol; 2-(metylamino)etanol |
203-710-0 |
109-83-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C≥5% |
|
|
603-081-00-6 |
2,2'-sulfándiyldietanol; tiodiglykol |
203-874-3 |
111-48-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-082-00-1 |
1-aminopropán-2-ol; izopropanolamín |
201-162-7 |
78-96-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
603-083-00-7 |
1,1'-iminodi(propán-2-ol); diizopropanolamín |
203-820-9 |
110-97-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-084-00-2 |
styrén oxid; oxiranylbenzén; fenyloxirán |
202-476-7 |
96-09-3 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H312 H319 |
GHS08 GHS07 Dgr |
H350 H312 H319 |
|
|
|
|
603-085-00-8 |
bronopol (INN); 2-bróm-2-nitropropán-1,3-diol |
200-143-0 |
52-51-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H312 H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H335 H315 H318 H400 |
|
M=10 |
|
|
603-086-00-3 |
etirimol (ISO); 5-butyl-2-(etylamino)-6-metylpyrimidín-4-ol |
245-949-3 |
23947-60-6 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
603-087-00-9 |
2-etylhexán-1,3-diol; oktylénglykol; etoexadiol |
202-377-9 |
94-96-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-088-00-4 |
2-(oktylsulfanyl)etanol;(2-hydroxyetyl)(oktyl)sulfán |
222-598-4 |
3547-33-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-089-00-X |
7,7-dimetyl-3-oxa-6-azaoktán-1-ol |
400-390-6 |
— |
Skin Corr. 1A Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Dgr |
H314 H302 |
|
|
|
|
603-090-00-5 |
2-(2-brómetoxy)anizol |
402-010-4 |
4463-59-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-091-00-0 |
exo-1-metyl-4-izopropyl-7-oxabicyklo[2.2.1]heptán-2-ol |
402-470-6 |
87172-89-2 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
603-092-00-6 |
4-fenyl-2-metylpentán-1-ol |
402-770-7 |
92585-24-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
603-093-00-1 |
tinmetylín (ISO); exo-(±)-1-metyl-2-(2-metylbenzyloxy)-4-izopropyl-7-oxabicyklo[2.2.1]heptán |
402-410-9 |
87818-31-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Dgr |
H332 H411 |
|
|
|
|
603-094-00-7 |
1,3-bis(oxiranylmetoxy)-2,2-dimetylpropán |
241-536-7 |
17557-23-2 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
603-095-00-2 |
2-(propyloxy)etanol; EGPE |
220-548-6 |
2807-30-9 |
Acute Tox. 4 * Eye Irrit. 2 |
H312 H319 |
GHS07 Wng |
H312 H319 |
|
|
|
|
603-096-00-8 |
2-(2-butoxyetoxy)etanol; dietylénglykol-monobutyléter |
203-961-6 |
112-34-5 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-097-00-3 |
1,1',1''-nitrilotripropán-2-ol; triizopropanolamín |
204-528-4 |
122-20-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-098-00-9 |
2-fenoxyetanol |
204-589-7 |
122-99-6 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
603-099-00-4 |
hydrochlorid 3-{metyl[4-(metylamino)-3-nitrofenyl]amino}propán-1,2-diolu |
403-440-5 |
93633-79-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-100-00-8 |
1,2-dimetoxypropán |
404-630-0 |
7778-85-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
603-101-00-3 |
2-izobutyl-4-metyltetrahydropyrán-4-ol, zmes izomérov (cis a trans) |
405-040-6 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-103-00-4 |
oxirán, mono[(C12-14-alkyloxy)metyl]deriváty |
271-846-8 |
68609-97-2 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
603-104-00-X |
fenarimol (ISO); (2-chlórfenyl)(4-chlórfenyl)(pyrimidín-5-yl)metanol |
262-095-7 |
60168-88-9 |
Repr. 2 Lact. Aquatic Chronic 2 |
H361fd H362 H411 |
GHS08 GHS09 Wng |
H361fd H362 H411 |
|
|
|
|
603-105-00-5 |
furán |
203-727-3 |
110-00-9 |
Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
EUH019 |
|
|
|
603-106-00-0 |
2-metoxypropán-1-ol |
216-455-5 |
1589-47-5 |
Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H360D *** H335 H315 H318 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H360D *** H335 H315 H318 |
|
|
|
|
603-107-00-6 |
2-(2-metoxyetoxy)etanol; dietylénglykol-monometyléter |
203-906-6 |
111-77-3 |
Repr. 2 |
H361d *** |
GHS08 Wng |
H361d *** |
|
|
|
|
603-108-00-1 |
2-metylpropán-1-ol; izobutanol |
201-148-0 |
78-83-1 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H315 H318 H336 |
|
|
|
|
603-109-00-7 |
reakčná zmes zložená z týchto látok: 1-etoxy-1,1,2,3,3,3-hexafluór-2-(trifluórmetyl)propán; 1-etoxy-1,1,2,2,3,3,4,4,4-nonafluórbután |
425-340-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-110-00-2 |
reakčná zmes zložená z týchto látok: cis-2-izobutyl-5-metyl-1,3-dioxán trans-2-izobutyl-5-metyl-1,3-dioxán |
426-130-1 |
166301-21-9 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
603-111-00-8 |
reakčná zmes zložená z týchto látok: cis-1-etoxy-4-terc-pentylcyklohexán;trans-1-etoxy-4-terc-pentylcyklohexán |
426-530-6 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-112-00-3 |
cyklopentyl(2-fenyletyl)éter |
428-340-9 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-113-00-9 |
2,2’-[naftalén-1,6-diylbis(oxymetylén)]bisoxirán |
429-960-2 |
27610-48-6 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H341 H312 H315 H317 H412 |
GHS08 GHS07 Wng |
H341 H312 H315 H317 H412 |
|
|
|
|
603-114-00-4 |
9-(alyloxy)tricyklo[5.2.1.02,6]dec-3(alebo 4)-én |
430-830-2 |
26912-64-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-115-00-X |
reakčná zmes zložená z týchto látok: metyltris[(4-metylpentán-2-ylidénamino)oxy]silán (3 stereoizoméry) |
423-580-0 |
— |
STOT RE 2 * Aquatic Chronic 4 |
H373** H413 |
GHS08 Wng |
H373** H413 |
|
|
|
|
603-116-00-5 |
hydrochlorid (Z)-(2,4-difluórfenyl)(piperidín-4-yl)metanón-oxímu |
424-740-2 |
138271-16-6 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
603-117-00-0 |
propán-2-ol; izopropylalkohol; izopropanol |
200-661-7 |
67-63-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
603-118-00-6 |
6-(dimetylamino)hexán-1-ol |
404-680-3 |
1862-07-3 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
603-119-00-1 |
3,3'-(2-alylfenoxy)-1,1'-(1,3-fenyléndioxy)di(propán-2-ol) |
405-840-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
603-120-00-7 |
5-fenyl-2-metylpentán-1-ol |
405-890-8 |
25634-93-9 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
603-121-00-2 |
4-[4-(1,3-dihydroxypropán-2-yl)fenylamino]-1,8-dihydroxy-5-nitro-9,10-antrachinón |
406-057-1 |
114565-66-1 |
Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Wng |
H351 H317 H413 |
|
|
|
|
603-122-00-8 |
nátrium-2-etylhexán-1-olát |
406-150-7 |
38411-13-1 |
Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 |
H228 H314 H412 |
GHS02 GHS05 Dgr |
H228 H314 H412 |
|
|
T |
|
603-123-00-3 |
4-metyl-8-metyléntricyklo[3.3.1.13,7]dekán-2-ol |
406-330-5 |
122760-84-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
603-124-00-9 |
1,4-bis[2-(vinyloxy)etoxy]benzén |
406-900-3 |
84563-49-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-125-00-4 |
2-(2,4-dichlórfenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-én-2-ol |
407-850-5 |
89544-40-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
603-126-00-X |
2-[(4-metyl-2-nitrofenyl)amino]etanol |
408-090-7 |
100418-33-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
603-127-00-5 |
bután-2-ol; [1] (S)-bután-2-ol; [2] (R)-bután-2-ol; [3] (±)-bután-2-ol [4] |
201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] |
78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H226 H319 H335 H336 |
GHS02 GHS07 Wng |
H226 H319 H335 H336 |
|
|
C |
|
603-128-00-0 |
2-(fenylmetoxy)naftalén |
405-490-3 |
613-62-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-129-00-6 |
1-terc-butoxypropán-2-ol |
406-180-0 |
57018-52-7 |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
603-130-00-1 |
reakčná zmes zložená z izomérov: α-(dimetylbifenyl)-ω-hydroxypoly(oxyetylénu) |
406-325-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-131-00-7 |
reakčná zmes zložená z týchto látok: 1-[dodekanoyl(metyl)amino]-1-deoxy-D-glucitol; 1-[metyl(tetradekanoyl)amino]-1-deoxy-D-glucitol (3:1) |
407-290-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-132-00-2 |
9-metyl-6-izopropyl-1,4-dioxaspiro[4.5]dekán-2-metanol |
408-200-3 |
63187-91-7 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
603-133-00-8 |
reakčná zmes zložená z týchto látok: 3-[(4-amino-2-chlór-5-nitrofenyl)amino]propán-1,2-diol;3,3'-(2-chlór-5-nitro-1,4-fenyléndiimino)di(propán-1,2-diol) |
408-240-1 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-134-00-3 |
Reakčná zmes zložená z dodecylom a/alebo tetradecylom substituovaných oligoalkyldifenyléterov. Táto látka sa pripravuje Friedelovou-Craftsovou reakciou. Katalyzátor sa oddelí od produktu reakcie. Difenyléter je substituovaný C1-C10-alkylovými skupinami. Alkylové skupiny sú naviazané náhodne v polohách C1 až C6. 12- a C14-alkylové skupiny sú lineárne, použité boli v pomere 50/50. |
410-450-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-135-00-9 |
bis{[2,2',2''-nitrilotri(etanoláto)]-1-N, O}-bis[2-(2-metoxyetoxy)etanoláto]titaničitý komplex |
410-500-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
603-136-00-4 |
3-({4-[bis(2-hydroxyetyl)amino]-2-nitrofenyl}amino)propán-1-ol |
410-910-3 |
104226-19-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
603-137-00-X |
reakčná zmes zložená z týchto látok: 1-[hexadekanoyl(metyl)amino]-1-deoxy-D-glucitol; 1-[metyl(oktadekanoyl)amino]-1-deoxy-D-glucitol |
411-130-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-138-00-5 |
3-(3-hydroxy-2,2-dimetylpropyl)toluén; (alt.): 2,2-dimetyl-3-(3-metylfenyl)propán-1-ol |
403-140-4 |
103694-68-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-139-00-0 |
bis(2-metoxyetyl)éter |
203-924-4 |
111-96-6 |
Flam. Liq. 3 Repr. 1B |
H226 H360FD |
GHS02 GHS08 Dgr |
H226 H360FD |
EUH019 |
|
|
|
603-140-00-6 |
2,2' -oxydietanol; dietylénglykol |
203-872-2 |
111-46-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
603-141-00-1 |
reakčná zmes zložená z týchto látok: α-(1-metylpentadecyl)-ω-(dodecyloxy)poly{oxy[(hydroxymetyl)etylén]}; α-(1-metylheptadecyl)- ω-(dodecyloxy)poly{oxy[(hydroxymetyl)etylén]} |
413-780-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-142-00-7 |
2-[2-(2-hydroxyetoxy)etyl]-2-aza-bicyklo[2.2.1]heptán |
407-360-1 |
116230-20-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H373 ** H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H312 H302 H373 ** H315 H318 |
|
|
|
|
603-143-00-2 |
R-oxiránmetanol |
404-660-4 |
57044-25-4 |
Self-react. C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
|
|
|
|
603-144-00-8 |
reakčná zmes zložená z týchto látok 2,6,9-trimetylcyklododeka-2,5,9-trién-1-ol;6,9-dimetyl-2-metylidéncyklododeka-5,9-dién-1-ol |
413-530-6 |
111850-00-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-145-00-3 |
2-izopropyl-1,3-dimetoxy-2-(1-metylbutyl)propán |
406-970-5 |
129228-11-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-146-00-9 |
2-({2-[2-(dimetylamino)etoxy]etyl}(metyl)amino)etanol |
406-080-7 |
83016-70-0 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
603-147-00-4 |
(-)-trans-4-(4-fluórfenyl)-N-metylpiperidín-3-metanol |
406-030-4 |
105812-81-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
603-148-00-X |
1,4-bis[(vinyloxy)metyl]cyklohexán |
413-370-7 |
17351-75-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
603-149-00-5 |
reakčná zmes zložená z diastereoizomérov 1-(1-hydroxyetyl)-4-izopropylcyklohexánu |
407-640-3 |
63767-86-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
603-150-00-0 |
(±)-trans-3,3-dimetyl-5-(2,2,3-trimetyl-cyklopent-3-én-1-yl)pent-4-én-2-ol |
411-580-3 |
107898-54-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-151-00-6 |
(±)-2-(2,4-dichlórfenyl)-3-(1H-1,2,4-triazol-1-yl)propán-1-ol |
413-570-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-152-00-1 |
2-(4-terc-butylfenyl)etanol |
410-020-5 |
5406-86-0 |
Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H361f *** H373 ** H318 H411 |
|
|
|
|
603-153-00-7 |
3-[2-nitro-4-(trifluórmetyl)fenylamino]propán-1,2-diol |
410-010-0 |
104333-00-8 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-154-00-2 |
1-(2-terc-butylcyklohexyloxy)bután-2-ol |
412-300-2 |
139504-68-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-156-00-3 |
2-alyl-2-(2,4-dichlórfenyl)oxirán |
411-210-0 |
89544-48-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
603-157-00-9 |
6,9-bis(hexadecyloxymetyl)-4,7-dioxanonán-1,2,9-triol |
411-450-6 |
143747-72-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-158-00-4 |
reakčná zmes zložená zo štyroch diastereoizomérov 2,7-dimetyl-10-izopropyl-1-oxaspiro[4.5]deka-3,6-diénu |
412-460-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-159-00-X |
2-cyklododecylpropán-1-ol |
411-410-8 |
118562-73-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-160-00-5 |
1,2-dietoxypropán |
412-180-1 |
10221-57-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
603-161-00-0 |
1,3-dietoxypropán |
413-140-6 |
3459-83-4 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
603-162-00-6 |
α-(2-{[(2-hydroxyetyl)(metyl)amino]acetamido}propyl)-ω-(nonylfenoxy)poly[oxy(metyletán-1,2-diyl)] |
413-420-8 |
144736-29-8 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
603-163-00-1 |
2-fenylpropán-1,3-diol |
411-810-2 |
1570-95-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-164-00-7 |
2-butyl-5-(hydroxymetyl)-4-chlór-1-{2'-[2-(trifenylmetyl)-1,2,3,4-2H-tetrazol-5-yl]-1,1'-bifenyl-4-metyl}-4,5-dihydro-1H-imidazol |
412-420-5 |
133909-99-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-165-00-2 |
reakčná zmes zložená z týchto látok: 4-alyl-2,6-bis(oxiranylmetyl)fenol; 4-alyl-2-(3-{4-alyl-2-[3-(4-alyl-2-{3-[4-alyl-2,6-bis(oxiranylmetyl)fenoxy]-2-hydroxypropyl}-6-(oxiranylmetyl)fenoxy)-2-hydroxypropyl]-6-(oxiranylmetyl)fenoxy}-2-hydroxypropyl)-6-(oxiranylmetyl)fenol; 4-alyl-2-{3-[4-alyl-2,6-bis(oxiranylmetyl)fenoxy]-2-hydroxypropyl}-6-(oxiranylmetyl)fenol; 4-alyl-2-[3-(4-alyl-2-{3-[4-alyl-2,6-bis(oxiranylmetyl)fenoxy]-2-hydroxypropyl}-6-(oxiranylmetyl)fenoxy)-2-hydroxypropyl]-6-(oxiranylmetyl)fenol |
417-470-1 |
— |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
|
603-166-00-8 |
(R)-(chlórmetyl)oxirán; (R)-1-chlór-2,3-epoxypropán |
424-280-2 |
51594-55-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
|
|
|
603-167-00-3 |
3,3',5,5'-tetra-terc-butylbifenyl-2,2'-diol |
407-920-5 |
6390-69-8 |
Aquatic Chronic 4 |
H413 |
GHS05 Dgr |
H413 |
|
|
|
|
603-168-00-9 |
3-(2-etylhexyloxy)propán-1,2-diol |
408-080-2 |
70445-33-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
603-169-00-4 |
(±)-trans-4-(4-fluórfenyl)-N-metylpiperidín-3-metanol |
415-550-0 |
109887-53-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
603-170-00-X |
reakčná zmes zložená z týchto látok: 2-metyl-1-(6-metylbicyklo[2.2.1]hept-5-én-2-yl)pent-1-én-3-ol; 2-metyl-1-(1-metylbicyklo[2.2.1]hept-5-én-2-yl)pent-1-én-3-ol; 2-metyl-1-(5-metylbicyklo[2.2.1]hept-5-én-2-yl)pent-1-én-3-ol |
415-990-3 |
67739-11-1 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
603-171-00-5 |
tiazol-5-metanol |
414-780-9 |
38585-74-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
603-172-00-0 |
{1-[(2-hydroxyetyl)etoxy]-4-(dibenzo[b, f][1,4]tiazepín-11-yl)piperazínium}-hydrogen-trans-buténdioát |
415-180-1 |
773058-82-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
603-173-00-6 |
4,4-dimetyl-3,5,8-trioxabicyklo[5.1.0]oktán |
421-750-9 |
57280-22-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
603-174-00-1 |
4-cyklohexyl-2-metylbután-2-ol |
420-630-3 |
83926-73-2 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
603-175-00-7 |
2-[2-(hexyloxy)etoxy]etanol; DEGHE; dietylénglykol-monohexyléter;3,6-dioxa-1-dodekanol; hexyl-karbitol;3,6-dioxadodekán-1-ol |
203-988-3 |
112-59-4 |
Acute Tox. 4 * Eye Dam. 1 |
H312 H318 |
GHS05 GHS07 Dgr |
H312 H318 |
|
|
|
|
603-176-00-2 |
1,2-bis(2-metoxyetoxy)etán; TEGDME; trietylénglykol-dimetyléter; triglym |
203-977-3 |
112-49-2 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
EUH019 |
|
|
|
603-177-00-8 |
1-etoxypropán-2-ol; 2PG1EE; 1-etoxy-2-propanol; propylénglykol-monoetyléter; [1](1-etoxypropán-2-yl)-acetát; 2PG1EEA [2] |
216-374-5 [1] 259-370-9 [2] |
1569-02-4 [1] 54839-24-6 [2] |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
603-178-00-3 |
2-(hexyloxy)etanol; etylénglykol-monohexyléter n-hexylglykol |
203-951-1 |
112-25-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
603-179-00-9 |
ergokalciferol (ISO); vitamín D2 |
200-014-9 |
50-14-6 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
|
603-180-00-4 |
kolekalciferol; vitamín D3 |
200-673-2 |
67-97-0 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
|
603-181-00-X |
terc-butyl(metyl)éter; MTBE; 2-metoxy-2-metylpropán |
216-653-1 |
1634-04-4 |
Flam. Liq. 2 Skin Irrit. 2 |
H225 H315 |
GHS02 GHS07 Dgr |
H225 H315 |
|
|
|
|
603-182-00-5 |
produkt reakcie týchto látok: čiastočne esterifikovaných alkoholov rastlinného pôvodu (Brassica napus L., Brassica rapa L., Heliantus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) s dlhým nasýteným, mononenasýteným a oligonenasteným reťazcom; s O, O-diizobutyl-hydrogen-fosforoditioátom, 2-etylhexán-1-amínom a peroxidom vodíka |
428-630-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-183-00-0 |
2-[2-(2-butoxyetoxy)etoxy]etanol; TEGBE; trietylénglykol-monobutyléter; butoxytrietylénglykol |
205-592-6 |
143-22-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
Eye Dam.1; H318: C≥30% Eye Irrit. 2; H319: 20% ≤C< 30 % |
|
|
603-184-00-6 |
2-(hydroxymetyl)-2-{[2-hydroxy-3-(izooktadecyloxy)propoxy]metyl}propán-1,3-diol |
416-380-1 |
146925-83-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-185-00-1 |
3-etyl-2,4-dichlór-6-nitrofenol |
420-740-1 |
99817-36-4 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
|
603-186-00-7 |
trans-(5RS,6SR)-6-amino-2,2-dimetyl-1,3-dioxepán-5-ol |
419-050-3 |
79944-37-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-187-00-2 |
1,1’-dimetyl-4,4’-({6-[bis(2-hydroxyetyl)amino]-1,3,5-triazín-2,4-diyl}bis[(imino)(4,1-fenylén)(etén-2,1-diyl)])dipyridínium-dichlorid |
419-360-9 |
163661-77-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-188-00-8 |
reakčná zmes zložená z týchto látok: 6,7-epoxy-1,2,3,4,5,6,7,8-oktahydro-1,1,2,4,4,7-hexametylnaftalén;7,8-epoxy-1,2,3,4,6,7,8,8a-oktahydro-1,1,2,4,4,7-hexametylnaftalén |
426-970-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-189-00-3 |
reakčná zmes zložená z titaničitých komplexov: 2,2'-oxydietanolu, amónium-laktátu, nitrilotri(propán-2-olu) a etán-1,2-diolu |
405-250-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-190-00-9 |
7-izopropyl-8,8-dimetyl-6,10-dioxaspiro[4.5]dekán |
424-030-2 |
62406-73-9 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
603-191-00-4 |
2-[4,6-bis(2,4-dimetylfenyl)-1,3,5-triazín-2-yl]-5-[3-(2-etylhexyloxy)-2-hydroxypropoxy]fenol |
419-740-4 |
137658-79-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-192-00-X |
(E,E)-3,7,11-trimetyldodeka-1,4,6,10-tetraén-3-ol |
423-240-1 |
125474-34-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
603-193-00-5 |
dinátrium-naftalén-9,10-diolát |
426-030-8 |
46492-07-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
603-194-00-0 |
2-[(2-aminoetyl)amino]etanol; (AEEA) |
203-867-5 |
111-41-1 |
Repr. 1B Skin Corr. 1B Skin Sens. 1 |
H360Df H314 H317 |
GHS05 GHS08 GHS07 Dgr |
H360Df H314 H317 |
|
STOT SE 3; H335: C≥5% |
|
|
603-195-00-6 |
2-[4-fenyl-6-(4-metoxyfenyl)-1,3,5-triazín-2-yl]fenol |
430-810-3 |
154825-62-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-196-00-1 |
2-(7-etyl-1H-indol-3-yl)etanol |
431-020-1 |
41340-36-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
603-199-00-8 |
etoxazol (ISO); (RS)-1-{5-terc-butyl-2-[2-(2,6-difluórfenyl)-4,5-dihydro-1,3-oxazol-4-yl]fenyl}propán-1-ón |
— |
153233-91-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 |
|
|
603-200-00-1 |
pentán-1-ol; [1]pentán-3-ol [2] |
200-752-1 [1] 209-526-7 [2] |
71-41-0 [1] 584-02-1 [2] |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H226 H332 H335 H315 |
GHS02 GHS07 Wng |
H226 H332 H335 H315 |
|
|
|
|
603-201-00-7 |
(E,7R,11R)-3,7,11,15-tetrametylhexadec-2-én-1-ol |
416-120-5 |
— |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
603-202-00-2 |
4,4,5,5,5-pentafluórpentán-1-ol |
421-360-9 |
148043-73-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-203-00-8 |
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13- hexametyl-4,6- dioxatetracyklo[6.5.1.01,10.03,7] tetradekán |
427-580-1 |
— |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
603-204-00-3 |
reakčná zmes zložená z týchto látok: 2,2'-(heptán-1,7-diyl)bis(1,3-dioxolán);2,2'-(heptán-1,6-diyl)bis(1,3-dioxolán) |
428-110-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-205-00-9 |
hydrochlorid (1S-cis)-4-(2-amino-6-chlór-9H-purín-9-yl)cyklopent-2-én-1-metanolu |
426-200-1 |
172015-79-1 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H372** H302 H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H372** H302 H318 H317 H412 |
|
|
|
|
603-206-00-4 |
2,2-dichlór-1,3-benzodioxol |
426-850-6 |
2032-75-9 |
Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 |
H226 H314 H302 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H314 H302 H317 |
EUH014 |
|
|
|
603-207-00-X |
3,3-bis(metoxymetyl)-2,5-dimetylhexán |
430-800-9 |
129228-21-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-208-00-5 |
1,2-dietoxyetán |
211-076-1 |
629-14-1 |
Flam. Liq. 2 Repr. 1A Eye Irrit. 2 |
H225 H360Df H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H360Df H319 |
EUH019 |
|
|
|
603-209-00-0 |
spinosad (ISO) (reakčná zmes spinosýnu A a spinosýnu D v pomere v rozmedzí 95: 5 až 50: 50); reakčná zmes 50-95 % (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(2,3,4-tri-O-metyl-6-deoxy-α-L-manopyranozyloxy)-13-[4-(dimetylamino)-2,3,4,6-tetradeoxy-β-D-erytropyranozyloxy]-9-etyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadekahydro-14-metyl-1H-8-oxacyklododeka[b]as-indacén-7,15-diónu a 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(2,3,4-tri-O-metyl-6-deoxy-α-L-manopyranozyloxy)-13-[4-(dimetylamino)-2,3,4,6-tetradeoxy-β-D-erytropyranozyloxy]-9-etyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadekahydro-4,14-dimetyl-1H-8-oxacyklododeka[b]as-indacén-7,15-diónu; [1] spinosýn A; [2] spinosýn D [3] |
-[1] -[2] -[3] |
-[1] 131929-60-7 [2] 131929-63-0 [3] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
|
603-210-00-6 |
2,4-dietylpentán-1,5-diol |
429-310-8 |
57987-55-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-211-00-1 |
trimetyl(oxiranylmetyl)amónium-chlorid ... %; (glycidyl)tri(metyl)amónium-chlorid ... % |
221-221-0 |
3033-77-0 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
|
|
B |
|
603-212-00-7 |
4,6,6,7,8,8-hexametyl-1,3,4,6,7,8-hexahydroindeno[5,6-c]pyrán; galaxolid; (HHCB) |
214-946-9 |
1222-05-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-213-00-2 |
2-metoxy-2-metylbután; metyl(terc-pentyl)éter |
213-611-4 |
994-05-8 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 |
H225 H302 H336 |
GHS02 GHS07 Dgr |
H225 H302 H336 |
|
|
|
|
603-214-00-8 |
1,1-diizopropoxycyklohexán |
413-740-8 |
1132-95-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
603-215-00-3 |
1-fluór-4-hydroxy-1,4-diazóniabicyklo[2.2.2]oktán-bis(tetrafluoroborát) |
418-330-2 |
162241-33-0 |
Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H302 H373** H318 H317 H400 H410 |
GHS01 GHS05 GHS08 GHS07 GHS09 Dgr |
H201 H302 H373** H318 H317 H410 |
|
|
|
|
603-216-00-9 |
cis-1-amino-2,3-dihydro-1H-indén-2-ol |
422-660-2 |
7480-35-5 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
603-217-00-4 |
(2,4,6-tri-terc-butylfenyl)-(2-butyl-2- etylpropán-1,3-diyl)-fosfit |
423-560-1 |
161717-32-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
603-220-00-0 |
1-{benzyl[2-(2-metoxyfenoxy)etyl]amino}-3-(9H-karbazol-4-yloxy)propán-2-ol |
432-890-5 |
72955-94-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-221-00-6 |
4-chlór-2-(2,2,2-trifluór-1,1-dihydroxyetyl)anilínium-chlorid;[s obsahom < 0,1 % 4-chlóranilínu (ES č. 203-401-0)] |
433-580-2 |
214353-17-0 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
603-221-01-3 |
4-chlór-2-(2,2,2-trifluór-1,1-dihydroxyetyl)anilínium-chlorid;[s obsahom ≥ 0,1 % 4-chlóranilínu (ES č. 203-401-0)] |
433-580-2 |
214353-17-0 |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H350 H302 H314 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H350 H302 H314 H411 |
|
|
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[4-(dimetylamino)-3-hydroxy-6-metyltetrahydropyrán-2-yloxy]-2-etyl-3,4,12-trihydroxy-9-metoxy-3,5,7,9,11,13-hexametyl-1-oxacyklotetradekán-6,14-dión |
433-820-6 |
118058-74-5 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-223-00-7 |
2-cyklopentylidéncyklopentanol;1,1'-bi(cyklopentylidén)-2-ol |
434-270-1 |
6261-30-9 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
603-224-00-2 |
3-etoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodekafluór-2-(trifluórmetyl)hexán |
435-790-1 |
297730-93-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-225-00-8 |
erytromycín A9-oxím (E); (3R,4S,5S,6R,7R,9R,10E,11R,12R,13S,14R)-14-etyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexametyl-4-(3-C-metyl-3-O-metyl-2,6-dideoxy-α-L-ribo-hexopyranozyloxy)-6-[3-(dimetylamino)-3,4,6-trideoxy-β-D-xylo-hexapyranozyloxy]-1-oxacyklotetradekán-2,10-dión-10-oxím (E) |
437-070-0 |
13127-18-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-226-00-3 |
4,4'-[4-(4-metoxyfenyl)-1,3,5-triazín-2,4-diyl]bis(benzén-1,3-diol) |
444-500-0 |
1440-00-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-227-00-9 |
éter α-hydro-ω-{[(terc-butylperoxy)karbonyl]oxy}-poly[oxy(propán-1,2-diyl)]u s (metántetrayl)tetrametanolom (4:1); produkt reakcie éteru α-hydro-ω-[(chlórkarbonyl)oxy]-poly[oxy(propán-1,2-diyl)]u s (metántetrayl)tetrametanoloma kálium-terc-butyl-peroxyoxalátom |
445-060-2 |
203574-04-3 |
**** Aquatic Acute 1 Aquatic Chronic 1 |
**** H400 H410 |
**** GHS09 Wng |
**** H410 |
|
|
|
|
603-228-00-4 |
(+/-)-(R*,R*)-6-fluór-3,4-dihydro-2-oxiranyl-2H-1-benzopyrán; 6-fluór-2-oxiranylchromán |
419-620-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
603-229-00-X |
nátrium-(Z)-1-hydroxy-3-chlór-3-(4-chlórfenyl)prop-2-én-1-sulfonát |
420-800-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
603-230-00-5 |
2,6,6,7,8,8-hexametyldekahydro-2H-indeno[4,5-b]furán |
440-030-5 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 |
H315 H318 H413 |
GHS05 Dgr |
H315 H318 H413 |
|
|
|
|
603-231-00-0 |
(S)-1,1-difenylpropán-1,2-diol |
443-220-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-232-00-6 |
3,3,8,8,10,10-hexametyl-9-{1-[4-(oxiranylmetoxy)fenyl]-etoxy}-1,5-dioxa-9-aza-spiro[5.5]undekán |
444-420-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-233-00-1 |
reakčná zmes zložená z týchto látok: 4-(1,3a,4,6,7,7a-hexahydro-4,7-metanoindén-5-ylidén)-3-metylbután-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-metanoindén-5-ylidén)-3-metylbután-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-metanoindén-5-ylidén)pentán-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-metanoindén-5-ylidén)pentán-3-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-metanoindén-5-yl)-3-metylbut-3-én-2-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-metanoindén-5-yl)-3-metylbut-3-én-2-ol |
444-430-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-234-00-7 |
(1R,4R)-4-metoxy-2,2,7,7-tetrametyltricyklo[6.2.1.01,6]undec-5-én |
444-480-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
604-001-00-2 |
fenol; kyselina karbolová; monohydroxybenzén; fenylalkohol |
203-632-7 |
108-95-2 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B |
H341 H331 H311 H301 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H341 H331 H311 H301 H373 ** H314 |
|
* Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315 1% ≤ C<3% Eye Irrit. 2; H319:1% ≤C<3% |
|
|
604-002-00-8 |
pentachlórfenol |
201-778-6 |
87-86-5 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
604-003-00-3 |
nátrium-pentachlórfenolát; [1] kálium-pentachlórfenolát [2] |
205-025-2 [1] 231-911-3 [2] |
131-52-2 [1] 7778-73-6 [2] |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
604-004-00-9 |
meta-krezol; [1] orto-krezol; [2] para-krezol; [3] zmes krezolov [4] |
203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] |
108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
* |
C |
|
604-005-00-4 |
benzén-1,4-diol; hydrochinón; chinol |
204-617-8 |
123-31-9 |
Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H302 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H341 H302 H318 H317 H400 |
|
M=10 |
|
|
604-006-00-X |
3,4-dimetylfenol; [1] 2,5-dimetylfenol; [2] 2,4-dimetylfenol; [3] 2,3-dimetylfenol; [4] 2,6-dimetylfenol; [5] dimetylfenol; [6] 2,4(alebo 2,5)-dimetylfenol [7] |
202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] |
95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H301 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H301 H314 H411 |
|
|
C |
|
604-007-00-5 |
2-naftol |
205-182-7 |
135-19-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
|
|
|
|
604-008-00-0 |
2-chlórfenol; [1] 4-chlórfenol; [2] 3-chlórfenol; [3] chlórfenol [4] |
202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] |
95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H312 H302 H411 |
GHS07 GHS09 Wng |
H332 H312 H302 H411 |
|
|
C |
|
604-009-00-6 |
pyrogalol; benzén-1,2,3-triol |
201-762-9 |
87-66-1 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H341 H332 H312 H302 H412 |
GHS08 GHS07 Wng |
H341 H332 H312 H302 H412 |
|
* |
|
|
604-010-00-1 |
rezorcinol; benzén-1,3-diol |
203-585-2 |
108-46-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H302 H319 H315 H400 |
|
* |
|
|
604-011-00-7 |
2,4-dichlórfenol |
204-429-6 |
120-83-2 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H411 |
|
|
|
|
604-012-00-2 |
4-chlór-orto-krezol; 4-chlór-2-metylfenol |
216-381-3 |
1570-64-5 |
Acute Tox. 3 * Skin Corr. 1A Aquatic Acute 1 |
H331 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H314 H400 |
|
STOT SE 3; H335: C≥1% |
|
|
604-013-00-8 |
2,3,4,6-tetrachlórfenol |
200-402-8 |
58-90-2 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H315 H410 |
|
* Eye Irrit. 2; H319:C≥5% Skin Irrit. 2; H315: C≥5% |
|
|
604-014-00-3 |
chlórkrezol; 4-chlór-meta-krezol; 4-chlór-3-metylfenol |
200-431-6 |
59-50-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H312 H302 H318 H317 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H318 H317 H400 |
|
* |
|
|
604-015-00-9 |
3,3’,4,4’,6,6’-hexachlór-2,2'-metyléndifenol; hexachlorofén |
200-733-8 |
70-30-4 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
* |
|
|
604-016-00-4 |
benzén-1,2-diol; pyrokatechol |
204-427-5 |
120-80-9 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H312 H302 H319 H315 |
GHS07 Wng |
H312 H302 H319 H315 |
|
|
|
|
604-017-00-X |
2,4,5-trichlórfenol |
202-467-8 |
95-95-4 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
* Eye Irrit. 2; H319: C≥5% Skin Irrit.2; H315: C ≥5% |
|
|
604-018-00-5 |
2,4,6-trichlórfenol |
201-795-9 |
88-06-2 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H315 H410 |
|
|
|
|
604-019-00-0 |
dichlorofén (ISO) |
202-567-1 |
97-23-4 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
604-020-00-6 |
2-fenylfenol (ISO); bifenyl-2-ol; 2-hydroxybifenyl |
201-993-5 |
90-43-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
|
|
|
|
604-021-00-1 |
nátrium-bifenyl-2-olát; sodná soľ bifenyl-2-olu |
205-055-6 |
132-27-4 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Wng |
H302 H335 H315 H318 H400 |
|
|
|
|
604-022-00-7 |
2,2-dimetyl-1,3-benzodioxol-4-ol |
400-900-7 |
22961-82-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
604-023-00-2 |
3-etyl-2,4-dichlórfenol |
401-060-4 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
604-024-00-8 |
4,4’-(4-metylpentán-2,2-diyl)difenol |
401-720-1 |
6807-17-6 |
Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H319 H400 H410 |
GHS08 GHS09 Dgr |
H360F *** H319 H410 |
|
|
|
|
604-025-00-3 |
2,5-bis(1,1-dimetylbutyl)benzén-1,4-diol |
400-220-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-026-00-9 |
2,2’-spirobi[4,4,7-trimetylchromán]-6,6’-diol |
400-270-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-027-00-4 |
2-metyl-5-(1,1,3,3-tetrametylbutyl)benzén-1,4-diol |
400-530-6 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
604-028-00-X |
4-amino-3-fluórfenol |
402-230-0 |
399-95-1 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H411 |
|
|
|
|
604-029-00-5 |
1-naftol |
201-969-4 |
90-15-3 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H335 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H335 H315 H318 |
|
|
|
|
604-031-00-6 |
guajakol |
201-964-7 |
90-05-1 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
604-032-00-1 |
tymol |
201-944-8 |
89-83-8 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
604-033-00-7 |
izobutyl-but-3-enoát |
401-170-2 |
24342-03-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
604-034-00-2 |
2,2'-dimetyl-4,4'-sulfándiyldifenol |
403-330-7 |
24197-34-0 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
604-035-00-8 |
4-nonylfenol, produkty reakcie s formaldehydom a dodekán-1-tiolom |
404-160-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
604-036-00-3 |
4,4'-[oxybis(etylénsulfándiyl)]difenol |
404-590-4 |
90884-29-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
604-037-00-9 |
3,5-xylenol;3,5-dimetylfenol |
203-606-5 |
108-68-9 |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
|
|
|
604-038-00-4 |
4-chlór-3,5-dimetylfenol; [1] chlórdi(metyl)fenol [2] |
201-793-8 [1] 215-316-6 [2] |
88-04-0 [1] 1321-23-9 [2] |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H315 H317 |
GHS07 Wng |
H302 H319 H315 H317 |
|
|
|
|
604-039-00-X |
O-etyl-2-{4-[(6-chlórbenzoxazol-2-yl)oxy]fenoxy}propanoát; fenoxaprop-etyl |
266-362-9 |
66441-23-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
604-040-00-5 |
fomezafén (ISO);5-[2-chlór-4-(trifluórmetyl)fenoxy]-N-(metánsulfonyl)-2-nitrobenzamid |
276-439-9 |
72178-02-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
604-041-00-0 |
acifluorfén (ISO);kyselina 5-[2-chlór-4-(trifluórmetyl)fenoxy]-2-nitrobenzoová [1] nátrium-5-[2-chlór-4-(trifluórmetyl) fenoxy]-2-nitrobenzoát; acifluorfén-nátrium [2] |
256-634-5 [1] 263-560-7 [2] |
50594-66-6 [1] 62476-59-9 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
604-042-00-6 |
4-nitrózofenol |
203-251-6 |
104-91-6 |
Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H341 H302 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H302 H318 H411 |
|
|
|
|
604-043-00-1 |
monobenzón; benzyl(4-hydroxyfenyl)éter; 4-(benzyloxy)fenol |
203-083-3 |
103-16-2 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
604-044-00-7 |
mechinol; 4-metoxyfenol; hydrochinón-monometyléter |
205-769-8 |
150-76-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
604-045-00-2 |
2,3,5-trimetylbenzén-1,4-diol |
211-838-3 |
700-13-0 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H335 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H332 H335 H315 H318 H317 H410 |
|
|
|
|
604-046-00-8 |
4-(4-izopropoxyfenylsulfonyl)fenol |
405-520-5 |
95235-30-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-047-00-3 |
4-(4-tolyloxy)bifenyl |
405-730-7 |
51601-57-1 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
|
604-048-00-9 |
4,4',4''-(etán-1,1,1-triyl)trifenol |
405-800-7 |
27955-94-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-049-00-4 |
4,4'-[metylénbis(oxyetylénsulfándiyl)]difenol |
407-480-4 |
93589-69-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-051-00-5 |
3,5-bis(3,5-di-terc-butyl-4-hydroxybenzyl)-2,4,6-trimetylfenol |
401-110-5 |
87113-78-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
604-052-00-0 |
2,2'-metylénbis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetrametylbutyl)fenol] |
403-800-1 |
103597-45-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
604-053-00-6 |
4-terc-butyl-2-(hexadekán-2-yl)-6-metylfenol |
410-760-9 |
157661-93-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
604-054-00-1 |
reakčná zmes zložená z týchto látok: 2-metoxy-4-(4-metylidén-tetrahydro-2-H-pyrán-2-yl)fenol; 2-metoxy-4-4-metyl-3,6-dihydro-2-H-pyrán- 2-yl)fenol |
412-020-0 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
604-055-00-7 |
3,3',5,5'-tetrametyl-4,4'-bis(oxiranylmetoxy)bifenyl |
413-900-7 |
85954-11-6 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
|
604-056-00-2 |
2-(2-hydroxyetylamino)-4,6-dinitrofenol |
412-520-9 |
99610-72-7 |
Flam. Sol. 2 Repr. 2 Acute Tox. 4 * |
H228 H361f *** H302 |
GHS02 GHS07 GHS08 Dgr |
H228 H361f *** H302 |
|
|
|
|
604-058-00-3 |
1,2-bis(3-metylfenoxy)etán |
402-730-9 |
54914-85-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-059-00-9 |
2-n-hexadecylbenzén-1,4-diol |
406-400-5 |
— |
STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H373 ** H315 H317 H413 |
GHS08 GHS07 Wng |
H373 ** H315 H317 H413 |
|
|
|
|
604-060-00-4 |
4,4’-(fluorén-9,9-diyl)difenol |
406-950-6 |
3236-71-3 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
604-061-00-X |
reakčná zmes zložená z týchto látok: 2-chlór-5-(C14-alkyl)benzén-1,4-diol; kde C14-alkyl je tetradekán-2-yl; tetradekán-3-yl; tetradekán-4-yl; tetradekán-5-yl; tetradekán-6-yl; tetradekán-7-yl |
407-740-7 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
604-062-00-5 |
2-(hexadekán-2-yl)-4,6-dimetylfenol |
411-220-5 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
604-063-00-0 |
indol-5,6-diol |
412-130-9 |
3131-52-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
604-064-00-6 |
2-(4,6-difenyl-1,3,5-triazín-2-yl)-5-(hexyloxy)fenol |
411-380-6 |
147315-50-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
604-065-00-1 |
4,4',4''-(bután-1,3,3-triyl)tris(2-cyklohexyl- 5-metylfenol) |
407-460-5 |
111850-25-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-066-00-7 |
reakčná zmes zložená z týchto látok: 2-terc-butyl-4-dodecyl-6-(5-dodecyl-2-hydroxybenzyl)fenol (C41-zlúčenina); 2,2'-metylénbis(6-terc-butyl-4-dodecylfenol) (C45-zlúčenina); 2,6-di-terc-butyl-4-dodecylfenol; 2-terc-butyl-4-dodecylfenol; 2,6-bis(3-terc-butyl-5-dodecyl-2- hydroxybenzyl)-4-dodecylfenol; 2-(3-terc-butyl-5-dodecyl-2- hydroxybenzyl)-4-dodecyl-6-(5-dodecyl-2-hydroxybenzyl)fenol |
414-550-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-067-00-2 |
reakčná zmes zložená z týchto látok: 2,2'-{[(2-hydroxyetyl)imino]bis(metylén)}bis(4-dodecylfenol); oligomér formaldehydu so 4-dodecylfenolom a 2-aminoetanolom (n = 2); oligomér formaldehydu so 4-dodecylfenolom a 2-aminoetanolom (n = 3, 4 a viac) |
414-520-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
604-068-00-8 |
(±)-[2-hydroxy-2-(4-hydroxyfenyl)etyl][4-(4-hydroxyfenyl)bután-2-yl]amóniumchlorid |
415-170-5 |
90274-24-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 |
H332 H302 H317 |
GHS07 Wng |
H332 H302 H317 |
|
|
|
|
604-069-00-3 |
2-sek-butyl-4-terc-butylfenol |
421-740-4 |
51390-14-8 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
604-070-00-9 |
triklosán; 2,4,4'-trichlór-2'-hydroxydifenyléter; 5-chlór-2-(2,4-dichlórfenoxy)fenol |
222-182-2 |
3380-34-5 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
M = 100 |
|
|
604-071-00-4 |
4,4'-(1-{4-[2-(4-hydroxyfenyl)propán-2-yl]fenyl}etán-1,1-diyl)difenol |
425-600-3 |
110726-28-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
604-072-00-X |
1,2-bis(fenoxymetyl)benzén |
428-620-0 |
10403-74-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-073-00-5 |
(E)-3-(1-{4-[2-(dimetylamino)etoxy]fenyl}-2-fenylbut-1-én-1-yl)fenol |
428-010-4 |
82413-20-5 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360F*** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H317 H410 |
|
|
|
|
604-074-00-0 |
tetrabrómbisfenol-A; 2,2',6,6'-tetrabróm-4,4'-(propán-2,2-diyl)difenol |
201-236-9 |
79-94-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-075-00-6 |
4-(1,1,3,3-tetrametylbutyl)fenol; 4-terc-oktylfenol |
205-426-2 |
140-66-9 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
M=10 |
|
|
604-076-00-1 |
fenolftaleín |
201-004-7 |
77-09-8 |
Carc. 1B Muta. 2 Repr. 2 |
H350 H341 H361f*** |
GHS08 Dgr |
H350 H341 H361f*** |
|
Carc. 1B; H350: C ≥1% |
|
|
604-077-00-7 |
2-(benzotriazol-2-yl)-4-metyl-6-(2-metylalyl)fenol |
419-750-9 |
98809-58-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
604-079-00-8 |
4,4'-[1,3-fenylénbis(propán-2,2-diyl)]difenol |
428-970-4 |
13595-25-0 |
Repr. 2 Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H361f*** H317 H411 |
|
|
|
|
604-080-00-3 |
4-fluór-3-(trifluórmetyl)fenol |
432-560-0 |
61721-07-1 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 |
H332 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H314 H317 H411 |
|
|
|
|
604-081-00-9 |
4,4'-(1-fenyletán-1,1-diyl)difenol |
433-130-5 |
1571-75-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-082-00-4 |
2-fluór-6-chlórfenol |
433-890-8 |
2040-90-6 |
Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H340 H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H340 H361f*** H302 H314 H317 H411 |
|
|
|
|
604-083-00-X |
4,4'-sulfonyldifenol, polymér s chloridom amónnym (NH4Cl), chloridom fosforečným a fenolom |
439-270-3 |
260408-02-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
604-084-00-5 |
1-etoxy-2,3-difluórbenzén |
441-000-4 |
121219-07-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
604-087-00-1 |
reakčná zmes zložená z týchto látok: monoester 4,4′-(1-{4-[2-(4- hydroxyfenyl)propán-2-yl]fenyl}etán-1,1- diyl)difenolu s 5,6-bis(diazo)-5,6- dihydronaftalén-1-sulfonylchloridom alebo príslušnou sulfónovou kyselinou; diester 4,4′-(1-{4-[2-(4- hydroxyfenyl)propán-2-yl]fenyl}etán-1,1- diyl)difenolu s 5,6-bis(diazo)-5,6- dihydronaftalén-1-sulfonylchloridom alebo príslušnou sulfónovou kyselinou; triester 4,4′-(1-{4-[2-(4- hydroxyfenyl)propán-2-yl]fenyl}etán-1,1- diyl)difenolu s 5,6-bis(diazo)-5,6- dihydronaftalén-1-sulfonylchloridom alebo príslušnou sulfónovou kyselinou |
433-640-8 |
— |
Pyr. Sol. 1 Aquatic Chronic 4 |
H250 H413 |
GHS02 Dgr |
H250 H413 |
EUH044 |
|
|
|
604-089-00-2 |
5-terc-butyl-2-metylbenzéntiol |
444-970-7 |
— |
Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H361d*** H373** H304 H319 H315 H317 H336 H410 |
|
|
|
|
604-090-00-8 |
4-terc-butylfenol |
202-679-0 |
98-54-4 |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 |
H361f H315 H318 |
GHS08 GHS05 Dgr |
H361f H315 H318 |
|
|
|
|
604-091-00-3 |
etofenprox (ISO); 2-(4-etoxyfenyl)-2-metylpropyl 3-fenoxybenzyl éter |
407-980-2 |
80844-07-1 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
|
M = 100 M = 1 000 |
|
|
605-001-00-5 |
formaldehyd ...% |
200-001-8 |
50-00-0 |
Carc. 1B Muta. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 |
H350 H341 H301 H311 H331 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H301 H311 H331 H314 H317 |
|
*Skin Corr. 1B; H314: C ≥25% Skin Irrit. 2; H315: 5% ≤C < 25% Eye Irrit. 2; H319: 5% ≤ C <25 % STOT SE 3; H335: C ≥ 5% SkinSens. ; H317: C ≥ 0,2 % |
B, D |
|
605-002-00-0 |
1,3,5-trioxán; trioxymetylén |
203-812-5 |
110-88-3 |
Flam. Sol. 1 Repr. 2 STOT SE 3 |
H228 H361d *** H335 |
GHS02 GHS08 GHS07 Dgr |
H228 H361d *** H335 |
|
|
T |
|
605-003-00-6 |
acetaldehyd; etanál |
200-836-8 |
75-07-0 |
Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H224 H351 H319 H335 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H319 H335 |
|
|
|
|
605-004-00-1 |
2,4,6-trimetyl-1,3,5-trioxán; paraldehyd |
204-639-8 |
123-63-7 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
605-005-00-7 |
2,4,6,8-tetrametyl-1,3,5,7-tetraoxacyklooktán; metaldehyd |
203-600-2 |
108-62-3 |
Flam. Sol. 2 Acute Tox. 4 * |
H228 H302 |
GHS02 GHS07 Wng |
H228 H302 |
|
|
|
|
605-006-00-2 |
butyraldehyd |
204-646-6 |
123-72-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
605-007-00-8 |
1,1-dimetoxyetán; acetaldehyd-dimetylacetál akrylaldehyd |
208-589-8 |
534-15-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
605-008-00-3 |
akroleín; propenál; akrylaldehyd |
203-453-4 |
107-02-8 |
Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H225 H330 H300 H311 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H225 H330 H300 H311 H314 H410 |
EUH071 |
Skin Corr. 1B; H314:C≥ 0,1 % M = 100 M = 1 |
D |
|
605-009-00-9 |
krotónaldehyd; but-2-enál; [1] (E)-but-2-enál; (E)-krotónaldehyd [2] |
224-030-0 [1] 204-647-1 [2] |
4170-30-3 [1] 123-73-9 [2] |
Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
|
|
|
|
605-010-00-4 |
2-furaldehyd |
202-627-7 |
98-01-1 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H331 H301 H312 H319 H335 H315 |
GHS06 GHS08 Dgr |
H351 H331 H301 H312 H319 H335 H315 |
|
|
|
|
605-011-00-X |
2-chlórbenzaldehyd; orto-chlórbenzaldehyd |
201-956-3 |
89-98-5 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
605-012-00-5 |
benzaldehyd |
202-860-4 |
100-52-7 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
605-014-00-6 |
chlorál-hydrát; 2,2,2-trichlóretán-1,1-diol |
206-117-5 |
302-17-0 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
|
|
|
|
605-015-00-1 |
1,1-dietoxyetán; acetaldehyd-dietylacetál |
203-310-6 |
105-57-7 |
Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 |
H225 H319 H315 |
GHS02 GHS07 Dgr |
H225 H319 H315 |
|
|
|
|
605-016-00-7 |
glyoxál...%; etándiál...% |
203-474-9 |
107-22-2 |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H341 H332 H319 H315 H317 |
GHS07 GHS08 Wng |
H341 H332 H319 H315 H317 |
|
* |
B |
|
605-017-00-2 |
1,3-dioxolán |
211-463-5 |
646-06-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
605-018-00-8 |
propanál; propiónaldehyd |
204-623-0 |
123-38-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
605-019-00-3 |
citrál |
226-394-6 |
5392-40-5 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
605-020-00-9 |
safrol; 5-alyl-1,3-benzodioxol |
202-345-4 |
94-59-7 |
Carc. 1B Muta. 2 Acute Tox. 4 * |
H350 H341 H302 |
GHS08 GHS07 Dgr |
H350 H341 H302 |
|
|
|
|
605-021-00-4 |
produkty reakcie formaldehydu s butylfenolom |
294-145-9 |
91673-30-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-024-00-0 |
2-bróm-5-hydroxy-4-metoxybenzaldehyd |
426-540-0 |
2973-59-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-025-00-6 |
chlóracetaldehyd |
203-472-8 |
107-20-0 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H351 H330 H311 H301 H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H330 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5% |
|
|
605-026-00-1 |
2,5,7,7-tetrametyloktanál |
405-690-0 |
114119-97-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
605-027-00-7 |
reakčná zmes zložená z týchto látok: 3a,4,5,6,7,7a-hexahydro-4,7-metano-1-H-indén-6-karbaldehyd; 3a,4,5,6,7,7a-hexahydro-4,7-metano-1-H-indén-5-karbaldehyd |
410-480-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-028-00-2 |
3-(3-izopropylfenyl)butanál |
412-050-4 |
125109-85-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
605-029-00-8 |
2-cyklohexylpropanál |
412-270-0 |
2109-22-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-030-00-3 |
(para-metoxyfenyl)acetaldehyd-oxím |
411-510-1 |
3353-51-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-031-00-9 |
reakčná zmes zložená z týchto látok: 2,2-dimetoxyetanál (Táto zložka sa považuje za bezvodú z hľadiska identity, štruktúry a zloženia.2,2-dimetoxyetanál však môže existovať vo forme hydrátu. 60 % roztok bezvodého 2,2-dimetoxyetanálu je ekvivalentom 70,4 % roztoku jeho hydrátu); voda (vrátane voľnej vody a vody viazanej v hydráte 2,2-dimetoxyetanálu) |
421-890-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-032-00-4 |
(E)-3-[3-(4-fluórfenyl)-1-izopropyl-1H-indol-2-yl]propenál |
425-370-4 |
93957-50-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
605-033-00-X |
reakčná zmes zložená z týchto látok cis-3,7,11-trimetyldodeka-6,10-dienál; trans-3,7,11-trimetyldodeka-6,10-dienál |
425-910-9 |
32480-08-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
605-034-00-5 |
reakčná zmes zložená z týchto látok: (1RS,2RS,3SR,6RS,9SR)-9-metoxytricyklo[5.2.1.02,6]dekán-3-karbaldehyd; (1RS,2RS,3RS,6RS,8SR)-8-metoxytricyklo[5.2.1.02,6]dekán-3-karbaldehyd; (1RS,2RS,4SR,6RS,8SR)-8-metoxytricyklo[5.2.1.02,6]dekán-4-karbaldehyd |
429-860-9 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-035-00-0 |
(E)-3-[4-(4-fluórfenyl)-2,6-diizopropyl-5-(metoxymetyl)pyridín-3-yl]propenál |
426-330-9 |
177964-68-0 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H319 H317 H413 |
GHS07 Wng |
H319 H317 H413 |
|
|
|
|
605-036-00-6 |
2-brómmalónaldehyd |
430-470-6 |
2065-75-0 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
605-037-00-1 |
trans-3-[2-(7-chlórchinolín-2-yl)vinyl]benzaldehyd; (E)-3-[2-(7-chlórchinolín-2-yl)vinyl]benzaldehyd |
421-800-1 |
120578-03-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
605-038-00-7 |
5-fenyl-3-metylpentál |
433-900-0 |
55066-49-4 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H315 H317 H411 |
GHS07 GHS09 Wng |
H302 H315 H317 H411 |
|
|
|
|
605-039-00-2 |
3,4-dihydroxy-5-nitrobenzaldehyd |
441-810-8 |
116313-85-0 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
606-001-00-8 |
acetón; propán-2-ón; propanón |
200-662-2 |
67-64-1 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
606-002-00-3 |
butanón; etyl(metyl)ketón |
201-159-0 |
78-93-3 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
606-003-00-9 |
heptán-3-ón; butyl(etyl)ketón |
203-388-1 |
106-35-4 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 |
H226 H332 H319 |
GHS02 GHS07 Wng |
H226 H332 H319 |
|
|
|
|
606-004-00-4 |
4-metylpentán-2-ón; izobutyl(metyl)ketón |
203-550-1 |
108-10-1 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
EUH066 |
|
|
|
606-005-00-X |
2,6-dimetylheptán-4-ón; diizobutylketón |
203-620-1 |
108-83-8 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
606-006-00-5 |
pentan-3-ón; dietylketón |
202-490-3 |
96-22-0 |
Flam. Liq. 2 STOT SE 3 STOT SE 3 |
H225 H335 H336 |
GHS02 GHS07 Dgr |
H225 H335 H336 |
EUH066 |
|
|
|
606-007-00-0 |
3-metylbután-2-ón; izopropyl(metyl)ketón |
209-264-3 |
563-80-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
606-009-00-1 |
4-metylpent-3-én-2-ón; mezityloxid |
205-502-5 |
141-79-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 |
|
* |
|
|
606-010-00-7 |
cyklohexanón |
203-631-1 |
108-94-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
606-011-00-2 |
2-metylcyklohexanón |
209-513-6 |
583-60-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
606-012-00-8 |
3,5,5-trimetylcyklohex-2-enón; izoforón |
201-126-0 |
78-59-1 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H351 H312 H302 H319 H335 |
GHS08 GHS07 Wng |
H351 H312 H302 H319 H335 |
|
STOT SE 3; H335: C ≥10% |
|
|
606-013-00-3 |
para-benzochinón; chinón |
203-405-2 |
106-51-4 |
Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H331 H301 H319 H335 H315 H400 |
GHS06 GHS09 Dgr |
H331 H301 H319 H335 H315 H400 |
|
M=10 |
|
|
606-016-00-X |
pindón (ISO); 2-(dimetylpropanoyl)indán-1,3-dión |
201-462-8 |
83-26-1 |
Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H372 ** H410 |
|
|
|
|
606-017-00-5 |
diketén; 4-metylidénoxetán-2-ón |
211-617-1 |
674-82-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
D |
|
606-018-00-0 |
dichlón (ISO); 2,3-dichlór-1,4-naftochinón |
204-210-5 |
117-80-6 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
606-019-00-6 |
chlórdekón (ISO); perchlórpentacyklo[5,3,0,02,6,03,9,04,8] dekan-5-on; dekachlórpentacyklo[5,2,1,02,6,03,9,05,8] dekan-4-on |
205-601-3 |
143-50-0 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H410 |
|
|
|
|
606-020-00-1 |
5-metylheptán-3-ón |
208-793-7 |
541-85-5 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
STOT SE 3; H335: C≥10% |
|
|
606-022-00-2 |
1-fenylpyrazolidín-3-ón |
202-155-1 |
92-43-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
606-023-00-8 |
4-metoxy-4-metylpentán-2-ón |
203-512-4 |
107-70-0 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
606-024-00-3 |
heptán-2-ón; metyl(pentyl)ketón |
203-767-1 |
110-43-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
|
|
|
606-025-00-9 |
cyklopentanón |
204-435-9 |
120-92-3 |
Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 |
H226 H319 H315 |
GHS02 GHS07 Wng |
H226 H319 H315 |
|
|
|
|
606-026-00-4 |
5-metylhexán-2-ón izoamyl(metyl)ketón |
203-737-8 |
110-12-3 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
606-027-00-X |
heptán-4-ón; di-n-propylketón |
204-608-9 |
123-19-3 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
606-028-00-5 |
2,4-dimetylpentán-3-ón; diizopropylketón |
209-294-7 |
565-80-0 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
606-029-00-0 |
pentán-2,4-dión; acetylacetón |
204-634-0 |
123-54-6 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
|
|
|
606-030-00-6 |
hexán-2-ón; butyl(metyl)ketón |
209-731-1 |
591-78-6 |
Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 |
H226 H361f *** H372 ** H336 |
GHS02 GHS08 GHS07 Dgr |
H226 H361f *** H372 ** H336 |
|
|
|
|
606-031-00-1 |
propano-3-laktón; oxetán-2-ón |
200-340-1 |
57-57-8 |
Carc. 1B Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 |
H350 H330 H319 H315 |
GHS06 GHS08 Dgr |
H350 H330 H319 H315 |
|
|
|
|
606-032-00-7 |
hexachlóracetón |
204-129-5 |
116-16-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
606-033-00-2 |
2-(3,4-dichlórfenyl)-4-metyl-1,2,4- oxadiazolidíndión; metazol |
243-761-6 |
20354-26-1 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H411 |
|
|
|
|
606-034-00-8 |
metribuzín (ISO); 4-amino-6-terc-butyl-3-(metylsulfanyl)- 1,2,4-triazín-5(4H)-ón |
244-209-7 |
21087-64-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=10 |
|
|
606-035-00-3 |
chloridazón (ISO); 5-amino-2-fenyl-4-chlórpyridazín-3(2H)-ón pyrazón |
216-920-2 |
1698-60-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
606-036-00-9 |
chinometionát; chinometionát (ISO); 6-metyl-1,3-ditiolo[4,5-b]chinoxalin-2-ón |
219-455-3 |
2439-01-2 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H332 H312 H302 H373 ** H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H332 H312 H302 H373 ** H319 H317 H410 |
|
|
|
|
606-037-00-4 |
triadimefón (ISO); 1-(4-chlórfenoxy)-3,3-dimetyl-1-(1,2,4-triazol-1-yl)bután-2-ón |
256-103-8 |
43121-43-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
606-038-00-X |
difacinón (ISO); 2-(difenylacetyl)indán-1,3-dión |
201-434-5 |
82-66-6 |
Acute Tox. 2 * STOT RE 1 |
H300 H372 ** |
GHS06 GHS08 Dgr |
H300 H372 ** |
|
|
|
|
606-039-00-5 |
5(alebo 6)-terc-butyl-6'-(etylamino)-2'-chlór-3',7'-dimetylspiro[izobenzofurán-1(1H),9'-xantén]-3-ón |
400-680-2 |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H400 H410 |
GHS07 GHS09 Wng |
H332 H410 |
|
|
|
|
606-040-00-0 |
N-benzyl-N-etyl-2-(3-hydroxyfenyl)-2-oxoetán-1-amónium-chlorid |
401-840-4 |
55845-90-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
606-042-00-1 |
acetofenón |
202-708-7 |
98-86-2 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
606-043-00-7 |
2,4-di-terc-butylcyklohexanón |
405-340-7 |
13019-04-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
606-044-00-2 |
fenyl(2,4,6-trimetylfenyl)metanón |
403-150-9 |
954-16-5 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
606-045-00-8 |
oxadiazón (ISO); 5-terc-butyl-3-(2,4-dichlór-5-izopropoxyfenyl)-1,3,4-oxadiazol-2(3H)-ón |
243-215-7 |
19666-30-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-046-00-3 |
reakčná zmes zložená z cis- a trans-cyklohexadec-8-én-1-ónu |
401-700-2 |
3100-36-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-047-00-9 |
2-benzyl-2-(dimetylamino)-1-(4-morfolinofenyl)bután-1-ón |
404-360-3 |
119313-12-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-048-00-4 |
2'-anilino-6'-(dipentylamino)-3'-metylspiro[izobenzofurán-1,9'-xantén]-3-ón |
406-480-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-049-00-X |
1-[4-(trans-4-propylcyklohexyl)fenyl]etanón |
406-700-6 |
78531-61-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-050-00-5 |
6-anilino-1-benzoyl-4-(4-tercpentylfenoxy)nafto[1,2,3-de]chinolín-(3H),7-dión |
412-480-2 |
72453-58-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-051-00-0 |
4-pentylcyklohexanón |
406-670-4 |
61203-83-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-052-00-6 |
kyselina 2-[4-(dibutylamino)-2- hydroxybenzoyl]benzoová |
410-410-5 |
54574-82-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
606-053-00-1 |
flurtamón (ISO); (RS)-2-fenyl-5-(metylamino)-4-[3- (trifluórmetyl)fenyl]furán-3(2H)-ón |
— |
96525-23-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-055-00-2 |
1-(1-izopropyl-1,3,3,6-tetrametyl-2,3-dihydro-1H-indén-5-yl)etanón |
411-180-9 |
92836-10-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
606-056-00-8 |
(4-chlórfenyl)(3,4-dimetoxyfenyl)metanón |
404-610-1 |
116412-83-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-057-00-3 |
4-propylcyklohexanón |
406-810-4 |
40649-36-3 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
606-058-00-9 |
1-(4-fluórfenyl)-2,2-dimetoxyetanón |
407-500-1 |
21983-80-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
606-059-00-4 |
hydrochlorid 1-(2,4-difluórfenyl)-2-(1H-1,2,4-triazol-1-yl)etanónu |
412-390-3 |
86386-75-6 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
606-060-00-X |
reakčná zmes zložená z týchto látok: trans-2,4-dimetyl-2-(5,5,8,8-tetrametyl-5,6,7,8-tetrahydronaftalén-2-yl)-1,3-dioxolán cis-2,4-dimetyl-2-(5,5,8,8-tetrametyl-5,6,7,8-tetrahydronaftalén-2-yl)-1,3-dioxolán |
412-950-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-061-00-5 |
(3-chlórfenyl)(4-metoxy-3-nitrofenyl)metanón |
423-290-4 |
66938-41-8 |
Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H400 H410 |
GHS08 GHS09 Wng |
H341 H410 |
|
|
|
|
606-062-00-0 |
tetrahydrotiopyrán-3-karbaldehyd |
407-330-8 |
61571-06-0 |
Repr. 1B Eye Dam. 1 Aquatic Chronic 3 |
H360D *** H318 H412 |
GHS08 GHS05 Dgr |
H360D *** H318 H412 |
|
|
|
|
606-063-00-6 |
(E)-2-(4-fluórfenyl)-3-(2-chlórfenyl)propenál |
410-980-5 |
112704-51-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
606-064-00-1 |
pregn-5-én-3,20-dión-bis(etylénketál) |
407-450-0 |
7093-55-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-065-00-7 |
1-(4-morfolinofenyl)bután-1-ón |
413-790-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-066-00-2 |
(E)-5[(4-chlórfenyl)metylidén]-2,2-dimetylcyklopentanón |
410-440-9 |
164058-20-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-067-00-8 |
reakčná zmes zložená z týchto látok: 1-(1,1-dimetyl-2,3,6,7,8,9-hexahydro-1-H-benzo[g]indén-4-yl)etanón; 1-(1,1-dimetyl-2,3,5,6,7,8-hexahydro-1-H-benzo[f]indén-4-yl)etanón; 1-(1,1-dimetyl-2,3,6,7,8,9-hexahydro-1-H-benzo[g]indén-5-yl)etanón; 1-(3,3-dimetyl-2,3,6,7,8,9-hexahydro-1-H-benzo[g]indén-5-yl)etanón |
414-870-8 |
96792-67-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-068-00-3 |
2,7,11-trimetyl-13-(2,6,6-trimetylcyklohex-1-én-1-yl)trideka-2,4,6,8,10,12-hexaenál |
415-770-7 |
1638-05-7 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 GHS07 Wng |
H373 ** H317 H412 |
|
|
|
|
606-069-00-9 |
1',1',5',5'-tetrametyloktahydro-2'H-spiro[1,3-dioxolán-2,8'-[2,4a]metanonaftalén] |
415-460-1 |
154171-76-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-070-00-4 |
butroxydím (ISO); 5-(3-butanoyl-2,4,6-trimetylfenyl)-2-[1-(etoxyimino)propyl]-3-hydroxycyklohex-2-én-1-ón |
414-790-3 |
138164-12-2 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H302 H315 H410 |
|
|
|
|
606-071-00-X |
5',5'-dimetylspiro[androsta-1,4-dién-17,2'-[1,3]dioxán]-3-ón |
421-050-3 |
13258-43-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-072-00-5 |
3-acetyl-1-fenyl-pyrolidín-2,4-dión |
421-600-2 |
719-86-8 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
|
606-073-00-0 |
bis[4-(dimetylamino)fenyl]metanón; Michlerov ketón |
202-027-5 |
90-94-8 |
Carc. 1B Muta. 2 Eye Dam. 1 |
H350 H341 H318 |
GHS08 GHS05 Dgr |
H350 H341 H318 |
|
|
|
|
606-074-00-6 |
reakčná zmes zložená z týchto látok: 1-[(1R*,2S*)-1,2,8,8-tetrametyl- 1,2,3,4,5,6,7,8-oktahydronaftalén-2- yl]etanón 1-[(2R*,3S*)-2,3,8,8-tetrametyl- 1,2,3,4,5,6,7,8-oktahydronaftalén-2- yl]etanón |
425-570-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-075-00-1 |
1-benzyl-5-etoxyimidazolidín-2,4-dión |
417-340-4 |
65855-02-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
606-076-00-7 |
(2,5-dioxopyrolidín-1-yl)-chinolín-2-karboxylát |
418-630-3 |
136465-99-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
606-077-00-2 |
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]oxetán-2-ón |
418-650-2 |
104872-06-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-078-00-8 |
1-oktylazepín-2-ón |
420-040-6 |
59227-88-2 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
606-079-00-3 |
2-butylbenzo[d]izotiazol-3-ón |
420-590-7 |
4299-07-4 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
606-081-00-4 |
(3β,5α,6β)-3-acetoxy-5-bróm-6-hydroxyandrostán-17-ón |
419-790-7 |
4229-69-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
606-082-00-X |
reakčná zmes zložená z týchto látok: bután-2-ón-oxím; bis[(bután-2-ylidénamino)oxy]di(etoxy)silán |
406-930-7 |
|
STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H372 ** H317 H412 |
GHS08 GHS07 Dgr |
H372 ** H317 H412 |
|
|
|
|
606-083-00-5 |
5-sek-hexadecyl-2-chlórbenzén-1,4-diol |
407-750-1 |
137193-60-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Wng |
H319 H315 H317 H412 |
|
|
|
|
606-084-00-0 |
3-fenyl-1-(4-metoxybenzofurán-5-yl)propán-1,3-dión |
414-540-3 |
484-33-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-085-00-6 |
(1R,4S)-2-azabicyklo[2.2.1]hept-5-én-3-ón |
418-530-1 |
79200-56-9 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
606-086-00-1 |
1-(3,3-dimetylcyklohexyl)pent-4-én-1-ón |
422-330-8 |
56973-87-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-087-00-7 |
6-etyl-5-fluórpyrimid-4(3H)-ón |
422-460-5 |
137234-87-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
606-088-00-2 |
2,4,4,7-tetrametyl-6-oktén-3-ón |
422-520-0 |
74338-72-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
606-089-00-8 |
reakčná zmes zložená z týchto látok: 1,4-diamino-2-chlór-3-fenoxy-9,10-antrachinón; 1,4-diamino-2,3-bisfenoxy-9,10- antrachinón |
423-220-2 |
12223-77-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-090-00-3 |
1-{3-[(dimetylamino)metyl]-4-hydroxyfenyl}etanón |
430-920-1 |
73096-98-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
606-091-00-9 |
6-chlór-5-(2-chlóretyl)-1,3-dihydroindol-2-ón |
421-320-0 |
118289-55-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-092-00-4 |
reakčná zmes zložená z týchto látok: (E)-oxacyklohexadec-12-én-2-ón; (E)-oxacyklohexadec-13-én-2-ón; a) (Z)-oxacyklohexadec-(12)-én-2-ón a b) (Z)-oxacyklohexadec-(13)-én-2-ón |
422-320-3 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-093-00-X |
5-etyl-4-(2-fenoxyetyl)-2,4-dihydro-3H-1,2,4-triazol-3-ón |
414-470-3 |
95885-13-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
606-094-00-5 |
N-[etyl(3-metylbutyl)amino]-1-fenyl-3-metyl-spiro[[1]benzopyrano[2,3-c]pyrazol-4(1H),1'(3'H)-izobenzofurán]-3'-ón |
417-460-7 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-095-00-0 |
(R,S)-2-azabicyklo[2.2.1]hept-5-én-3-ón |
421-830-3 |
49805-30-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
606-096-00-6 |
3-[6-O-(6-deoxy-α-L-manopyranozyl-O-(α-D-glukopyranozyl)-(β-D-glukopyranozyl)oxy]-2-(3,4-dihydroxyfenyl)-5,7-dihydroxy-4H-1-benzopyrán-4-ón |
424-170-4 |
130603-71-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
606-097-00-1 |
1,1'-difenyl-1,1'-{(2-hydroxypropán-1,3-diyl)bis[oxy(2-hydroxy-4,1-fenylén)]}dimetanón |
424-210-0 |
23911-85-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-098-00-7 |
1-benzyl-5-(hexadecyloxy)imidazolidín-2,4-dión |
431-220-9 |
158574-65-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-099-00-2 |
5-metoxy-1-[4-(trifluórmetyl)fenyl]pentán-1-ón |
425-000-1 |
61718-80-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-100-00-6 |
2-butanoyl-3-hydroxy-5-sulfanylcyklohexán-3-yl-cyklohex-2-én-1-ón |
425-150-8 |
94723-86-1 |
Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H360F*** H302 H317 H412 |
GHS08 GHS07 Dgr |
H360F*** H302 H317 H412 |
|
|
|
|
606-101-00-1 |
reakčná zmes zložená z týchto látok: 1,5-bis[(2-etylhexyl)amino]-9,10- dihydroantracén-9,10-dión; 1-[(2-etylhexyl)amino]-5-({3-[(2- etylhexyl)oxy]propyl}amino)-9,10- dihydroantracén-9,10-dión; 1,5-bis({3-[(2- etylhexyl)oxy]propyl}amino)-9,10- dihydroantracén-9,10-dión; 1-[(2-etylhexyl)amino]-5-[(3- metoxypropyl)amino]-9,10- dihydroantracén-9,10-dión; 1-({3-[(2-etylhexyl)oxy]propyl}amino)-5-[(3-metoxypropyl)amino]-9,10- dihydroantracén-9,10-dión; 1,5-bis[(3-metoxypropyl)amino]-9,10- dihydroantracén-9,10-dión |
426-050-7 |
165038-51-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-102-00-7 |
fenyl{2-hydroxy-4-[3-(trietoxysilyl)propoxy]fenyl}metanón |
431-490-8 |
79876-59-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-103-00-2 |
trans-1-[4-(4-etylcyklohexyl)fenyl]etanón |
426-460-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-104-00-8 |
trans-1-[4-(4-pentylcyklohexyl)fenyl]etanón |
426-830-7 |
78531-59-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-105-00-3 |
3,4,3',4'-tetrafenyl-1,1'-(etán-1,2-diyl)bis(pyrol-2,5-dión) |
431-500-0 |
226065-73-2 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-106-00-9 |
trans-1-[4-(4-butylcyklohexyl)fenyl]etanón |
427-320-7 |
83626-30-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-107-00-4 |
8-azaspiro[4.5]dekán-7,9-dión |
427-770-4 |
1075-89-4 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
606-108-00-X |
1,1,1,2,2,4,5,5,5-nonafluór-4-(trifluórmetyl)pentán-3-ón |
436-710-6 |
756-13-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
606-109-00-5 |
2-(4-metylpent-3-én-1-yl)-9,10-dihydroantracén-9,10-dión |
428-320-1 |
71308-16-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 |
H302 H317 H413 |
GHS07 Wng |
H302 H317 H413 |
|
|
|
|
606-110-00-0 |
5-etoxy-5H-furán-2-ón |
428-330-4 |
2833-30-9 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H312 H302 H373** H317 |
GHS05 GHS08 GHS07 Dgr |
H314 H312 H302 H373** H317 |
|
|
|
|
606-111-00-6 |
5-amino-6-metyl-1,3-dihydrobenzoimidazol-2-ón |
428-410-9 |
67014-36-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
606-112-00-1 |
(4aR*,8aR*)-3-metoxy-11-metyl-4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepín-6-ón |
428-690-2 |
1668-86-6 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Wng |
H302 H319 H412 |
|
|
|
|
606-113-00-7 |
1-[4-(4-benzoylfenylsulfanyl)fenyl]-2-metyl-2-(4-metylfenylsulfonyl)propán-1-ón |
429-040-0 |
272460-97-6 |
Eye Dam. 1 Aquatic Chronic 4 |
H318 H413 |
GHS05 Dgr |
H318 H413 |
|
|
|
|
606-114-00-2 |
4,4',5,5',6,6',7,7'-oktachlór-2,2'-bi(izoindol)-1,1',3,3'-tetraón |
429-150-9 |
67887-47-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-115-00-8 |
profoxydím (ISO); 3-hydroxy-2-{(EZ)-1-[(2RS)-2-(4-chlórfenoxy)propoxyimino]butyl}-5-tián-3-yl)cyklohex-2-én-1-ón |
— |
139001-49-3 |
Carc. 2 Repr. 2 Skin Sens. 1 |
H351 H361d H317 |
GHS08 GHS07 Wng |
H351 H361d H317 |
|
|
|
|
606-116-00-3 |
tepraloxydím (ISO); (RS)-(EZ)-3-hydroxy-2-{1-[(2E)-(3-chlóralyloxy)imino]propyl}-5-(tetrahydropyrán-4-yl)cyklohex-2-én-1-ón |
— |
149979-41-9 |
Carc. 2 Repr. 2 |
H351 H361fd |
GHS08 Wng |
H351 H361fd |
|
|
|
|
606-117-00-9 |
2,6-di-terc-butyl-4-(fenylmetylidén)cyklohexa-2,5-dién-1-ón |
429-460-4 |
7078-98-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-118-00-4 |
N-fenyl-N'-(4-metylpentán-2-yl)-1,4-benzochinón-diimín |
429-640-2 |
52870-46-9 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
|
606-119-00-X |
(E)-3-metylcyklopentadec-5-én-1-ón |
429-900-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
606-120-00-5 |
2,5-dihydroxy-5-metyl-3-(morfolín-4-yl)cyklopent-2-én-1-ón |
430-170-5 |
114625-74-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
606-121-00-0 |
(+)-(1S,2S,3S,5R)-2,6,6-trimetylbicyklo[3.1.1]heptán-3-spiro-1'-(cyklohex-2'-én-4'-ón) |
430-460-1 |
133636-82-5 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
606-122-00-6 |
3-(2-brómpropanoyl)-4,4-dimetyl-1,3-oxazolán-2-ón |
430-820-8 |
114341-88-7 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H315 H318 H317 H410 |
|
|
|
|
606-123-00-1 |
1-fenyl-4-hexadecylpyrazolidín-3-ón |
430-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-124-00-7 |
1-cyklopropyl-3-[2-(metylsulfanyl)-4-(trifluórmetyl)fenyl]propán-1,3-dión |
421-080-7 |
161462-35-7 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
|
606-125-00-2 |
1-benzylimidazolidín-2,4-dión |
421-340-1 |
6777-05-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
606-126-00-8 |
1,4-bis(2,3-dihydroxypropylamino)antracén-9,10-dión |
421-470-7 |
99788-75-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-128-00-9 |
2,2'-(1,3-fenylén)bis(5-chlór-1H-izoindol-1,3(2H)-dión) |
422-650-8 |
148935-94-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-129-00-4 |
5-amino-[2S-di(metylfenyl)amino]-1,6-difenylhex-4Z-én-3-ón; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6- difenylhex-4-én-3-ón |
423-090-7 |
156732-13-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-130-00-X |
4-(1,4-dioxaspiro[4.5]dekán-8-yl)cyklohexanón |
423-860-2 |
56309-94-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
606-131-00-5 |
cyklický 3-(etán-1,2-diylacetál) estra-5(10),9(11)-dién-3,17-diónu |
427-230-8 |
5571-36-8 |
Repr. 1B STOT RE 2 * Aquatic Chronic 2 |
H360F*** H373** H411 |
GHS08 GHS09 Dgr |
H360F*** H373** H411 |
|
|
|
|
606-132-00-0 |
(6β)-6,19-epoxyandrost-4-én-3,17-dión |
433-490-3 |
6563-83-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
606-134-00-1 |
androsta-1,4,9(11)-trién-3,17-dión |
433-560-3 |
15375-21-0 |
Repr. 2 |
H361f*** |
GHS08 Wng |
H361f*** |
|
|
|
|
606-135-00-7 |
cyklohexadekanón |
438-930-8 |
2550-52-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-136-00-2 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18- dibenzyl-3,9,15,21-tetraizobutyl- 4,10,12,16,22,24-hexametyl-1,7,13,19- tetraoxa-4,10,16,22-tetraazacyklotetrakozán- 2,5,8,11,14,17,20,23-oktaón |
444-350-6 |
133413-70-4 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
606-137-00-8 |
trans-7,7'-dimetyl-(4H,4H')-2,2'-bi(benzo[1,4]tiazinylidén)-3,3'-dión |
444-750-0 |
211387-26-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-138-00-3 |
(2-butyl-5-nitrobenzofurán-3-yl){4-[3-(dibutylamino)propoxy]fenyl}metanón |
444-800-1 |
141645-23-0 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Dgr |
H226 H302 H373** H315 H318 H317 H410 |
|
M=10 |
|
|
606-139-00-9 |
(S)-4-(3,4-dichlórfenyl)-3,4-dihydro-2H-naftalén-1-ón |
444-830-5 |
124379-29-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-140-00-4 |
2,2'-dihydroxy-2,2'-dimetyl-1,1'- [metylénbis(4,1-fenylén)]di(propán-1-ón) |
444-860-9 |
474510-57-1 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wn |
H373** H410 |
|
|
|
|
606-141-00-X |
nátrium-3-(metoxykarbonyl)-4-oxo-3,4,5,6-tetrahydropyridín-2-olát |
418-410-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
606-142-00-5 |
reakčná zmes zložená z týchto látok: (1RS,2SR,7SR,8SR,E)-9 etylidén-3- oxatricyklo[6.2.1.02,7]undekán-4-ón; (1RS,2SR,7SR,8SR,E)-10-etylidén-3- oxatricyklo[6.2.1.02,7]undekán-4-ón; (1RS,2SR,7SR,8SR,Z)-10-etylidén-3-oxatricyklo[6.2.1.02,7]undekán-4-ón; (1RS,2SR,7SR,8SR,Z)-9-etylidén-3- oxatricyklo[6.2.1.02,7]undekán-4-ón |
434-290-9 |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
606-143-00-0 |
abamektín (zmes avermektínu B1a a avermektínu B1b) (ISO) [1] avermektín B1a (čistota ≥ 80 %); [2] |
_ [1] 265-610-3 [2] |
71751-41-2 [1] 65195-55-3 [2] |
Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H300 H330 H372 (nervový systém) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d H300 H330 H372 (nervový systém) H410 |
|
STOT RE 1; H372: C ≥ 5% STOT RE 2; H373: 0,5 % ≤C< 5% M = 10 000 |
|
|
606-144-00-6 |
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaftalén-2-yl acetát |
— |
57960-19-7 |
Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H370 (pľúca) (inhalácia) H373 (krvný obeh) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H317 H370 (pľúca) (inhalácia) H373 (krvný obeh) H410 |
|
M = 1 000 |
|
|
606-145-00-1 |
sulkotrión (ISO); 2-[2-chlór-4-(metylsulfonyl)benzoyl]cyklohexán-1,3-dión |
|
99105-77-8 |
Repr. 2 STOT RE 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (obličky) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (obličky) H317 H410 |
|
M = 1 M = 10 |
|
|
606-146-00-7 |
tralkoxydím (ISO); 2-(N-etoxypropanimidoyl)-3-hydroxy-5-mezitylcykohex-2-én-1-ón |
— |
87820-88-0 |
Carc. 2 Acute Tox. 4 Aquatic Chronic 2 |
H351 H302 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H411 |
|
|
|
|
606-147-00-2 |
cykloxydím (ISO); 2-(N-etoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-tiopyrán-3-yl)cyklohex-2-én-1-ón |
405-230-9 |
101205-02-1 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
607-001-00-0 |
kyselina mravčia ... % |
200-579-1 |
64-18-6 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 90% Skin Corr. 1B; H314: 10% ≤ C < 90% Skin Irrit. 2; H315: 2% ≤C < 10 % Eye Irrit. 2; H319: 2%≤ <10 % |
B |
|
607-002-00-6 |
kyselina octová ... % |
200-580-7 |
64-19-7 |
Flam. Liq. 3 Skin Corr. 1A |
H226 H314 |
GHS02 GHS05 Dgr |
H226 H314 |
|
Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25%≤ C <90 % Skin Irrit. 2; H315: 10% ≤C <25 % Eye Irrit. 2; H319: 10% ≤ C < 25 % |
B |
|
607-003-00-1 |
kyselina chlóroctová |
201-178-4 |
79-11-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H331 H311 H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5% |
|
|
607-004-00-7 |
TCA (ISO); kyselina trichlóroctová |
200-927-2 |
76-03-9 |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 1% |
|
|
607-005-00-2 |
TCA-nátrium (ISO); nátrium-trichlóracetát |
211-479-2 |
650-51-1 |
STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H400 H410 |
GHS07 GHS09 Wng |
H335 H410 |
|
|
|
|
607-006-00-8 |
kyselina šťaveľová |
205-634-3 |
144-62-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
|
|
607-007-00-3 |
soli kyseliny šťaveľovej, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
A |
|
607-008-00-9 |
acetanhydrid |
203-564-8 |
108-24-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H302 H314 |
|
Skin Corr. 1B; H314: C ≥ 2% Skin Irrit. 2; H315: 5% ≤C < 25% Eye Dam. 1; H318: 5% ≤ C < 25% Eye Irrit. 2; H319: 1% ≤C < 5% STOT SE 3; H335: C ≥ 5% |
|
|
607-009-00-4 |
ftalanhydrid |
201-607-5 |
85-44-9 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H335 H315 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H335 H315 H318 H334 H317 |
|
|
|
|
607-010-00-X |
propiónanhydrid |
204-638-2 |
123-62-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H315: 10% ≤ C < 25% Eye Irrit. 2; H319: 10% ≤ C < 25 % |
|
|
607-011-00-5 |
acetylchlorid |
200-865-6 |
75-36-5 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
|
|
607-012-00-0 |
benzoylchlorid |
202-710-8 |
98-88-4 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H332 H312 H302 H314 H317 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 H317 |
|
|
|
|
607-013-00-6 |
dimetyl-karbonát |
210-478-4 |
616-38-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
607-014-00-1 |
metyl-formiát |
203-481-7 |
107-31-3 |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H224 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H224 H332 H302 H319 H335 |
|
|
|
|
607-015-00-7 |
etyl-formiát |
203-721-0 |
109-94-4 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H302 H319 H335 |
|
|
|
|
607-016-00-2 |
propyl-formiát; [1] izopropyl-formiát [2] |
203-798-0 [1] 210-901-2 [2] |
110-74-7 [1] 625-55-8 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H225 H319 H335 H336 |
GHS02 GHS07 Dgr |
H225 H319 H335 H336 |
|
|
C |
|
607-017-00-8 |
butyl-formiát; [1] terc-butyl-formiát; [2] izobutyl-formiát [3] |
209-772-5 [1] 212-105-0 [2] 208-818-1 [3] |
592-84-7 [1] 762-75-4 [2] 542-55-2 [3] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-018-00-3 |
izopentyl-formiát; [1] 2-metylbutyl-formiát [2] |
203-769-2 [1] 252-343-2 [2] |
110-45-2 [1] 35073-27-9 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-019-00-9 |
metyl-chlórmetanoát |
201-187-3 |
79-22-1 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H312 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H312 H302 H314 |
|
|
|
|
607-020-00-4 |
etyl-chlórmetanoát |
208-778-5 |
541-41-3 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H302 H314 |
|
|
|
|
607-021-00-X |
metyl-acetát |
201-185-2 |
79-20-9 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
607-022-00-5 |
etyl-acetát |
205-500-4 |
141-78-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
607-023-00-0 |
vinyl-acetát |
203-545-4 |
108-05-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 |
H225 H351 H332 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H335 |
|
|
D |
|
607-024-00-6 |
propyl-acetát; [1] izopropyl-acetát [2] |
203-686-1 [1] 203-561-1 [2] |
109-60-4 [1] 108-21-4 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
C |
|
607-025-00-1 |
n-butyl-acetát |
204-658-1 |
123-86-4 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
EUH066 |
|
|
|
607-026-00-7 |
sek-butyl-acetát; [1] izobutyl-acetát; [2] terc-butyl-acetát [3] |
203-300-1 [1] 203-745-1 [2] 208-760-7 [3] |
105-46-4 [1] 110-19-0 [2] 540-88-5 [3] |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH066 |
|
C |
|
607-027-00-2 |
metyl-propanoát |
209-060-4 |
554-12-1 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
607-028-00-8 |
etyl-propanoát |
203-291-4 |
105-37-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
607-029-00-3 |
n-butyl-propanoát; [1] sek-butyl-propanoát; [2] izobutyl-propanoát [3] |
209-669-5 [1] -[2] 208-746-0 [3] |
590-01-2 [1] 591-34-4 [2] 540-42-1 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-030-00-9 |
propyl-propanoát |
203-389-7 |
106-36-5 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
607-031-00-4 |
butyl-butanoát |
203-656-8 |
109-21-7 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-032-00-X |
etyl-akrylát |
205-438-8 |
140-88-5 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 H335 H315 H317 |
|
Skin Irrit. 2; H315: C ≥ 5% Eye Irrit. 2; H319: C ≥ 5% STOT SE 3; H335: C ≥ 5% |
D |
|
607-033-00-5 |
n-butyl-metakrylát |
202-615-1 |
97-88-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
607-034-00-0 |
metyl-akrylát; metyl-propenoát |
202-500-6 |
96-33-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 H335 H315 H317 |
|
|
D |
|
607-035-00-6 |
metyl-metakrylát; metyl-2-metylprop-2-enoát; O-metyl-2-metylpropenoát |
201-297-1 |
80-62-6 |
Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H335 H315 H317 |
|
|
D |
|
607-036-00-1 |
(2-metoxyetyl)-acetát; metylglykol-acetát |
203-772-9 |
110-49-6 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H360FD H332 H312 H302 |
GHS08 GHS07 Dgr |
H360FD H332 H312 H302 |
|
|
|
|
607-037-00-7 |
(2-etoxyetyl)-acetát; etylglykol-acetát |
203-839-2 |
111-15-9 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
607-038-00-2 |
(2-butoxyetyl)-acetát; butylglykol-acetát |
203-933-3 |
112-07-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 |
GHS07 Wng |
H332 H312 |
|
|
|
|
607-039-00-8 |
2,4-D (ISO); kyselina (2,4-dichlórfenoxy)octová |
202-361-1 |
94-75-7 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H335 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H335 H318 H317 H412 |
|
|
|
|
607-040-00-3 |
soli 2,4-D |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
A |
|
607-041-00-9 |
2,4,5-T (ISO); kyselina (2,4,5-trichlórfenoxy)octová |
202-273-3 |
93-76-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
607-042-00-4 |
soli a estery 2,4,5-T; soli a estery kyseliny (2,4,5-trichlórfenoxy)octovej |
— |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
A |
|
607-043-00-X |
dikamba (ISO); kyselina 3,6-dichlór-2-metoxybenzoová |
217-635-6 |
1918-00-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
607-044-00-5 |
kyselina 3,6-dichlór-2-metoxybenzoová, zlúčenina s dimetylamínom (1:1); [1] kálium-3,6-dichlór-2-metoxybenzoát [2] |
218-951-7 [1] 233-002-7 [2] |
2300-66-5 [1] 10007-85-9 [2] |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
607-045-00-0 |
dichlórprop (ISO); kyselina 2-(2,4-dichlórfenoxy)propánová |
204-390-5 |
120-36-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H315 H318 |
|
|
|
|
607-046-00-6 |
soli dichlórpropu |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
A |
|
607-047-00-1 |
fenoprop (ISO); kyselina 2-(2,4,5-trichlórfenoxy)propánová |
202-271-2 |
93-72-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
607-048-00-7 |
soli fenopropu; soli kyseliny 2-(2,4,5-trichlórfenoxy)propánovej |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-049-00-2 |
mekoprop (ISO); 2-(4-chlór-o- tolyloxy) propiónová kyselina; (RS)-(4-chlór-o-tolyloxy) propiónová kyselina; [1] 2-(4-chlór-2- metylfenoxy) propiónová kyselina [2] |
230-386-8 [1] 202-264-4 [2] |
7085-19-0 [1] 708519-0 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
M=100 |
|
|
607-050-00-8 |
soli mekopropu |
— |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
A |
|
607-051-00-3 |
MCPA (ISO); kyselina (4-chlór-2-metylfenoxy)octová |
202-360-6 |
94-74-6 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
607-052-00-9 |
soli a estery MCPA |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-053-00-4 |
MCPB (ISO); kyselina 4-(4-chlór-2-metylfenoxy)butánová |
202-365-3 |
94-81-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-054-00-X |
soli a estery of MCPB |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
|
607-055-00-5 |
endotál-nátrium (ISO); dinátrium-7-oxabicyklo[2.2.1]heptán-2,3-dikarboxylát |
204-959-8 |
129-67-9 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
607-057-00-6 |
kumachlór (ISO); 4-hydroxy-3-[1-(4-chlórfenyl)-3-oxobutyl]- 2H-chromén-2-ón |
201-378-1 |
81-82-3 |
STOT RE 2 * Aquatic Chronic 3 |
H373 ** H412 |
GHS08 Wng |
H373 ** H412 |
|
|
|
|
607-058-00-1 |
kumafuryl (ISO); fumarín; (RS)-4-(2-furyl)-4-(4-hydroxy-2-oxo-2H-chromén-3-yl)bután-2-ón; |
204-195-5 |
117-52-2 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H301 H372 ** H412 |
GHS06 GHS08 Dgr |
H301 H372 ** H412 |
|
|
|
|
607-060-00-2 |
dikumarol; 4,4'-dihydroxy-3,3'-metylénbis(2Hchromén- 2-ón) |
200-632-9 |
66-76-2 |
STOT RE 1 Acute Tox. 4 * Aquatic Chronic 2 |
H372 ** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H302 H411 |
|
|
|
|
607-061-00-8 |
kyselina akrylová; kyselina propénová |
201-177-9 |
79-10-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 H400 |
|
STOT SE 3; H335: C ≥ 1% |
D |
|
607-062-00-3 |
n-butyl-akrylát |
205-480-7 |
141-32-2 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
607-063-00-9 |
kyselina 2-metylpropánová |
201-195-7 |
79-31-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
607-064-00-4 |
benzyl-chlórmetanoát |
207-925-0 |
501-53-1 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
607-065-00-X |
kyselina brómoctová |
201-175-8 |
79-08-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H331 H311 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H317 H400 |
|
|
|
|
607-066-00-5 |
kyselina dichlóroctová |
201-207-0 |
79-43-6 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
607-067-00-0 |
dichlóracetylchlorid |
201-199-9 |
79-36-7 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
607-068-00-6 |
kyselina jódoctová |
200-590-1 |
64-69-7 |
Acute Tox. 3 * Skin Corr. 1A |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
|
|
|
607-069-00-1 |
etyl-brómacetát |
203-290-9 |
105-36-2 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
607-070-00-7 |
etyl-chlóracetát |
203-294-0 |
105-39-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H331 H311 H301 H400 |
GHS06 GHS09 Dgr |
H331 H311 H301 H400 |
|
|
|
|
607-071-00-2 |
etyl-metakrylát; O-etyl-2-metylpropenoát |
202-597-5 |
97-63-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 H317 |
|
|
D |
|
607-072-00-8 |
(2-hydroxyetyl)-akrylát |
212-454-9 |
818-61-1 |
Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H311 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H314 H317 H400 |
|
* Skin Sens. 1; H317: C ≥ 0,2 % |
D |
|
607-073-00-3 |
4-CPA (ISO); kyselina (4-chlórfenoxy)octová |
204-581-3 |
122-88-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-074-00-9 |
chlórfenak (ISO); kyselina (2,3,6-trichlórfenyl)octová |
201-599-3 |
85-34-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-075-00-4 |
chlórfenprop-metyl; O-metyl-2-chlór-3-(4-chlórfenyl)propanoát |
238-413-5 |
14437-17-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
607-076-00-X |
dodín (ISO); dodecylguanidínium-acetát |
219-459-5 |
2439-10-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
607-077-00-5 |
erbón (ISO); O-[2-(2,4,5-trichlórfenoxy)etyl]-2,2-dichlórpropanoát |
— |
136-25-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-078-00-0 |
fluenetil (ISO); (2-fluóretyl)-bifenyl-4-ylacetát |
— |
4301-50-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
607-079-00-6 |
keleván (ISO); O-etyl-5-(perchlór-5-hydroxypentacyklo[5.3.0.02,6.03,9.04,8]dekán-5-yl)-4-oxopentanoát; O-etyl-[3-hydroxy-5-(1,2,4,5,6,7,8,8,9,10-dekachlór-pentacyklo[5.3.0.02,6.04,10.05,9]dekán-3-yl)-4-oxopentanoát |
— |
4234-79-1 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H311 H302 H411 |
GHS06 GHS09 Dgr |
H311 H302 H411 |
|
|
|
|
607-080-00-1 |
chlóracetylchlorid |
201-171-6 |
79-04-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Aquatic Acute 1 |
H331 H311 H301 H372 ** H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H311 H301 H372 ** H314 H400 |
EUH014 EUH029 |
|
|
|
607-081-00-7 |
kyselina fluóroctová |
205-631-7 |
144-49-0 |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
|
|
607-082-00-2 |
fluóracetáty, rozpustné |
— |
— |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
A |
|
607-083-00-8 |
2,4-DB (ISO); kyselina 4-(2,4-dichlórfenoxy)butánová |
202-366-9 |
94-82-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-084-00-3 |
soli 2,4-DB |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
A |
|
607-085-00-9 |
benzyl-benzoát |
204-402-9 |
120-51-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-086-00-4 |
dialyl-ftalát |
205-016-3 |
131-17-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-088-00-5 |
kyselina metakrylová; kyselina 2-metylpropénová |
201-204-4 |
79-41-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1% |
D |
|
607-089-00-0 |
propánová kyselina ... % |
201-176-3 |
79-09-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25% Skin Irrit. 2; H319 10% ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25% STOT SE 3; H335: C ≥ 10% |
B |
|
607-090-00-6 |
kyselina tioglykolová |
200-677-4 |
68-11-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H331 H311 H301 H314 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 |
|
* |
|
|
607-091-00-1 |
kyselina trifluóroctová . . . % |
200-929-3 |
76-05-1 |
Acute Tox. 4 * Skin Corr. 1A Aquatic Chronic 3 |
H332 H314 H412 |
GHS05 GHS07 Dgr |
H332 H314 H412 |
|
* |
B |
|
607-092-00-7 |
metyl-laktát; [1] metyl-(±)-laktát; [2] metyl-(R)-laktát; [3] metyl (S)-(-)-laktát [4] |
208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] |
547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
|
C |
|
607-093-00-2 |
propanoylchlorid |
201-170-0 |
79-03-8 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
B D |
|
607-094-00-8 |
kyselina peroxyoctová . . . % |
201-186-8 |
79-21-0 |
Flam. Liq. 3 Org. Perox. D **** Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H242 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H242 H332 H312 H302 H314 H400 |
|
* STOT SE 3; H335: C ≥ 1% |
B D |
|
607-095-00-3 |
kyselina maleínová |
203-742-5 |
110-16-7 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H335 H315 H317 |
GHS07 Wng |
H302 H319 H335 H315 H317 |
|
Skin Sens. 1; H317: C ≥0,1 % |
|
|
607-096-00-9 |
maleínanhydrid |
203-571-6 |
108-31-6 |
Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H302 H314 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H314 H334 H317 |
|
|
|
|
607-097-00-4 |
1,2-anhydrid kyseliny benzén-1,2,4-trikarboxylovej; anhydrid kyseliny trimellitovej |
209-008-0 |
552-30-7 |
STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H335 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H335 H318 H334 H317 |
|
|
|
|
607-098-00-X |
benzén-1,2:4,5-tetrakarboxdianhydrid 1,2:4,5-dianhydrid kyseliny benzén-1,2,4,5-tetrakarboxylovej |
201-898-9 |
89-32-7 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
|
|
607-099-00-5 |
1,2,3,6-tetrahydroftalanhydrid; [1] cis-1,2,3,6-tetrahydroftalanhydrid; [2] 3,4,5,6-tetrahydroftalanhydrid; [3] tetrahydroftalanhydrid [4] |
201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] |
85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H334 H317 H412 |
GHS08 GHS05 Dgr |
H318 H334 H317 H412 |
|
|
C |
|
607-100-00-9 |
dianhydrid kyseliny benzofenón-3,3',4,4'-tetrakarboxylovej 4,4'-karbonyldi(ftalanhydrid) |
219-348-1 |
2421-28-5 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit 2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
|
|
607-101-00-4 |
1,4,5,6,7,7-hexachlórbicyklo[2.2.1]hept-5-én-2,3-dikarboxylanhydrid |
204-077-3 |
115-27-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
Skin Irrit.2; H315: C ≥ 1% Eye Irrit. 2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
|
|
607-102-00-X |
cyklohexán-1,2-dikarboxanhydrid; [1] cis-cyklohexán-1,2-dikarboxanhydrid; [2] trans-cyklohexán-1,2-dikarboxanhydrid [3] |
201-604-9 [1] 236-086-3 [2] 238-009-9 [3] |
85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-103-00-5 |
sukcínanhydrid |
203-570-0 |
108-30-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H302 H319 H335 |
GHS07 Wng |
H302 H319 H335 |
|
* Eye Irrit. 2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
|
|
607-104-00-0 |
cyklopentán-1,2:3,4-tetrakarboxdianhydrid |
227-964-7 |
6053-68-5 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit. 2; H319: C ≥ 1% STOT SE 3; H335: C ≥ 1% |
|
|
607-105-00-6 |
norborn-5-én-2,3-dikarboxanhydrid; [1] 1,2,3,6-tetrahydro-3,6-metanoftalanhydrid; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6- metanoftalanhydrid [3] |
204-957-7 [1] 212-557-9 [2] 220-384-5 [3] |
129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-106-00-1 |
1-metylnorborn-5-én-2,3-dikarboxanhydrid; 1-metylbicyklo[2.2.1]hept-5-én-2,3- dikarboxanhydrid |
— |
123748-85-6 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H302 H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H302 H319 H335 H315 H334 |
|
STOT SE 3; H335: C ≥ 10% |
C |
|
607-107-00-7 |
(2-etylhexyl)-akrylát |
203-080-7 |
103-11-7 |
STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H335 H315 H317 |
GHS07 Wng |
H335 H315 H317 |
|
|
D |
|
607-108-00-2 |
(1-hydroxypropán-2-yl)-akrylát; [1] (2-hydroxypropyl)-akrylát; [2] kyselina akrylová, monoester s propán-1,2- diolom [3] |
220-852-9 [1] 213-663-8 [2] 247-118-0 [3] |
2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
C D |
|
607-109-00-8 |
(hexán-1,6-diyl)-diakrylát; diakrylát hexán-1,6-diolu |
235-921-9 |
13048-33-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-110-00-3 |
triakrylát pentaerytritolu |
222-540-8 |
3524-68-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-111-00-9 |
(propán-1,1,1-triyltrimetylén)-triakrylát; triakrylát propán-1,1,1-trimetanolu |
239-701-3 |
15625-89-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-112-00-4 |
(2,2-dimetylpropán-1,3-diyl)-diakrylát; diakrylát neopentylglykolu |
218-741-5 |
2223-82-7 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* |
D |
|
607-113-00-X |
izobutyl-metakrylát |
202-613-0 |
97-86-9 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H226 H319 H335 H315 H317 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H315 H317 H400 |
|
|
D |
|
607-114-00-5 |
etylén-dimetakrylát |
202-617-2 |
97-90-5 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
STOT SE 3; H335: C ≥ 10% |
D |
|
607-115-00-0 |
izobutyl-akrylát |
203-417-8 |
106-63-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H226 H332 H312 H315 H317 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 H317 |
|
|
D |
|
607-116-00-6 |
cyklohexyl-akrylát |
221-319-3 |
3066-71-5 |
STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H335 H315 H411 |
GHS07 GHS09 Wng |
H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10% |
D |
|
607-117-00-1 |
(oxiranylmetyl)-akrylát; glycidyl-akrylát |
203-440-3 |
106-90-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
D |
|
607-118-00-7 |
1-metylnorborn-5-én-2,3-dikarboxanhydrid; diakrylát 1,3-butylénglykolu |
243-105-9 |
19485-03-1 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
607-119-00-2 |
(bután-1,4-diyl)-diakrylát; diakrylát 1,4-butylénglykolu |
213-979-6 |
1070-70-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
607-120-00-8 |
(2,2'-oxydietyl)-diakrylát dietylénglykol |
223-791-6 |
4074-88-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* Skin Sens. 1; H317:C≥0,2 % |
D |
|
607-121-00-3 |
(2-norbornyl)-akrylát; (bicyklo[2.2.1]heptán-2-yl)-akrylát |
— |
10027-06-2 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H312 H315 H317 |
GHS07 Wng |
H312 H315 H317 |
|
|
D |
|
607-122-00-9 |
tetraakrylát pentaerytritolu |
225-644-1 |
4986-89-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-124-00-X |
(2-hydroxyetyl)-metakrylát |
212-782-2 |
868-77-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-125-00-5 |
(2-hydroxypropyl)-metakrylát; O-(2-hydroxyetyl)-2-metylpropenoát [1] (3-hydroxypropyl)-metakrylát; O-(3-hydroxypropyl)-2-metylpropenoát [2] |
213-090-3 [1] 220-426-2 [2] |
923-26-2 [1] 2761-09-3 [2] |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
C D |
|
607-126-00-0 |
[2,2'-(etyléndioxy)dietyl]-diakrylát; trietylénglykol-diakrylát |
216-853-9 |
1680-21-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-127-00-6 |
[2-(dietylamino)etyl]-metakrylát |
203-275-7 |
105-16-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H319 H315 H317 |
GHS07 Wng |
H332 H319 H315 H317 |
|
|
D |
|
607-128-00-1 |
[2-(terc-butylamino)etyl]-metakrylát; |
223-228-4 |
3775-90-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
607-129-00-7 |
etyl-laktát; etyl-laktát; [1] etyl-(S)-2-hydroxypropanoát; etyl-L-laktát; etyl-(S)-laktát [2] |
202-598-0 [1] 211-694-1 [2] |
97-64-3 [1] 687-47-8 [2] |
Flam. Liq. 3 STOT SE 3 Eye Dam. 1 |
H226 H335 H318 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H318 |
|
|
C |
|
607-130-00-2 |
pentyl-acetát; [1] izopentyl-acetát; [2] (pentán-2-yl)-acetát; [3] (2-metylbutyl)-acetát; [4] [2(alebo 3)-metylbutyl]-acetát [5] |
211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] |
628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
EUH066 |
|
C |
|
607-131-00-8 |
izopentyl-propanoát; [1] pentyl-propanoát; [2] (2-metylbutyl)-propanoát [3] |
203-322-1 [1] 210-852-7 [2] 219-449-0 [3] |
105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-132-00-3 |
[2-(dimetylamino)etyl]-metakrylát; O-[2-(dimetylamino)etyl]-2-metylpropenoát |
220-688-8 |
2867-47-2 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H315 H317 |
GHS07 Wng |
H312 H302 H319 H315 H317 |
|
|
D |
|
607-133-00-9 |
monoalkyl- alebo monoaryl alebo monoalkylaryl- estery kyseliny akrylovej, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H335 H315 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10% |
A |
|
607-134-00-4 |
monoalkyl alebo monoaryl alebo monoalkylaryl estery kyseliny metakrylovej, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOTSE 3; H335: C ≥ 10% |
A |
|
607-135-00-X |
kyselina maslová; kyselina butánová |
203-532-3 |
107-92-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
607-136-00-5 |
butanoylchlorid |
205-498-5 |
141-75-3 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
607-137-00-0 |
metyl-acetoacetát; O-metyl-3-oxobutanoát |
203-299-8 |
105-45-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-138-00-6 |
butyl-chlórmetanoát; butylester kyseliny chlórmetánovej |
209-750-5 |
592-34-7 |
Flam. Liq. 3 Acute Tox. 3 * Skin Corr. 1B |
H226 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H314 |
|
|
|
|
607-139-00-1 |
kyselina 2-chlórpropánová; 2-metylpropanoylchlorid |
209-952-3 |
598-78-7 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
607-140-00-7 |
izobutyrylchlorid |
201-194-1 |
79-30-1 |
Flam. Liq. 2 Skin Corr. 1A |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
607-141-00-2 |
oxydietylén-bis(chlórmetanoát) |
203-430-9 |
106-75-2 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H411 |
|
|
|
|
607-142-00-8 |
propyl-chlórmetanoát; propylester kyseliny chlórmetánovej; n-propyl-chlórmetanoát |
203-687-7 |
109-61-5 |
Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H331 H314 |
|
|
|
|
607-143-00-3 |
kyselina valerová |
203-677-2 |
109-52-4 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
607-144-00-9 |
kyselina adipová |
204-673-3 |
124-04-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-145-00-4 |
kyselina metánsulfónová |
200-898-6 |
75-75-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
607-146-00-X |
kyselina fumarová; kyselina (E)-buténdiová |
203-743-0 |
110-17-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-147-00-5 |
dietylester kyseliny šťaveľovej dietyl-oxalát |
202-464-1 |
95-92-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
607-148-00-0 |
guanidínium-chlorid; hydrochlorid guanidínu |
200-002-3 |
50-01-1 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
607-149-00-6 |
uretán (INN); etyl-karbamát |
200-123-1 |
51-79-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
607-150-00-1 |
endotál (ISO); kyselina 7-oxabicyklo[2.2.1]heptán-2,3-dikarboxylová |
205-660-5 |
145-73-3 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
607-151-00-7 |
propargit (ISO); [2-(4-terc-butylfenoxy)cyklohexyl]-(prop-2-inyl)-sulfit |
219-006-1 |
2312-35-8 |
Carc. 2 Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H315 H318 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H331 H315 H318 H410 |
|
M = 10 |
|
|
607-152-00-2 |
2,3,6-TBA (ISO); kyselina 2,3,6-trichlórbenzoová |
200-026-4 |
50-31-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-153-00-8 |
benazolín (ISO); kyselina 4-chlór-2-oxo-2,3-dihydro-1,3-benzotiazol-3-octová |
223-297-0 |
3813-05-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
607-154-00-3 |
O-etyl-N-benzoyl-N-(3,4-dichlórfenyl)-DLalaninát; benzoylprop-etyl (ISO) |
244-845-5 |
22212-55-1 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-155-00-9 |
kyselina 5-[3-amino-5-(1- metylguanidino)pentánamido]-2-(4-amino- 2(1H)-oxopyrimidín-1-yl)-5,6-dihydro-2Hpyrán- 2-karboxylová; blasticidín-s |
— |
2079-00-7 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
607-156-00-4 |
chlórfensón (ISO); O-(4-chlórfenyl)-4-chlórbenzénsulfonát |
201-270-4 |
80-33-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
607-158-00-5 |
sodná soľ kyseliny chlóroctovej; nátrium-chlóracetát; chlóroctan sodný |
223-498-3 |
3926-62-3 |
Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 |
H301 H315 H400 |
GHS06 GHS09 Dgr |
H301 H315 H400 |
|
|
|
|
607-159-00-0 |
chlórbenzilát (ISO); O-etyl-2-hydroxy-2,2-bis(4-chlórfenyl)acetát; O-etyl-4,4'-dichlórbenzilát |
208-110-2 |
510-15-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-160-00-6 |
O-izobutyl-2-[4-(4-chlórfenoxy)fenoxy]propanoát; klofop-izobutyl (ISO) |
— |
51337-71-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-161-00-1 |
soľ 4-CPA s 2,2'-iminodietanolom |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-162-00-7 |
dalapón; kyselina 2,2-dichlórpropánová; [1] dalapón-nátrium; nátrium-2,2-dichlórpropanoát [2] |
200-923-0 [1] 204-828-5 [2] |
75-99-0 [1] 127-20-8 [2] |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-163-00-2 |
3-acetyl-6-metyl-2H-pyrán-2,4(3H)-dión; kyselina dehydracetová |
208-293-9 |
520-45-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-164-00-8 |
nátrium-3-acetyl-4-oxo-6-metyl-4H-pyrán-2-olát |
224-580-1 |
4418-26-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-165-00-3 |
dikofop-metyl (ISO); O-metyl-2-[4-(2,4-dichlórfenoxy)fenoxy]propanoát; O-metyl-(RS)-2-[4-(2,4-dichlórfenoxy)fenoxy]propanoát |
257-141-8 |
51338-27-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-166-00-9 |
medinoterb-acetát (ISO); (6-terc-butyl-3-metyl-2,4-dinitrofenyl)-acetát |
219-634-6 |
2487-01-6 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
607-167-00-4 |
nátrium-3-chlórakrylát |
— |
4312-97-4 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
607-168-00-X |
O,O-dipropyl-6,7-metyléndioxy-3-metyl-1,2,3,4-tetrahydronaftalén-1,2-dikarboxylát; propylizóm |
— |
83-59-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H400 H410 |
GHS06 GHS09 Dgr |
H311 H302 H410 |
|
|
|
|
607-169-00-5 |
nátrium-fluóracetát; fluóroctan sodný |
200-548-2 |
62-74-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H330 H310 H300 H400 |
GHS06 GHS09 Dgr |
H330 H310 H300 H400 |
|
|
|
|
607-170-00-0 |
bis[dimetyl(1,2,3-tritiacyklohexán-4-yl)amónium]-oxalát; tiocyklám-oxalát |
250-859-2 |
31895-22-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
607-173-00-7 |
O,O-dimetyl-3,3’-(N-{4-[(3-etoxykarbonyl- 5-nitro-2-tienyl)diazenyl]-3- metylfenyl}imino)dipropanoát |
400-460-6 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-174-00-2 |
reakčná zmes zložená z O-dodecyl-3-(2,2,4,4-tetrametyl-21-oxo- 3,20-diaza-7- oxadispiro[5.1.11.2]henikozán-20- yl)propanoátu a O-tetradecyl-3-(2,2,4,4-tetrametyl-21-oxo- 3,20-diaza-7- oxadispiro[5.1.11.2]henikozán-20- yl)propanoátu |
400-580-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-175-00-8 |
O-metyl-2-(2-nitrobenzylidén)-3-oxobutanoát |
400-650-9 |
39562-27-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-176-00-3 |
z α-hydro-ω-{3-[3-(2H-benzotriazol-2-yl)-5-terc-butyl-4- hydroxyfenyl]propanoyloxy}poly(oxyetylénu) a α-{3-[3-(2H-benzotriazol-2-yl)-5-tercbutyl- 4-hydroxyfenyl]propanoyl}-ω-{3-[3- (2H-benzotriazol-2-yl)-5-terc-butyl-4- hydroxyfenyl]propanoyloxy}poly (oxyetylénu) |
400-830-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-177-00-9 |
tribenuron-metyl (ISO); O-metyl-2-{[3-(4-metoxy-6-metyl-1,3,5- triazín-2-yl)-3- metylureido]sulfonyl}benzoát |
401-190-1 |
101200-48-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 100 |
|
|
607-178-00-4 |
O-metyl-2-({[3-(4,6-dimetoxypyrimidín-2- yl)ureido]sulfonyl}metyl)benzoát |
401-340-6 |
83055-99-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-179-00-X |
kyselina (benzotiazol-2-ylsulfanyl)jantárová |
401-450-4 |
95154-01-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-180-00-5 |
kálium-2-hydroxykarbazol-1-karboxylát |
401-630-2 |
96566-70-0 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H302 H319 H335 H412 |
GHS07 Wng |
H302 H319 H335 H412 |
|
|
|
|
607-181-00-0 |
2,4-difluór-3,5-dichlórbenzoylfluorid |
401-800-6 |
101513-70-6 |
Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H331 H314 H302 H317 H412 |
GHS06 GHS05 Dgr |
H331 H314 H302 H317 H412 |
EUH029 |
|
|
|
607-182-00-6 |
O-metyl-3-sulfamoyltiofén-2-karboxylát |
402-050-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-183-00-1 |
zinkium-5-(C13-18-alkyl)-2-hydroxybenzoát |
402-280-3 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
607-184-00-7 |
S-[(3-trimetoxysilyl)propyl]-N-(6-{[2,4- bis(izokyanátohexyl)alofanyl]amino}hexyl)tiokarbamát |
402-290-8 |
85702-90-5 |
Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 |
H226 H334 H317 |
GHS02 GHS08 Dgr |
H226 H334 H317 |
|
|
|
|
607-185-00-2 |
etyl-trans-3-(dimetylamino)akrylát |
402-650-4 |
1117-37-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-186-00-8 |
chinchlorak (ISO); kyselina 3,7-dichlórchinolín-8-karboxylová |
402-780-1 |
84087-01-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-187-00-3 |
bis(2,2,6,6-tetrametylpiperidín-4-yl)-sukcinát |
402-940-0 |
62782-03-0 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
607-188-00-9 |
nátrium-hydrogen-N-(karboxyetyl)-N-(oktadec-9-én-1-yl)maleamát |
402-970-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-189-00-4 |
kyselina propán-1,3-diamíntetraoctová; kyselina propán-1,3-diylbis(nitrilo)tetraoctová |
400-400-9 |
1939-36-2 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
607-190-00-X |
O-metyl-2-(akrylamido)-2-metoxyacetát (s obsahom ≥ 0,1 % akrylamidu) |
401-890-7 |
77402-03-0 |
Carc. 1B Muta. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H340 H302 H319 |
GHS08 GHS07 Dgr |
H350 H340 H302 H319 |
|
|
|
|
607-191-00-5 |
izobutyl-oxiránacetát |
401-920-9 |
100181-71-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
607-192-00-0 |
dinátrium-N-[2-(2-hydroxyetoxy)etyl]iminodiacetát |
402-360-8 |
92511-22-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-194-00-1 |
propán-1,2-diyl-karbonát; 4-metyl-1,3-dioxolán-2-ón |
203-572-1 |
108-32-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-195-00-7 |
(1-metoxypropán-2-yl)-acetát |
203-603-9 |
108-65-6 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
607-196-00-2 |
kyselina heptánová |
203-838-7 |
111-14-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
607-198-00-3 |
O-propyl-3,4,5-trihydroxybenzoát |
204-498-2 |
121-79-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
607-199-00-9 |
O-oktyl-3,4,5-trihydroxybenzoát |
213-853-0 |
1034-01-1 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
607-200-00-2 |
O-dodecyl-3,4,5-trihydroxybenzoát |
214-620-6 |
1166-52-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-201-00-8 |
tiokarbonylchlorid; dichlorid-sulfid uhličitý |
207-341-6 |
463-71-8 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H331 H302 H319 H335 H315 |
GHS06 Dgr |
H331 H302 H319 H335 H315 |
|
|
|
|
607-203-00-9 |
O-(2-etylhexyl)-2-[(3,5-di-terc-butyl-4-hydroxybenzyl)sulfanyl]acetát |
279-452-8 |
80387-97-9 |
Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H360D *** H317 H412 |
GHS08 GHS07 Dgr |
H360D *** H317 H412 |
|
|
|
|
607-204-00-4 |
chlór(chlórbenzyl)toluén, zmes izomérov |
400-140-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-205-00-X |
metyl-chlóracetát |
202-501-1 |
96-34-4 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H331 H301 H335 H315 H318 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H301 H335 H315 H318 |
|
|
|
|
607-206-00-5 |
izopropyl-chlóracetát |
203-301-7 |
105-48-6 |
Flam. Liq. 3 Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H301 H319 H335 H315 |
GHS02 GHS06 Dgr |
H226 H301 H319 H335 H315 |
|
|
|
|
607-207-00-0 |
haloxyfop-etotyl (ISO); O-(2-etoxyetyl)-2-{4-[3-chlór-5- (trifluórmetyl)-2- pyridyloxy]fenoxy}propanoát |
402-560-5 |
87237-48-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-208-00-6 |
kyselina 4,8,12-trimetyltrideka-3,7,11-triénová, zmes izomérov |
403-000-2 |
91853-67-7 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
607-209-00-1 |
reakčná zmes zložená z O,O'-diizopropyl- (pentasulfándiyl)di(tioformiát) a O,O'-diizopropyl-(trisulfándiyl)di(tioformiát) a O,O'-diizopropyl- (tetrasulfándiyl)di(tioformiát) |
403-030-6 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-210-00-7 |
metyl-(akrylamido)(hydroxy)acetát (s obsahom ≥ 0,1 % akrylamidu) |
403-230-3 |
77402-05-2 |
Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 |
H350 H340 H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H340 H314 H317 |
|
|
|
|
607-211-00-2 |
O-metyl-3-(3-terc-butyl-4-hydroxy-5-metylfenyl)propanoát |
403-270-1 |
6386-39-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-212-00-8 |
poly[oxy(1- oxobután-1,3-diyl)-co-oxy(1-oxopentán-1,3-diyl)] (73:27 mol %) |
403-300-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-213-00-3 |
O-etyl-3,3-bis(terc-pentylperoxy)butanoát |
403-320-2 |
67567-23-1 |
Org. Perox. D**** Flam. Liq. 3 Aquatic Chronic 2 |
H242 H226 H411 |
GHS02 GHS09 Dgr |
H242 H226 H411 |
|
|
|
|
607-214-00-9 |
kyselina hydrazín-1,1-dioctová |
403-510-5 |
19247-05-3 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H373 ** H317 H412 |
GHS06 GHS08 Dgr |
H301 H373 ** H317 H412 |
|
|
|
|
607-215-00-4 |
kyselina 3-(3-terc-butyl-4-hydroxyfenyl)propánová |
403-920-4 |
107551-67-7 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
607-216-00-X |
kyselina glutámová, produkty reakcie s N-(C 12-14-alkyl)propán-1,2-diamínom |
403-950-8 |
— |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H330 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H314 H400 |
|
|
|
|
607-217-00-5 |
O-(2-etoxyetyl)-2-[4-(7-fenyl-2,6-dioxo-2,6-dihydro-1,5-dioxaindacén-3-yl)fenoxy]acetát |
403-960-2 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-218-00-0 |
dichlórprop-P (ISO); kyselina (+)-(R)-2-(2,4-dichlórfenoxy)propánová |
403-980-1 |
15165-67-0 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-219-00-6 |
bis(2-etylhexyl)-disulfándiyldiacetát |
404-510-8 |
62268-47-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
607-221-00-7 |
kyselina 6-(dokozyloxy)-1-hydroxy-4-[1-(4- hydroxy-3-metylfenantrén-1-yl)-3-oxo-2- oxafenalén-1-yl]naftalén-2-karboxylová |
404-550-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-222-00-2 |
[6-(2,3-dimetylmaleimido)hexyl]-metakrylát |
404-870-6 |
63740-41-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-223-00-8 |
transflutrín (ISO); (2,3,5,6-tetrafluórbenzyl)-trans-2-(2,2-dichlórvinyl)-3,3-dimetylcyklopropánkarboxylát |
405-060-5 |
118712-89-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
607-224-00-3 |
O-metyl-2-(3-nitrobenzylidén)-3-oxobutanoát |
405-270-7 |
39562-17-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-225-00-9 |
kyselina 3-(azidosulfonyl)benzoová |
405-310-3 |
15980-11-7 |
Self-React. C **** STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H241 H373 ** H318 H317 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H241 H373 ** H318 H317 |
|
|
|
|
607-226-00-4 |
reakčná zmes zložená z [2-(akryloyloxy)etyl]-hydrogencyklohexán-1,2-dikarboxylátu a [2-(metakryloyloxy)etyl]-hydrogencyklohexán-1,2-dikarboxylátu |
405-360-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H315 H318 H317 H412 |
|
|
|
|
607-227-00-X |
oktahydrát kálium-2-amino-2-metylpropanoátu |
405-560-3 |
120447-91-8 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
607-228-00-5 |
bis(2-metoxyetyl)-ftalát |
204-212-6 |
117-82-8 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
607-229-00-0 |
dietylkarbamoylchlorid |
201-798-5 |
88-10-8 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H332 H302 H319 H335 H315 |
GHS08 GHS07 Wng |
H351 H332 H302 H319 H335 H315 |
|
|
|
|
607-230-00-6 |
kyselina 2-etylhexánová |
205-743-6 |
149-57-5 |
Repr. 2 |
H361d *** |
GHS08 Wng |
H361d *** |
|
|
|
|
607-231-00-1 |
klopyralid (ISO); kyselina 3,6-dichlórpyridín-2-karboxylová |
216-935-4 |
1702-17-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-232-00-7 |
pyridát (ISO); O-(3-fenyl-6-chlórpyridazín-4-yl)-S-oktyltiokarbonát |
259-686-7 |
55512-33-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
607-233-00-2 |
hexyl-akrylát |
219-698-5 |
2499-95-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
|
|
|
607-234-00-8 |
flurenol (ISO); kyselina 9-hydroxy-9H-fluorén-9-karboxylová |
207-397-1 |
467-69-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-235-00-3 |
mekrilát; O-metyl-2-kyanoakrylát |
205-275-2 |
137-05-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
607-236-00-9 |
O-etyl-2-kyanoakrylát |
230-391-5 |
7085-85-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
607-237-00-4 |
O-benzyl-2-chlór-4-(trifluórmetyl)tiazol-5-karboxylát; flurazol |
276-942-3 |
72850-64-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-238-00-X |
tau-fluvalinát (ISO); O-[(3-fenoxyfenyl)(kyano)metyl]-N-[2-chlór-4-(trifluórmetyl)fenyl]-D-valinát |
— |
102851-06-9 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
607-239-00-5 |
fenpropatrín (ISO); O-[(3-fenoxyfenyl)(kyano)metyl]-2,2,3,3-tetrametylcyklopropánkarboxylát |
254-485-0 |
39515-41-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
|
|
|
607-240-00-0 |
cis-4-metyl-1,2,3,6-tetrahydroftalanhydrid;[1] 4-metyl-1,2,3,6-tetrahydroftalanhydrid; [2] 3-metyl-1,2,3,6-tetrahydroftalanhydrid; [3] metyltetrahydroftalanhydrid; [4] metyl-1,2,3,6-tetrahydroftalanhydrid; [5] 4-metyltetrahydroftalanhydrid; [6] 2-metyl-2,3,5,6-tetrahydroftalanhydrid [7] |
216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] |
1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-241-00-6 |
4-metylcyklohexán-1,2-dikarboxanhydrid; [1] metylcyklohexán-1,2-dikarboxanhydrid; [2] 1-metylcyklohexán-1,2-dikarboxanhydrid; [3] 3-metylcyklohexán-1,2-dikarboxanhydrid [4] |
243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] |
19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-242-00-1 |
tetrachlórftalanhydrid |
204-171-4 |
117-08-8 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H317 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H318 H334 H317 H410 |
|
|
|
|
607-243-00-7 |
nátrium-3,6-dichlór-2-metoxybenzoát; [1] kyselina 3,6-dichlór-2-metoxybenzoová, zlúčenina s 2,2'-iminodietanolom (1:1); [2] kyselina 3,6-dichlór-2-metoxybenzoová, zlúčenina s 2-aminoetanolom (1:1) [3] |
217-846-3 [1] 246-590-5 [2] 258-527-9 [3] |
1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-244-00-2 |
izooktyl-akrylát |
249-707-8 |
29590-42-9 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
607-245-00-8 |
terc-butyl-akrylát |
216-768-7 |
1663-39-4 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H312 H302 H335 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H312 H302 H335 H315 H317 H411 |
|
|
D |
|
607-246-00-3 |
alyl-metakrylát; alylester kyseliny 2-metylpropénovej |
202-473-0 |
96-05-9 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H331 H312 H302 H400 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H312 H302 H400 |
|
|
|
|
607-247-00-9 |
dodecyl-metakrylát |
205-570-6 |
142-90-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
607-248-00-4 |
naptalám-nátrium (ISO); nátrium-2-(1-naftylkarbamoyl)benzoát |
205-073-4 |
132-67-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-249-00-X |
1,2’-dimetyl[(propán-1,2-diyl)bis(oxy)]dietyl-diakrylát |
256-032-2 |
42978-66-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
STOT SE 3; H335: C ≥ 10% |
|
|
607-250-00-5 |
4H-3,1-benzoxazín-2,4(1H)-dión |
204-255-0 |
118-48-9 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
607-251-00-0 |
(2-metoxypropyl)-acetát |
274-724-2 |
70657-70-4 |
Flam. Liq. 3 Repr. 1B STOT SE 3 |
H226 H360D *** H335 |
GHS02 GHS08 GHS07 Dgr |
H226 H360D *** H335 |
|
|
|
|
607-252-00-6 |
lambda-cyhalotrín (ISO); reakčná zmes zložená z (S)-[3-(fenoxyfenyl)(kyano)metyl]-(Z)-(1R)-cis-2,2-dimetyl-3-(3,3,3-trifluór-2-chlórpropenyl)cyklopropánkarboxylátu a (R)-[3-(fenoxyfenyl)(kyano)metyl]-(Z)-(1S)-cis-2,2-dimetyl-3-(3,3,3-trifluór-2-chlórpropenyl)cyklopropánkarboxylátu (1:1) |
415-130-7 |
91465-08-6 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
M=10000 |
|
|
607-253-00-1 |
cyflutrín (ISO); O-[(3-fenoxy-4-fluórfenyl)metyl]-3-(2,2-dichlórvinyl)-2,2-dimetylcyklopropánkarboxylát |
269-855-7 |
68359-37-5 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H331 H400 H410 |
GHS06 GHS09 Dgr |
H300 H331 H410 |
|
M=1000 |
|
|
607-254-00-7 |
O-[(3-fenoxy-4-fluórfenyl)(kyano)metyl]-3-(2,2-dichlórvinyl)-2,2-dimetylcyklopropánkarboxylát; beta-cyflutrín |
269-855-7 |
68359-37-5 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
|
607-255-00-2 |
fluroxypyr (ISO); kyselina (4-amino-6-fluór-3,5-dichlór-2-pyridyloxy)octová |
— |
69377-81-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-256-00-8 |
azoxystrobín (ISO); O-metyl-(E)-2-{2-[6-(2-kyanofenoxy)pyrimidín-4-yloxy]fenyl}-3-metoxyakrylát |
— |
131860-33-8 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H400 H410 |
GHS06 GHS09 Dgr |
H331 H410 |
|
|
|
|
607-257-00-3 |
izopropyl-propanoát |
211-300-8 |
637-78-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
607-258-00-9 |
O-dodecyl-3-[2-(3-benzyl-4-etoxy-2,5-dioxoimidazolidín-1-yl)-2-(4-metoxybenzoyl)acetamido]-4-chlórbenzoát |
403-990-6 |
70950-45-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-259-00-4 |
metyl-(2R,3S)-(-)-3-(4-metoxyfenyl)oxiránkarboxylát |
404-130-2 |
105560-93-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-260-00-X |
O-etyl-2-(3-nitrobenzylidén)-3-oxobutanoát |
404-490-0 |
39562-16-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-261-00-5 |
O-izo(C10-C14-alkyl)-[(3,5-di-terc-butyl-4-hydroxybenzyl)sulfanyl]acetát |
404-800-4 |
118832-72-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-262-00-0 |
kyselina 1-cyklopropyl-6-fluór-7-chlór-4-oxo-1,4-dihydrochinolín-3-karboxylová |
405-050-0 |
86393-33-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
607-263-00-6 |
hemihydrát {([propán-1,3-diylbis(nitrilo)]tetraacetáto}železitanu draselného |
405-680-6 |
— |
Self-heat. 2 **** Aquatic Chronic 2 |
H252 H411 |
GHS02 GHS09 Wng |
H252 H411 |
|
|
|
|
607-264-00-1 |
kyselina 2-chlór-4-(metylsulfonyl)benzoová |
406-520-8 |
53250-83-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-265-00-7 |
O-etyl-2,2-difenyl-2-chlóracetát |
406-580-5 |
52460-86-3 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
607-266-00-2 |
reakčná zmes zložená z týchto látok: (hydroxyalumínium)-bis(3,5-di-terc-butyl-2-hydroxybenzoát); kyselina 3,5-di-terc-butyl-2-hydroxybenzoová |
406-890-0 |
130296-87-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-267-00-8 |
O-terc-butyl-(5S,6R,7R)-3-(brómmetyl)-7-(2-fenylacetamido)-5,8-dioxo-5-tia-1-azabicyklo[4.2.0]okt-2-én-2-karboxylát |
407-620-4 |
33610-13-8 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Dgr |
H334 H317 H412 |
|
|
|
|
607-268-00-3 |
(2-metylpropyl)-(R)-2-hydroxypropanoát |
407-770-0 |
61597-96-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-269-00-9 |
kyselina (R)-2-(4-hydroxyfenoxy)propánová |
407-960-3 |
94050-90-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-270-00-4 |
2,2'-[(2,4,8,10- tetraoxaspiro[5.5]undekán-3,9-diyl)bis(2,2-dimetyletyl)]-bis[3-(3-terc-butyl-4-hydroxy-5-metylfenyl)propanoát] |
410-730-5 |
90498-90-1 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
607-271-00-X |
(2-hydroxypropyl)-(2-izopropyl-5-metylcyklohexyl)-karbonát |
417-420-9 |
156324-82-2 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
607-272-00-5 |
fluroxypyr-meptyl (ISO); O-(metylheptyl)-(4-amino-6-fluór-3,5-dichlór-2-pyridyloxy)acetát; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-metyletyl, O-(1-butoxy-propán-2-yl)-(4-amino-6-fluór-3,5-dichlór-2-pyridyloxy)acetát [2] |
279-752-9 [1] -[2] |
81406-37-3 [1] 154486-27-8 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-273-00-0 |
amónium-7-[8-(2,2-dimetylbutanoyloxy)-2,6-dimetyl-1,2,6,7,8,8a-hexahydro-1-naftyl]-3,5-dihydroxyheptanoát |
404-520-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-274-00-6 |
O-{2-[benzyl(metyl)amino]etyl}-3-aminobut-2-enoát |
405-350-1 |
54527-73-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-275-00-1 |
nátrium-4-(benzoyloxy)benzénsulfonát |
405-450-5 |
66531-87-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-276-00-7 |
bis(2-etylhexanoáto)-bis(1-metylimidazol)zinočnatý komplex |
405-635-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-277-00-2 |
reakčná zmes zložená z týchto látok: 2-(hexylsulfanyl)etán-1-amónium-chlorid; nátrium-propanoát |
405-720-2 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
607-278-00-8 |
reakčná zmes zložená z izomérov: nátrium-(2-fenyletyl)naftalénsulfonát; nátrium-[2-(naftyl)etyl]benzénsulfonát |
405-760-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-279-00-3 |
reakčná zmes zložená z 2,2’-(oktadecylimino)dietyl-bis(hydrogen-maleátu); 2,2’-(oktadecylimino)dietyl-(hydrogen-maleát)-(hydrogen-ftalátu) |
405-960-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-280-00-9 |
nátrium 1-hydroxy-4-chlórbután-1-sulfonát |
406-190-5 |
54322-20-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
607-281-00-4 |
reakčná zmes zložená z O-alkyl-3-[3-(2H-benzotriazol-2-yl)-5-terc-butyl-4-hydroxyfenyl]propanoátov, kde alkyl je rozvetvený a lineárny C7-C9 |
407-000-3 |
127519-17-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-282-00-X |
[2-(acetoxymetyl)-4-(benzyloxy)butyl]-acetát |
407-140-5 |
131266-10-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-283-00-5 |
O-etyl-(E)-4-fenyl-4-oxobut-2-enoát |
408-040-4 |
15121-89-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H317 H410 |
|
|
|
|
607-284-00-0 |
reakčná zmes zložená z týchto látok: nátrium-3,3'-{(1,4-fenylén)bis[(karbonylimino)(propán-3,1-diyl)(imino)]}bis(10-amino-6,13-dichlór[1,4]benzoxazino[2,3-b]fenoxazín-4,11-disulfonát); lítium-3,3'-{(1,4-fenylén)bis[(karbonylimino)(propán-3,1-diyl)(imino)]}bis(10-amino-6,13-dichlór[1,4]benzoxazino[2,3-b]fenoxazín-4,11-disulfonát) (9:1) |
410-040-4 |
136213-76-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-285-00-6 |
reakčná zmes zložená z týchto látok: kyselina 7-(3-aminobenzénsulfónamido)naftalén-1,3-disulfónová; nátrium-7-(3-aminobenzénsulfónamido)naftalén-1,3-disulfonát; kálium-7-(3-aminobenzénsulfónamido)naftalén-1,3-disulfonát |
410-065-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
|
|
|
|
|
607-286-00-1 |
reakčná zmes zložená z týchto látok: kálium- a nátrium-7-[4-({4-[(2-hydroxy-1-naftyl)diazenyl]fenyl}diazenyl)benzénsulfónamido]naftalén-1,3-disulfonát |
410-070-8 |
141880-36-6 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-287-00-7 |
O’-metyl-O-[1-(metakryloyloxy)propán-2-yl]-1,2,3,6-tetrahydroftalát |
410-140-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-288-00-2 |
[c-(N-{3-[(1-{3-[(e,6-dichlór-5-kyanopyrimidín-f-yl)(metyl)amino]propyl}-2-hydroxy-4-metyl-6-oxo-1,6-dihydro-3-pyridyl)diazenyl]-4-sulfonátofenyl}sulfamoyl)-a, b,d-trisulfonátoftalocyanín]nikelnatan tetrasodný, kde a je 1, 2, 3 alebo 4; b je 8, 9, 10 alebo 11; c je 15, 16, 17 alebo 18; d je 22, 23, 24 alebo 25 a kde e je 2 a zároveň f je 4 alebo e je 2 a zároveň f je 4 |
410-160-7 |
148732-74-5 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
607-289-00-8 |
kyselina 3-[(3-{N-[4-(2,4-di-terc-pentylfenoxy)butyl]karbamoyl}-4-hydroxy-1-naftyl)sulfanyl]propánová |
410-370-9 |
105488-33-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-290-00-3 |
reakčná zmes zložená z týchto látok (v neurčenom pomere): amónium-1-[(C14-C18-alkyl)oxykarbonyl]-2- [3-(alyloxy)-2- hydroxypropoxykarbonyl]etán-1-sulfonát; amónium-2-[(C14-C18-alkyl)oxykarbonyl]-1- [3-(alyloxy)-2- hydroxypropoxykarbonyl]etán-1-sulfonát |
410-540-2 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
607-291-00-9 |
O-dodecyl-ω-(C5/C6-cykloalkyl)alkanoát |
410-630-1 |
104051-92-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-292-00-4 |
reakčná zmes zložená z týchto látok: kyselina [1-(C12-alkoxy)-3-metoxypropán- 2-yloxy]octová; kyselina [1-(C14-alkoxy)-3-metoxypropán- 2-yloxy]octová |
410-640-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-293-00-X |
reakčná zmes zložená z týchto látok: soľ 1-(2-aminoetyl)piperazín-1,4-diia s disulfonátom (2,4,6- trimetylnonyl)difenyléteru (1:1); soľ 1-(2-aminoetyl)piperazín-1,4-diia s disulfonátom bis(2,4,6- trimetylnonyl)difenyléteru (1:1) |
410-650-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-294-00-5 |
nátrium-2-(benzoyloxy)-1-hydroxyetánsulfonát |
410-680-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-295-00-0 |
reakčná zmes zložená z týchto látok: tetranátrium-fosfonátobutándioát; hexanátrium-fosfonátobután-1,2,3,4- tetrakarboxylát |
410-800-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-296-00-6 |
reakčná zmes zložená z týchto látok: tetraestery metántetrayltetrametanolu s kyselinou heptánovou a kyselinou 2-etylhexánovou |
410-830-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-297-00-1 |
kyselina (E,E)-2,2'-dioxo-3,3'-(1,4- fenyléndimetylidén)bis(1,7,7-trimetylbicyklo[2.2.1]heptán-1- metánsulfónová |
410-960-6 |
92761-26-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-298-00-7 |
1-[2-(trimetylamónio)etoxy]-4-sulfonátobenzoát |
411-010-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-299-00-2 |
O-metyl-3-(acetylsulfanyl)-2-metylpropanoát |
411-040-7 |
97101-46-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-300-00-6 |
[2-(2,6-difluór-5-chlórpyrimidín-4- ylamino)-5-(b-sulfamoyl-c,d-disulfonátoftalocyanín- a-yl- K4,N29,N30,N31,N32-sulfónamido)benzoáto(5- )]meďnatan trisodný, kde a = 1, 2, 3 alebo 4; b = 8, 9, 10 alebo 11; c = 15, 16, 17 alebo 18; d = 22, 23, 24 alebo 25 |
411-430-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-301-00-1 |
reakčná zmes zložená z týchto látok: kyselina dodekánová; estery oligo(1-7)laktátov s kyselinou dodekánovou |
411-860-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-302-00-7 |
reakčná zmes zložená z týchto látok: kyselina tetradekánová; estery oligo(1-7)laktátov s kyselinou tetradekánovou |
411-910-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
607-303-00-2 |
kyselina 1-cyklopropyl-6,7-difluór-4-oxo-1,4-dihydrochinolín-3-karboxylová |
413-760-7 |
93107-30-3 |
Repr. 2 Aquatic Chronic 3 |
H361f *** H412 |
GHS08 Wng |
H361f *** H412 |
|
|
|
|
607-304-00-8 |
fluazifop-butyl (ISO); O-butyl-(RS)-2-[4-(5-trifluórmetyl-2-pyridyloxy)fenoxy]propanoát |
274-125-6 |
69806-50-4 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H400 H410 |
GHS08 GHS09 Dgr |
H360D *** H410 |
|
|
|
|
607-305-00-3 |
fluazifop-P-butyl (ISO); O-butyl-(R)-2-[4-(5-trifluórmetyl-2-pyridyloxy)fenoxy]propanoát |
— |
79241-46-6 |
Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H400 H410 |
GHS08 GHS09 Wng |
H361d *** H410 |
|
|
|
|
607-306-00-9 |
chlozolinát (ISO); O-etyl-(RS)-3-3,5-dichlórfenyl)-5-metyl-2,4-dioxooxazolidín-5-karboxylát |
282-714-4 |
84332-86-5 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
607-307-00-4 |
vinklozolín (ISO); N-(3,5-dichlórfenyl)-5-metyl-5-vinyl-1,3-oxazolidín-2,4-dión |
256-599-6 |
50471-44-8 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H360FD H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360FD H317 H411 |
|
|
|
|
607-308-00-X |
estery 2,4-D; estery kyseliny (2,4-dichlórfenoxy)octovej |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-309-00-5 |
karféntrazón-etyl (ISO); O-etyl-(RS)-3-{5-[4-(difluórmetyl)-3-metyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluór-2-chlórfenyl}-2-chlórpropanoát |
— |
128639-02-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-310-00-0 |
krezoxím-metyl (ISO); O-metyl-(E)-2-(metoxyimino)-[2-(orto-tolyloxymetyl)fenyl]acetát |
— |
143390-89-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
607-311-00-6 |
benazolín-etyl; O-etyl-4-chlór-2-oxo-2H-benzotiazol-3-acetát |
246-591-0 |
25059-80-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-312-00-1 |
kyselina metoxyoctová |
210-894-6 |
625-45-6 |
Repr. 1B Acute Tox. 4 * Skin Corr. 1B |
H360FD H302 H314 |
GHS08 GHS05 GHS07 Dgr |
H360FD H302 H314 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
607-313-00-7 |
7,7-dimetyloktanoylchlorid |
254-875-0 |
40292-82-8 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS06 Dgr |
H330 H302 H314 |
|
STOT SE 3; H335: C ≥ 5% |
|
|
607-314-00-2 |
etofumezát (ISO); (±)-2-etoxy-3,3-dimetyl-2,3-dihydrobenzofurán-5-(metánsulfonát) |
247-525-3 |
26225-79-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-315-00-8 |
glyfozát (ISO); N-(fosfonometyl)glycín |
213-997-4 |
1071-83-6 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
607-316-00-3 |
trimetylsulfónium-glyfozát; (trimetylsulfónium)-hydrogen-{[(karboxymetyl)amino]metyl}fosfonát |
— |
81591-81-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-317-00-9 |
bis(2-etylhexyl)-ftalát; di(2-etylhexyl)-ftalát; DEHP |
204-211-0 |
117-81-7 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
607-318-00-4 |
dibutyl-ftalát; DBP |
201-557-4 |
84-74-2 |
Repr. 1B Aquatic Acute 1 |
H360Df H400 |
GHS08 GHS09 Dgr |
H360Df H400 |
|
|
|
|
607-319-00-X |
deltametrín (ISO); O-[(S)-(3-fenoxyfenyl)(kyano)metyl]- (1R,3R)-3-(2,2-dibrómvinyl)-2,2- dimetylcyklopropánkarboxylát |
258-256-6 |
52918-63-5 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
M=1000000 |
|
|
607-320-00-5 |
bis[4-(etenyloxy)butyl]-benzén-1,3-dikarboxylát |
413-930-0 |
130066-57-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-321-00-0 |
O-metyl-(S)-2-chlórpropanoát |
412-470-8 |
73246-45-4 |
Flam. Liq. 3 STOT RE 2 * Eye Irrit. 2 |
H226 H373 ** H319 |
GHS02 GHS08 Wng |
H226 H373 ** H319 |
|
|
|
|
607-322-00-6 |
kyselina 4-(4,4-dimetyl-3-oxo-pyrazolidín-1-yl)benzoová |
413-120-7 |
107144-30-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-323-00-1 |
{2-[1-(2-hydroxy-3,5-di-terc-pentylfenyl)etyl]-4,6-di-terc-pentylfenyl}-akrylát |
413-850-6 |
123968-25-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-324-00-7 |
reakčná zmes zložená z týchto látok: N,N-di(hydrogenovaný C14-C18-alkyl)-2- karbamoylbenzoát; di(hydrogenovaný C14-C18-alkyl)amín |
413-800-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-325-00-2 |
kyselina (S)-2-chlórpropánová |
411-150-5 |
29617-66-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
607-326-00-8 |
reakčná zmes zložená z týchto látok: 1-izobutyl-hydrogen-2-(2,4,6-trimetylnon- 2-én-1-yl)sukcinát; 1-izobutyl-hydrogen-3-(2,4,6-trimetylnon- 2-én-1-yl)sukcinát |
410-720-0 |
141847-13-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
607-327-00-3 |
[2-(2-jódetyl)propán-1,3-diyl]-diacetát |
411-780-0 |
127047-77-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-328-00-9 |
O-metyl-4-(brómmetyl)-3-metoxybenzoát |
410-310-1 |
70264-94-7 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
607-329-00-4 |
reakčná zmes zložená z týchto látok: nátrium-2-[(lineárny C12-18- alkyl)amino]butándioát; nátrium-2-(oktadecenylamino)butándioát |
411-250-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-330-00-X |
kyselina (S)-2,3-dihydro-1H-indol-2-karboxylová |
410-860-2 |
79815-20-6 |
Repr. 2 STOT RE 2 * Skin Sens. 1 |
H361f *** H373 ** H317 |
GHS08 GHS07 Wng |
H361f *** H373 ** H317 |
|
|
|
|
607-331-00-5 |
reakčná zmes zložená z týchto látok: bis[2,2,6,6-tetrametyl-1- (oktyloxy)piperidín-4-yl]-dekándioát; 10,10'-[2,2,6,6-tetrametyl-1- (oktyloxy)piperidín-4-yl]-1,1'-{oktán-1,8- diylbis[oxy(2,2,6,6-tetrametylpiperidín-1,4- diyl)]}bis(dekán-1,10-dión) |
406-750-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-332-00-0 |
cyklopentyl-chlórmetanoát |
411-460-0 |
50715-28-1 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H226 H331 H302 H373 ** H318 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H331 H302 H373 ** H318 H317 |
|
|
|
|
607-333-00-6 |
reakčná zmes zložená z týchto látok: O-dodecyl-3-[(2,2,6,6-tetrametylpiperidín- 4-yl)amino]propanoát; O-tetradecyl-3-[(2,2,6,6- tetrametylpiperidín-4-yl)amino]propanoát |
405-670-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H410 |
|
|
|
|
607-334-00-1 |
O-etyl-1-etyl-6,7,8-trifluór-4-oxo-1,4- dihydrochinolín-3-karboxylát |
405-880-3 |
100501-62-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-335-00-7 |
O-metyl-(R)-2-{4-[3-chlór-5- (trifluórmetyl)-2- pyridyloxy]fenoxy}propanoát |
406-250-0 |
72619-32-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
607-336-00-2 |
(4-metyl-8- metylidéntricyklo[3.3.1.13,7]dekán-2-yl)-acetát |
406-560-6 |
122760-85-4 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
607-337-00-8 |
di(terc-C12-14-alkyl)amónium-(benzotiazol-2-ylsulfanyl)sukcinát |
406-052-4 |
125078-60-6 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H302 H315 H318 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H302 H315 H318 H411 |
|
|
|
|
607-338-00-3 |
O-(2-metylpropyl)-2-hydroxy-2-metylbut-3-enoát |
406-235-9 |
72531-53-4 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
607-339-00-9 |
2,3,4,5-tetrachlórbenzoylchlorid |
406-760-3 |
42221-52-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
607-340-00-4 |
[1,3-bis(4-benzoyl-3- hydroxyfenoxy)propán-2-yl]-acetát |
406-990-4 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-341-00-X |
(9S)-9-amino-9-deoxyerytromycín |
406-790-7 |
26116-56-3 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
607-342-00-5 |
(4-chlórbutyl)-pentanoát |
410-950-1 |
69788-75-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-343-00-0 |
[(hexahydro-4,7-metanoindándiyl)dimetyl]- bis(2-karboxybenzoát) |
407-410-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-344-00-6 |
reakčná zmes zložená z týchto látok: kyselina N-[3-(dimetylamino)propyl]-3- (perfluór-C4-8-alkánsulfónamido)propánová; [N, N-dimetyl-3-(perfluór-C4-8- alkánsulfónamido)propán-1-amónium]- propanoát; {3-[(2-karboxyetyl)(perfluór-C4-8-alkánsulfónamido)amino]-N, N-dimetylpropán- 1-amónium}-propanoát |
407-810-7 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-345-00-1 |
kálium-(R)-2-(2,4-dichlórfenoxy)propanoát |
413-580-9 |
113963-87-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-346-00-7 |
3-ikozyl-4-henikozylidénoxetán-2-ón |
401-210-9 |
83708-14-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-347-00-2 |
nátrium-(R)-2-(2,4-dichlórfenoxy)propanoát |
413-340-3 |
119299-10-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-348-00-8 |
magnézium-bis[(R)-2-(2,4- dichlórfenoxy)propanoát] |
413-360-2 |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-349-00-3 |
(dodecylamónium)-hydrogen-2,2'- sulfándiyldibenzoát |
411-270-8 |
— |
Aquatic Chronic 3 |
H412 |
|
H412 |
|
|
|
|
607-350-00-9 |
tetraetyl-2,2'-[metylénbis(2- metylcyklohexán-4,1- diylimino)]di(butándioát) |
412-060-9 |
136210-32-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-351-00-4 |
metyl-(4-amino-6-fluór-3,5-dichlórpyridín-2-yloxy)acetát |
407-550-4 |
69184-17-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-352-00-X |
4,4'-oxydiftalanhydrid |
412-830-4 |
1823-59-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-353-00-5 |
reakčná zmes zložená z týchto látok: etyl-exo-tricyklo[5.2.1.02,6]dekán-endo-2-karboxylát; etyl-endo-tricyklo[5.2.1.02,6]dekán-exo-2-karboxylát |
407-520-0 |
80657-64-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-354-00-0 |
O-etyl-2-cyklohexylpropanoát |
412-280-5 |
2511-00-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-355-00-6 |
O-para-tolyl-4-chlórbenzoát |
411-530-0 |
15024-10-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-356-00-1 |
O-etyl-trans-2,2,6- trimetylcyklohexánkarboxylát |
412-540-8 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-357-00-7 |
reakčná zmes zložená z týchto látok: (trans-4-metyl-2-propyltetrahydro-2H-pyrán-4-yl)-acetát; (cis-4-metyl-2-propyltetrahydro-2H-pyrán-4-yl)-acetát |
412-450-9 |
131766-73-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-358-00-2 |
O-(4-nitrobenzyl)-(1S,3S,5R,6R)-6- (fenylacetamido)-3,3-dimetyl-4,7-dioxo- 4λ4-tia-1-azabicyklo[3.2.0]heptán-2- karboxylát |
412-670-5 |
54275-93-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
607-359-00-8 |
O-(4-nitrobenzyl)-(1S,4R,6R,7R)-7- (fenylacetamido)-3-metylidén-5,8-dioxo- 5λ4-tia-1-azabicyklo[4.2.0]oktán-2- karboxylát |
412-800-0 |
76109-32-5 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
607-360-00-3 |
nátrium-4-(3-oxobutanoylamino)-5-metoxy-2-metylbenzénsulfonát |
411-680-7 |
133167-77-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-361-00-9 |
O-metyl-(R)-2-(4-hydroxyfenoxy)propanoát |
411-950-4 |
96562-58-2 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-362-00-4 |
reakčná zmes zložená z týchto látok: (3-metoxypropylamónium)/[tris(2- hydroxyetyl)]amónium]-{2-[({2-[bis(2- hydroxyetyl)amino]etoxy}karbonyl)metyl]h exadec-4-enoát}; (3-metoxypropylamónium)/[tris(2- hydroxyetyl)]amónium]-{2-[({2-[bis(2- hydroxyetyl)amino]etoxy}karbonyl)metyl]tetradec-4-enoát}; (3-metoxypropylamónium)/[tris(2- hydroxyetyl)]amónium]-(2-{[N-(3- metoxypropyl)karbamoyl]metyl}hexadec-4-enoát); (3-metoxypropylamónium)/[tris(2- hydroxyetyl)]amónium]-(2-{[N-(3- metoxypropyl)karbamoyl]metyl}tetradec-4-enoát) |
413-500-2 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H315 H318 H411 |
GHS05 GHS09 Dgr |
H315 H318 H411 |
|
|
|
|
607-363-00-X |
O-metyl-3-metoxyakrylát |
412-900-4 |
5788-17-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-364-00-5 |
3-fenyl-7-[4-(tetrahydrofurfuryloxy)fenyl]- 1,5-dioxa-s-indacén-2,6-dión |
413-330-9 |
134724-55-3 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
607-365-00-0 |
hydrochlorid 2-(2-amino-1,3-tiazol-4-yl)-(Z)-2-(metoxyimino)acetylchloridu |
410-620-7 |
119154-86-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
607-366-00-6 |
3,5-dimetylbenzoylchlorid |
413-010-9 |
6613-44-1 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
607-367-00-1 |
monohydrát bis[N-metyliminodiacetáto(2-)- N,O,O,N]železitanu draselného |
411-640-9 |
153352-59-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-368-00-7 |
O-etyl-2-[3-terc-butyl-1- (dimetylkarbamoyl)-1H-1,2,4-triazol-5- ylsulfanyl]acetát |
411-650-3 |
110895-43-7 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
607-369-00-2 |
reakčná zmes zložená z týchto látok: kyselina trans-(2R)-5-acetoxy-1,3- oxatiolán-2-karboxylová; kyselina cis-(2R)-5-acetoxy-1,3-oxatiolán-2-karboxylová |
411-660-8 |
147027-04-1 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-370-00-8 |
[2-terc-butyl-6-(3-terc-butyl-2- hydroxybenzyl)-3-metylfenyl]-acetát |
412-210-3 |
41620-33-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-371-00-3 |
3-etyl-5-metyl-2-{[2-(1,3-dioxo-1,3- dihydro-(2H)-izoindol-2-yl)etoxy]metyl}-4- (2-chlórfenyl)-6-metyl-1,4-dihydropyridín-3,5-dikarboxylát |
413-410-3 |
88150-62-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-372-00-9 |
etoxylovaný 4,4'-(propán-2,2-diyl)difenylbis(norbornénkarboxylát) |
412-410-0 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-373-00-4 |
(RS)-tetrahydrofurfuryl-(R)-2-[4-(6- chlórchinoxalín-2- yloxy)fenyloxy]propanoát |
414-200-4 |
119738-06-6 |
Muta. 2 Repr. 1B Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360Df H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H341 H360Df H302 H373 ** H410 |
|
|
|
|
607-374-00-X |
5-amino-2,4,6-trijódbenzén-1,3- dikarbonyldichlorid |
417-220-1 |
37441-29-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-376-00-0 |
O-benzyl-2,4-dibrómbutanoát |
420-710-8 |
23085-60-1 |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H315 H317 H410 |
|
|
|
|
607-377-00-6 |
monohydrochlorid trans-4-cyklohexyl-Lprolínu |
419-160-1 |
90657-55-9 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H361f *** H302 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H361f *** H302 H315 H318 H317 |
|
|
|
|
607-378-00-1 |
amónium-(Z)-α-(metoxyimino)furán-2- acetát |
405-990-1 |
97148-39-5 |
Flam. Sol. 2 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
607-379-00-7 |
reakčná zmes zložená z týchto látok: {2-[N-(2- hydroxyetyl)oktadekánamido]etyl}- oktadekanoát; nátrium-{bis[2- (oktadekanoyloxy)etyl]amino}metánsulfonát; nátrium-[bis(2- hydroxyetyl)amino]metánsulfonát; N,N-bis(2-hydroxyetyl)stearamid |
401-230-8 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-380-00-2 |
reakčná zmes zložená z týchto látok: amónium-1,2- bis(hexyloxykarbonyl)etánsulfonát; amónium-1-(hexyloxykarbonyl)-2- (oktyloxykarbonyl)etánsulfonát; amónium-2-(hexyloxykarbonyl)-1- (oktyloxykarbonyl)etánsulfonát |
407-320-3 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-381-00-8 |
reakčná zmes zložená z triesterov propán-1,1,1-triyltrimetanolu s kyselinami C7-alkánovými a kyselinou 2-etylhexánovou |
413-710-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-382-00-3 |
kyselina 2-[(4-amino-2- nitrofenyl)amino]benzoová |
411-260-3 |
117907-43-4 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-383-00-9 |
reakčná zmes zložená z týchto látok: (2,2,6,6-tetrametylpiperidín-4-yl)- hexadekanoát; (2,2,6,6-tetrametylpiperidín-4-yl)- oktadekanoát |
415-430-8 |
86403-32-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
607-384-00-4 |
reakčná zmes zložená z týchto látok: O-(rozvetvené C14-C15-alkyl)-3-(3,5-di-tercbutyl- 4-hydroxyfenyl)propanoáty; O-(rozvetvené a lineárne C15-alkyl)-3-(3,5-di-terc-butyl-4-hydroxyfenyl)propanoáty; O-(rozvetvené a lineárne C13-alkyl)-3-(3,5-di-terc-butyl-4-hydroxyfenyl)propanoáty |
413-750-2 |
171090-93-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-385-00-X |
kopolymér vinylalkoholu a vinyl-acetátu čiastočne acetalizovaný 4-[2-(4-formylfenyl)vinyl]-1- metylpyridínium-metyl-sulfátom |
414-590-6 |
125229-74-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-386-00-5 |
kyselina tetradekánová (42,5-47,5 %); estery oligo(1-7)laktátov s kyselinou tetradekánovou (52,5-57,5 %) |
412-580-6 |
174591-51-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
607-387-00-0 |
reakčná zmes zložená z týchto látok: kyselina dodekánová (35-40 %); estery oligo(1-7)laktátov s kyselinou dodekánovou (60-65 %) |
412-590-0 |
58856-63-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
607-388-00-6 |
kyselina 4-(etylamino)-3-nitrobenzoová |
412-090-2 |
2788-74-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
607-389-00-1 |
trinátrium 2,2’-[N-(2-hydroxy-2- karboxylátoetyl)imino]diacetát |
414-130-4 |
119710-96-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-390-00-7 |
6-nitro-1,2,3,4-tetrahydrochinoxalín |
414-270-6 |
41959-35-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-391-00-2 |
dimetyl-cyklopropán-1,1-dikarboxylát |
414-240-2 |
6914-71-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-392-00-8 |
O-(2-fenoxyetyl)-4-(2-hydroxy-5-kyano- 1,4-dimetyl-6-oxo-1,6-dihydropyridín-3- yldiazenyl)benzoát |
414-260-1 |
88938-37-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-393-00-3 |
kyselina 7-amino-3-[(Z)-prop-1-én-1-yl]-8- oxo-5-tia-1-azabicyklo[4.2.0]okt-2-én-2- karboxylová |
415-750-8 |
106447-44-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-394-00-9 |
kyselina 5-metylpyrazín-2-karboxylová |
413-260-9 |
5521-55-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-395-00-4 |
reakčná zmes zložená z týchto látok: nátrium-1-(alyloxy)-2-(tridecyloxy)-1,4- dioxobután-2-sulfonát; nátrium-2-(alyloxy)-1-(tridecyloxy)-1,4- dioxobután-2-sulfonát; nátrium-1-(alyloxy)-2-(dodecyloxy)-1,4- dioxobután-2-sulfonát; nátrium-2-(alyloxy)-1-(dodecyloxy)-1,4- dioxobután-2-sulfonát |
410-230-7 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
607-396-00-X |
O, O’-bis(1,2,2,6,6-pentametylpiperidín-4-yl)-2-(4-metoxybenzylidén)malonát |
414-840-4 |
147783-69-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-397-00-5 |
reakčná zmes zložená z týchto látok: kalcium-2-hydroxybenzoáty alkylované rozvetvenými C10-14- a C18-30-alkylmi; kalcium-fenoláty alkylované rozvetvenými C10-14- a C18-30-alkylmi; kalcium-benzéntioláty alkylované rozvetvenými C10-14- a C18-30-alkylmi) |
415-930-6 |
— |
Repr. 2 Skin Sens. 1 |
H361f*** H317 |
GHS08 GHS07 Wng |
H361f*** H317 |
|
|
|
|
607-398-00-0 |
O-etyl-N-{3-[4-(dietylamino)-2- metylfenylimino]-5-chlór-4-metyl-6- oxocyklohexa-1,4-dienyl}karbamát |
414-820-5 |
125630-94-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-399-00-6 |
O-(3-metylbut-3-én-1-yl)-2,2- dimetylpropanoát |
415-610-6 |
104468-21-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
607-400-00-X |
O-metyl-3- [(dibutyltiokarbamoyl)sulfanyl]propanoát |
414-400-1 |
32750-89-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-401-00-5 |
O-etyl-3-hydroxy-5-oxocyklohex-3- énkarboxylát |
414-450-4 |
88805-65-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
607-402-00-0 |
O-metyl-N-(fenoxykarbonyl)-L-valinát |
414-500-5 |
153441-77-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-403-00-6 |
reakčná zmes zložená z týchto látok: bis({(1S,2S,4S)-1-benzyl-4-[(tercbutoxykarbonyl) amino]-5-fenyl-2- hydroxypentyl}amónium)-sukcinát; izopropylalkohol |
414-810-0 |
— |
STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H410 |
|
|
|
|
607-404-00-1 |
reakčná zmes zložená z týchto látok: kyselina [(Z)-3,7-dimetylokta-2,6- dién-1-yl]oxykarbonylpropánová; bis[(E)-3,7-dimetylokta-2,6-dién-1-yl]- butándioát; bis[(Z)-3,7-dimetylokta-2,6-dién-1-yl]- butándioát; [(Z)-3,7-dimetylokta-2,6-dién-1-yl]- hydrogen-butándioát; kyselina [(E)-3,7-dimetylokta-2,6-dién-1-yl]oxykarbonylpropánová |
415-190-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-405-00-7 |
O-(2-hexyldecyl)-4-hydroxybenzoát |
415-380-7 |
148348-12-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-406-00-2 |
kálium-2,5-dichlórbenzoát |
415-700-5 |
184637-62-5 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
607-407-00-8 |
etyl-hydrogen-(2-tienylmetyl)propándioát |
415-680-8 |
143468-96-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
607-408-00-3 |
kálium-[(4-fluórfenyl)amino]acetát |
415-710-1 |
184637-63-6 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H318 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H373 ** H318 H317 H412 |
|
|
|
|
607-409-00-9 |
reakčná zmes zložená z týchto látok: kyselina (3R)-3-((1S)-(1α,2α,6β)-2,6- dimetyl-1-{[(2S)-2-metylbutanoyl]oxy}- 1,2,4a,7,8,8a-hexahydro-1-naftyl)-3,5- dihydroxypentánová; inertná biomasa z Aspergillus terreus |
415-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-410-00-4 |
[2-(dimetylamino)etyl]-hydrogen-2- (hexadec-2-én-1-yl)butándioát a/alebo [2-(dimetylamino)etyl]-hydrogen-3-(hexadec-2-én-1-yl)butándioát |
415-880-5 |
779343-34-9 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
607-411-00-X |
O-[(S)-oxiranylmetyl]-4- metylbenzénsulfonát |
417-210-7 |
70987-78-9 |
Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H350 H341 H318 H317 H411 |
|
|
|
|
607-412-00-5 |
O-etyl-2-(1-kyanocyklohexyl)acetát |
415-970-4 |
133481-10-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373 ** H412 |
GHS08 GHS07 Wng |
H302 H373 ** H412 |
|
|
|
|
607-413-00-0 |
trans-4-fenyl-L-prolín |
416-020-1 |
96314-26-0 |
Repr. 2 Skin Sens. 1 |
H361f *** H317 |
GHS08 GHS07 Wng |
H361f *** H317 |
|
|
|
|
607-414-00-6 |
tris(2-etylhexyl)-4,4',4''-(1,3,5-triazín-2,4,6-triyltriimino)tribenzoát |
402-070-1 |
88122-99-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-415-00-1 |
poly((metyl-metakrylát)-co-(butylmetakrylát)- co-{[4-(akryloyloxy)butylizopropenyl]-( 2-fenylpropán-2- yl)karbamát}-co-maleínanhydrid) |
419-590-1 |
— |
Flam. Sol. 1 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Dgr |
H228 H317 |
|
|
T |
|
607-416-00-7 |
N-[3-(dodecyloxy)propyl]-1-hydroxy-5- {[(izobutyloxy)karbonyl]amino}-4-{2- [(karboxymetyl)sulfanyl]etoxy}naftalén-2-karboxamid |
420-730-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-417-00-2 |
(3-chlórpropyl)-chlórmetanoát |
425-770-9 |
628-11-5 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H331 H302 H373** H315 H318 H317 |
GHS06 GHS05 GHS08 Dgr |
H331 H302 H373** H315 H318 H317 |
|
|
|
|
607-418-00-8 |
O-(2-etylhexyl)-4-aminobenzoát |
420-170-3 |
26218-04-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-419-00-3 |
kyselina 5-[1-(3-etyl-2,3-dihydrobenzotiazol-2- ylidén)propán-2-ylidén]-4,4'-dioxo-2'-tioxo-2,5'-bitiazolidín-3,3'-dioctová |
422-240-9 |
166596-68-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-420-00-9 |
kyselina 2,2-bis(hydroxymetyl)butánová |
424-090-1 |
10097-02-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-421-00-4 |
cis/trans-cypermetrín (40/60); O-[(RS)-(3-fenoxyfenyl)(kyano)metyl]- (1RS,3RS;1RS,3SR)-3-(2,2-dichlóretenyl)- 2,2-dimetylcyklopropánkarboxylát |
257-842-9 |
52315-07-8 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H335 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H335 H410 |
|
|
|
|
607-422-00-X |
α-cypermetrín; racemát obsahujúci O-[(R)-(3- fenoxyfenyl)(kyano)metyl]-(1S,3S)-3-(2,2-dichlóretenyl)-2,2- dimetylcyklopropánkarboxylát; O-[(S)-(3-fenoxyfenyl)(kyano)metyl]- (1R,3R)-3-(2,2-dichlóretenyl)-2,2- dimetylcyklopropánkarboxylát |
257-842-9 |
67375-30-8 |
Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H335 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373** H335 H410 |
|
M=1000 |
|
|
607-423-00-5 |
estery mekopropu a mekopropu-P; estery kyseliny (RS)-2-(4-chlór-2- metylfenoxy)propánovej a (R)-2-(4-chlór-2- metylfenoxy)propánovej |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-424-00-0 |
trifloxystrobín (ISO); O-metyl-(E)-α-(metoxyimino)-2-{[(E)-({1-[3- (trifluórmetyl)fenyl]etylidén}amino)oxy]metyl}benzén-1-acetát |
— |
141517-21-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-425-00-6 |
metalaxyl (ISO); O-metyl-(RS)-2-[(2,6- dimetylfenyl)(metoxyacetyl)amino]propano át |
260-979-7 |
57837-19-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
607-426-00-1 |
di(rozvetvený a lineárny C5-alkyl)-ftalát; [1] izopentyl-pentyl-ftalát; [2] dipentyl-ftalát; [3] diizopentyl-ftalát [4] |
284-032-2 [1] -[2] 205-017-9 [3] 210-088-4 [4] |
84777-06-0 [1] -[2] 131-18-0 [3] 605-50-5 [4] |
Repr. 1B Aquatic Acute 1 |
H360FD H400 |
GHS08 GHS09 Dgr |
H360FD H400 |
|
|
|
|
607-427-00-7 |
bromoxynil-heptanoát (ISO); (2,6-dibróm-4-kyanofenyl)-heptanoát |
260-300-4 |
56634-95-8 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d *** H332 H302 H317 H410 |
|
|
|
|
607-428-00-2 |
tetranátrium-etyléndiamíntetraacetát |
200-573-9 |
64-02-8 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
607-429-00-8 |
kyselina etyléndiamíntetraoctová; (EDTA) |
200-449-4 |
60-00-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-430-00-3 |
BBP; benzyl-butyl-ftalát |
201-622-7 |
85-68-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
|
|
|
607-431-00-9 |
praletrín (ISO); ETOC; O-[2-metyl-4-oxo-3-(prop-2-ín-1- yl)cyklopent-2-én-1-yl]-2,2-dimetyl-3-(2-metylprop-1-én-1-yl) cyklopropánkarboxylát |
245-387-9 |
23031-36-9 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
|
607-432-00-4 |
S-metolachlor; reakčná zmes zložená z týchto látok: (S)-N-(2-etyl-6-metylfenyl)-2-chlór-N-(1- metoxypropán-2-yl)acetamid (80-100 %); [1] (R)-N-(2-etyl-6-metylfenyl)-2-chlór-N-(1- metoxypropán-2-yl)acetamid (0-20 %) [2] |
-[1] -[2] |
87392-12-9 [1] 178961-20-1 [2] |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-433-00-X |
cis/trans-cypermetrín (80/20); O-[(RS)-(3-fenoxyfenyl)(kyano)metyl]- (1RS,3RS;1RS,3SR)-3-(2,2-dichlóretenyl)- 2,2-dimetylcyklopropánkarboxylát |
257-842-9 |
52315-07-8 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H335 H315 H317 H410 |
|
|
|
|
607-434-00-5 |
mekoprop-P [1] a jeho soli; kyselina (R)-2-(4-chlór-2- metylfenoxy)propánová a jej soli |
240-539-0 |
16484-77-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-435-00-0 |
O-[(1R,2S,5R)-2-izopropyl-5- metylcyklohexyl]-2,2-dihydroxyacetát |
416-810-6 |
111969-64-3 |
STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H411 |
|
|
|
|
607-436-00-6 |
O-[(2-etyl-4-metylimidazol-1-yl)-2- hydroxypropyl]-2,2-dimetyloktanoát |
417-350-9 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-437-00-1 |
kyselina 3-(4-aminofenyl)-2-kyanopropénová |
417-480-6 |
252977-62-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-438-00-7 |
O-metyl-2-[(aminosulfonyl)metyl]benzoát |
419-010-5 |
112941-26-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
607-439-00-2 |
metyl-tetrahydrofurán-2-karboxylát |
420-670-1 |
37443-42-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-440-00-8 |
O-metyl-2-sulfamoyl-6- (trifluórmetyl)pyridín-3-karboxylát |
421-220-7 |
144740-59-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-441-00-3 |
kyselina 3-{3-[2-(dodecyloxy)-5- metylfenylkarbamoyl]-4-hydroxy-1- naftylsulfanyl}propánová |
421-490-6 |
167684-63-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-442-00-9 |
benzyl-[(4- fenylbutyl)(hydroxy)fosfanyl]acetát |
416-050-5 |
87460-09-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-444-00-X |
reakčná zmes zložená z týchto látok: (cis-cyklohexán-1,4-diyldimetyl)-dibenzoát; (trans-cyklohexán-1,4-diyldimetyl)- dibenzoát |
416-230-3 |
35541-81-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-445-00-5 |
ferium(III)-tris(4-metylbenzénsulfonát) |
420-960-8 |
77214-82-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-446-00-0 |
O-metyl-2-[4-(2-chlór-4- nitrofenyldiazenyl)-3-(propánamido)anilino]propanoát |
416-240-8 |
155522-12-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-447-00-6 |
nátrium-4-[4-(4- hydroxyfenyldiazenyl)fenylamino]-3- nitrobenzénsulfonát |
416-370-5 |
156738-27-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-448-00-1 |
kyselina 2,3,5,6-tetrafluórbenzoová |
416-800-1 |
652-18-6 |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
|
607-449-00-7 |
reakčná zmes zložená z týchto látok: 4,4',4''-{(2,4,6-trioxohexahydro-1,3,5- triazín-1,3,5-triyl)tris[metylén(3,5,5- trimetylcyklohexán-3,1- diyl)iminokarbonyloxyetylén(etylimino)]}tri(benzén-1-diazónium)- tris(diizobutylnaftalénsulfonát); 4,4',4'',4'''-({ureylénbis[(1,5,5- trimetylcyklohexán-3,1-diyl)metylén(2,4,6- trioxohexahydro-1,3,5-triazín-1,3- triyl)]}tetrakis[metylén(3,5,5- trimetylcyklohexán-3,1- diyl)iminokarbonyloxyetylén(etylimino)])tetra(benzén-1-diazónium)- tetrakis(diizobutylnaftalénsulfonát) |
417-080-1 |
— |
Self-react. D **** Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
|
607-450-00-2 |
O-terc-butyl-2-((Z)-{[1-(2-aminotiazol-4-yl)- 2-(benzotiazol-2-ylsulfanyl)-2- oxoetylidén]amino}oxy)-2-metylpropanoát |
419-040-9 |
89604-92-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-451-00-8 |
nátrium-4-amino-6-({5-[4-({8-amino-1- hydroxy-3,6-disulfonáto-7-[(4-{[2- (sulfonátooxy)etyl]sulfonyl}fenyl)diazenyl]-2-naftyl}diazenyl)benzamido]-2- sulfonátofenyl}diazenyl)-5-hydroxy-3-[(4-{[2- (sulfonátooxy)etyl]sulfonyl}fenyl)diazenyl] naftalén-2,7-disulfonát |
417-640-5 |
161935-19-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-453-00-9 |
[(benzylimino)bis(2-hydroxypropán-3,1- diyl)]-bis(2,2-dimetyloktanoát) |
418-100-1 |
172964-15-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-454-00-4 |
reakčná zmes zložená z týchto látok: kyselina trans-2-izopropyl-1,3-dioxán-5- karboxylová; kyselina cis-2-izopropyl-1,3-dioxán-5- karboxylová |
418-170-3 |
116193-72-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-455-00-X |
lítno-sodná soľ kyseliny 1-amino-4-{3-[4-(2,5-disulfofenylamino)-6- chlór-1,3,5-triazín-2-ylamino]-2,2- dimetylpropylamino}-9,10-dioxo-9,10- dihydroantracén-2-sulfónovej |
419-520-8 |
172890-93-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-456-00-5 |
hexadecylester kyseliny 3-amino-4-chlórbenzoovej |
419-700-6 |
143269-74-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-457-00-0 |
tetranátrium-dihydrogen-2,2'-(1,4- fenylénbis{(imino)[{6-[4-(2-aminoetyl)piperazín-1-yl]})-1,3,5-triazín-4,2-diyl](imino)(8-hydroxy-3,6- disulfonátonaftalén-7,1- diyl)(diazéndiyl)})di(naftalén-1-sulfonát) |
420-350-1 |
172277-97-3 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
607-458-00-6 |
reakčná zmes zložená z týchto látok: monoester 2,2'-{(propán-2,2-diyl)bis[(2,6- dibróm-4,1-fenylén)oxy]}dietanolu s kyselinou akrylovou; 2,2'-{(propán-2,2-diyl)bis[(2,6-dibróm- 4,1-fenylén)oxy]}dietyl-diakrylát; 2,2'-{propán-2,2-diylbis[(2,6-dibróm-4,1-fenylén)oxy]}dietanol |
420-850-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-459-00-1 |
O-izopentyl-({1-[2-(2-izopropoxyetoxy)-2-oxoetyl]-5-kyano-4-metyl-2,6-dioxo- 1,2,3,6-tetrahydropyridín-3- ylidén}hydrazino)benzoát |
418-930-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-460-00-7 |
[3-(tridecyloxy)propán-1-amónium]- oktadec-9-enoát |
418-990-1 |
778577-53-0 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H410 |
|
|
|
|
607-461-00-2 |
reakčná zmes zložená z týchto látok: pentanátrium-2-({4-[3-metyl-4-({6- sulfonáto-4-[(2-sulfonátofenyl)diazenyl]-1-naftyl}diazenyl)anilino]-6-(3-{[2- (sulfonátooxy)etyl]sulfonyl}anilino)-1,3,5-triazín-2-yl}amino)-benzén-1,4-disulfonát; pentanátrium-2-({4-[3-metyl-4-({7- sulfonáto-4-[(2-sulfonátofenyl)diazenyl]-1-naftyl}diazenyl)anilino}-6-(3-{[2- (sulfonátooxy)etyl]sulfonyl}anilino]-1,3,5-triazín-2-yl}amino)-benzén-1,4-disulfonát |
421-160-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-462-00-8 |
reakčná zmes zložená z týchto látok: (hexán-1-yl)-acetát; (hexán-2-yl)-acetát; (3-metylpentán-1-yl)-acetát; (4-metylpentán-1-yl)-acetát; ďalšie (rozvetvené C6-alkyl)-acetáty |
421-230-1 |
88230-35-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-463-00-3 |
kyselina 3-(fenotiazín-10-yl)propánová |
421-260-5 |
362-03-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-464-00-9 |
reakčná zmes zložená z týchto látok: kyselina 1-etyl-6-fluór-7-chlór-4-oxo-1,4-dihydrochinolín-3-karboxylová; kyselina 1-etyl-6-fluór-5-chlór-4-oxo-1,4-dihydrochinolín-3-karboxylová |
421-280-4 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-465-00-4 |
tris[(2-hydroxyetyl)amónium]-7-(2-etoxy-4-{4-[4-hydroxy-2-(kyanoamino)-6-oxidopyrimidín-5-yldiazenyl]benzamido}fenyldiazenyl)naftalén-1,3-disulfonát |
421-440-3 |
778583-04-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-466-00-X |
reakčná zmes zložená z týchto látok: O-fenyl-1-{1-[5-(hexadecyloxykarbonyl)-2-chlórfenylkarbamoyl]-3,3-dimetyl-2- oxobutyl}-1H-2,3,3a,7atetrahydrobenzotriazol- 5-karboxylát; O-fenyl-2-{1-[5-(hexadecyloxykarbonyl)-2- chlórfenylkarbamoyl]-3,3-dimetyl-2- oxobutyl}-1H-2,3,3a,7atetrahydrobenzotriazol- 5-karboxylát; O-fenyl-3-{1-[5-(hexadecyloxykarbonyl)-2- chlórfenylkarbamoyl]-3,3-dimetyl-2- oxobutyl}-1H-2,3,3a,7atetrahydrobenzotriazol- 5-karboxylát |
421-480-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-467-00-5 |
(1,1,3,3-tetrabutyldistanoxán-1,3-diyl)- dioktanoát |
419-430-9 |
56533-00-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H410 |
|
|
|
|
607-468-00-0 |
reakčná zmes zložená z týchto látok: nátrium-dihydrogen-2-[6-hydroxy-1,4- dimetyl-2-oxo-5-(sulfonátometyl)-1,2- dihydropyridín-3-yldiazenyl]-4-{[4-chlór-6- (2-metoxy-5-sulfonátofenylamino)-1,3,5- triazín-2-yl]amino}benzénsulfonát; dinátrium-hydrogen-2-[6-hydroxy-1,4- dimetyl-2-oxo-5-(sulfonátometyl)-1,2- dihydropyridín-3-yldiazenyl]-4-{[4-chlór-6- (2-metoxy-5-sulfonátofenylamino)-1,3,5- triazín-2-yl]amino}benzénsulfonát; trinátrium-2-[6-hydroxy-1,4-dimetyl-2-oxo- 5-(sulfonátometyl)-1,2-dihydropyridín-3- yldiazenyl]-4-{[4-chlór-6-(2-metoxy-5- sulfonátofenylamino)-1,3,5-triazín-2- yl]amino}benzénsulfonát; tetranátrium-2-[1,4-dimetyl-6-oxido-2-oxo- 5-(sulfonátometyl)-1,2-dihydropyridín-3- yldiazenyl]-4-{[4-chlór-6-(2-metoxy-5- sulfonátofenylamino)-1,3,5-triazín-2- yl]amino}benzénsulfonát |
419-450-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-469-00-6 |
dinátrium-7-[(4,6-bis{[3- (dietylamino)propyl]amino}-1,3,5-triazín-2-yl)amino]-4-hydroxy-3-({4-[(4- sulfonátofenyl)diazenyl]fenyldiazenyl}naftalén-2-sulfonát |
419-460-2 |
120029-06-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-470-00-1 |
kálium-nátrium-6,13-dichlór-3,10-bis[(2- {[4-(2,5-disulfonátoanilino)-6-(3-{[2- (sulfonátooxy)ety]sulfonyl}anilino)-1,3,5-triazín-2-yl]amino}etyl)amino]benzo[5,6][1,4]oxazino[2,3-b]fenoxazín-4,11-disulfonát |
414-100-0 |
154336-20-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-471-00-7 |
1,6- bis[(dibenzyltiokarbamoyl)disulfanyl]hexán |
429-280-6 |
151900-44-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-473-00-8 |
zmesné estery pentaerytritolu a dipentaerytritolu s mastnými C6-10-alkánovými kyselinami, kyselinou adipovou, heptánovou a izostearovou; zmesné estery (metántetrayl)tetrametanolu a {oxybis[(metylén)(metántetrayl)]}hexametanolu s mastnými C6-10-alkánovými kyselinami, kyselinou hexánovou, heptánovou a 16-metylheptadekánovou |
426-590-3 |
187412-41-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-474-00-3 |
kyselina 4-{4-[4-(dimetylamino)benzylidén]-3- metyl-5-oxo-2-pyrazolín-1-yl}benzoová |
410-430-4 |
117573-89-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-475-00-9 |
reakčná zmes zložená z týchto látok: tetranátrium-7-(4-{4-chlór-6-[metyl(3- sulfonátofenyl)amino]-1,3,5-triazín-2- ylamino}-2-ureidofenyldiazenyl)naftalén- 1,3,6-trisulfonát; tetranátrium-7-(4-{4-chlór-6-[metyl(4- sulfonátofenyl)amino]-1,3,5-triazín-2- ylamino}-2-ureidofenyldiazenyl)naftalén- 1,3,6-trisulfonát (1:1) |
412-940-2 |
148878-18-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-476-00-4 |
trinátrium-N-(2- karboxylátoetyl)iminodiacetát |
414-070-9 |
129050-62-0 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
607-477-00-X |
(1α,5α,6α)-6-nitro-3-benzyl-3- azóniabicyklo[3.1.0]hexán-(metánsulfonát) |
426-740-8 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-478-00-5 |
tetrametylamónium-hydrogen-ftalát |
416-900-5 |
79723-02-7 |
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H400 |
|
|
|
|
607-479-00-0 |
O-hexadecyl-3-[2-(5,5-dimetyl-2,4-dioxo-1,3-oxazolidín-3-yl)-4,4-dimetyl-3-oxopentánamido]-4-chlórbenzoát |
418-550-9 |
168689-49-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-480-00-6 |
di(rozvetvené a lineárne C7-11-alkyl)-ftaláty |
271-084-6 |
68515-42-4 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
607-481-00-1 |
reakčná zmes zložená z týchto látok: trihexyl-citrát; dihexyl-oktyl-citrát; hexyl-dioktyl-citrát; decyl-dihexyl-citrát |
430-290-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-482-00-7 |
etyl-(S)-4-fenyl-2-[(S)-4-metyl-2,5-dioxo- 1,3-oxazolidín-3-yl]butanoát; N-[1-(S)-etoxykarbonyl-3-fenylpropyl]-Lalanyl-N-karboxanhydrid |
430-360-8 |
84793-24-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-483-00-2 |
di(C6-8-alkyl)-benzén-1,2-dikarboxylát, kde alkyly sú rozvetvené, bohaté na C7 |
276-158-1 |
71888-89-6 |
Repr. 1B |
H360D*** |
GHS08 Dgr |
H360D*** |
|
|
|
|
607-484-00-8 |
etyl-2-{[3-acetamido-4-(6-bróm-2-metyl- 1,3-dioxo-2,3-dihydro-1H-izoindol-5- yldiazenyl)fenyl](etyl)amino}propanoát |
430-480-0 |
221452-67-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-485-00-3 |
fenyl-(3S,trans)-3-[(1,3-benzodioxol-5- yloxy)metyl]-4-(4-fluórfenyl)piperidín-1-karboxylát |
430-510-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-486-00-9 |
kálium-nátrium-2-{1-hydroxy-8-[6-chlór-4- ({2-[2-(vinylsulfonyl)etoxy]etyl}amino)- 1,3,5-triazín-2-ylamino]-3,6- disulfonátonaftalén-2-yldiazenyl}naftalén- 1,5-disulfonát |
402-110-8 |
110081-40-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-487-00-4 |
reakčná zmes zložená z týchto látok: dinátrium-4-(4-{etoxykarbonyl}-3-{5-[4- (etoxykarbonyl)-2-hydroxy-1-(4- sulfonátofenyl)pyrazol-3-yl]penta-2,4- dienylidén}-2-oxo-2,3-dihydropyrazol-1- yl)benzénsulfonát; trinátrium-4-(4-{etoxykarbonyl}-3-{5-[4-(etoxykarbonyl)-2-oxido-1-(4- sulfonátofenyl)pyrazol-3-yl]penta-2,4- dienylidén}-2-oxo-2,3-dihydropyrazol-1- yl)benzénsulfonát |
402-660-9 |
— |
Repr. 1B Aquatic Chronic 3 |
H360D *** H412 |
GHS08 Dgr |
H360D *** H412 |
|
|
|
|
607-488-00-X |
etyl-(2-acetamido-5-fluór-4- izotiokyanátofenoxy)acetát |
414-210-9 |
147379-38-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-489-00-5 |
reakčná zmes zložená z týchto látok: (2-etylhexyl)-linolenát, (2-etylhexyl)-linolát a (2-etylhexyl)-oleát; (2-etylhexyl)-epoxyoleát; (2-etylhexyl)-diepoxylinolát; (2-etylhexyl)-triepoxylinolenát |
414-890-7 |
71302-79-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-490-00-0 |
kyselina {[2-hydroxy-3-(C12-16- alkyloxy)propyl](metyl)amino]octová |
415-060-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-491-00-6 |
reakčná zmes zložená z týchto látok: diester 4,4'-metylénbis[2-(2-hydroxy-5- metylbenzyl)-3,6-dimetylfenolu] s kyselinou 6-diazo-5-oxo-5,6- dihydronaftalén-1-sulfónovou (1:2); triester 4,4'-metylénbis[2-(2-hydroxy-5- metylbenzyl)-3,6-dimetylfenolu] s kyselinou 6-diazo-5-oxo-5,6- dihydronaftalén-1-sulfónovou (1:3) |
427-140-9 |
— |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
607-492-00-1 |
{2-[1-(3,3-dimetylcyklohexyl)etoxy]-2- metylpropyl}-propanoát |
415-490-5 |
141773-73-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-493-00-7 |
O-metyl-(3aR,4R,7aR)-2-metyl-4-[(1S,2R)- 1,2,3-triacetoxypropyl]-3a,7a-dihydro-4Hpyrano[ 3,4-d]oxazol-6-karboxylát |
415-670-3 |
78850-37-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-494-00-2 |
bis(2-etylhexyl)-oktylfosfonát |
417-170-0 |
52894-02-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-495-00-8 |
nátrium-4-(sulfofenyl)-6- (nonánamido)hexanoát |
417-550-6 |
168151-92-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-496-00-3 |
[2,2'-metylénbis(4,6-di-terc-butyl-fenyl)]- (2-etylhexyl)-fosfit |
418-310-3 |
126050-54-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-497-00-9 |
cérium-oxid-(16-metylheptadekanoát) |
419-760-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-498-00-4 |
(E)-(3,7-dimetylokta-2,6-dién-1-yl)- hexadekanoát |
421-370-3 |
3681-73-0 |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
607-499-00-X |
bis[(2-hydroxyetyl)di(metyl)amónium]- (etán-1,2-diyl)-bis(hexadecenylsukcinát) |
421-660-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-500-00-3 |
kalcium-2,2-bis(5-dodecyl-2- hydroxyfenyl)acetát |
421-670-4 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
607-501-00-9 |
reakčná zmes zložená z týchto látok: trifenyl-fosforotioát a jeho na fenyloch terc-butylované deriváty |
421-820-9 |
192268-65-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-502-00-4 |
[benzyltri(butyl)amónium]-4- dodecylbenzénsulfonát |
422-200-0 |
178277-55-9 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H314 H302 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H411 |
|
|
|
|
607-503-00-X |
2,4,6-tripropyl-1,3,5,2λ5,4λ5,6λ5- trioxatrifosfinán-2,4,6-trión |
422-210-5 |
68957-94-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
607-504-00-5 |
diamónium-4-[4-(7-amino-1-hydroxy-3- sulfonátonaftalén-2-yldiazenyl)-2,5- dimetoxyfenyldiazenyl]benzoát |
422-670-7 |
— |
Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f H301 H373** H410 |
|
|
|
|
607-505-00-0 |
pentanátrium-7-(4-{[4-(5-amino-4- sulfonáto-2-{4-[(2- sulfonátoetoxy)sulfonyl]fenyldiazenyl}fenylamino)-6-chlór-1,3,5-triazín-2-yl]amino}-2-ureidofenyldiazenyl)naftalén-1,3,6- trisulfonát |
422-930-1 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-506-00-6 |
reakčná zmes zložená z týchto látok: stroncium-4-chlór-2-{[4-metyl-2-oxo-1-(3-sulfonátofenyl)-2,3-dihydro-1H-pyrazol-3-yl]diazenyl}-5-metylbenzénsulfonát; dinátrium-4-chlór-2-{[4-metyl-2-oxo-1-(3-sulfonátofenyl)-2,3-dihydro-1H-pyrazol-3-yl]diazenyl}-5-metylbenzénsulfonát |
422-970-8 |
|
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-507-00-1 |
draselno-sodná soľ kyseliny 2,4-diamino-3- {4-[(2-sulfoetoxy)sulfonyl]fenyldiazenyl}- 5-{4-[(2-sulfoetoxy)sulfonyl)]-2- sulfofenyldiazenyl}benzénsulfónovej |
422-980-2 |
187026-95-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-508-00-7 |
dinátrium-3,3'-{iminobis[(sulfonyl)(4,1- fenylén)(5-hydroxy-3-metylpyrazol-1,4- diyl)(diazéndiyl)(4,1-fenylén)(sulfonyl)(imino)(4-amino-6- hydroxypyrimidín-2,5-diyl)(diazéndiyl)(4,1- fenylén)(sulfonyl)(imino)(4-amino-6- hydroxypyrimidín-2,5- diyl)(diazéndiyl)]}di(benzénsulfonát) |
423-110-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-509-00-2 |
(2-fenoxyetyl)-4-aminobenzoát |
430-880-5 |
88938-23-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-510-00-8 |
kyselina (2S,5R)-6,6-dibróm-3,3-dimetyl- 4,4,7-trioxo-4-tia-1- azabicyklo[3.2.0]heptán-2-karboxylová |
427-200-4 |
76646-91-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-511-00-3 |
reakčná zmes zložená z týchto látok: kyselina 4-[(3-decyloxypropyl)(1,4- diizobutoxy-1,4-dioxobután-2-yl)amino]-4-oxobutánová; kyselina 4-[(1,4-diizobutoxy-1,4- dioxobután-2-yl)(3-oktyloxypropyl)amino]- 4-oxobutánová |
423-750-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
607-512-00-9 |
trinátrium-2,4-diamino-3,5-bis-[4-(2- sulfonátoetoxy)sulfonyl)fenyldiazenyl]benzénsulfonát |
423-970-0 |
182926-43-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-513-00-4 |
reakčná zmes zložená z týchto látok: trinátrium-5-benzamido-3-[1-sulfonáto-6-(vinylsulfonyl)naftalén-2-yldiazenyl)-4-hydroxynaftalén-2,7-disulfonát; tetranátrium-5-benzamido-4-hydroxy-3-(1-sulfonáto-6-{[2- (sulfonátooxy)etyl]sulfonyl}-2- naftyldiazenyl)naftalén-2,7-disulfonát; kyselina 5-benzamido-4-hydroxy-3-(1- sulfo-6-{[2-(sulfooxy)etyl]sulfonyl}-2- naftyldiazenyl)naftalén-2,7-disulfónová |
423-200-3 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-514-00-X |
kálium-2-amino-N-[1- (metoxykarbonyl)prop-1-én-2-yl]-3- metylbutanoát |
427-240-2 |
134841-35-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-515-00-5 |
reakčná zmes zložená z týchto látok: dinátrium-hexyl(oxy)di(benzénsulfonát); dinátrium-dihexyl(oxy)di(benzéndisulfonát) |
429-650-7 |
147732-60-3 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
607-516-00-0 |
N,N'-bis(trifluóracetyl)-S,S'-bis-Lhomocysteín |
429-670-6 |
105996-54-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-517-00-6 |
kyselina (S)-α- (acetylsulfanyl)benzénpropánová |
430-300-0 |
76932-17-7 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
607-518-00-1 |
kyselina 3-oxoandrost-4-én-17β-karboxylová |
414-990-0 |
302-97-6 |
Repr. 2 Aquatic Chronic 4 |
H361f H413 |
GHS08 Wng |
H361f H413 |
|
|
|
|
607-519-00-7 |
polymér formaldehydu s 2-(N-etylanilino)etanolom a N, N'-dietyl-N, N'-(oxybisetán-2,1- diyl)dianilínom, produkty reakcie s 2-(N-etylanilino)etanolom, oxidované, soli s kyselinou octovou |
427-280-0 |
176429-27-9 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
607-520-00-2 |
reakčná zmes zložená z týchto látok: nátrium-N-etyl-2-[(propanoáto)(C6-18- alkyl)]-4,5-dihydro-3H-imidazólium-fosfát; dinátrium-2-N-etyl-[(dipropanoáto)(C6-18-alkyl)]-4,5-dihydro-3H-imidazólium-fosfát |
427-740-0 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-521-00-8 |
tetraetyl-N,N'-[metylénbis(cyklohexán-4,1-diyl)]di-DL-aspartát |
429-270-1 |
136210-30-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-522-00-3 |
sodná soľ polyméru nátrium-2-metylbuta-1,3-dién-1-sulfonátu s kyselinou akrylovou a O-(2-hydroxyetyl)-2-metylakrylátom |
429-720-7 |
184246-86-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-523-00-9 |
reakčná zmes zložená z týchto látok: mono- až tetra(lítium a/alebo nátrium)-3- amino-10-{4-(4-amino-3-sulfonátoanilino)- 6-[metyl(2-sulfonátoetyl)amino]-1,3,5- triazín-2-ylamino}-6,13-dichlórbenzo[1,2- b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát; mono- až tetra(lítium a/alebo nátrium)-3- amino-10-[4,6-bis(4-amino-3- sulfonátoanilino)-1,3,5-triazín-2-ylamino]- 6,13-dichlórbenzo[1,2-b:4,5- b']di[1,4]benzoxazín-4,11-disulfonát; mono- až penta(lítium a/alebo nátrium)- 10,10'-diamino-6,6',13,13'-tetrachlór-3,3'- [6-[metyl(2-sulfonátoetyl)amino]-1,3,5- triazín-2,4-diylbis(imino)]bis(benzo[1,2- b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát); mono- až hepta(lítium a/alebo nátrium)-10- amino-6,6',13,13'-tetrachlór-10'-[4-(4- amino-3-sulfonátoanilino)-[6-metyl-(2- sulfonátoetyl)amino]-1,3,5-triazín-2,4- diylbis(imino)]bis(benzo[1,2-b:4,5- b']di[1,4]benzoxazín-4,11-disulfonát); mono- až hepta(lítium a/alebo nátrium)- 10,10'-diamino-6,6',3,3'-[(2-sulfonáto)-1,4- fenyléndiiminobis[6-metyl-(2- sulfonátoetyl)amino]-1,3,5-triazín-2,4- diyldiimino]bis[benzo[1,2-b:4,5- b']di[1,4]benzoxazín-4,11-disulfonát |
430-200-7 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-524-00-4 |
2-[(tetrahydro-2H-pyrán-2- yl)sulfanyl]etylestery kyselín z talového oleja |
430-310-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
607-525-00-X |
kyselina (Z)-2-(metoxymino)-2-[2- (tritylamino)tiazol-4-yl]octová |
431-520-1 |
64485-90-1 |
Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 |
H228 H351 H412 |
GHS02 GHS08 Dgr |
H228 H351 H412 |
|
|
|
|
607-526-00-5 |
kartap (ISO); [2-(dimetylamino)propán-1,3-diyl]- bis(tiokarbamát) |
— |
15263-53-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-527-00-0 |
reakčná zmes zložená z týchto látok: 1-(1H,1H,2H,2H-tridekafluóroktyl)-12- (1H,1H,2H,2H-tridekafluóroktyl)- dodekándioát; 1-(1H,1H,2H,2H-tridekafluóroktyl)-12- (1H,1H,2H,2H-heptadekafluórdecyl)- dodekándioát; 1-(1H,1H,2H,2H-tridekafluóroktyl)-12- (1H,1H,2H,2H-heneikozafluórdodecyl)- dodekándioát; 1-(1H,1H,2H,2H-tridekafluóroktyl)-12- (1H,1H,2H,2H-pentakozafluórtetradecyl)- dodekándioát; 1-(1H,1H,2H,2H-heptadekafluórdecyl)-12-(1H,1H,2H,2H-heptadekafluórdecyl)- dodekándioát; 1-(1H,1H,2H,2H-heptadekafluórdecyl)-12-(1H,1H,2H,2H-heneikozafluórdodecyl)- dodekándioát |
423-180-6 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-528-00-6 |
kyselina (S)-3-metyl-2-(2- oxotetrahydropyrimidín-1-yl)butánová |
430-900-2 |
192725-50-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-529-00-1 |
cis-[4-(benzyloxykarbonyl)cyklohexán-1-amínium]-4-metylbenzénsulfonát |
426-070-6 |
67299-45-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-530-00-7 |
reakčná zmes izomérov O-(C7-9-alkyl)-3-(3,5-di-terc-butyl-4- hydroxyfenyl)propanoátu |
406-040-9 |
125643-61-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-531-00-2 |
O-metyl-3-amino-4,6-dibróm-2- metylbenzoát |
425-190-6 |
119916-05-1 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
607-532-00-8 |
(cyklohexánamínium)-(S)-1-[2-(tercbutoxykarbonyl)- 3-(2-metoxyetoxy)propyl]cyklopentán-1- karboxylát |
425-510-4 |
167944-94-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-533-00-3 |
pentanátrium-monohydrogen-3,10-bis({2-[4-(2,4-disulfonátoanilino)-6-chlór-1,3,5-triazín-2-yl-amino]etyl}amino)-13-etyl-6- chlórbenzo[5,6][1,4]oxazino[2,3- b]fenoxazín-4,11-disulfonát |
414-910-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-534-00-9 |
O-etyl-2-(3-benzoylfenyl)propanoát |
414-920-9 |
60658-04-0 |
Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H372** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H372** H317 H411 |
|
|
|
|
607-535-00-4 |
kálium-5-jód-2-karboxybenzénsulfonát; kyselina draselno-4-jód-2-sulfonáto-benzoová |
426-620-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-536-00-X |
kyselina (2,6-dimetylfenoxy)octová |
430-910-7 |
13335-71-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
607-537-00-5 |
(propán-2-amínium)-2-(3- benzoylfenyl)propanoát |
417-970-1 |
— |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H372** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H312 H372** H318 H410 |
|
|
|
|
607-539-00-6 |
dipropyl-2,2'-[({4-[(5-oxo-3- propylizoxazolidín-4- ylidén)metyl]fenyl}imino)bismetylén] diacetát |
431-000-2 |
198705-81-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-540-00-1 |
kyselina 2-[1-(sulfanylmetyl)cyklopropyl]octová |
420-240-3 |
162515-68-6 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H312 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H312 H302 H317 H411 |
|
|
|
|
607-541-00-7 |
kyselina [(propán-1,2- diyl)bis[nitrilobis(metylén)]]tetrafosfónová |
421-940-1 |
28698-31-9 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
607-542-00-2 |
O-metyl-2-[4-(bután-1- sulfónamido)fenoxy]tetradekanoát |
422-110-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-543-00-8 |
polymér formaldehydu s 2-(N-etylanilino)etanolom a N, N'-(oxydietán-2,1-diyl)bis(N-etylanilínom), produkty reakcie s 2-(N-etyl-3-metylanilino)etanolom, oxidované, soli s kyselinou octovou |
427-480-8 |
176429-22-4 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
607-544-00-3 |
O-etyl-6,8-difluór-1-(N-metylformamido)- 7-(4-metylpiperazín-1-yl)-4-oxo-1,4- dihydrochinolín-3-karboxylát |
427-490-2 |
158585-86-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-545-00-9 |
[1,2-dimetyl-3-(prop-1-én-2- yl)cyklopentyl]-acetát |
424-070-0 |
94346-09-5 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-546-00-4 |
reakčná zmes zložená z týchto látok: dimetyl-2,2'-{[5-acetamido-4-(2-chlór-4- nitrofenyldiazenyl)fenyl]imino}diacetát; etyl-metyl-2,2'-{[5-acetamido-4-(2-chlór-4-nitrofenyldiazenyl)fenyl]imino}diacetát |
424-290-7 |
188070-47-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-547-00-X |
O-(18-metylnonadecyl)-2,2- dimetylpropanoát |
424-370-1 |
125496-22-2 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
607-548-00-5 |
{1-[2-(2,4-dichlórfenyl)-2-oxoetyl]-1Himidazólium}- metánsulfonát |
431-010-7 |
154486-26-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-549-00-0 |
O-metyl-(E)-2-{[3-(1,3-benzodioxol-5-yl)-2-metylprop-1-én-1-yl]amino}benzoát |
424-430-7 |
125778-19-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-550-00-6 |
kyselina 2-amino-4-bróm-5-chlórbenzoová |
424-700-4 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-551-00-1 |
tetrabutylamónna soľ 2-amino-6-jódpurínu |
424-710-9 |
156126-48-6 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H373** H315 H318 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H312 H302 H373** H315 H318 H317 H411 |
|
|
|
|
607-552-00-7 |
O-hexadecyl-3-amino-4-izopropoxybenzoát |
424-830-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-553-00-2 |
produkt kopulácie kyseliny 7-amino-4-hydroxynaftalén-2-sulfónovej s kyselinou 5(alebo 8)-amino-8(alebo 5)-[4-({4-[4-amino-6(alebo 7)-sulfo-1- naftyldiazenyl]fenyl}amino)-3- sulfofenyldiazenyl]naftalén-2-sulfónovou a kyselinou 7-anilino-4-hydroxynaftalén-2-sulfónovou, sodná soľ |
424-850-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-554-00-8 |
kyselina 2,4-diamino-5-{4-[(2- sulfoxyetyl)sulfonyl]fenyldiazenyl}benzénsulfónová |
424-870-1 |
27624-67-5 |
Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 |
H201 H318 H412 |
GHS01 GHS05 Dgr |
H201 H318 H412 |
|
|
|
|
607-555-00-3 |
OO-(1,1,3,3-tetrametylbutyl)-2,2- dimetylperoxypropanoát |
424-980-8 |
22288-41-1 |
Flam. Liq. 2 Org. Perox. D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H242 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H242 H315 H317 H411 |
|
|
|
|
607-556-00-9 |
(2-acetoxy-5-acetylbenzyl)-acetát |
425-160-2 |
24085-06-1 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
|
607-557-00-4 |
[(1S,cis)-2-hydroxy-2,3-dihydro-1H-indén-1-amínium]-(2R,3R)-2,3- dihydroxybutándioát |
425-210-3 |
169939-84-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-558-00-X |
O-[(1R,2S,5R)-2-izopropyl-5- metylcyklohexyl]-(2R,5S)-5-(4-amino-2- oxo-2H-pyrimidín-1-yl)-1,3-oxatiolán-2- karboxylát |
425-250-1 |
147027-10-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-559-00-5 |
produkty reakcie kokosového oleja s estermi glycerolu s kyselinou 3-(3,5-diterc- butyl-4-hydroxyfenyl)propánovou |
425-400-6 |
179986-09-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-560-00-0 |
kyselina (RS)-2-butyloktándiová |
431-210-4 |
50905-10-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-561-00-6 |
nátrium-4-hydroxy-3-{N'-[2-(2- hydroxyetylsulfonyl)etyl]ureido}-5- nitrobenzénsulfonát |
425-460-3 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-562-00-1 |
reakčná zmes zložená z týchto látok: [(2R,3R)-3-(2-etoxyfenoxy)-3-fenyl-2- hydroxypropán-1-amínium]-metánsulfonát; [(2S,3S)-3-(2-etoxyfenoxy)-3-fenyl-2- hydroxypropán-1-amínium]-metánsulfonát |
425-530-3 |
98769-75-6 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-563-00-7 |
kyselina 4-hydroxy-5,7-dichlórchinolín-3-karboxylová |
431-250-2 |
171850-30-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-564-00-2 |
(hexán-1,6-diamínium)-nátrium-5- sulfonátobenzén-1,3-dikarboxylát |
425-730-0 |
51178-75-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-565-00-8 |
3-etyl-5-metyl-2-(2-aminoetoxymetyl)-4-(2-chlórfenyl)-6-metyl-1,4-dihydropyridín-3,5- dikarboxylát |
425-820-1 |
88150-42-9 |
Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H373** H318 H410 |
|
|
|
|
607-566-00-3 |
reakčná zmes zložená z týchto látok: (dodecylfenyl)-dodecyl(hydroxy)benzoát; [bis(dodecylfenyl)dodecyl]- hydroxybenzéndikarboxylát |
426-140-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-567-00-9 |
kálium-3-jód-6-metylbenzénsulfonát |
426-300-5 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-568-00-4 |
kálium-3-(benzyloxy)-2-chlórpropanoát |
426-350-8 |
138666-92-9 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
|
607-569-00-X |
reakčná zmes zložená z týchto látok: nátrium-2-amino-4-(2,6-difluórpyrimidín-4- ylamino)benzénsulfonát; nátrium-2-amino-4-(4,6-difluórpyrimidín-4- ylamino)benzénsulfonát |
426-470-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-570-00-5 |
monohydrát nátrium-(6R,trans)-7-amino-8- oxo-3-({[1-(sulfonátometyl)-1H-tetrazol-5-yl]sulfanyl}metyl)-5-tia-1- azóniabicyklo[4.2.0]okt-2-én-2-karboxylátu |
426-520-1 |
71420-85-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-571-00-0 |
{3-[(metoxykarbonyl)metyl]-2- pentylcyklopent-1-enyl}-acetát |
431-400-7 |
57374-49-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-572-00-6 |
O-(O,O-dietylfosforotioyl)-(Z)-(2- aminotiazol-4-yl)(metoxyimino)acetát |
426-790-0 |
162208-27-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373** H317 H410 |
|
|
|
|
607-573-00-1 |
reakčná zmes zložená z týchto látok: dinátrium-7-(2,4-difluórpyrimidín-6- ylamino)-4-hydroxy-3-(4-metoxy-2- sulfonátofenyldiazenyl)naftalén-2-sulfonát; dinátrium-7-(4,6-difluórpyrimidín-2- ylamino)-4-hydroxy-3-(4-metoxy-2- sulfonátofenyldiazenyl)naftalén-2-sulfonát |
426-840-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-574-00-7 |
[(1R-1α,2β,5α)-2-izopropyl-5-metylcyklohexyl]-hydrogen-butándioát |
426-890-4 |
77341-67-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-575-00-2 |
trietylamónna soľ kyseliny 4-(6-hydroxy-5-{5-[1-(4-karboxyfenyl)- 2,4,6-trioxohexahydropyrimidín-5- ylidén]penta-1,3-dién-1-yl}-2,4-dioxo- 1,2,3,4-tetrahydropyrimidín-1-yl)benzoovej |
426-900-7 |
— |
STOT SE 3 Aquatic Chronic 3 |
H335 H412 |
GHS07 Wng |
H335 H412 |
|
|
|
|
607-576-00-8 |
O-(rozvetvený C8-alkyl)-3-(3,5-di-tercbutyl- 4-hydroxyfenyl)propanoát |
427-030-0 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-577-00-3 |
zlúčenina (2R*,3S*)-2-(2,4-difluórfenyl)-3-(5- fluórpyrimidín-4-yl)-1-(1H-1,2,4-triazol-1-yl)bután-2-olu s kyselinou (1R)-gáfor-10-sulfónovou |
427-100-0 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
|
607-578-00-9 |
O-etyl-4-{[4-(dietylamino)-2- metylfenyl]imino}-1-izopropyl-5-oxo-4,5-dihydro-1H-pyrazol-3-karboxylát |
427-110-5 |
— |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 4 |
H302 H373** H413 |
GHS08 GHS07 Wng |
H302 H373** H413 |
|
|
|
|
607-579-00-4 |
dietyl-[(4-etoxyanilino)metylidén]malonát |
431-430-0 |
103976-28-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
607-580-00-X |
O-etyl-1-(2,4-difluórfenyl)-6-fluór-7-chlór-4-oxo-1,4-dihydro-1,8-naftyridín-3-karboxylát |
422-360-1 |
100491-29-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-581-00-5 |
kyselina[3-etoxy-4-(etoxykarbonyl)fenyl]octová |
427-630-2 |
99469-99-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-582-00-0 |
reakčná zmes zložená z týchto látok: tetranátrium-7-(4-{4-fluór-6-[4-(2- sulfonátoetylsulfonyl)anilino]-1,3,5-triazín-2-ylamino}-2-ureidofenyldiazenyl)naftalén- 1,3,6-trisulfonát; tetranátrium 7-(4-{4-hydroxy-6-[4-(2- sulfonátoetylsulfonyl)anilino]-1,3,5-triazín-2-ylamino}-2-ureidofenyldiazenyl)naftalén- 1,3,6-trisulfonát |
427-650-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-583-00-6 |
kyselina 4-amino-3-{4-[2- (sulfooxy)etylsulfonyl]fenyldiazenyl}naftalén-1-sulfónová |
427-680-5 |
188907-52-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-584-00-1 |
trinátrium-3-(2-acetamido-4-{4-chlór-6-[4-(2-sulfonátoxyetylsulfonyl)anilino]-1,3,5-triazín-2-ylamino}fenyldiazenyl)naftalén- 1,5-disulfonát |
427-710-7 |
215612-56-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-585-00-7 |
stroncium-2-[(2-hydroxy-6- sulfonátonaftalén-1-yl)diazenyl]naftalén-1-sulfonát |
427-930-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-586-00-2 |
O-dodecyl-3-amino-4-chlórbenzoát |
428-020-9 |
6195-20-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-587-00-8 |
O-etyl-cis-4-(4-{[2-(2,4-dichlórfenyl)-2- (1H-imidazol-1-ylmetyl)-1,3-dioxolán-4- yl]metoxy}fenyl)piperazín-1-karboxylát |
428-030-3 |
67914-69-6 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
|
607-588-00-3 |
reakčná zmes zložená z týchto látok: O-(2-etylhexyl)-2,3,4,5-tetrabrómbenzoát; 1,2-bis(2-etylhexyl)-3,4,5,6-tetrabrómftalát |
428-050-2 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-589-00-9 |
tetrakis(1,2,2,6,6-pentametylpiperidín-4-yl)-bután-1,2,3,4-tetrakarboxylát |
428-070-1 |
91788-83-9 |
STOT RE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H372** H302 H410 |
|
|
|
|
607-590-00-4 |
O-hexadecyl-3-[2-(5,5-dimetyl-2,4-dioxo- 1,3-oxazolidín-3-yl)-4,4-dimetyl-3- oxopentánamido]-4-izopropoxybenzoát |
428-140-1 |
210706-50-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-591-00-X |
reakčná zmes zložená z týchto látok: trinátrium-5-[4-fluór-6-(morfolín-4-yl)- 1,3,5-triazín-2-ylamino]-4-hydroxy-3-{4-[2- (sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát; dinátrium-5-[4-fluór-6-(morfolín-4-yl)- 1,3,5-triazín-2-ylamino]-4-hydroxy-3-[4- (vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát |
428-400-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-592-00-5 |
di(C9-11-alkyl)-cyklohexán-1,4-dikarboxylát |
428-870-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-593-00-0 |
O-[4-(2-metylakryloyloxy)fenyl]-4- (alyloxy)benzoát |
429-000-2 |
159235-16-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-594-00-6 |
O-etyl-(1S,5R,6S)-5-(pentán-3-yloxy)-7- oxabicyklo[4.1.0]hept-3-én-3-karboxylát |
429-020-1 |
204254-96-6 |
STOT RE 2 * Skin Sens. 1 |
H373** H317 |
GHS08 GHS07 Wng |
H373** H317 |
|
|
|
|
607-595-00-1 |
[1-(karboxymetyl)-1-metylguanidínium]-2- oxopropanoát; soľ kyseliny (1-metylguanidino)octovej s kyselinou 2-oxopropánovou (1:1) |
429-120-5 |
208535-04-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-596-00-7 |
O-etyl-2-(4-fenoxyfenyl)laktát |
429-220-9 |
132584-17-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-597-00-2 |
tetranátrium-4,4'-(etén-1,2-diylbis{(3- sulfonáto-4,1-fenylén)(diazéndiyl)(4,1- fenylén)(imino)[6-(2-hydroxyetylamino)- 1,3,5-triazín-4,2- diyl](imino)})bis(benzénsulfonát) |
429-230-3 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-598-00-8 |
trinátrium-3-amino-4-{4-[4-({2-[2- (etenylsulfonyl)etoxy]etyl}amino)-6-fluór- 1,3,5-triazín-2-ylamino]-2- sulfonátofenyldiazenyl}-5-hydroxynaftalén- 2,7-disulfonát |
429-240-8 |
212652-59-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-599-00-3 |
OO-terc-pentyl-3,5,5- trimetylperoxyhexanoát |
431-610-9 |
68860-54-8 |
Org. Perox. D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
|
607-600-00-7 |
O-((1S)-{1-[(1R)-3,3- dimetylcyklohexyl]etoxykarbonyl}metyl)-propanoát |
431-700-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-601-00-2 |
tris(1,4-dihydroxy-2,2,6,6- tetrametylpiperidinium)-2-hydroxypropán- 1,2,3-trikarboxylát |
429-370-5 |
220410-74-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-602-00-8 |
O-etyl-[3-(kyanometyl)-4-oxo-3,4- dihydroftalazín-1-yl]acetát |
429-680-0 |
122665-86-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-603-00-3 |
lítno-sodná soľ kyseliny 4,4',4''-{nitrilotris[(etán-2,1-diyl)imino(6- chlór-1,3,5-triazín-4,2-diyl)imino]}tris[5- hydroxy-6-(1-sulfonaftalén-2- yldiazenyl)naftalén-2,7-disulfonát] |
429-730-1 |
193562-37-7 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-604-00-9 |
guanidínium-benzoát |
429-820-0 |
26739-54-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-605-00-4 |
O-metyl-4-jód-2-[3-(4-metoxy-6-metyl- 1,3,5-triazín-2-yl)ureidosulfonyl]benzoát |
429-890-2 |
144550-06-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-606-00-X |
kyselina (Z)-2-[2-(terc-butoxykarbonylamino)tiazol- 4-yl]pent-2-énová |
430-100-3 |
86978-24-7 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-607-00-5 |
reakčná zmes zložená z týchto látok: kalcium-bis[(rozvetvený C10-14-alkyl)-2-hydroxybenzoát); kalcium-bis[(C18-30- alkyl)(hydroxy)benzoát]; kalcium-(C18-30-alkyl)[(rozvetvený C10-14-alkyl)-2-hydroxy-1-karboxylátobenzén-nyl]- 2-hydroxybenzoát; kalcium-bis[(rozvetvený C10-14- alkyl)fenolát]; kalcium-bis[(C18-30-alkyl)fenolát]; kalcium-(C18-30-alkyl)[(rozvetvený C10-14-alkyl)(oxido)fenyl]fenolát; (rozvetvený C10-14-alkyl)fenol; (C18-30-alkyl)fenol |
430-180-1 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-608-00-0 |
pentakálium-2-(4-{5-[1-(2,5- disulfonátofenyl)-3-(metylkarbamoyl)-5- oxo-4,5-dihydropyrazol-4-ylidén]-3-(2-oxopyrolidín-1-yl)penta-1,3-dién-1-yl}-3-(metylkarbamoyl)-5-oxopyrazol-1-yl)benzén-1,4-disulfonát |
430-210-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-609-00-6 |
etyl-(3R)-3-hydroxy-4-kyanobutanoát |
430-220-6 |
141942-85-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-610-00-1 |
trinátrium-4-hydroxy-6- (sulfonátometylamino)-5-{2-[2- (sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2-sulfonát |
430-280-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-611-00-7 |
metyl-3-amino-2,2,3-trimetylbutanoát |
431-720-7 |
90886-53-6 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
|
|
|
|
607-612-00-2 |
reakčná zmes zložená z týchto látok: kyselina 3,3,4,4,5,5,6,6,7,7,8,8,8- tridekafluóroktán-1-sulfónová; amónium-3,3,4,4,5,5,6,6,7,7,8,8,8- tridekafluóroktán-1-sulfonát |
432-190-1 |
182176-52-9 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 |
H302 H373** H318 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 |
|
|
|
|
607-613-00-8 |
reakčná zmes zložená z týchto látok:: kyselina jantárová; kyselina monoperoxyjantárová; kyselina diperoxyjantárová; metyl-hydrogen-sukcinát; metyl-hydrogen-peroxysukcinát; dimetyl-sukcinát; kyselina glutárová; kyselina monoperoxyglutárová; kyselina diperoxyglutárová; metyl-hydrogen-glutarát; metyl-hydrogen-peroxyglutarát; dimetyl-glutarát; kyselina adipová; kyselina monoperoxyadipová; kyselina diperoxyadipová; metyl-hydrogen-adipát; metyl-hydrogen-peroxyadipát; dimetyl-adipát; peroxid vodíka; metanol; voda |
432-790-1 |
|
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B STOT SE 2 |
H332 H312 H302 H314 H371 (oči) |
GHS07 GHS05 GHS08 Dgr |
H332 H312 H302 H314 H371 (oči) |
|
|
|
|
607-614-00-3 |
kyselina 2-(10-oxo-10H-9-oxa-10- fosfafenantrén-10-ylmetyl)jantárová |
426-480-5 |
63562-33-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-615-00-9 |
produkt reakcie tioglycerolu s kyselinou sulfanyloctovou, ktorý obsahuje najmä (3-sulfanylpropán-1,2-diyl)- bis(sulfanylacetát) a oligoméry tejto látky |
431-120-5 |
— |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H331 H302 H319 H317 |
GHS06 Dgr |
H331 H302 H319 H317 |
|
|
|
|
607-616-00-4 |
5-fluór-2,4-dichlórbenzoylchlorid |
428-390-1 |
86393-34-2 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H335 H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H317 H412 |
|
|
|
|
607-617-00-X |
bis(2-etylhexyl)-4,5-epoxycyklohexán-1,2-dikarboxylát |
430-700-5 |
10138-36-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-618-00-5 |
menadión-nátrium-bisulfit; sodná soľ kyseliny 2-metyl-1,4-dioxo-1,2,3,4-tetrahydronaftalén-2-sulfónovej |
204-987-0 |
130-37-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
607-619-00-0 |
menadión-nikotínamid-bisulfit; zlúčenina kyseliny 2-metyl-1,4-dioxo-1,2,3,4-tetrahydronaftalén-2-sulfónovej s nikotín-3-amidom (1:1) |
277-543-7 |
73581-79-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
607-620-00-6 |
trinátrium-2,2',2''-nitrilotriacetát |
225-768-6 |
5064-31-3 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 |
H351 H302 H319 |
GHS08 GHS07 Wng |
H351 H302 H319 |
|
Carc. 2; H351: C ≥ 5% |
|
|
607-621-00-1 |
milbemektín (ISO); [reakčná zmes milbemycínu A3 (CAS č. 51596-10-2) a milbemycínu A4 (CAS č. 51596-11-3) (30:70)] |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
M=100 |
|
|
607-622-00-7 |
O-(2-etylhexyl)-2-etylhexanoát |
231-057-1 |
7425-14-1 |
Repr. 2 |
H361d*** |
GHS08 Wng |
H361d*** |
|
|
|
|
607-624-00-8 |
kyselina perfluóroktán-1-sulfónová; kyselina heptadekafluóroktán-1-sulfónová [1] kálium-perfluóroktán-1-sulfonát; kálium-heptadekafluóroktán-1-sulfonát; [2] bis(2-hydroxyetyl)amónium-perfluóroktán-1-sulfonát; bis(2-hydroxyetyl)amóniumheptadekafluóroktán-1-sulfonát; [3] amónium-perfluóroktán-1-sulfonát; amónium-heptadekafluóroktán-1-sulfonát; [4] lítium-perfluóroktán-1-sulfonát; lítium-heptadekafluóroktán-1-sulfonát [5] |
217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] |
1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] |
Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Lact. Aquatic Chronic 2 |
H351 H360D*** H372** H332 H302 H362 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D*** H372** H332 H302 H362 H411 |
|
|
|
|
607-625-00-3 |
klodinafop-propargyl (ISO); O-(prop-2-inyl)-(R)-2-[4-(3-fluór-5- chlórpyridín-2-yloxy)fenoxy]propanoát |
— |
105512-06-9 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
Skin Sens. 1; H317: C ≥ 0,001 % M=1 |
|
|
607-626-00-9 |
O-etyl-1-(2,4-dichlórfenyl)-5- (trichlórmetyl)-1H-1,2,4-triazol-3- karboxylát |
401-290-5 |
103112-35-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
607-627-00-4 |
O-{[(4S,5S)-4-benzyl-2-oxo-5-oxazolidín-5- yl]metyl}-4-nitrobenzénsulfonát |
416-360-0 |
162221-28-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-628-00-X |
(4-etylmorfolín-4-ium)-4-oxo-4-para-tolylbutanoát |
419-240-6 |
171054-89-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-629-00-5 |
kyselina {(4-fenylbutyl)[2-metyl-1- (propanoyloxy)propoxy]fosfanyl} octová |
419-270-1 |
123599-82-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-630-00-0 |
O-[3-(trimetoxysilyl)propyl]-akrylát |
419-560-6 |
4369-14-6 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H332 H314 H317 H412 |
GHS05 GHS07 Dgr |
H332 H314 H317 H412 |
|
|
|
|
607-631-00-6 |
reakčná zmes zložená z týchto látok: (2,2'-oxydietyl)-bis[fenyl(oxo)acetát]; O-[2-(2-hydroxyetoxy)etyl]- fenyl(oxo)acetát |
442-300-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-632-00-1 |
N-[3-(2,4-di-terc-pentylfenoxy)propyl]-1- hydroxy-5-(izobutoxykarbonylamino)-2- naftamid |
420-210-1 |
111244-14-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-633-00-7 |
trinátrium-4-hydroxy-5-{[4-chlór-6-(1-naftylamino)-1,3,5-triazín-2-yl]amino}-3-[(E)-(4-metoxy-2- sulfonátofenyl)diazenyl]naftalén-2,7- disulfonát |
440-480-2 |
341026-59-3 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-634-00-2 |
(S)-(-)-2-acetoxypropanoylchlorid; [(1S)-1-chlór-1-oxopropán-2-yl]-acetát |
420-610-4 |
36394-75-9 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
607-635-00-8 |
trinátrium-N-(2-karboxylátoetyl)-L-aspartát |
422-090-4 |
172737-80-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-636-00-3 |
(1-bróm-2-metylpropyl)-propanoát |
422-900-6 |
158894-67-8 |
Flam. Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 |
H226 H351 H314 H317 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H226 H351 H314 H317 |
|
|
|
|
607-637-00-9 |
dinátrium-8-amino-5-{4-[2- (sulfonátoetoxy)sulfonyl]fenyldiazenyl}naftalén-2-sulfonát |
423-730-5 |
250688-43-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-638-00-4 |
O-(2-butyloktyl)-2-hydroxybenzoát |
431-090-3 |
190085-41-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-639-00-X |
{2-[2-oxo-5-(1,1,3,3-tetrametylbutyl)-2,3- dihydro-1-benzofurán-3-yl]-4-(1,1,3,3-tetrametylbutyl)fenyl}-acetát |
431-770-1 |
216698-07-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-641-00-0 |
kyselina 2-(formamido)tiofén-3-karboxylová |
431-930-9 |
43028-69-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
607-642-00-6 |
(3,6,9-tritiaundekán-1,11-diyl)-dimetakrylát |
432-210-7 |
141631-22-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-643-00-1 |
dimetyl-(2S)-2-hydroxysukcinát |
432-310-0 |
617-55-0 |
Flam. Liq. 3 Eye Dam. 1 Skin Sens. 1 |
H226 H318 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H318 H317 |
|
|
|
|
607-644-00-7 |
O-metyl-2,2-dimetyl-6- metylidéncyklohexánkarboxylát |
432-350-9 |
81752-87-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
607-645-00-2 |
tetranátrium-2-[4-fluór-6-(metyl{2-[2- (sulfonátooxy)etylsulfonyl]etyl}amino)-1,3,5-triazín-2-ylamino]-5-hydroxy-6-(4-metyl-2-sulfonátofenyldiazenyl)naftalén- 1,7-disulfonát |
432-550-6 |
243858-01-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-646-00-8 |
O-terc-butyl-2-[(4R,6S)-6-(hydroxymetyl)- 2,2-dimetyl-1,3-dioxán-4-yl]acetát |
432-960-5 |
124655-09-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-647-00-3 |
O-{[(RS)-5-acetoxy-1,3-oxatiolán-2- yl]metyl}-butanoát |
433-530-1 |
143446-73-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 |
H302 H317 H400 |
GHS07 GHS09 Wng |
H302 H317 H400 |
|
|
|
|
607-649-00-4 |
[3-(chlórkarbonyl)-2-metylfenyl]-acetát |
433-690-0 |
167678-46-8 |
Skin Corr. 1A Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
607-650-00-X |
(2-metylpentán-1,5-diamínium)-benzén-1,3-dikarboxylát |
433-910-5 |
145153-52-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-651-00-5 |
nátrium-2-(nonanoyloxy)benzénsulfonát |
434-360-9 |
91125-43-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-652-00-0 |
hydrochlorid O-etyl-N 2-dodekanoyl-L-argininátu |
434-630-6 |
60372-77-2 |
Eye Dam. 1 Aquatic Acute 1 |
H318 H400 |
GHS05 GHS09 Dgr |
H318 H400 |
|
|
|
|
607-653-00-6 |
tetrakis[bis(2- hydroxyetyl)(metyl)amónium]-3-[4-(7-acetamido-1-hydroxy-3-sulfonátonaftalén- 2-yldiazenyl)-5-metoxy-2- sulfonátofenyldiazenyl]-7-(4-amino-3-sulfonátoanilino)-4-hydroxynaftalén-2-sulfonát |
434-840-8 |
225786-91-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-654-00-1 |
(S)-3-hydroxytetrahydrofurán-2-ón; (S)-3-hydroxy-γ-butyrolaktón |
434-990-4 |
7331-52-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-655-00-7 |
O-etyl-6,8-dichlóroktanoát |
435-080-1 |
1070-64-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-656-00-2 |
sodná soľ kyseliny 4-amino-5-hydroxy-3,6-bis{5-[4-chlór-6-(2- metyl-4-sulfoanilino)-1,3,5-triazín-2- ylamino]-2-sulfofenyldiazenyl}naftalén-2,7- disulfónovej |
435-350-7 |
141250-43-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-657-00-8 |
pentanátrium-7-[4-(4-{3-[2- sulfonátooxy)etylsulfonyl]anilino}-6-{4-[2- (sulfonátooxy)etylsulfonyl]anilino}-1,3,5-triazín-2-ylamino)-2- ureidofenyldiazenyl]naftalén-1,3,6- trisulfonát |
436-920-8 |
172399-10-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-658-00-3 |
draselno-lítno-sodná soľ kyseliny 3,10-diamino-2-[6-(4-terc-butylbenzénsulfónamido) naftalén-2-ylsulfonyl]-6,13-dichlórtrifenodioxazín- 4,11-disulfónovej |
440-770-9 |
371921-63-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-659-00-9 |
pentanátrium-7-(4-{4-chlór-6-[5-(3- karboxyetylamino)-4-sulfonáto-2- {4-[2- (sulfonátooxy)etylsulfonyl]fenyldiazenyl}a nilino]-1,3,5-triazín-2-ylamino}-2- ureidofenyldiazenyl)naftalén-1,3,6- trisulfonát |
442-030-0 |
321912-47-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-660-00-4 |
trinátrium-7-{4-[4-(4-fluór-6-{2-[2- (vinylsulfonyl)etoxy]etylamino}-1,3,5-triazín-2- ylamino)fenyldiazenyl]fenyldiazenyl}naftalén-1,3,5-trisulfonát |
442-230-8 |
321679-52-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-661-00-X |
O-terc-butyl-4'-(brómmetyl)bifenyl-2-karboxylát |
442-850-9 |
114772-40-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-662-00-5 |
O-metyl-2-(acetamido)-3-chlórpropanoát |
442-860-3 |
87333-22-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
607-663-00-0 |
bis(2-etylhexyl)-naftalén-2,6-dikarboxylát |
442-980-6 |
127474-91-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-664-00-6 |
O-metyl-2-(chlórsulfonyl)-4- [(metánsulfónamido)metyl]benzoát |
443-120-2 |
393509-79-0 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
607-665-00-1 |
O-metyl-(E)-2-etylbut-2-enoát |
443-150-6 |
101226-85-1 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
607-666-00-7 |
kyselina (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3- dihydro-2H-izoindol-2-yl)-5-oxopentánová |
443-560-5 |
88784-33-2 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
607-667-00-2 |
(1-chlóretyl)-cyklohexyl-karbonát |
444-950-8 |
99464-83-2 |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
|
607-668-00-8 |
kyselina trans-2-izopropyl-1,3-dioxán-5-karboxylová |
445-770-2 |
42031-28-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-669-00-3 |
O-[(9-acetoxy-3,8,10-trietyl-7,8,10- trimetyl-1,5-dioxa-9-azaspiro[5.5]undekán- 3-yl)metyl]-oktadekanoát |
445-990-9 |
376588-17-9 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-670-00-9 |
{3-[4-(5-amónio-2-butylbenzo[b]furán-3- ylkarbonyl)fenoxy]-N,N-dibutylpropán-1-amínium}-oxalát; {3-[4-(5-amónio-2-butylbenzo[b]furán-3- ylkarbonyl)fenoxy]-N,N-dibutylpropán-1- amínium)-dihydrogen-dioxalát |
448-700-9 |
500791-70-8 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H373** H318 H317 H410 |
|
M=10 |
|
|
607-671-00-4 |
dietyl-cyklohexán-1,4-dikarboxylát |
417-310-0 |
72903-27-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-672-00-X |
reakčná zmes zložená z týchto látok: O-[2-hydroxy-3-(metakryloyloxy)propyl]-2-benzoylbenzoát; O-[1-(hydroxymetyl)-2- (metakryloyloxy)etyl]-2-benzoylbenzoát; O-[x-hydroxy-y- (metakryloyloxy)propyl(alebo etyl)]-2-benzoylbenzoát |
419-000-0 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-673-00-5 |
(1-etyl-5,6,7,8-tetrahydrochinolínium)-tozylát |
419-570-0 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
607-675-00-6 |
reakčná zmes zložená z týchto látok: kyselina (Z)-oktadec-9-éndiová; kyselina (9Z,12Z)-oktadeka-9,12-diéndiová; kyselina hexadekándiová; kyselina oktadekándiová |
422-260-8 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
607-676-00-1 |
reakčná zmes zložená z týchto látok: kyselina 2-metylnonándiová; kyselina 4-(metoxykarbonyl)-2,4- dimetylundekándiová; kyselina 2,4,6-trimetyl-4,6- bis(metoxykarbonyl)tridekándiová; kyselina 8,9-bis(metoxykarbonyl)-8,9-dimetylhexadekándiová |
423-670-1 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-677-00-7 |
O-(2,5-dioxopyrolidín-1-yl)-N-{[N-metyl-N-(2-izopropyltiazol-4- ylmetyl)karbamoyl]karbonyl}-L-valinát |
424-660-8 |
— |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H373** H318 H317 |
|
|
|
|
607-678-00-2 |
reakčná zmes zložená z týchto látok: O-etyl-(2R,3R)-3- izopropylbicyklo[2.2.1]hept-5-én-2- karboxylát; O-etyl-(2S,3S)-3- izopropylbicyklo[2.2.1]hept-5-én-2- karboxylát |
427-090-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-679-00-8 |
reakčná zmes zložená z týchto látok: (3-{6-hydroxy-5-[3-(4-{2-hydroxy-4-metyl-1-[3-(metylamónio)propyl]-6-oxo-1,6-dihydropyridín-3- yldiazenyl}benzamido)fenyldiazenyl]-4-metyl-2-oxo-1,2-dihydropyridín-1-yl}-N-metylpropán- 1-amínium)-di(acetát); (3-{6-hydroxy-5-[4-(3-{2-hydroxy-4-metyl-1-[3-(metylamónio)propyl]-6-oxo-1,6-dihydropyridín-3- yldiazenyl}benzamido]fenyldiazenyl]-4-metyl-2-oxo-1,2-dihydropyridín-1-yl}-N,N-dimetylpropán- 1-amínium)-di(acetát); (3-{6-hydroxy-5-[3-(4-{1-[3- (dimetylamónio)propyl]-2-hydroxy-4-metyl-6-oxo-1,6-dihydropyridín-3- yldiazenyl}benzamido)fenyldiazenyl]-4-metyl-2-oxo-1,2-dihydropyridín-1-yl}-N,N-dimetylpropán-1-amínium]-di(acetát) |
431-440-5 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
607-680-00-3 |
O-terc-butyl-((4S,6S)-6-{2-[4-(4- fluórfenyl)-6-izopropyl-2-(Nmetylmetánsulfónamido) pyrimidín-5- yl]vinyl}-2,2-dimetyl-1,3-dioxán-4- yl)acetát |
432-810-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-681-00-9 |
reakčná zmes zložená z týchto látok: O 19-hexadecyl-hydrogen-9-nonyl-10-oktylnonadekándioát; O 19-oktadecyl-hydrogen-9-nonyl-10-oktylnonadekándioát; O 1,O 19-di(hexadecyl)-9-nonyl-10- oktylnonadekándioát; O 1-oktadecyl-O 19-hexadecyl-9-nonyl-10-oktylnonadekándioát; O 1,O 19-di(oktadecyl)-9-nonyl-10- oktylnonadekándioát |
432-910-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-682-00-4 |
komplexná reakčná zmes z pôsobenia kyseliny akrylovej na čínsku kolofóniu |
434-230-1 |
144413-22-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-683-00-X |
reakčná zmes zložená z týchto látok: O-metyl-2,2-dimetyl-3-((1E)-2-metylprop- 1-én-1-yl)cyklopropánkarboxylát; O-metyl-2,2-dimetyl-3-((1Z)-2-metylprop- 1-én-1-yl)cyklopropánkarboxylát (20: 80) |
435-450-0 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-684-00-5 |
destilačné zvyšky z produktov hydroformylácie C12-14-alkénov, C-(hydrogen sulfobutándioáty), disodné soli |
435-660-2 |
243662-67-1 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
607-685-00-0 |
amónium-2-(alkanoyloxy)etán-1-sulfonát, kde alkanoyl je z kokosového oleja |
441-050-7 |
— |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
|
607-686-00-6 |
kyselina 5,5'-dioxo-6,6'-(metylénbis{[5-(6-diazo-5- oxo-5,6-dihydronaftalén-1-sulfonyloxy)-6-metyl-2,1-fenylén]diazéndiyl})bis(5,6- dihydronaftalén-1-sulfónová) |
441-550-5 |
— |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
607-687-00-1 |
reakčná zmes zložená z týchto látok: 2-[3,6-bis(2-etyl-N-metylanilino)xantén-9- ýlium-9-yl]benzénsulfonát (2 – 10 %); 2-[3,6-bis(N,2,3-trimetylanilino)xantén-9- ýlium-9-yl]benzénsulfonát (2 – 10 %); 2-[3,6-bis(N,2,4-trimetylanilino)xantén-9- ýlium-9-yl]benzénsulfonát (2 – 10 %); 2-[3,6-bis(N,2,5-trimetylanilino)xantén-9- ýlium-9-yl]benzénsulfonát (2 – 10 %); 2-[3-(2-etyl-N-metylanilino)-6-(N,2,3- trimetylanilino)xantén-9-ýlium-9- yl]benzénsulfonát (7 – 20 %); 2-[3-(2-etyl-N-metylanilino)-6-(N,2,4- trimetylanilino)xantén-9-ýlium-9-yl]benzénsulfonát (7 – 20 %); 2-[3-(2-etyl-N-metylanilino)-6-(N,2,5- trimetylanilino)xantén-9-ýlium-9- yl]benzénsulfonát (7 – 20 %); 2-[3-(N,2,3-trimetylanilino)-6-(N,2,4- trimetylanilino)xantén-9-ýlium-9- yl]benzénsulfonát (7 – 20 %); 2-[3-(N,2,3-trimetylanilino)-6-(N,2,5- trimetylanilino)xantén-9-ýlium-9- yl]benzénsulfonát (7 – 20 %); 2-[3-(N,2,4-trimetylanilino)-6-(N,2,5- trimetylanilino)xantén-9-ýlium-9- yl]benzénsulfonát (7 – 20 %) |
442-800-6 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-688-00-7 |
(R)-[(cyklohexa-1,4- dienyl)(metoxykarbonyl)metyl]amóniumchlorid |
444-320-2 |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-689-00-2 |
reakčná zmes zložená z týchto látok: O-metyl-1,4-dimetylcyklohexánkarboxylát („para-izomér“ vrátane cis- a transizomérov); O-metyl-1,3-dimetylcyklohexánkarboxylát („meta-izomér“ vrátane cis- a transizomérov) |
444-920-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-690-00-8 |
O,O'-dimetyl-[2S,2S']-6,6,6',6'-tetrametoxy-2,2'-[N, N'-bis(trifluóracetyl)-S, S'-bi(Lhomocysteinyl) bisimino]dihexanoát |
432-860-1 |
255387-46-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-691-00-3 |
horečnaté soli C16-18- a C18-nenasýtených mastných kyselín s rozvetveným a nerozvetveným reťazcom |
448-690-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-692-00-9 |
zinočnaté soli C16-18- a C18-nenasýtených mastných kyselín s rozvetveným a nerozvetveným reťazcom |
446-470-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-693-00-4 |
O-hexyl-2- {[(dietylamino)(hydroxyl)fenyl]metanoyl}benzoát |
443-860-6 |
302776-68-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-694-00-X |
O-etyl-5,5-difenyl-2-izoxazolín-3- karboxylát |
443-870-0 |
163520-33-0 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-696-00-0 |
pentyl-formiát |
211-340-6 |
638-49-3 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Dgr |
H226 H319 H335 |
|
|
C |
|
607-697-00-6 |
terc-butyl-propanoát |
— |
20487-40-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
C |
|
607-698-00-1 |
kyselina 4-terc-butylbenzoová |
202-696-3 |
98-73-7 |
Repr. 1B STOT RE 1 Acute Tox. 4 |
H360F H372 H302 |
GHS07 GHS08 Dgr |
H360F H372 H302 |
|
|
|
|
607-699-00-7 |
bifenthrín (ISO); (2-metylbifenyl-3-yl)metyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-én-1-yl]-2,2-dimetylcyklopropánkarboxylát |
|
82657-04-3 |
Carc. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H300 H372 (nervový systém) H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H300 H372 (nervový systém) H317 H410 |
|
M = 10 000 M = 100 000 |
|
|
607-700-00-0 |
indoxakarb (ISO); metyl (4aS)-7-chloro-2-{(metoxykarbonyl)[4-(trifluorometoxy)fenyl]karbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazín-4a(3H)-karboxylát [1] reakčná zmes zložená z týchto látok: (S)-Indoxakarb a (R)-Indoxakarb 75:25; metyl 7-chloro-2-{(metoxykarbonyl)[4-(trifluorometoxy)fenyl]karbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazín-4a(3H)-karboxylát [2] |
|
173584-44-6 [1] 144171-61-9 [2] |
Acute Tox. 3 Acute Tox. 4 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H372 (krvný obeh, nervový systém, srdce) H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H372 (krvný obeh, nervový systém, srdce) H317 H410 |
|
M = 1 M = 1 |
|
|
607-702-00-1 |
dihexyl-ftalát |
201-559-5 |
84-75-3 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
607-703-00-7 |
amónium-pentadekafluóroktanoát |
223-320-4 |
3825-26-1 |
Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam.1 |
H351 H360D H362 H332 H302 H372 (liver) H318 |
GHS08 GHS07 GHS05 Dgr |
H351 H360D H362 H332 H302 H372 (pečeň) H318 |
|
|
|
|
607-704-00-2 |
kyselina pentadekafluóroktánová |
206-397-9 |
335-67-1 |
Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam. 1 |
H351 H360D H362 H332 H302 H372 (liver) H318 |
GHS08 GHS07 GHS05 Dgr |
H351 H360D H362 H332 H302 H372 (pečeň) H318 |
|
|
|
|
607-705-00-8 |
kyselina benzoová |
200-618-2 |
65-85-0 |
STOT RE 1 Skin Irrit. 2 Eye Dam. 1 |
H372 (pľúca) (inhalácia) H315 H318 |
GHS08 GHS05 Dgr |
H372 (pľúca) (inhalácia) H315 H318 |
|
|
|
|
607-706-00-3 |
metyl 2,5-dichlorobenzoát |
220-815-7 |
2905-69-3 |
Acute Tox. 4 STOT SE 3 Aquatic Chronic 2 |
H302 H336 H411 |
GHS07 GHS09 Wng |
H302 H336 H411 |
|
|
|
|
608-001-00-3 |
acetonitril; kyanometán |
200-835-2 |
75-05-8 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H225 H332 H312 H302 H319 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 |
|
|
|
|
608-002-00-9 |
trichlóracetonitril |
208-885-7 |
545-06-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
|
608-003-00-4 |
akrylonitril |
203-466-5 |
107-13-1 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
|
* |
D |
|
608-004-00-X |
2-hydroxy-2-metylpropánnitril; acetón-kyanohydrín |
200-909-4 |
75-86-5 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
|
|
608-005-00-5 |
butyronitril; butánnitril |
203-700-6 |
109-74-0 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H311 H301 |
GHS02 GHS06 Dgr |
H225 H331 H311 H301 |
|
|
|
|
608-006-00-0 |
bromoxynil (ISO); 3,5-dibróm-4-hydroxybenzonitril |
216-882-7 |
1689-84-5 |
Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H330 H301 H317 H410 |
|
M = 10 |
|
|
608-007-00-6 |
joxynil (ISO); 4-hydroxy-3,5-dijódbenzonitril |
216-881-1 |
1689-83-4 |
Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H301 H312 H373 ** H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H301 H312 H373 ** H319 H410 |
|
M = 10 |
|
|
608-008-00-1 |
chlóracetonitril |
203-467-0 |
107-14-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
|
608-009-00-7 |
malononitril |
203-703-2 |
109-77-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
608-010-00-2 |
metakrylonitril; 2-metylprop-2-énnitril |
204-817-5 |
126-98-7 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 |
H225 H331 H311 H301 H317 |
GHS02 GHS06 Dgr |
H225 H331 H311 H301 H317 |
|
* Skin Sens. 1; H317: C ≥0,2 % |
D |
|
608-011-00-8 |
oxalonitril |
207-306-5 |
460-19-5 |
Press. Gas Flam. Gas 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
|
608-012-00-3 |
benzonitril |
202-855-7 |
100-47-0 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
608-013-00-9 |
2-chlórbenzonitril |
212-836-5 |
873-32-5 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H312 H302 H319 |
GHS07 Wng |
H312 H302 H319 |
|
|
|
|
608-014-00-4 |
chlorotalonil (ISO); tetrachlórizoftalonitril |
217-588-1 |
1897-45-6 |
Carc. 2 Acute Tox. 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H335 H318 H317 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H330 H335 H318 H317 H410 |
|
M=10 |
|
|
608-015-00-X |
dichlobenil (ISO); 2,6-dichlórbenzonitril |
214-787-5 |
1194-65-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H312 H411 |
GHS07 GHS09 Wng |
H312 H411 |
|
|
|
|
608-016-00-5 |
2,3,5,6-tetrachlórbenzén-1,4-dikarbonitril |
401-550-8 |
1897-41-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
608-017-00-0 |
bromoxynil-oktanoát (ISO); (2,6-dibróm-4-kyanofenyl)-oktanoát |
216-885-3 |
1689-99-2 |
Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H302 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H302 H317 H410 |
|
M = 10 |
|
|
608-018-00-6 |
joxynil-oktanoát (ISO); (2,6-dijód-4-kyanofenyl)-oktanoát |
223-375-4 |
3861-47-0 |
Repr. 2 Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H301 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H301 H319 H317 H410 |
|
M = 10 |
|
|
608-019-00-1 |
2,2'-dimetyl-2,2'-diazéndiyldi(propánnitril); ADZN |
201-132-3 |
78-67-1 |
Self-react. C Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H242 H332 H302 H412 |
GHS02 GHS07 Dgr |
H242 H332 H302 H412 |
|
|
T |
|
608-020-00-7 |
(difenoxymetylidén)kyánamid; O,O'-difenyl-N-kyanokarbonimidát |
427-300-8 |
79463-77-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
608-021-00-2 |
3-{[2-(guanidín-2-yl)tiazol-4- ylmetyl]sulfanyl}propánnitril |
403-710-2 |
76823-93-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
608-022-00-8 |
3,7-dimetyloktánnitril |
403-620-3 |
40188-41-8 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
608-023-00-3 |
fenbukonazol (ISO); 2-fenyl-4-(4-chlórfenyl)-2-(1H-1,2,4- triazol-1-ylmetyl)butánnitril |
406-140-2 |
114369-43-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-024-00-9 |
2-{4-[butyl(fenetyl)amino]fenyl}etén-1,1,2-trikarbonitril |
407-650-8 |
97460-76-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
608-025-00-4 |
[4,5-bis(benzyloxy)-2-nitrofenyl]acetonitril |
410-970-0 |
117568-27-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
608-026-00-X |
5-oxo-1,3,3-trimetylcyklohexánkarbonitril |
411-490-4 |
7027-11-4 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 ** H317 H412 |
GHS08 GHS07 Wng |
H302 H373 ** H317 H412 |
|
|
|
|
608-027-00-5 |
reakčná zmes zložená z týchto látok: 3-(4-etylfenyl)-2,2-dimetylpropánnitril; 3-(2-etylfenyl)-2,2-dimetylpropánnitril; 3-(3-etylfenyl)-2,2-dimetylpropánnitril |
412-660-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
608-028-00-0 |
(cyklohexán-1,4-diyl)dimetyl-bis(3-anilino-2-kyanoakrylát) |
413-510-7 |
147374-67-2 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H373 ** H317 H411 |
GHS08 GHS09 Wng |
H373 ** H317 H411 |
|
|
|
|
608-029-00-6 |
6-hydroxy-1-[3-(izopropoxy)propyl]-4- metyl-2-oxo-1,2-dihydropyridín-3- karbonitril |
411-990-2 |
68612-94-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
608-030-00-1 |
N-acetyl-N-{3-[2-(dibutylamino)-4-fenyltiazol-5-yl-metylidén]-5-kyano-4-metyl-2,6-dioxo-1,2,3,6-tetrahydropyridín-1-yl]benzamid |
412-340-0 |
147741-93-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-031-00-7 |
2-benzyl-2-metylbut-3-énitril |
407-870-4 |
97384-48-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
608-032-00-2 |
acetamiprid (ISO); (E)-N 1-[(6-chlórpyridín-3-yl)metyl]-N 2-kyano-N 1-metylacetimidamid |
— |
135410-20-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
608-033-00-8 |
N-butyl-4-(2-chlór-4-nitrofenylhydrazono)-2-kyano-3-metylpent-2-énimid; N-butyl-5-(2-chlór-4-nitrofenylhydrazono)-4-metyl-2(1H),6(5H)-dioxopyridín-3-karbonitril |
407-970-8 |
75511-91-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
608-034-00-3 |
chlórfenapyr (ISO); 4-bróm-1-(etoxymetyl)-2-(4-chlórfenyl)-5-(trifluórmetyl)pyrol-3-karbonitril |
— |
122453-73-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
M=100 |
|
|
608-035-00-9 |
(RS)-2-[(2-acetyl-5-metylfenyl)-amino]-2-(2,6-dichlórfenyl)acetonitril |
419-290-9 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
608-036-00-4 |
3,4’-[(1,4-fenylén)bis(etén-2,1-diyl)]di(benzonitril) |
419-060-8 |
79026-02-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
608-037-00-X |
reakčná zmes zložená z týchto látok: (E)-trideka-2,12-diénnitril; (E)-trideka-3,12-diénnitril; (Z)-trideka-3,12-diénnitril |
422-190-8 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-038-00-5 |
2,2,4-trimetyl-4-fenylbutánnitril |
422-580-8 |
75490-39-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
608-039-00-0 |
2-fenylhexánnitril |
423-460-8 |
3508-98-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
608-040-00-6 |
4,4'-disulfándiylbis{5-amino-1-[2,6-dichlór-4-(trifluórmetyl)fenyl]-1H-pyrazol-3-karbonitril} |
423-490-1 |
130755-46-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-041-00-1 |
4'-(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-én-3-ylmetyl)bifenyl-2-karbonitril |
423-500-4 |
138401-24-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-042-00-7 |
hydrobromid (S)-2,2-difenyl-2-(pyrolidín-3-yl)acetonitrilu; (S)-3-[difenyl(kyano)metyl] pyrolidíniumbromid |
421-810-4 |
194602-27-2 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
608-043-00-2 |
3-(cis-hex-3-én-1-yloxy)propánnitril |
415-220-6 |
142653-61-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
|
608-044-00-8 |
2-cyklohexylidén-2-fenylacetonitril |
423-740-1 |
10461-98-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
608-046-00-9 |
6-hydroxy-5-(4-chlór-2-nitrofenyldiazenyl)-1,4-dimetyl-2-oxo-1,2-dihydropyridín-3-karbonitril |
425-310-7 |
77889-90-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
608-047-00-4 |
2-(piperidín-1-yl)benzonitril |
427-330-1 |
72752-52-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
608-048-00-X |
1-[3-(cyklopentyloxy)-4-metoxyfenyl]-4-oxocyklohexánkarbonitril |
427-450-4 |
152630-47-2 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H411 |
|
|
|
|
608-049-00-5 |
2-(4-{4-[butyl(heptán-2-yl)amino]fenyl}-3-kyano-5-oxo-1,5-dihydropyrol-2-ylidén)propándinitril |
429-180-2 |
157362-53-3 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
608-050-00-0 |
reakčná zmes zložená z týchto látok: 6-anilino-2-{[2-(2-hydroxyetoxy)etyl]amino}-5-2-kyano-4-nitrofenyldiazenyl)-4-metylnikotinonitril; 2-anilino-6-{[2-(2-hydroxyetoxy)etyl]amino}-5-(2-kyano-4-nitrofenyldiazenyl)-4-metylnikotinonitril |
429-760-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
608-051-00-6 |
(R)-4-[4-(dimetylamino)-1-(4-fluórfenyl)-1-hydroxybutyl]-3-(hydroxymetyl)benzonitril |
430-760-2 |
219861-18-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
608-052-00-1 |
(S)-4-[4-(dimetylamino)-1-(4-fluórfenyl)-1-hydroxybutyl]-3-(hydroxymetyl)benzonitril |
430-770-7 |
128173-52-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
608-053-00-7 |
(RS)-4-[4-(dimetylamino)-1-(4-fluórfenyl)-1-hydroxybutyl]-3-(hydroxymetyl)benzonitril |
430-780-1 |
103146-25-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
608-054-00-2 |
hemisulfát (RS)-4-[4-(dimetylamino)-1-(4-fluórfenyl)-1-hydroxybutyl]-3-(hydroxymetyl)benzonitrilu; bis{4-(fluórfenyl)-4-hydroxy-4-[2-(hydroxymetyl)-4-kyanofenyl]-N, N-dimetylbután-1-amínium}-sulfát |
430-790-6 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
608-056-00-3 |
[4-(kyanometyl)-4-morfolín-4-ium]-metyl-sulfát |
429-340-1 |
— |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
608-057-00-9 |
[4-(kyanometyl)-4-metylmorfolín-4-ium]-hydrogen-sulfát |
431-200-1 |
208538-34-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
608-058-00-4 |
esfenvalerát (ISO); (S)-[(3-fenoxyfenyl)(kyano)metyl]-(S)-2-(4-chlórfenyl)-3-metylbutanoát |
— |
66230-04-4 |
Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H317 H410 |
|
M = 10000 |
|
|
608-059-00-X |
5-amino-1-[2,6-dichlór-4-(trifluórmetyl)fenyl]-1H-pyrazol-3-karbonitril |
421-240-6 |
120068-79-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
608-060-00-5 |
5-metyl-2-(2-nitroanilino)tiofén-3-karbonitril |
421-300-1 |
138564-59-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
608-062-00-6 |
2-fluór-4-hydroxybenzonitril |
422-810-7 |
82380-18-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
608-063-00-1 |
(S)-3-fenoxy-α-hydroxy-benzénacetonitril; (S)-2-(3-fenoxyfenyl)-2-hydroxyacetonitril |
441-070-6 |
61826-76-4 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
|
608-064-00-7 |
[(kyanometyl)tri(metyl)amónium]-metyl-sulfát |
433-720-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
608-065-00-2 |
soli bromoxynilu, okrem tých, ktoré sú špecifikované inde v tejto prílohe; soli 3,5-dibróm-4-hydroxybenzonitrilu |
— |
— |
Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H330 H301 H317 H410 |
|
M = 10 |
A |
|
608-066-00-8 |
soli joxynilu, okrem tých, ktoré sú špecifikované inde v tejto prílohe; soli 4-hydroxy-3,5-dijódbenzonitrilu |
— |
— |
Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H301 H312 H373 ** H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H301 H312 H373 ** H319 H410 |
|
M = 10 |
A |
|
609-001-00-6 |
1-nitropropán |
203-544-9 |
108-03-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H 226 H332 H312 H302 |
|
* |
|
|
609-002-00-1 |
2-nitropropán |
201-209-1 |
79-46-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H226 H350 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H350 H332 H302 |
|
|
|
|
609-003-00-7 |
nitrobenzén |
202-716-0 |
98-95-3 |
Carc. 2. Repr. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 |
H351 H360F H301 H331 H311 H372 (krv) H412 |
GHS06 GHS08 Dgr |
H351 H360F H301 H331 H311 H372 (krv) H412 |
|
|
|
|
609-004-00-2 |
dinitrobenzén; [1] 1,4-dinitrobenzén; [2] 1,3-dinitrobenzén; [3] 1,2-dinitrobenzén [4] |
246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] |
25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
|
|
|
609-005-00-8 |
1,3,5-trinitrobenzén |
202-752-7 |
99-35-4 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H330 H310 H300 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373** H410 |
|
|
|
|
609-006-00-3 |
4-nitrotoluén |
202-808-0 |
99-99-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
|
|
609-007-00-9 |
2,4-dinitrotoluén; dinitrotoluén, technický; [1] dinitrotoluén [2] |
204-450-0 [1] 246-836-1 [2] |
121-14-2 [1] 25321-14-6 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f*** H331 H311 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f*** H331 H311 H301 H373** H410 |
|
|
|
|
609-008-00-4 |
2,4,6-trinitrotoluén; TNT |
204-289-6 |
118-96-7 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H201 H331 H311 H301 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373 ** H411 |
|
|
|
|
609-009-00-X |
2,4,6-trinitrofenol; kyselina pikrová |
201-865-9 |
88-89-1 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H201 H331 H311 H301 |
GHS01 GHS06 Dgr |
H201 H331 H311 H301 |
|
|
|
|
609-010-00-5 |
soli kyseliny pikrovej; soli 2,4,6-trinitrofenolu |
— |
— |
Unst. Expl Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H201 H331 H311 H301 |
GHS01 GHS06 Dgr |
H201 H331 H311 H301 |
|
|
T |
|
609-011-00-0 |
2,4,6-trinitroanizol |
— |
606-35-9 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H201 H332 H312 H302 H411 |
GHS01 GHS07 GHS09 Wng |
H201 H332 H312 H302 H411 |
|
|
|
|
609-012-00-6 |
3-metyl-2,4,6-trinitrofenol |
210-027-1 |
602-99-3 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Wng |
H201 H332 H312 H302 |
|
|
|
|
609-013-00-1 |
2,4-dimetyl-1,3,5-trinitrobenzén |
211-187-5 |
632-92-8 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H201 H332 H312 H302 H373 ** |
GHS01 GHS08 GHS07 Wng |
H201 H332 H312 H302 H373 ** |
|
|
|
|
609-015-00-2 |
4-nitrofenol; para-nitrofenol |
202-811-7 |
100-02-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H332 H312 H302 H373 ** |
GHS08 GHS07 Wng |
H332 H312 H302 H373 ** |
|
|
|
|
609-016-00-8 |
dinitrofenol (reakčná zmes izomérov); [1] 2,4(alebo 2,6)-dinitrofenol [2] |
247-096-2 [1] 275-732-9 [2] |
25550-58-7 [1] 71629-74-8 [2] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
|
609-018-00-9 |
2,4,6-trinitrobenzén-1,3-diol; kyselina styfnová |
201-436-6 |
82-71-3 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Dgr |
H201 H332 H312 H302 |
|
|
|
|
609-019-00-4 |
2,4,6-trinitrobenzén-1,3-dioxid olovnatý; plumbium-2,4,6-trinitrobenzén-1,3-diolát styfnát olova |
239-290-0 |
15245-44-0 |
Unst. Expl Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
609-019-01-1 |
2,4,6-trinitrobenzén-1,3-dioxid olovnatý; plumbium-2,4,6-trinitrobenzén-1,3-diolát; styfnát olova (≥ 20 % inertnej zrieďujúcej látky) |
239-290-0 |
15245-44-0 |
Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
609-020-00-X |
DNOC (ISO); 2-metyl-4,6-dinitrofenol |
208-601-1 |
534-52-1 |
Muta. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H310 H300 H315 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H330 H310 H300 H315 H318 H317 H410 |
EUH044 |
|
|
|
609-021-00-5 |
sodná soľ DNOC; nátrium-2-metyl-4,6-dinitrofenolát; [1] draselná soľ DNOC; kálium-2-metyl-4,6-dinitrofenolát [2] |
219-007-7 [1] -[2] |
2312-76-7 [1] 5787-96-2 [2] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
|
609-022-00-0 |
amónna soľ DNOC; amónium-2-metyl-4,6-dinitrofenolát |
221-037-0 |
2980-64-5 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
|
|
|
609-023-00-6 |
dinokap (ISO); zmes týchto látok: [2,6-dinitro-4-(oktán-2-yl)fenyl]-but-2-enoát; [2,6-dinitro-4-(oktán-3-yl)fenyl]-but-2-enoát; [2,6-dinitro-4-(oktán-4-yl)fenyl]-but-2-enoát; [2,4-dinitro-6-(oktán-2-yl)fenyl]-but-2-enoát; [2,4-dinitro-6-(oktán-3-yl)fenyl]-but-2-enoát; [2,4-dinitro-6-(oktán-4-yl)fenyl]-but-2-enoát |
254-408-0 |
39300-45-3 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H332 H302 H373** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360D*** H332 H302 H373** H315 H317 H410 |
|
M=100 |
|
|
609-024-00-1 |
binapakryl (ISO); O-(2-sek-butyl-4,6-dinitrofenyl)-3-metylbut-2-enoát |
207-612-9 |
485-31-4 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360D *** H312 H302 H410 |
|
|
|
|
609-025-00-7 |
dinoseb (ISO); 6-sek-butyl-2,4-dinitrofenol |
201-861-7 |
88-85-7 |
Repr. 1B Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H311 H301 H319 H410 |
EUH044 |
|
|
|
609-026-00-2 |
soli a estery dinosebu, okrem tých, ktoré sú špecifikované inde v tejto prílohe; soli a estery 6-sek-butyl-2,4-dinitrofenolu |
— |
— |
Repr. 1B Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H311 H301 H319 H410 |
EUH044 |
|
A |
|
609-027-00-8 |
dinoktón; reakčná zmes zložená z izomérov: metyl-(2-oktyl-4,6-dinitrofenyl)-karbonátu, metyl-(4-oktyl-2,6-dinitrofenyl)-karbonátu |
— |
63919-26-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
609-028-00-3 |
dinex (ISO); 2-cyklohexyl-4,6-dinitrofenol |
205-042-5 |
131-89-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
609-029-00-9 |
soli a estery dinexu; soli a estery 2-cyklohexyl-4,6-dinitrofenolu |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
A |
|
609-030-00-4 |
dinoterb (ISO); 2-terc-butyl-4,6-dinitrofenol |
215-813-8 |
1420-07-1 |
Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D *** H300 H311 H410 |
EUH044 |
|
|
|
609-031-00-X |
soli a estery dinoterbu; soli a estery 2-terc-butyl-4,6-dinitrofenolu |
— |
— |
Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D *** H300 H311 H410 |
|
|
A |
|
609-032-00-5 |
bromofenoxím (ISO); 3,5-dibróm-4-hydroxybenzaldehyd-O-(2,4-dinitrofenyl)oxím |
236-129-6 |
13181-17-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
609-033-00-0 |
dinosám (ISO); 2,4-dinitro-6-(pentán-2-yl)-fenol |
— |
4097-36-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
609-034-00-6 |
soli a estery dinosámu; soli a estery 2,4-dinitro-6-(pentán-2-yl)-fenolu |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
A |
|
609-035-00-1 |
nitroetán |
201-188-9 |
79-24-3 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
* |
|
|
609-036-00-7 |
nitrometán |
200-876-6 |
75-52-5 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
* |
|
|
609-037-00-2 |
5-nitroacenaftén |
210-025-0 |
602-87-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
609-038-00-8 |
2-nitronaftalén |
209-474-5 |
581-89-5 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
|
609-039-00-3 |
4-nitrobifenyl |
202-204-7 |
92-93-3 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
|
609-040-00-9 |
nitrofén (ISO); 2,4-dichlórfenyl(4-nitrofenyl)éter |
217-406-0 |
1836-75-5 |
Carc. 1B Repr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360D *** H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H360D *** H302 H410 |
|
|
|
|
609-041-00-4 |
2,4-dinitrofenol |
200-087-7 |
51-28-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H311 H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H400 |
|
|
|
|
609-042-00-X |
pendimetalín (ISO); N-(pentán-3-yl)-3,4-dimetyl-2,6-dinitroanilín |
254-938-2 |
40487-42-1 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
609-043-00-5 |
kvintozén (ISO); pentachlórnitrobenzén |
201-435-0 |
82-68-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
609-044-00-0 |
teknazén (ISO); 1,2,4,5-tetrachlór-3-nitrobenzén |
204-178-2 |
117-18-0 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
609-045-00-6 |
reakčná zmes zložená z týchto látok: [4,6-dinitro-2-(oktán-3-yl)fenyl]-metyl-karbonát a [4,6-dinitro-2-(oktán-4-yl)fenyl]-metyl-karbonát; dinoktón-6 |
— |
8069-76-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
609-046-00-1 |
trifluralín (ISO) (s obsahom < 0,5 ppm NPDA); α, α,α-trifluór-2,6-dinitro-N, N-dipropyl-para-toluidín (s obsahom < 0,5 ppm NPDA); 2,6-dinitro-N, N-dipropyl-4-(trifluórmetyl)anilín (s obsahom < 0,5 ppm NPDA); N, N-dipropyl-2,6-dinitro-4-(trifluórmetyl)anilín (s obsahom < 0,5 ppm NPDA) |
216-428-8 |
1582-09-8 |
Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H317 H410 |
|
M=10 |
|
|
609-047-00-7 |
2-nitroanizol |
202-052-1 |
91-23-6 |
Carc. 1B Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
|
|
609-048-00-2 |
nátrium-3-nitrobenzénsulfonát |
204-857-3 |
127-68-4 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
609-049-00-8 |
2,6-dinitrotoluén |
210-106-0 |
606-20-2 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
|
|
|
|
609-050-00-3 |
2,3-dinitrotoluén |
210-013-5 |
602-01-7 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f *** H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H410 |
|
|
|
|
609-051-00-9 |
3,4-dinitrotoluén |
210-222-1 |
610-39-9 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
|
|
|
|
609-052-00-4 |
3,5-dinitrotoluén |
210-566-2 |
618-85-9 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
|
|
|
|
609-053-00-X |
hydrazínium-trinitrometanid |
414-850-9 |
— |
Expl. 1.1 **** Self-react. A Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 |
H201 H240 H350 H331 H301 H317 |
GHS01 GHS06 GHS08 Dgr |
H201 H240 H350 H331 H301 H317 |
|
|
|
|
609-054-00-5 |
2,3-dinitrofenol; [1] 2,5-dinitrofenol; [2] 2,6-dinitrofenol; [3] 3,4-dinitrofenol; [4] soli dinitrofenolov [5] |
200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4]-[5] |
66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4]-[5] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
|
|
609-055-00-0 |
2,5-dinitrotoluén |
210-581-4 |
619-15-8 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
|
|
|
|
609-056-00-6 |
2,2-dibróm-2-nitroetanol |
412-380-9 |
69094-18-4 |
Expl. 1.1 Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H302 H373 ** H314 H317 H400 H410 |
GHS01 GHS08 GHS05 GHS07 GHS09 Dgr |
H201 H351 H302 H373 ** H314 H317 H410 |
|
* STOT SE 3; H335: C ≥ 1 % |
T |
|
609-057-00-1 |
1,3-difluór-2-chlór-4-nitrobenzén |
411-980-8 |
3847-58-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
|
|
|
|
609-058-00-7 |
2-fenyl-2-nitropropán-1,3-diol |
410-360-4 |
5428-02-4 |
STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H372 ** H312 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H312 H302 H317 H411 |
EUH070 |
|
|
|
609-059-00-2 |
2-(etylamino)-6-chlór-4-nitrofenol |
411-440-1 |
131657-78-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
609-060-00-8 |
4-[(3-hydroxypropyl)amino]-3-nitrofenol |
406-305-9 |
92952-81-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
609-061-00-3 |
(E, Z)-(4-chlórfenyl)(cyklopropyl)ketón-O-(4-nitrobenzyl)oxím |
406-100-4 |
94097-88-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
609-062-00-9 |
2-bróm-2-nitropropán-1-ol |
407-030-7 |
24403-04-1 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H373 ** H314 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H311 H302 H373 ** H314 H317 H410 |
|
|
|
|
609-063-00-4 |
2-[(4-chlór-2-nitrofenyl)amino]etanol |
413-280-8 |
59320-13-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
609-064-00-X |
mezotrión(ISO); 2-[4-(metylsulfonyl)-2-nitrobenzoyl]cyklohexán-1,3-dión |
— |
104206-82-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
609-065-00-5 |
2-nitrotoluén |
201-853-3 |
88-72-2 |
Carc. 1B Muta. 1B Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 |
H350 H340 H361f *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H361f *** H302 H411 |
|
|
|
|
609-066-00-0 |
lítno-draselná soľ kyseliny 3-amino-10-{4-(10-amino-6,13-dichlór-4,11-disulfobenzo[5,6][1,4]oxazino[2,3-b]fenoxazín-3-ylamino)-6-[metyl(2-sulfoetyl)amino]-1,3,5-triazín-2-ylamino}-6,13-dichlórbenzo[5,6][1,4]oxazino[2,3-b]fenoxazín-4,11-disulfónovej |
418-870-9 |
154212-58-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 2 ** |
H332 H312 H302 H371 ** |
GHS08 GHS07 Dgr |
H332 H312 H302 H371 ** |
|
|
|
|
609-067-00-6 |
draselno-sodná soľ kyseliny 2,2’-{[6-(3-aminopropylamino)-1,3,5-triazín-2,4-diyl]bis[(1-hydroxy-3-sulfonaftalén-6,2-diyl)diazenyl]}bis(5-metoxybenzénsulfónovej) |
416-280-6 |
156769-97-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
609-068-00-1 |
xylén pyžmový; 1-terc-butyl-3,5-dimetyl-2,4,6-trinitrobenzén |
201-329-4 |
81-15-2 |
Expl. 1.1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H400 H410 |
GHS01 GHS08 GHS09 Wng |
H201 H351 H410 |
|
|
T |
|
609-069-00-7 |
ketón pyžmový; 3,5-dinitro-2,6-dimetyl-4-terc-butylacetofenón; 4'-terc-butyl-2',6'-dimetyl-3',5'-dinitroacetofenón |
201-328-9 |
81-14-1 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
609-070-00-2 |
1-(1,1,2,3,3,3-hexafluórpropoxy)-2,5-dichlór-4-nitrobenzén |
415-580-4 |
130841-23-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
609-071-00-8 |
reakčná zmes zložená z týchto látok: 2,2’-[6-(metylsulfanyl)-1,3,5-triazín-2,4-diyl]bis(5-metoxyfenol); 2-[4,6-bis(metylsulfanyl)-1,3,5-triazín-2-yl]-5-metoxyfenol |
423-520-3 |
156137-33-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
609-072-00-3 |
4-mezyl-2-nitrotoluén |
430-550-0 |
1671-49-4 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H361f*** H302 H317 H412 |
GHS08 GHS07 Wng |
H361f*** H302 H317 H412 |
|
|
|
|
609-073-00-9 |
lítium-kálium-nátrium-N, N''-bis{7-[4-(4-chlór-1,3,5-triazín-2-yl)amino-4-(2-ureidofenyldiazenyl)]naftalén-1,3,6-trisulfonáto}-N'-(2-aminoetyl)piperazín |
427-850-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
610-001-00-3 |
trichlórnitrometán; chlórpikrín |
200-930-9 |
76-06-2 |
Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H330 H302 H319 H335 H315 |
GHS06 Dgr |
H330 H302 H319 H335 H315 |
|
|
|
|
610-002-00-9 |
1,1-dichlór-1-nitroetán |
209-854-0 |
594-72-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
610-003-00-4 |
chlórdinitrobenzén |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
C |
|
610-004-00-X |
2-chlór-1,3,5-trinitrobenzén |
201-864-3 |
88-88-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H330 H310 H300 H400 H410 |
GHS01 GHS06 GHS09 Dgr |
H201 H330 H310 H300 H410 |
|
|
|
|
610-005-00-5 |
1-chlór-4-nitrobenzén |
202-809-6 |
100-00-5 |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H351 H341 H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H351 H341 H331 H311 H301 H373 ** H411 |
|
|
|
|
610-006-00-0 |
chlórnitroanilíny, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H310 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H411 |
|
|
A C |
|
610-007-00-6 |
1-chlór-1-nitropropán |
209-990-0 |
600-25-9 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
|
610-008-00-1 |
2,6-dichlór-4-nitroanizol |
403-350-6 |
17742-69-7 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
610-009-00-7 |
2-chlór-4-nitroanilín |
204-502-2 |
121-87-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
610-010-00-2 |
2-bróm-1-(2-furyl)-2-nitroetén |
406-110-9 |
35950-52-8 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H317 H410 |
|
|
|
|
611-001-00-6 |
difenyldiazén |
203-102-5 |
103-33-3 |
Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H341 H332 H302 H373 ** H410 |
|
|
|
|
611-002-00-1 |
difenyldiazén-oxid |
207-802-1 |
495-48-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
611-003-00-7 |
fenaminosulf (ISO); nátrium-[4-(dimetylamino)fenyl]diazénsulfonát |
205-419-4 |
140-56-7 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 3 |
H301 H312 H412 |
GHS06 Dgr |
H301 H312 H412 |
|
|
|
|
611-004-00-2 |
[(metyl-ONN-azoxy)metyl]-acetát; metyl azoxy metyl acetát |
209-765-7 |
592-62-1 |
Carc. 1B Repr. 1B |
H350 H360D *** |
GHS08 Dgr |
H350 H360D *** |
|
|
|
|
611-005-00-8 |
dihydrogen-[2-oxido-5-{4'-[2,6-oxido-3-(2-oxido-5-sulfonátofenyldiazenyl)fenyldiazenyl]bifenyl-4-yldiazenyl}benzoáto(6-)]meďnatan disodný; CI primárna hnedá 95 |
240-221-1 |
16071-86-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
611-006-00-3 |
4-o-tolylazo-o-toluidín; 2-metyl-4-(2-metylfenyldiazenyl)anilín; stála garnetová GBC báza; AAT; o-aminoazotoulén |
202-591-2 |
97-56-3 |
Carc. 1B Skin Sens. 1 |
H350 H317 |
GHS08 Dgr |
H350 H317 |
|
|
|
|
611-007-00-9 |
tricyklazol (ISO); 5-metyl-1,2,4-triazolo[3,4-b]benzo-1,3-tiazol |
255-559-5 |
41814-78-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
611-008-00-4 |
4-aminoazobenzén; 4-(fenyldiazenyl)anilín |
200-453-6 |
60-09-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
611-009-00-X |
(1-{5-[4-(4-anilino-3-sulfonátofenyldiazenyl)-5-(metánsulfónamido)-2-metylfenyldiazenyl]-3-(fenyldiazenyl)-4-hydroxy-2-oxidofenyldiazenyl}-6-nitro-4-sulfonátonaftalén-2-oláto)železnatan sodný |
401-220-3 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
|
|
|
611-010-00-5 |
5'-(dipropylamino)-2'-(2-kyano-4,6-dinitrofenyldiazenyl)propánanilid |
403-010-7 |
106359-94-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
611-011-00-0 |
N, N,N',N'-tetrametyl-3,3'-{propán-1,2-diylbis[iminokarbonyl-4,1-fenyléndiazéndiyl(2-hydroxy-4-metyl-6-oxo-1,6-dihydropyridín-3,1-diyl)]}di(propán-1-amónium)-dilaktát |
403-340-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dg |
H318 H411 |
|
|
|
|
611-012-00-6 |
reakčná zmes zložená z {bis(2-hydroxyetyl)amónium}-6-metyl-2-[4-(2,4,6-triaminopyrimidín-5-yldiazenyl)fenyl]benzotiazol-7-sulfonátu a [2-hydroxyetyl(metyl)amónium]-6-metyl-2-[4-(2,4,6-triaminopyrimidín-5-yldiazenyl)fenyl]benzotiazol-7-sulfonátu a [dietyl(3-aminopropyl)amónium]-6-metyl-2-[4-(2,4,6-triaminopyrimidín-5-yldiazenyl)fenyl]benzotiazol-7-sulfonátu |
403-410-1 |
114565-65-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-013-00-1 |
trilítium-4-hydroxy-3-{3-metyl-4-[2-metoxy-4-(3-sulfonátofenyldiazenyl)fenyldiazenyl]fenyldiazenyl}-6-3-sulfonátoanilino)-naftalén-2-sulfonát |
403-650-7 |
117409-78-6 |
Expl. 1.3 **** Aquatic Chronic 2 |
H203 H411 |
GHS01 GHS09 Dgr |
H203 H411 |
|
|
|
|
611-014-00-7 |
tetranátrium-(1-{4-[3-acetamido-4-(4'-nitro-2,2'-disulfonátostilbén-4-yldiazenyl)anilino]-6-(2,5-disulfonátoanilino)-1,3,5-triazín-2-yl}pyridínium-3-karboxylát) |
404-250-5 |
115099-55-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-015-00-2 |
tetranátrium-4-amino-5-hydroxy-6-(4-{2-[2-(sulfonátooxy)etylsulfonyl]etylkarbamoyl}fenyldiazenyl)-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát |
404-320-5 |
116889-78-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-016-00-8 |
reakčná zmes zložená zo zmesi izomérov 1,1'-[(dihydroxyfenylén)bis(diazéndiyl-3,1-fenyléndiazéndiyl{1-[3-(dimetylamónio)propyl]-6-hydroxy-4-metyl-2-oxo-1,2-dihydropyridín-5,3-diyl})]dipyridínium-tetrachloridu a 1-{1-[3-(dimetylamónio)propyl]-5-[3-(4-{1-[3-(dimetylamónio)propyl]-2-hydroxy-4-metyl-6-oxo-5-pyridínio-1,6-dihydro-3-pyridyldiazenyl]fenyldiazenyl}-2,4(alebo 2,6 alebo 3,5)-dihydroxyfenyldiazenyl)fenyldiazenyl]-6-hydroxy-4-metyl-2-oxo-1,2-dihydro-3-pyridyl}pyridínium-tetrachloridu |
404-540-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-017-00-3 |
2-{4-[3-(dietylamino)propylkarbamoyl]fenyldiazenyl}-3-oxo-N-(2-oxo-2,3-dihydrobenzimidazol-5-yl)butánamid |
404-910-2 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-018-00-9 |
tetraamónium-5-[4-(7-amino-1-hydroxy-3-sulfonáto-2-naftyldiazenyl)-6-sulfonáto-1-naftyldiazenyl]izoftalát |
405-130-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-019-00-4 |
tetralítium-6-amino-4-hydroxy-3-[7-sulfonáto-4-(4-sulfonátofenyldiazenyl)-1-naftyldiazenyl]naftalén-2,7-disulfonát |
405-150-4 |
106028-58-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-020-00-X |
tetrakis(tetrametylamónium)-6-amino-4-hydroxy-3-[7-sulfonáto-4-(4-sulfonátofenyldiazenyl)-1-naftyldiazenyl]naftalén-2,7-disulfonát |
405-170-3 |
116340-05-7 |
Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H317 H412 |
GHS06 Dgr |
H301 H317 H412 |
|
|
|
|
611-021-00-5 |
O-{2-[N-etyl-4-(4-kyano-3-metylizotiazol-5-yldiazenyl)-3-metylanilino]etyl}-acetát |
405-480-9 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 4 |
H302 H373 ** H315 H413 |
GHS08 GHS07 Wng |
H302 H373 ** H315 H413 |
|
|
|
|
611-022-00-0 |
[4-(dimetylamino)benzéndiazónium]-4-hydroxy-3-karboxybenzénsulfonát |
404-980-4 |
— |
Self-react. C Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H331 H301 H312 H373 ** H318 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H242 H331 H301 H312 H373 ** H318 H317 H410 |
|
|
T |
|
611-023-00-6 |
dinátrium-7-(4,6-dichlór-1,3,5-triazín-2-ylamino)-4-hydroxy-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2-sulfonát |
404-600-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-024-00-1 |
diazénové farbivá na báze benzidínu; 4,4'-bis(aryldiazenyl)bifenylové farbivá, okrem tých, ktoré sú špecifikované inde v tejto prílohe |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
|
611-025-00-7 |
dinátrium-4-amino-3-{4'-[(2,4-diaminofenyl)diazenyl]bifenyl-4-yldiazenyl}-5-hydroxy-6-(fenyldiazenyl)naftalén-2,7-disulfonát; C.I. primárna čierna 38 |
217-710-3 |
1937-37-7 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
|
611-026-00-2 |
tetranátrium-3,3'-[(bifenyl-4,4'-diyl)bis(diazéndiyl)]bis(5-amino-4-hydroxynaftalén-2,7-disulfonát); C.I. primárna modrá 6 |
220-012-1 |
2602-46-2 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
|
611-027-00-8 |
dinátrium-3,3'-[(bifenyl-4,4'-diyl)bis(diazéndiyl)]bis(4-aminonaftalén-1-sulfonát); C.I. primárna červená 28 |
209-358-4 |
573-58-0 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
|
611-028-00-3 |
diazéndikarboxamid |
204-650-8 |
123-77-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
G |
|
611-029-00-9 |
diazénové farbivá na báze 3,3’-dimetoxybifenyl-4,4’-diamínu; 4,4'-bis(aryldiazenyl)-3,3'-dimetoxybifenylové farbivá, okrem tých, ktoré sú uvedené inde v tejto prílohe |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
|
611-030-00-4 |
diazénové farbivá na báze 3,3’-dimetylbifenyl-4,4’-diamínu; 4,4'-bis(aryldiazenyl)-3,3'-dimetylfenylové farbivá, okrem tých, ktoré sú uvedené inde v tejto prílohe |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
|
611-031-00-X |
4-[bis(4-aminofenyl)metylidén]cyklohexa-2,5-diénimínium-chlorid; C.I. zásaditá červená 9 |
209-321-2 |
569-61-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
611-032-00-5 |
1,4,5,8-tetraaminoantrachinón; C.I. disperzná modrá 1 |
219-603-7 |
2475-45-8 |
Carc. 1B Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H350 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H315 H318 H317 |
|
|
|
|
611-033-00-0 |
[4,4''-azoxybis(2,2'-disulfonátostilbén-4,4'-diyldiazenyl)]bis[5'-sulfonátobenzén-2,2'-dioláto-O(2),O(2),N(1)]meďnatan hexasodný |
400-020-3 |
82027-60-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-034-00-6 |
5’-[bis(2-metoxyetyl)amino]-2’-(5-nitro-2,1-benzoizotiazol-3-yldiazenyl}acetanilid |
402-430-8 |
105076-77-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-035-00-1 |
tetralítium-6-amino-4-hydroxy-3-[7-sulfonáto-4-(5-sulfonáto-2-naftyldiazenyl)-1-naftyldiazenyl]naftalén-2,7-disulfonát |
403-660-1 |
107246-80-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-036-00-7 |
O-(2-{4-[5,6(alebo 6,7)-dichlór-1,3-benzotiazol-2-yldiazenyl]-N-metyl-3-metylanilino}etyl)-acetát |
405-440-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-037-00-2 |
3(alebo 5)-{4-[benzyl(etyl)amino]-2-metylfenyldiazenyl}1,4-dimetyl-1,2,4-triazólium)-metyl-sulfát |
406-055-0 |
124584-00-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
611-038-00-8 |
trinátrium-4-[4-(benzénsulfonyloxy)fenyldiazenyl]-4'-(1-hydroxy-4-sulfonáto-2-naftyldiazenyl)-3,3'-dimetylbifenyl-2,2'-disulfonát |
406-820-9 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
611-039-00-3 |
kyselina 7-(4,6-dichlór-1,3,5-triazín-2-ylamino)-4-hydroxy-3-(4-{[2-(sulfoxy)etyl]sulfonyl}fenyldiazenyl)naftalén-2-sulfónová |
407-050-6 |
117715-57-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-040-00-9 |
kyselina 3-[5-acetamido-4-(4-{4,6-bis[3-(dietylamino)propylamino]-1,3,5-triazín-2-ylamino}fenyldiazenyl)-2-(2-metoxyetoxy)fenyldiazenyl]-6-amino-4-hydroxynaftalén-2-sulfónová |
407-670-7 |
115099-58-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
611-041-00-4 |
2-(4-{4,6-bis[3-(dietylamino)propylamino]-1,3,5-triazín-2-ylamino}fenyldiazenyl)-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-3-oxobutánamid |
407-680-1 |
98809-11-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
611-042-00-X |
trinátrium-5-amino-3-[5-(2-brómakrylamido)-2-sulfonátofenyldiazenyl]-4-hydroxy-6-[4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát |
411-770-6 |
136213-71-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-043-00-5 |
reakčná zmes zložená z týchto látok (2:1:1): bis{7-[1-(fenylkarbamoyl)-2-hydroxyprop-1-én-1-yldiazenyl]-4-oxido-3-(oxidofenyldiazenyl)-8-sulfamoyl-naftalén-2-sulfonáto}chromitan trisodný; bis(7-{[(2-amino-4-hydroxyfenyl)diazenyl] alebo [(2-amino-6-hydroxyfenyl)diazenyl] alebo [(4-amino-2-hydroxyfenyl)diazenyl]}-4-oxido-3-(2-oxidofenyldiazenyl)-8-sulfamoylnaftalén-2-sulfonáto)chromitan trisodný; (7-{[(2-amino-4-hydroxyfenyl)diazenyl] alebo [(2-amino-6-hydroxyfenyl)diazenyl] alebo [(4-amino-2-hydroxyfenyl)diazenyl]}-4-oxido-3-(2-oxidofenyldiazenyl)-8-sulfamoylnaftalén-2-sulfonáto)-{7-[1-(fenylkarbamoyl)-2-hydroxyprop-1-én-1-yldiazenyl]-4-oxido-3-(oxidofenyldiazenyl)-8-sulfamoyl-naftalén-2-sulfonáto}chromitan trisodný |
402-850-1 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-044-00-0 |
reakčná zmes zložená z týchto látok: bis[1-(5-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]chromitan (terc-C12-C14-alkyl)amónia; bis[1-(4-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]chromitan (terc-C12-C14-alkyl)amónia; bis{1-[5-(1,1-dimetylpropyl)-3-nitro-2-oxidofenyldiazenyl]naftalén-2-oláto(-2-)}chromitan (terc-C12-C14-alkyl)amónia; [1-(4-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]-[1-(5-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]chromitan (terc-C12-C14-alkyl)amónia; {1-[5-(1,1-dimetylpropyl)-3-nitro-2-oxidofenyldiazenyl]naftalén-2-oláto(2-)}-[1-(5-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]chromitan (terc-C12-C14-alkyl)amónia; {1-[4(alebo 5)-nitro-2-oxidofenyldiazenyl)naftalén-2-oláto(2-)]-[1-(3-nitro-2-oxido-5-pentylfenyldiazenyl)naftalén-2-oláto(2-)]chromitan (terc-C12-C14-alkyl)amónia |
403-720-7 |
117527-94-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-045-00-6 |
O-(4-{[4-(3-acetyl-5-nitrotiofén-2-yldiazenyl)-3-metylfenyl](etyl)amino}butyl)-acetát |
404-830-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-046-00-1 |
3-metyl-4,4’-diazéndiyldi(anilín) |
407-590-2 |
43151-99-1 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H317 H410 |
|
|
|
|
611-047-00-7 |
reakčná zmes zložená z týchto látok (1:1): O-(2-{[4-(5,6-dichlórbenzotiazol-2-yldiazenyl)fenyl](etyl)amino}etyl)-acetát; O-(2-{[4-(6,7-dichlórbenzotiazol-2-yldiazenyl)fenyl](etyl)amino}etyl)-acetát |
407-890-3 |
111381-11-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-048-00-2 |
reakčná zmes zložená z týchto látok (1:1): 2,2’-{[4-(5,6-dichlórbenzotiazol-2-yldiazenyl)fenyl]imino}dietyl-diacetát; 2,2’-{[4-(6,7-dichlórbenzotiazol-2-yldiazenyl)fenyl]imino}dietyl-diacetát |
407-900-6 |
111381-12-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-049-00-8 |
reakčná zmes zložená z týchto látok (2:1:1): 7-{4-[3-(dietylamino)propylamino]-6-[3-(dietylamónio)propylamino]-1,3,5-triazín-2-ylamino}-3-[4-(fenyldiazenyl)fenyldiazenyl]-4-hydroxynaftalén-2-sulfonát; kyselina octová; kyselina mliečna |
408-000-6 |
118658-98-3 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 Wng |
H373 ** H317 H412 |
|
|
|
|
611-050-00-3 |
reakčná zmes zložená z týchto látok: pentanátrium-7-amino-3-[4-(4-{4-[4-(6-amino-1-hydroxy-3-sulfonátonaftalén-2-yldiazenyl)-7-sulfonáto-1-naftyldiazenyl]anilino}-3-sulfonátofenyldiazenyl)-6-sulfonátonaftalén-1-yldiazenyl]-4-hydroxynaftalén-2-sulfonát; pentanátrium-7-amino-8-[4-(4-{4-[4-(2-amino-5-hydroxy-7-sulfonátonaftalén-1-yldiazenyl)-7-sulfonátonaftalén-1-yldiazenyl]anilino}-3-sulfonátofenyldiazenyl)-6-sulfonátonaftalén-1-yldiazenyl]-4-hydroxynaftalén-2-sulfonát; pentanátrium-7-amino-8-[4-(4-{4-[4-(6-amino-1-hydroxy-3-sulfonátonaftalén-1-yldiazenyl)-7-sulfonátonaftalén-1-yldiazenyl]anilino}-3-sulfonátofenyldiazenyl)-6-sulfonátonaftalén-1-yldiazenyl]-4-hydroxynaftalén-2-sulfonát; tetranátrium-7-amino-4-hydroxy-3-(4-{4-[4-(4-hydroxy-7-sulfonátonaftalén-1-yldiazenyl)-2-sulfonátoanilino]fenyldiazenyl}-6-sulfonátonaftalén-1-yldiazenyl)naftalén-2-sulfonát; tetranátrium-7-amino-4-hydroxy-3-(4-{4-[4-(4-amino-7-sulfonátonaftalén-1-yldiazenyl)-2-sulfonáto-anilino]fenyldiazenyl}-6-sulfonátonaftalén-1-yldiazenyl)naftalén-2-sulfonát |
415-350-3 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-051-00-9 |
2-{4-[etyl(2-hydroxyetyl)amino]-2-metylfenyldiazenyl}-6-metoxy-3-metylbenzotiazólium-chlorid |
411-110-7 |
136213-74-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
611-052-00-4 |
aqua-{5-[5-(3,5-dinitro-2-oxidofenyldiazenyl)-2,4-dioxidofenyldiazenyl]naftalén-2-sulfonáto}železitan sodný |
400-720-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-053-00-X |
dihydrochlorid 2,2'-diazéndiylbis(2-metylpropánimidamidu) |
221-070-0 |
2997-92-4 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
611-055-00-0 |
C.I. disperzná žltá 3; N-[4-(2-hydroxy-5-metylfenyldiazenyl)fenyl]acetamid |
220-600-8 |
2832-40-8 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
|
611-056-00-6 |
C.I. rozpúšťadlová žltá 14; 1-(fenyldiazenyl)-2-naftol |
212-668-2 |
842-07-9 |
Carc. 2 Muta. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H341 H317 H413 |
GHS08 GHS07 Wng |
H351 H341 H317 H413 |
|
|
|
|
611-057-00-1 |
5-[4-(fenyldiazenyl)fenyldiazenyl]-6-hydroxy-1-(3-izopropoxypropyl)-4-metyl-2-oxo-1,2-dihydropyridín-3-karbonitril |
400-340-3 |
85136-74-9 |
Carc. 1B Aquatic Chronic 4 |
H350 H413 |
GHS08 Wng |
H350 H413 |
|
|
|
|
611-058-00-7 |
{3-[4-hydroxy-3-(2-metoxyfenyldiazenyl)-7-sulfonáto-2-naftylamino]-1,3,5-triazín-2,4-diyl}bis(2-aminopropán-1-amónium)-formiát |
402-060-7 |
108225-03-2 |
Carc. 1B Eye Dam. 1 Aquatic Chronic 2 |
H350 H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H350 H318 H411 |
|
|
|
|
611-059-00-2 |
oktanátrium-6-[6-(4-{3-[({4-[6-(3,5-disulfonáto-2-naftyldiazenyl)-5-hydroxy-2-naftylamino]-6-chlór-1,3,5-triazín-2-yl}(metyl)amino)metyl]fenylamino}-6-chlór-1,3,5-triazín-2-ylamino)-3-disulfonáto-1-hydroxy-2-naftyldiazenyl]naftalén-1,5-disulfonát |
412-960-1 |
148878-21-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
611-060-00-8 |
reakčná zmes zložená z týchto látok: sodná soľ kyseliny 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalovej; amónna soľ kyseliny 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalovej; kyselina 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalová |
413-180-4 |
187285-15-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-061-00-3 |
dinátrium-5-{5-[4-(2,6-difluór-5-chlórpyrimidín-4-ylamino)benzamido]-2-sulfonátofenyldiazenyl}-1-etyl-6-hydroxy-4-metyl-2-oxo-3-pyridylmetánsulfonát |
412-530-3 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-062-00-9 |
oktanátrium-2-(8-{4-[3-({4-[7-(1,5-disulfonátonaftalén-2-yldiazenyl)-8-hydroxy-3,6-disulfonáto-naftalén-1-ylamino]-6-chlór-1,3,5-triazín-2-yl}aminometyl)fenylamino]-6-chlór-1,3,5-triazín-2-ylamino}-3,6-disulfonáto-1-hydroxynaftalén-2-yldiazenyl)naftalén-1,5-disulfonát |
413-550-5 |
— |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
|
611-063-00-4 |
[5-(8-acetamido-3,6-disulfonáto-2-naftyldiazenyl)-5'-(6-benzamido-3-sulfonáto-2-naftyldiazenyl)bifenyl-3,4,3',4'-tetraoláto-O 3,O 4,O 3',O 4']meďnatan trisodný |
413-590-3 |
164058-22-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
611-064-00-X |
2,6-di-sek-butyl-4-(3,4-dichlórfenyldiazenyl)fenol |
410-600-8 |
124719-26-2 |
STOT RE 2 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H315 H410 |
|
|
|
|
611-065-00-5 |
2,6-di-sek-butyl-4-(4-nitrofenyldiazenyl)fenol |
410-610-2 |
111850-24-9 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H317 H410 |
|
|
|
|
611-066-00-0 |
tetranátrium-3-(1,5-disulfonátonaftalén-2-yldiazenyl)-5-[4-(N-etylanilino)-6-chlór-1,3,5-triazín-2-ylamino]-4-hydroxynaftalén-2,7-disulfonát |
411-540-5 |
130201-57-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
611-067-00-6 |
reakčná zmes zložená z týchto látok: bis{tris[2-(1-hydroxypropán-2-yloxy)etyl]amónium}-7-anilino-4-hydroxy-3-[2-metoxy-5-metyl-4-(4-sulfonátofenyldiaenyl)fenyldiazenyl]naftalén-2-sulfonát; bis{tris[2-(2-hydroxypropoxy)etyl]amónium}-7-anilino-4-hydroxy-3-[2-metoxy-5-metyl-4-(4-sulfonátofenyldiaenyl)fenyldiazenyl]naftalén-2-sulfonát |
406-910-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
611-068-00-1 |
tetranátrium-4-amino-5-hydroxy-3,6-bis(5-[4-(2-hydroxyetylamino)-6-chlór-1,3,5-triazín-2-ylamino]-2-sulfonátofenyldiazenyl)naftalén-2,7-disulfonát |
400-690-7 |
85665-98-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-069-00-7 |
4-[(3,5-dikyano-4-metyl-2-tienyl)diazenyl)]-3-metyl-N, N-di[poly(oxyetylén)-co-poly(oxypropán-2,1-diyl)]anilín |
413-380-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-070-00-2 |
reakčná zmes zložená z týchto látok: [3-(3,5-dinitro-2-oxidofenyldiazenyl)-7-(4-metoxyanilino)-4-oxidonaftalén-2-sulfonáto]-[1-(5-chlór-2-oxidofenyldiazenyl)naftalén-2-oláto]chromitan disodný; bis[3-(3,5-dinitro-2-oxidofenyldiazenyl)-7-(4-metoxyanilino)-4-oxidonaftalén-2-sulfonáto]chromitan trisodný |
405-665-4 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
611-071-00-8 |
tris(tetrametylamónium)-5-hydroxy-1-(4-sulfonátofenyl)-4-(4-sulfonátofenyldiazenyl)pyrazol-3-karboxylát |
406-073-9 |
131013-81-5 |
Acute Tox. 3 * Aquatic Chronic 3 |
H301 H412 |
GHS06 Dgr |
H301 H412 |
|
|
|
|
611-072-00-3 |
N, N,N’,N’-tetrametyl{2,2’-[2,4-dihydroxy-1,3-fenylénbis(diazéndiyl-4,1-fenylénkarbonyloxy)]bis(etánamónium)-dichlorid |
407-010-8 |
118208-02-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
611-073-00-9 |
O, O’-dimetyl-3,3'-{N-[4-(4-bróm-2,6-dikyanofenyldiazenyl)-3-hydroxyfenyl]imino}dipropanoát |
407-310-9 |
122630-55-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-074-00-4 |
reakčná zmes zložená z týchto látok (1:1): (3-{4-[5-(5-chlór-2,6-difluórpyrimidín-4-ylamino)-2-metoxy-3-sulfonátofenyldiazenyl]-2-oxidofenyldiazenyl}-2,5,7-trisulfonátonaftalén-4-oláto)meďnatan draselno-sodný; (3-{4-[5-(4,6-difluór-5-chlórpyrimidín-2-ylamino)-2-metoxy-3-sulfonátofenyldiazenyl]-2-oxidofenyldiazenyl}-2,5,7-trisulfonátonaftalén-4-oláto)meďnatan draselno-sodný |
407-100-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-075-00-X |
reakčná zmes zložená z týchto látok (2:1): tris(3,5,5-trimetylhexylamónium)-4-amino-3-{4-[4-(2-amino-4-hydroxyfenyldiazenyl)anilino]-3-sulfonátofenyldiazenyl}-6-(fenylhydrazono)-5-oxo-5,6-dihydronaftalén-2,7-disulfonát; tris(3,5,5-trimetylhexylamónium)-4-amino-3-{4-[4-(4-amino-2-hydroxyfenyldiazenyl)anilino]-3-sulfonátofenyldiazenyl}-6-(fenylhydrazono)-5-oxo-5,6-dihydronaftalén-2,7-disulfonát |
406-000-0 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-076-00-5 |
3-(2,6-dichlór-4-nitrofenyldiazenyl)-2-fenyl-1-metylindol |
406-280-4 |
117584-16-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
611-077-00-0 |
[3,3’-(3,3’-dioxidobifenyl-4,4’-diylbisdiazéndiyl)bis(5-amino-4-oxidonaftalén-2,7-disulfonáto)]dimeďnatan dilítno-disodný |
407-230-4 |
126637-70-5 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
611-078-00-6 |
mliečnan-octan [3,3'-[3,3'-dioxidobifenyl-4,4'-diyl)bis(diazéndiyl)]bis(7-{4-[(3-(dietylamino)propylamino]-6-[-3-(dietylamónio)propylamino]1,3,5-triazín-2-ylamino}-4-oxidonaftalén-2-sulfonáto)]dimeďný |
407-240-9 |
159604-94-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-079-00-1 |
dinátrium-7-[4-(N-etyl-2-metylanilino)-6-chlór-1,3,5-triazín-2-ylamino]-4-hydroxy-3-(4-metoxy-2-sulfonátofenyldiazenyl)naftalén-2-sulfonát |
410-390-8 |
147703-64-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-080-00-7 |
nátrium-3-{2-acetamido-4-[4-(2-hydroxybutoxy)fenyldiazenyl]fenyldiazenyl}benzénsulfonát |
410-150-2 |
147703-65-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-081-00-2 |
[7-{5-hydroxy-2-oxido-κO 2-7-sulfonáto-6-[4-(2,5,6-trichlór-pyrimidín-4-ylamino)fenyldiazenyl]-(N 1,N 7-N)-1-naftyldiazenyl}-8-oxido-κO 8-naftalén-1,3,5-trisulfonáto(6-)]meďnatan tetrasodný |
411-470-5 |
141048-13-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
611-082-00-8 |
reakčná zmes zložená z týchto látok: bis{1-[3(alebo 5)-(4-anilino-3-sulfonátofenyldiazenyl)-4-hydroxy-2-oxidofenyldiazenyl]-6-nitro-4-sulfonátonaftalén-2-oláto}železitan pentasodný; ({1-[3-(4-anilino-3-sulfonátofenyldiazenyl)-4-hydroxy-2-oxidofenyldiazenyl]-6-nitro-4-sulfonátonaftalén-2-oláto}-{1-[5-(4-anilino-3-sulfonátofenyldiazenyl)-4-hydroxy-2-oxidofenyldiazenyl]-6-nitro-4-sulfonátonaftalén-2-oláto}železitan pentasodný |
407-570-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-083-00-3 |
reakčná zmes zložená z týchto látok (1:1): {2-[4-(5,6-dichlórbenzotiazol-2-yldiazenyl)-N-etyl-3-metylanilino]etyl}-acetát; {2-[4-(6,7-dichlórbenzotiazol-2-yldiazenyl)-N-etyl-3-metylanilino]etyl}-acetát |
411-560-4 |
— |
STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H372 ** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H317 H411 |
|
|
|
|
611-085-00-4 |
reakčná zmes zložená z týchto látok: 6-[3-(2-fenoxyetoxy)propylamino]-2-(2-hydroxyetylamino)-5-(2-kyano-4-nitrofenyldiazenyl)-4-metylpyridín-3-karbonitril; 2-[3-(2-fenoxyetoxy)propylamino]-6-(2-hydroxyetylamino)-5-(2-kyano-4-nitrofenyldiazenyl)-4-metylpyridín-3-karbonitril; 2-amino-6-[3-(3-hydroxypropoxy)propylamino]-5-(2-kyano-4-nitrofenyldiazenyl)-4-metylpyridín-3-karbonitril; 6-amino-5-(2-kyano-4-nitrofenyldiazenyl)-4-metyl-2-[3-(3-metoxypropoxy)propylamino]pyridín-3-karbonitril |
411-880-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-086-00-X |
monohydrát 5-[2,4-dioxido-5-(2-oxido-3,5-dinitrofenyldiazenyl)fenyldiazenyl]naftalén-2-sulfonát]železitanu monolítneho |
411-360-7 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-087-00-5 |
reakčná zmes zložená z týchto látok: O-(2-fenoxyetyl)-3-(2-hydroxy-5-kyano-1,4-dimetyl-6-oxo-1,6-dihydropyridín-3-yldiazenyl)benzoát; [2-(2-etylfenoxy)etyl]-(3-[(2-hydroxy-5-kyano-1,4-dimetyl-6-oxo-1,6-dihydropyridín-3-yl)diazenyl]benzoát) |
411-710-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-088-00-0 |
reakčná zmes zložená z týchto látok: trilítium-4-amino-3-{4-[4-(2-amino-4-hydroxyfenyldiazenyl)fenylamino]-3-sulfonátofenyldiazenyl}-6-(fenyldiazenyl)5-hydroxynaftalén-2,7-disulfonát; trilítium-4-amino-3-{4-[4-(4-amino-2-hydroxyfenyldiazenyl)fenylamino]-3-sulfonátofenyldiazenyl}-6-(fenyldiazenyl)-5-hydroxynaftalén-2,7-disulfonát |
411-890-9 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
611-089-00-6 |
(2-{4-[etyl(2-hydroxyetyl)amino]-2-metylfenyldiazenyl}-6-metoxy-3-metylbenzotiazólium)-metyl-sulfát |
411-100-2 |
136213-73-5 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
|
611-090-00-1 |
[2,5-dibutoxy-4-(morfolín-4-yl)benzéndiazónium]-4-metylbenzénsulfonát |
413-290-2 |
93672-52-7 |
Self-react. C Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H242 H302 H318 H317 H412 |
GHS02 GHS05 GHS07 Dgr |
H242 H302 H318 H317 H412 |
|
|
T |
|
611-091-00-7 |
nátrium(1,0-1,95)/lítium(0,05-1)-{5-[5-(6-fluór-5-chlórpyrimidín-4-ylamino)-2-sulfonátofenyldiazenyl]-6-hydroxy-1,4-dimetyl-2-oxo-1,2-dihydropyridín-3-yl}metánsulfonát |
413-470-0 |
134595-59-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-092-00-2 |
bis(3-{4-[5-(1,1-dimetylpropyl)-3-nitro-2-oxidofenyldiazenyl]-3-metyl-5-oxidopyrazol-1-yl}benzénsulfónamidáto)chromitan terc-dodecyl(alebo tetradecyl)amónia |
413-210-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-093-00-8 |
nátrium-2-{4-[4-fluór-6-(2-sulfoetylamino)-1,3,5-triazín-2-ylamino]-2-ureidofenyldiazenyl}-5-(4-sulfofenyldiazenyl)benzén-1-sulfonát |
410-770-3 |
146177-84-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-094-00-3 |
reakčná zmes zložená z týchto látok (1:1): (2,2’-{N-[3-acetamido-4-(5,6-dichlór-1,3-benzotiazol-2-yldiazenyl)fenyl]imino}dietyl)-dietyl-dikarbonát; (2,2’-{N-[3-acetamido-4-(6,7-dichlór-1,3-benzotiazol-2-yldiazenyl)fenyl]imino}dietyl)-dietyldikarbonát |
411-600-0 |
143145-93-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-095-00-9 |
hexanátrium-1,1'-((1-amino-8-hydroxy-3,6-disulfonátonaftalén-2,7-diyl)bis{diazéndiyl(4-sulfonáto-1,3-fenylén)imino[6-[(4-chlór-3-sulfonátofenyl)amino]-1,3,5-triazín-2,4-diyl})bis(pyridínium-3-karboxylát) |
412-240-7 |
89797-03-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-096-00-4 |
metyl-N-[3-acetamido-4-(2-kyano-4-nitrofenyldiazenyl)fenyl]-N-(1-metoxyacetyl)glycinát |
413-040-2 |
149850-30-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-097-00-X |
reakčná zmes komplexov železa s týmito zlúčeninami: 4,4’-dihydroxy-N-fenyl-3,3’-[(a, b-dihydroxy-1,n-fenylén)bis(diazéndiyl)]di(benzénsulfónamid), kde n = 2, a = 3, b = 4 alebo n = 3, a = 2, b = 4 alebo n = 3, a = 4, b = 5; a kyselina 2-(4-{a, b-dihydroxy-c-[5-(fenylaminosulfonyl)-2-hydroxyfenyldiazenyl]fenyldiazenyl}fenylamino)-5-nitrobenzénsulfónová, kde a = 2, b = 6, c = 3 alebo a = 2, b = 4, c = 5 alebo a = 3, b = 5, c = 2 |
414-150-3 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-098-00-5 |
tetrakis(tetrametylamónium)-3,3'-{[6-(2-hydroxyetylamino)-1,3,5-triazín-2,4-diyl]bis[imino(2-metyl-4,1-fenylén)diazéndiyl]}di(naftalén-1,5-disulfonát) |
405-950-3 |
131013-83-7 |
Acute Tox. 3 * Aquatic Chronic 3 |
H301 H412 |
GHS06 Dgr |
H301 H412 |
|
|
|
|
611-099-00-0 |
1,1’-(metylénbis{4,1-fenyléndiazéndiyl[1-(3-(dimetylamónio)propyl)-6-hydroxy-4-metyl-2-oxo-1,2-dihydropyridín-5,3-diyl]}dipyridínium-tetrachlorid |
401-500-5 |
118658-99-4 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
|
611-100-00-4 |
kálium-nátrium-3,3'-{[3(alebo 4)-metyl-1,2-fenylén]bis[imino(6-chlór-1,3,5-triazín-4,2-diyl)imino(2-acetamido-5-metoxy-4,1-fenylén)diazéndiyl]}di(naftalén-1,5-disulfonát) |
403-810-6 |
140876-13-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-101-00-X |
2'-(5-formyl-4-chlór-3-kyano-2-tienyldiazenyl)-5'-(dietylamino)acetanilid |
405-200-5 |
104366-25-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-102-00-5 |
produkt reakcie C.I. leukoformy sírovej čiernej 1 a reakčnej zmesi zloženej z týchto látok: dinátrium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylfenyldiazenyl)-3,6- disulfonátonaftalén-2-yldiazenyl]benzénsulfónamido}benzéndiazónium-chlorid; dinátrium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonátonaftalén-1- yldiazenyl)fenyldiazenyl]benzénsulfónamido}benzéndiazónium-chlorid |
424-500-7 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-103-00-0 |
[3-2-karbamoyl-5-oxido-7-sulfonátonaftalén-1-yldiazenyl)-2-oxido-5-sulfonátobenzoáto]nikelnatan trisodný |
407-110-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
611-104-00-6 |
reakčná zmes zložená z týchto látok: [2,4(alebo 2,6 alebo 4,6)-bis(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxyfenoláto]-[2(alebo 4 alebo 6)-(3,5-dinitro-2-oxidofenyldiazenyl)5-hydroxy-4(alebo 2 alebo 6)-(4-nitro-2-sulfonátofenyldiazenyl)fenoláto]železitan trisodný; bis[2,4(alebo 2,6 alebo 4,6)-bis(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxyfenoláto]železitan trisodný; [2,4(alebo 2,6 alebo 4,6)-bis(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxyfenoláto]-[2(alebo 4 alebo 6)-(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxy-4(alebo 2 alebo 6)-(4-nitro-2-sulfonátofenyldiazenyl)fenoláto]železitan trisodný; [2,4(alebo 2,6 alebo 4,6)-bis(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxyfenoláto]-[2(alebo 4 alebo 6)-(3,5-dinitro-2-oxidofenyldiazenyl)-5-hydroxy-4(alebo 2 alebo 6)-(3-sulfonátofenyldiazenyl)fenoláto]železitan trisodný; dinátrium-3,3'-{[2,4-dihydroxy-1,3(alebo 1,5 alebo 3,5)-fenylén]bis(diazéndiyl)}di(benzénsulfonát) |
406-870-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-105-00-1 |
nátrium-4-[4-(N-etylanilino)-6-chlór-1,3,5-triazín-2-ylamino]-2-[5-hydroxy-1-(2-chlórfenyl)- 3-metyl-1H-pyrazol-4-yldiazenyl]benzénsulfonát |
407-800-2 |
136213-75-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-106-00-7 |
hexanátrium-4,4'-dihydroxy-3,3'-bis[2-sulfonáto-4-(4-sulfonátofenyldiazenyl)fenyldiazenyl]-7,7'-{[1,4-fenylénbis[imino(6-chlór-1,3,5-triazín-4,2-diyl)imino]}di(naftalén-2-sulfonát) |
410-180-6 |
157627-99-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-107-00-2 |
kálium-nátrium-4-{4-[7-(5,8-disulfonáto-naftalén-2-yldiazenyl)-8-hydroxy-3,6-disulfonátonaftalén-1-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}-5-hydroxy-6-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-1,7-disulfonát |
412-490-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-108-00-8 |
dinátrium-8-(fenylamino)-5-[4-(4-chlór-3-sulfonátofenyldiazenyl)-1-naftyldiazenyl]naftalén-1-sulfonát |
413-600-6 |
6527-62-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-109-00-3 |
produkty reakcie síranu meďnatého a tetranátrium-4,4’-dihydroxy-3,3’-bis(2-metoxy-5-sulfonátofenyldiazenyl)-7,7’-{[6-(2-hydroxyetylamino)-1,3,5-triazín-2,4-diyl]bis(imino)}di(naftalén-2-sulfonátu) (2:1) |
407-710-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-110-00-9 |
tetra(lítium/nátrium)-5-amino-3-{4-[4-(8-amino-1-hydroxy-3,6-disulfonátonaftalén-2-yldiazenyl)fenyldiazenyl]-2-metylfenyldiazenyl}-4-hydroxynaftalén-2,7-disulfonát |
408-210-8 |
124605-82-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-111-00-4 |
(2-{4-[(2-chlóretyl)sulfonyl]fenyl}-C-[(2-hydroxy-5-sulfonáto-3-{[2-(sulfonátooxy)etyl]sulfonyl}fenyl)diazenyl]-4-sulfonátobenzoáto)meďnatan disodný |
414-230-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-112-00-X |
tetranátrium-4-hydroxy-5-(4-(morfolín-4-yl)-6-{3-[2-(sulfonátooxy)etylsulfonyl]fenylamino}-1,3,5-triazín-2-ylamino)-3-(1-sulfonátonaftalén-2-yldiazenyl)naftalén-2,7-disulfonát |
413-070-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-113-00-5 |
{(2-[5-(2,5-dichlórfenyldiazenyl)-2- oxidobenzylidénamino]benzoáto(2-)}-[2-(1-fenyl-3-metyl-5-oxidopyrazol-4- yldiazenyl)-5-sulfonátobenzoáto(3-)]chromitan lítno-sodný |
414-280-0 |
149626-00-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-114-00-0 |
[4-(5-chlór-2-oxidofenyldiazenyl)-5-metyl-2,4-dihydro-3H-pyrazol-3-onáto(2-)]-{3-[3-metyl-1-(4-metylfenyl)-5-oxidopyrazol-4-yldiazenyl]-4-oxido-5-nitrobenzénsulfonáto(3-)}chromitan lítno-sodný |
414-250-7 |
149564-66-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
611-115-00-6 |
bis{4-[4-(dietylamino)-2- oxidofenyldiazenyl]-3-oxidonaftalén-1-sulfonáto(-3-)}chromitan trilítny |
414-290-5 |
149564-65-8 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
611-116-00-1 |
reakčná zmes zložená z týchto látok: trinátrium-5-{4-[2-(2,6-dichlór-5-kyanopyrimidín-4-ylamino)propylamino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-(1-sulfonátonaftalén-2-yldiazenyl)naftalén-2,7-disulfonát; trinátrium-5-{4-[1-(2,6-dichlór-5-kyanopyrimidín-4-ylamino)propán-2-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-(1-sulfonátonaftalén-2-yldiazenyl)naftalén-2,7-disulfonát; trinátrium-5-{4-[2-(4,6-dichlór-5-kyanopyrimidín-2-ylamino)propylamino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-(1-sulfonátonaftalén-2-yldiazenyl)naftalén-2,7-disulfonát; trinátrium-5-{4-[1-(4,6-dichlór-5-kyanopyrimidín-2-ylamino)propán-2-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-(1-sulfonátonaftalén-2-yldiazenyl)naftalén-2,7-disulfonát |
414-620-8 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-117-00-7 |
lítno-sodná soľ kyseliny 4,4’-bis(1-etyl-2-hydroxy-5-karbamoyl-4-metyl-6-oxo-1H-pyridín-3-yldiazenyl)-6,6’-{(propán-1,3-diyl)bis[imino(6-fluór-1,3,5-triazín-4,2-diyl)imino]}bis(benzén-1,3-disulfónovej) |
415-100-3 |
149850-29-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-118-00-2 |
tetranátrium-4,4’-{(propán-1,2- diyl)bis[imino(6-fluór-1,3,5-triazín-4,2-diyl)imino(3-ureido-4,1-fenylén)diazéndiyl(3-sulfonáto-4,1-fenylén)diazéndiyl]}di(benzénsulfonát) |
413-990-8 |
|
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
611-119-00-8 |
tetranátrium-3-(4,5-dimetyl-2- sulfonátofenyldiazenyl)-4-hydroxy-5-[4-chlór-6-(4-metyl-2-sulfonátofenylamino)--1,3,5-triazín-2-ylamino]naftalén-2,7-disulfonát |
415-400-4 |
148878-22-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-120-00-3 |
sodná soľ kyseliny 5-(4-{5-amino-2-[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]-4-sulfofenylamino}-6-chlór-1,3,5-triazín-2-ylamino)-4-hydroxy-3-(1-sulfonaftalén-2-yldiazenyl)-naftalén-2,7-disulfónovej |
418-340-7 |
157707-94-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-121-00-9 |
reakčná zmes, ktorej hlavnou zložkou je asymetrický izomér 1-{[5-(4- metoxyfenyldiazenyl)-2-oxidofenyldiazenyl]naftalén-2-oláto}-[3- oxido-4-(2-oxidonaftalén-1-yldiazenyl)-naftalén-1-sulfonáto]chromitanu sodného |
417-280-9 |
30785-74-1 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
611-122-00-4 |
{bis[N-(3-{4-[5-(5-amino-1-fenyl-3- metylpyrazol-4-yldiazenyl)-2,4-disulfonátoanilino]-6-chlór-1,3,5-triazín-2-ylamino}fenyl)sulfamoyl]disulfonátoftalocyanináto}nikelnatan hexasodný |
417-250-5 |
151436-99-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-123-00-X |
{3-[2,4-bis(4-{5-[4,6-bis(2- aminopropylamino)-1,3,5-triazín-2-ylamino]-4-hydroxy-2,7-disulfonaftalén-3-yldiazenyl}fenylamino)-1,3,5-triazín-6-ylamino]propyl}di(etyl)amónium-laktát |
424-310-4 |
178452-66-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-124-00-5 |
reakčná zmes zložená z týchto látok: pentanátrium-4-amino-3-[5-(2,3- dibrómpropánamido)-2-sulfonátofenyldiazenyl]-5-hydroxy-6-[5-(4-chlór-6-{4-[2-(sulfonátooxy)etoxysulfonyl]fenylamino}-1,3,5-triazín-2-ylamino)-2-sulfonátofenyldiazenyl]naftalén-2,7-disulfonát; pentanátrium-4-amino-3-[5-(2-brómakrylamido)-2-sulfonátofenyldiazenyl]-5-hydroxy-6-[5-(4-chlór-6-{4-[2-(sulfonátooxy)etoxysulfonyl]fenylamino}-1,3,5-triazín-2-ylamino)-2-sulfonátofenyldiazenyl]naftalén-2,7-disulfonát; tetranátrium-4-amino-3-[5-(2,3-dibrómpropánamido)-2-sulfonátofenyldiazenyl]-5-hydroxy-6-(5-{4-chlór-6-[4-(vinylsulfonyl)fenylamino]-1,3,5-triazín-2-ylamino}-2-sulfonátofenyldiazenyl)naftalén-2,7-disulfonát |
424-320-9 |
|
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-125-00-0 |
reakčná zmes zložená z týchto látok: (6-{[3-karboxy-5-oxo-1-(4-sulfonátofenyl)-4,5-dihydropyrazol-4-yl]diazenyl}-3-{[5-metoxy-2-oxido-4-(vinylsulfonyl)fenyl]diazenyl}-4-oxidonaftalén-2-sulfonáto)meďnatan disodný; [3-({4-[(2-hydroxyetyl)sulfonyl]-5-metoxyfenyl}diazenyl)-6-{[3-karboxyláto-5-oxo-1-(4-sulfonátofenyl)-4,5-dihydropyrazol-4-yl]diazenyl}-4-oxidonaftalén-2-sulfonáto]meďnatan disodný |
423-940-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-126-00-6 |
2,4-bis(2-{[4-(4- aminoanilino)fenyl]diazenyl}-1,3-dimetyl-1H-imidazol-1,3-diium-1-yl)-6-(dimetylamino)-1,3,5-triazín-dichlorid |
424-120-1 |
174514-06-8 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
611-127-00-1 |
pentanátrium-4-amino-6-(5-{4-(2-etylfenylamino)-6-[2-(sulfonátooxy)etylsulfonyl]-1,3,5-triazín-2-ylamino}-2-sulfonátofenyldiazenyl)-5-hydroxy-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát |
423-790-2 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
G |
|
611-128-00-7 |
tetranátrium-5,5’-dihydroxy-6,6’-bis[4-(vinylsulfonyl)fenyldiazenyl]-4,4’-[N-(2-hydroxyetyl)etylénbis(imino)]bis[(6-chlór-1,3,5-triazín-4,2-diyl)imino]bis(naftalén-2,7-disulfonát) |
419-500-9 |
171599-85-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-129-00-2 |
reakčná zmes zložená z týchto látok: kyselina 5-[4-(7-amino-1-hydroxy-3-sulfo-2-naftyldiazenyl)-2,5-dietoxyfenyldiazenyl]-2-(3-fosfonofenyldiazenyl)benzoová; kyselina 5-[4-(7-amino-1-hydroxy-3-sulfo-2-naftyldiazenyl)-2,5-dietoxyfenyldiazenyl]-3-(3-fosfonofenyldiazenyl)benzoová |
418-230-9 |
163879-69-4 |
Expl. 1.3 **** Repr. 2 STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H203 H361f *** H373 ** H317 H411 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H203 H361f *** H373 ** H317 H411 |
|
|
|
|
611-130-00-8 |
tetraamónium-2-{4-hydroxy-6-[8-hydroxy-7-(2-karboxylátofenyldiazenyl)-3,6-disulfonáto-1-naftylamino]-1,3,5-triazín-2-ylamino}benzoát |
418-520-5 |
183130-96-3 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
611-131-00-3 |
N-(2-chlórfenyl)-N’-(3-metylfenyl)-3,3’-dihydroxy-4,4’-[(9-oxofluorén-2,7-diyl)bis(diazéndiyl)]di(naftalén-2-karboxamid) |
420-580-2 |
151798-26-4 |
Repr. 1B Aquatic Chronic 4 |
H360D *** H413 |
GHS08 Dgr |
H360D *** H413 |
|
|
|
|
611-132-00-9 |
bis(6-{4-[(1-butyl-5-kyano-4-metyl-2-oxido-6-oxo-1H-3-pyridyl)diazenyl]benzénsulfónamido}-3-(5-nitro-2-oxido-3-sulfonátofenyldiazenyl)-4-oxidonaftalén-2-sulfonáto)chromitan pentasodný |
419-210-2 |
178452-71-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-133-00-4 |
sodné soli železitanových komplexov diazénových farbív: diazénové farbivá sa pripravili kopuláciou zmesi diazotovaného 3-amino-4-hydroxybenzénsulfanilidu a 3-amino-4-hydroxybenzénsulfónamidu s rezorcinolom; získaná zmes sa následne podrobila druhej kopulácii so zmesou diazotovanej kyseliny 3-aminobenzénsulfónovej (kyseliny metanilovej) a kyseliny 2-(4-aminofenylamino)-5-nitrobenzénsulfónovej; potom sa pridal chlorid železitý a pripravili sa sodné soli |
419-260-5 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-134-00-X |
(2-{fenyl[2-hydroxy-3-{4-[4-(2,3-dibrómpropánamido)-2-sulfonátofenylamino]-6-chlór-1,3,5-triazín-2-ylamino}-5-sulfonátofenyldiazenyl)metylidénhydrazino}-4-sulfonátobenzoáto)meďnatan trisodný |
423-770-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-135-00-5 |
produkt reakcie kyseliny 2-[(4-amino-2-ureidofenyldiazenyl)-5-[2-(sulfooxy)etylsulfonyl]benzénsulfónovej a 2,4,6-trifluórpyrimidínom po následnej čiastočnej hydrolýze na príslušný vinylsulfonylový derivát, zmiešaná draselno-sodná soľ |
424-250-9 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-136-00-0 |
(2-amino-2-{4-(2-amóniopropylamino)-6-[4-hydroxy-3-(2-metoxy-5-metyl-4-sulfamoylfenyldiazenyl)-2-sulfonátonaftalén-7-ylamino]-1,3,5-triazín-2-ylamino}propyl)-formiát |
424-260-3 |
— |
Repr. 2 Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H318 H411 |
GHS05 GHS08 GHS09 Dgr |
H361f *** H318 H411 |
|
|
|
|
611-137-00-6 |
6-terc-butyl-7-chlór-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazol |
419-870-1 |
159038-16-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
611-138-00-1 |
2-(4-aminofenyl)-6-terc-butyl-1H-pyrazolo[1,5-b][1,2,4]triazol |
415-910-7 |
152828-25-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
611-139-00-7 |
produkt reakcie C.I. leukoformy sírovej čiernej 1 s 2-hydroxy-3-chlór-N, N,N-trimetylpropán-1-amínium-chloridom |
424-510-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
611-140-00-2 |
azafenidín (ISO); 2-[2,4-dichlór-5-(prop-2-inyloxy)fenyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridín-3(2H)-ón |
— |
68049-83-2 |
Repr. 1B STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
M = 1 000 |
|
|
611-141-00-8 |
diamónium-nátrium-hydrogen-5,5'-{[6-(morfolín-4-yl)-1,3,5-triazín-2,4-diyl]bis[(imino)(4,1-fenylén)(diazéndiyl)]}di(izoftalát) |
414-410-6 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-142-00-3 |
produkt definovaný procesom prípravy: polydiazénové farbivo získané kopuláciou hydrogen-4-amino-3-{4-[(4-diazónioanilino)sulfonyl]fenyldiazenyl}-5-hydroxynaftalén-2,7-disulfonátu s reakčnou zmesou 4-diazóniobenzoátu a 2-diazónio-5-(4-diazónioanilino)benzénsulfonátu, a následnou kopuláciou získaných zlúčenín so zmesou sodných solí 2-naftolu a 3-aminofenolu; chlorid sodný |
425-740-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-143-00-9 |
reakčná zmes zložená z týchto látok: {2-[({2-[3-(2,6-difluórpyrimidín-4-ylamino)-2-oxido-5-sulfonátofenyl)]hydrazinylidén-κN}(fenyl)metyl)diazéndiyl]-4-sulfonátobenzoáto-κO}meďnatan trisodný; {2-[({2-[3-(4,6-difluórpyrimidín-2-ylamino)-2-oxido-5-sulfonátofenyl)]hydrazinylidén-κN}(fenyl)metyl)diazéndiyl]-4-sulfonátobenzoáto-κO}meďnatan trisodný |
428-260-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-144-00-4 |
reakčná zmes zložená z týchto látok: draselno-sodná soľ kyseliny 7-amino-4-hydroxy-3,8-bis[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]naftalén-2-sulfónovej; draselno-sodná soľ kyseliny 7-amino-4-hydroxy-3-[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]-8-[4-(2-sulfoxyetylsulfonyl)-2-sulfofenyldiazenyl]naftalén-2-sulfónovej; draselno-sodná soľ kyseliny 7-amino-4- hydroxy-8-[4-(2- sulfoxyetylsulfonyl)fenyldiazenyl]-3-[4-(2- sulfoxyetylsulfonyl)-2- sulfofenyldiazenyl]naftalén-2-sulfónovej; draselno-sodná soľ kyseliny 7-amino-4- hydroxy-3,8-bis-[4-(2-sulfoxyetylsulfonyl)- 2-sulfofenyldiazenyl]naftalén-2-sulfónovej |
429-070-4 |
214362-06-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-145-00-X |
reakčná zmes zložená z týchto látok: tetranátrium-2-[1-hydroxy-6-(4-chlór-3-sulfonáto-6-{4-[2-(sulfonátoxy)etylsulfonyl]anilino}-1,3,5-triazín-2-ylamino)naftalén-2-yldiazenyl]naftalén-1,5-disulfonát; sodná soľ kyseliny 2-[1-hydroxy-6-(4-chlór-3-sulfo-6-{4-[2-(sulfoxy)etylsulfonyl]anilino}-1,3,5-triazín-2-ylamino)naftalén-2-yldiazenyl]benzén-1,4-disulfónovej |
429-440-5 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-146-00-5 |
reakčná zmes zložená z týchto látok: pentanátrium 3-[4-(4-{7-[2,4-diamino-5-sulfonáto-3-(4-sulfonátofenyldiazenyl)fenyldiazenyl]-1-hydroxy-3-sulfonátonaftalén-2-yldiazenyl}-2-sulfonátoanilino)fenyldiazenyl]-4-hydroxy-6-[1-(fenylkarbamoyl)-2-oxopropyldiazenyl]naftalén-2-sulfonát; pentanátrium-6-(2,4-diamino-5-sulfonátofenyldiazenyl)-3-(4-{4-[7-(2,4-diamino-5-sulfonátofenyldiazenyl)-1-hydroxy-3-sulfonátonaftalén-2-yldiazenyl]anilino}-2-sulfonátofenyldiazenyl)-4-hydroxynaftalén-2-sulfonát; pentanátrium-6-[2,4-diamino-5-sulfonáto-3-(4-sulfonátofenyldiazenyl)fenyldiazenyl]-3-{4-[4-(1,7-dihydroxy-3-sulfonátonaftalén-2-yldiazenyl)-2-sulfonátoanilino]fenyldiazenyl}-4-hydroxynaftalén-2-sulfonát; hexanátrium-6-(2,4-diamino-5-sulfonátofenyldiazenyl)-3-[4-(4-{7-[2,4-diamino-5-sulfonáto-3-(4-sulfonátofenyldiazenyl)fenyldiazenyl]-1-hydroxy-3-sulfonátonaftalén-2-yldiazenyl}-2-sulfonátoanilino)fenyldiazenyl]-4-hydroxynaftalén-2-sulfonát |
430-070-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-147-00-0 |
kálium-lítium-nátrium-5-amino-4-hydroxy-3,6-bis(5-{4-chlór-6-[N-metyl-2-(metylamino)acetamido]-1,3,5-triazín-2-ylamino}-2-sulfonátofenyldiazenyl)naftalén-2,7-disulfonát |
430-090-0 |
205764-96-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-148-00-6 |
reakčná zmes zložená z týchto látok: 2-[3-(2,6-dichlór-4-nitrofenyldiazenyl)karbazol-9-yl]etanol; 2-{2-[3-(2,6-dichlór-4-nitro-fenyldiazenyl)karbazol-9-yl]etoxy}etanol; 3-(2,6-dichlór-4-nitrofenyldiazenyl)karbazol |
429-590-1 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
611-149-00-1 |
O-[2-(2-chlóracetoxy)etyl]-3-{N-etyl-4-[4-(fluórsulfonyl)-2,5-dichlórfenyldiazenyl]-3-metylanilino}propanoát |
427-570-7 |
193486-83-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
611-150-00-7 |
tetralítium-2-{4-hydroxy-6-[8-hydroxy-7-(2-karboxylátofenyldiazenyl)-3,6-disulfonátonaftalén-1-ylamino]-1,3,5-triazín-2-ylamino}benzoát |
440-460-3 |
— |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
611-151-00-2 |
chryzoidín; 4-(fenyldiazenyl)benzén-1,3-diamín |
207-803-7 |
495-54-5 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H315 H410 |
|
|
|
|
611-152-00-8 |
monohydrochlorid chryzoidínu; monohydrochlorid 4-(fenyldiazenyl)fenylén-1,3-diamínu; [1] monoacetát chryzoidínu; monoacetát 4-(fenyldiazenyl)benzén-1,3-diamínu; [2] acetát chryzoidínu; soľ kyseliny octovej s 4-(fenyldiazenyl)benzén-1,3-diamínom (1:1); [3] p-dodecylbenzénsulfonát chryzoidínu; soľ kyseliny dodecylbenzénsulfónovej s 4-(fenyldiazenyl)benzén-1,3-diamínom (1:1); [4] dihydrochlorid chryzoidínu; 4-(fenyldiazenyl)benzén-1,3-diamínium-dichlorid; [5] sulfát chryzoidínu; soľ kyseliny sírovej s 4-(fenyldiazenyl)benzén-1,3-diamínom (1:2) [6] |
208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] |
532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H302 H315 H318 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H341 H302 H315 H318 H410 |
|
|
|
|
611-153-00-3 |
C10-14-alkylderiváty chryzoidínu; soľ mono-C10-14-alkylderivátov kyseliny benzénsulfónovej s 4-(fenyldiazenyl)benzén-1,3-diamínom (1:1); [1] soľ kyseliny dibutylnaftalénsulfónovej s 4-(fenyldiazenyl)benzén-1,3-diamínom (1:1) [2] |
286-946-7 [1] 304-236-8 [2] |
85407-90-5 [1] 94247-67-3 [2] |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H341 H302 H315 H318 |
GHS05 GHS08 GHS07 Dgr |
H341 H302 H315 H318 |
|
|
|
|
611-154-00-9 |
trinátrium-5-benzamido-4-hydroxy-3-(4-metyl-2-sulfonátofenyldiazenyl)naftalén-2,7-disulfonát |
403-670-6 |
92408-46-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-155-00-4 |
4,4'-oxybis(benzénsulfonylazid) |
431-850-4 |
7456-68-0 |
Expl. 1.1**** STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H373** H400 H410 |
GHS01 GHS08 GHS09 Dgr |
H201 H373** H410 |
|
|
|
|
611-156-00-X |
triamónium-4-{4-[1-hydroxy-7-(4-karboxylátoanilino)-3-sulfonátonaftalén-2-yldiazenyl]-2,5-dimetoxyfenyldiazenyl}benzoát |
432-270-4 |
221354-37-6 |
Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H361f*** H373** H411 |
GHS08 GHS09 Wng |
H361f*** H373** H411 |
|
|
|
|
611-157-00-5 |
kálium-nátrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-3-sulfonátofenyldiazenyl]benzyl}-2,3-dihydroxyfenyl)diazenyl]benzénsulfonát |
432-590-4 |
243869-48-9 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
611-158-00-0 |
produkt reakcie 1,1'-[metylénbis(4,5,6-trihydroxy-3,1-fenylén)]di(etanónu) s 6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonylchloridom a 3-diazo-6-metoxy-4-oxo-3,4-dihydronaftalén-1-sulfonylchloridom |
421-520-8 |
— |
**** Aquatic Chronic 4 |
**** H413 |
**** |
**** H413 |
|
|
|
|
611-159-00-6 |
dinátrium-4-amino-6-{4-[4-(2,4-diaminofenyldiazenyl)fenylsulfamoyl]fenyldiazenyl}-5-hydroxy-3-(4-nitrofenyldiazenyl)naftalén-2,7-disulfonát |
421-880-6 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-160-00-1 |
reakčná zmes zložená z týchto látok: [4,4',4''-(etán-1,1,1-triyl)trifenyl]-tris(3-diazo-4-oxo-3,4-dihydronaftalén-1-sulfonát); [4,4',4''-(etán-1,1,1-triyl)trifenyl]-tris(6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonát); {4,4'-[1-(6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonyloxy)etán-1,1-diyl]difenyl}-bis(3-diazo-4-oxo-3,4-dihydronaftalén-1-sulfonát); {4,4'-[1-(3-diazo-4-oxo-3,4-dihydronaftalén-1-sulfonyloxy)etán-1,1-diyl]difenyl}-bis(6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfonát) |
422-760-6 |
— |
**** Aquatic Chronic 4 |
**** H413 |
**** |
**** H413 |
|
|
|
|
611-161-00-7 |
[5-amino-3-(4-nitro-2-oxido-κO-fenyldiazenyl-κN)-4-oxido-κO-naftalén-2,7-disulfonáto]-({(Z)-[(fenylkarbamoyl)prop-1-én-1-yldiazenyl]}-5-sulfamoylbenzéndioláto-O, O,N)chromitan trisodný |
423-100-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-162-00-2 |
(N, N,N',N'-tetrametyl-2,2'-{(2,4-dihydroxy-1,3-fenylén)bis[(diazéndiyl)(2,1-fenylén)(karbonyl)(oxy)]}bis(etán-1-amínium))-bis(metánsulfonát) |
429-600-4 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
611-163-00-8 |
(N, N,N',N'-tetrametyl-2,2'-{(2,4-dihydroxy-1,3-fenylén)bis[(diazéndiyl)(2,1-fenylén)(karbonyl)(oxy)]}bis(etán-1-amínium))-sulfát |
429-610-9 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
611-164-00-3 |
reakčná zmes zložená z týchto látok: 2,2'-dimetyl-2,2'-diazéndi(butánnitril); 2-(2-kyanopropán-2-yldiazenyl)-2-metylpentánnitril; 2,2'-dimetyl-2,2'-diazéndi(heptánnitril); 2-(2-kyanopropán-2-yldiazenyl)-2-metylheptánnitril; 2-(2-kyanobután-2-yldiazenyl)-2-metylheptánnitril |
429-710-2 |
— |
Self-react. D Acute Tox. 4 * Aquatic Chronic 2 |
H242 H302 H411 |
GHS02 GHS07 GHS09 Dgr |
H242 H302 H411 |
|
|
|
|
611-165-00-9 |
reakčná zmes zložená z týchto látok: tetranátrium-4-amino-6-[5-(2,6-difluórpyrimidin-4-ylamino)-2-sulfonátofenyldiazenyl]-5-hydroxy-3-{-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát; tetranátrium-4-amino-6-[5-(4,6-difluórpyrimidin-2-ylamino)-2-sulfonátofenyldiazenyl]-5-hydroxy-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát |
431-830-5 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-166-00-4 |
reakčná zmes zložená z týchto látok: pentanátrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-6-{(E)-2-sulfonáto-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát; tetranátrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-6-[(E)-2-sulfonáto-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; tetranátrium-4-amino-5-hydroxy-6-{(E)-2-sulfonáto-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-3-[(E)-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát |
432-100-9 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-167-00-X |
{3-[4-(6-anilino-1-oxido-κO-3-sulfonátonaftalén-2-yldiazenyl)-2-metyl-5-oxido-κO-fenyldiazenyl]naftalén-1,4-sulfonáto}meďnatan sodno-bis[tris(2-hydroxyetyl)amónny] |
435-240-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-168-00-5 |
reakčná zmes zložená z týchto látok: kyselina 3-{4-[7-(1,5-disulfonaftalén-2-yldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}-5-{4-[8-hydroxy-3,6-disulfo-7-(2-sulfofenyldiazenyl)naftalén-1-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}benzoová; kyselina 3,5-bis{4-[7-(1,5-disulfonaftalén-2-yldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-chlór-1,3,5-triazín-2-ylamino}benzoová |
435-440-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-169-00-0 |
nátrium-6-hydroxy-5-(2-karboxyfenyldiazenyl)naftalén-2-sulfonát |
435-800-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-170-00-6 |
reakčná zmes zložená z týchto látok: (2-{(fenyl)[2-oxido-κO-5-(2-sulfonátoetylsulfonyl)fenyldiazenyl-κN 2]metyldiazenyl-κN 1}4-sulfonátobenzoáto-κO]meďnatan trisodný; (2-{(fenyl)[2-oxido-κO-5-(vinylsulfonyl)fenyldiazenyl-κN 2]metyldiazenyl-κN 1}-4- sulfonátobenzoáto-κO)meďnatan disodný |
435-880-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
611-171-00-1 |
reakčná zmes zložená z týchto látok: trinátrium-3-[5-(2,6-difluórpyrimidin-4-ylamino)-2-sulfonátofenyldiazenyl]5-[4-fluór-6-(morfolín-4-yl)-1,3,5-triazín-2-ylamino]-4-hydroxynaftalén-2,7-disulfonát; trinátrium-3-[5-(4,6-difluórpyrimidin-2-ylamino)-2-sulfonátofenyldiazenyl]-5-[4-fluór-6-(morfolín-4-yl)-1,3,5-triazín-2-ylamino]-4-hydroxynaftalén-2,7-disulfonát |
436-890-6 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-172-00-7 |
reakčná zmes zložená z týchto látok: triamónium-6-amino-3-[2,5-dietoxy-4-(3-fosfonátofenyldiazenyl)fenyldiazenyl]-4-hydroxynaftalén-2-sulfonát; diamónium-3-[4-(7-amino-1-hydroxy-3-sulfonátonaftalén-2-yldiazenyl)-2,5-dietoxyfenyldiazenyl]benzoát |
438-310-7 |
— |
Self-react. C**** Repr. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H242 H361f*** H302 H373** H412 |
GHS02 GHS08 GHS07 Dgr |
H242 H361f*** H302 H373** H412 |
|
|
|
|
611-173-00-2 |
reakčná zmes zložená z týchto látok: trinátrium-3-[6-hydroxy-5-(5-{4-chlór-6-[4-(2-sulfonátooxyetylsulfonyl)anilino]-1,3,5-triazín-2-ylamino}-2-sulfonátofenyldiazenyl)-3-karbamoyl-4-metyl-2-oxo-1,2-dihydropyridín-1-yl]propanoát, trisodná soľ; dinátrium-3-[6-hydroxy-5-(5-{4-chlór-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazín-2-ylamino}-2-sulfonátofenyldiazenyl)-3-karbamoyl-4-metyl-2-oxo-1,2-dihydropyridín-1-yl]propanoát, disodná soľ |
440-510-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-174-00-8 |
reakčná zmes zložená z týchto látok: sodná soľ kyseliny 5-{4-[-4-(3-amino-5-hydroxy-2,7-disulfonaftalén-4-yldiazenyl)-3-sulfoanilino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-{2-sulfo-5-[4-(vinylsulfonyl)butánamido]fenyldiazenyl}naftalén-2,7-disulfónovej; sodná soľ kyseliny 5-{4-[-4-(3-amino-5-hydroxy-2,7-disulfonaftalén-4-yldiazenyl)-3-sulfoanilino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-{5-[4-(2-chlóretylsulfonyl)butánamido]-2-sulfofenyldiazenyl}naftalén-2,7-disulfónovej |
442-290-5 |
457624-86-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
611-175-00-3 |
reakčná zmes zložená z týchto látok: trinátrium-5-(4-{N-etyl-[3-(2-sulfonátooxy)etylsulfonyl]anilino}-6-chlór-1,3,5-triazín-2-ylamino)-4-hydroxy-3-[4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; trinátrium-5-{-4-[N-etyl-3-(vinylsulfonyl)anilino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát; dinátrium-5-{-4-[N-etyl-3-(vinylsulfonyl)anilino]-6-chlór-1,3,5-triazín-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; tetranátrium-5-(-4-{N-etyl-3-[2-(sulfonátooxy)etylsulfonyl]anilino}-6-chlór-1,3,5-triazín-2-ylamino)-4-hydroxy-3-{4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát |
444-050-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
611-176-00-9 |
ester 4,4'-(5-metyl-2-hydroxy-1,3-fenylén)bis(benzén-1,2,3-triolu) s kyselinou 6-diazo-5-oxo-5,6-dihydronaftalén-1-sulfónovou |
444-250-2 |
— |
Self-react. C**** Aquatic Chronic 2 |
H242 H411 |
GHS02 GHS09 Dgr |
H242 H411 |
|
|
|
|
611-177-00-4 |
reakčná zmes zložená z týchto látok: bis[7-anilino-4-oxido-κO-3-(2-oxido-κO-5-sulfonátofenyldiazenyl)naftalén-2-sulfonáto]kobaltitan pentasodný; [7-anilino-4-oxido-κO-3-(2-oxido-κO-5-sulfonátofenyldiazenyl)naftalén-2-sulfonáto]-[7-anilino-4-oxido-κO-3-(2-oxido-κO-5-sulfamoylfenyldiazenyl)naftalén-2-sulfonáto]kobaltitan tetrasodný; bis[7-anilino-4-oxido-κO-3-(2-oxido-κO-5-sulfamoylfenyldiazenyl)naftalén-2-sulfonáto]kobaltitan trisodný |
444-290-0 |
508202-43-5 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
611-178-00-X |
reakčná zmes zložená z týchto látok: pentanátrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-6-{(E)-2-sulfonáto-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}naftalén-2,7-disulfonát; tetranátrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-6-[(E)-2-sulfonáto-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; tetranátrium-4-amino-5-hydroxy-6-{(E)-2-sulfonáto-4-[2-(sulfonátooxy)etylsulfonyl]fenyldiazenyl}-3-[(E)-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; trinátrium-4-amino-5-hydroxy-6-[(E)-2-sulfonáto-4-(vinylsulfonyl)fenyldiazenyl]-3-[(E)-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; trinátrium-4-amino-5-hydroxy-3-[(2-hydroxyetylsulfonyl)fenyldiazenyl]-6-[(E)-2-sulfonáto-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát; trinátrium-4-amino-5-hydroxy-6-[-2-sulfonáto-4-(2-hydroxyetylsulfonyl)fenyldiazenyl]-3-[(E)-4-(vinylsulfonyl)fenyldiazenyl]naftalén-2,7-disulfonát |
445-280-9 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
611-179-00-5 |
reakčná zmes zložená z týchto látok: pentanátrium-2-(1-hydroxy-8-{4-chlór-6-[4-(2-sulfonátoetylsulfonyl)]anilino]-1,3,5-triazín-2-ylamino}-3,6-disulfonátonaftalén-2-yldiazenyl)naftalén-1,5-disulfonát; tetranátrium-2-(1-hydroxy-8-{4-chlór-6-[4-(vinylsulfonyl)anilino]1,3,5-triazín-2-ylamino}-3,6-disulfonátonaftalén-2-yldiazenyl)naftalén-1,5-disulfonát |
450-010-8 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
611-180-00-0 |
komplexy železa s diazotovaným 4-aminobenzénsulfónamidom, diazotovanou kyselinou 3-aminobenzénsulfónovou, diazotovaným 3-amino-4-hydroxybenzénsulfónamidom, diazotovaným 3-amino-N-fenyl-4-hydroxybenzénsulfónamidom, diazotovanou kyselinou 5-amino-2-anilinobenzénsulfónovou a rezorcinolom, sodné soli |
417-850-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
612-001-00-9 |
metylamín; [1] dimetylamín; [2] trimetylamín [3] |
200-820-0 [1] 204-697-4 [2] 200-875-0 [3] |
74-89-5 [1] 124-40-3 [2] 75-50-3 [3] |
Flam. Gas 1 Press. Gas Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H220 H332 H335 H315 H318 |
GHS02 GHS04 GHS05 GHS07 Dgr |
H220 H332 H335 H315 H318 |
|
* Skin Irrit. 2; H315: C ≥ 5% Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5% STOT SE 3; H335: C ≥ 5% |
U5 |
|
612-001-01-6 |
metylamín ... %; [1] dimetylamín ... %; [2] trimetylamín ... % [3] |
200-820-0 [1] 204-697-4 [2] 200-875-0 [3] |
74-89-5 [1] 124-40-3 [2] 75-50-3 [3] |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H224 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H224 H332 H302 H314 |
|
* STOT SE 3; H335: C ≥ 5 % |
B |
|
612-002-00-4 |
etylamín |
200-834-7 |
75-04-7 |
Flam. Gas 1 Press. Gas Eye Irrit. 2 STOT SE 3 |
H220 H319 H335 |
GHS02 GHS04 GHS07 Dgr |
H220 H319 H335 |
|
|
U |
|
612-003-00-X |
dietylamín |
203-716-3 |
109-89-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1% |
|
|
612-004-00-5 |
trietylamín |
204-469-4 |
121-44-8 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1% |
|
|
612-005-00-0 |
butylamín |
203-699-2 |
109-73-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
|
|
612-006-00-6 |
etyléndiamín; etán-1,2-diamín |
203-468-6 |
107-15-3 |
|||||||